data_1ytp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ytp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.49 ' HG2' HH11 ' A' ' 2' ' ' ARG . 2.2 ptp85 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.962 0.411 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 mt -134.85 130.53 52.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.28 114.98 27.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.6 t -166.49 -158.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.563 0.22 . . . . 0.0 110.463 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -155.17 167.65 29.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.26 -43.54 61.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 34.4 t -69.17 -45.4 70.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.11 55.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.55 142.9 48.06 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.019 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -67.15 135.06 52.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 23.5 tptp -55.44 131.56 46.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.7 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.36 -34.43 4.84 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.647 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.0 t -71.42 123.36 22.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.451 ' HG3' ' HE1' ' A' ' 17' ' ' PHE . 2.7 ptpp? -101.79 115.23 30.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.637 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 62.4 m-85 -92.47 135.93 33.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.3 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.9 m-85 -120.45 159.43 25.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -91.9 168.77 11.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.909 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -64.4 -31.75 73.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.547 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.15 -19.23 64.28 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.192 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.92 -4.04 52.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.659 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -89.4 148.25 23.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 21.0 t80 -70.56 128.49 36.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.809 HG12 HD12 ' A' ' 45' ' ' ILE . 79.6 t -90.54 -65.73 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.207 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.7 p -178.57 154.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.789 0.328 . . . . 0.0 111.186 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -92.92 153.38 18.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.47 123.51 31.0 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.072 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 11.3 pt-20 -90.3 26.51 1.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.779 0.323 . . . . 0.0 111.439 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -78.2 64.17 3.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.794 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 3.3 t70 -67.15 128.23 93.73 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.298 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.64 -19.56 59.94 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.946 2.431 . . . . 0.0 113.327 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.557 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 7.7 tpm_? -70.51 -37.64 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.34 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -116.68 133.29 23.05 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 0.0 111.195 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.26 126.6 17.38 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.345 2.03 . . . . 0.0 111.338 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -159.09 146.43 17.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.958 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.476 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -168.77 122.78 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.559 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 m -128.93 51.86 8.15 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.29 40.65 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.439 2.092 . . . . 0.0 111.384 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 38' ' ' PRO . 1.6 mpp_? -132.07 32.24 4.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.912 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -174.43 152.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.954 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.41 125.65 17.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.761 ' HB2' HG12 ' A' ' 45' ' ' ILE . 73.8 m-20 -78.64 126.66 82.33 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.19 -29.3 74.9 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 123.438 2.758 . . . . 0.0 113.448 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 18' ' ' SER . 1.2 ptm85 -88.22 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.275 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.809 HD12 HG12 ' A' ' 24' ' ' VAL . 28.7 mm -79.21 94.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.25 -45.43 9.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.806 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -157.63 159.92 37.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.683 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -137.74 131.81 5.63 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.034 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.39 93.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 93.4 m -88.74 139.55 29.46 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.4 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.69 136.46 39.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.578 2.185 . . . . 0.0 112.231 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.9 -33.62 39.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.97 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.613 179.728 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.539 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 121.055 0.455 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tt -160.18 127.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.304 0.573 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.76 130.41 45.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.699 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.785 HG21 HG22 ' A' ' 45' ' ' ILE . 10.1 t -175.93 -148.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.484 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.468 ' HA ' HG13 ' A' ' 45' ' ' ILE . 17.0 p30 -154.62 164.96 37.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 m -48.99 -49.28 41.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 50.0 t -63.33 -43.58 97.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.053 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.49 29.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.913 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.64 144.79 15.86 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.2 m -63.1 121.92 14.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.679 0.276 . . . . 0.0 110.38 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 57.3 mtmt -54.07 130.55 38.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.891 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.83 -39.7 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -72.8 121.81 20.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 24.0 ttmm -93.11 120.88 33.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.542 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 77.0 m-85 -95.86 142.49 28.05 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.344 0.592 . . . . 0.0 111.933 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.562 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 11.3 m-85 -130.33 162.83 28.17 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.1 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.91 162.02 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.835 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.423 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.17 -32.15 73.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.75 -2.36 11.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.565 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 23' ' ' PHE . 89.8 m -88.23 146.96 25.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.51 0.671 . . . . 0.0 111.162 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 5.0 t80 -73.15 131.86 42.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.708 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.509 HG13 HD12 ' A' ' 45' ' ' ILE . 68.0 t -103.98 -67.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.375 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.3 p -179.11 147.19 0.33 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.685 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 pm0 -87.91 167.11 14.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.47 125.4 23.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.732 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -122.08 49.32 1.59 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.495 0.664 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 18.3 m -75.99 52.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.816 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 20.3 t70 61.42 130.37 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 123.836 0.855 . . . . 0.0 112.133 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.19 -40.08 78.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.21 1.94 . . . . 0.0 112.533 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 31.4 ttm-85 -66.4 -53.39 36.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB3' ' O ' ' A' ' 32' ' ' ARG . 9.5 p30 142.86 -36.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 125.088 1.355 . . . . 0.0 114.294 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' OD2' ' A' ' 30' ' ' ASP . 16.7 Cg_exo -69.79 68.71 1.7 Allowed 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.52 2.147 . . . . 0.0 115.173 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 29' ' ' SER . 58.7 tttm -160.82 129.66 4.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.848 0.356 . . . . 0.0 110.414 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -162.41 142.33 9.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.54 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -127.97 72.15 78.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.713 0.292 . . . . 0.0 111.514 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.32 39.86 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.086 2.524 . . . . 0.0 112.012 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HD3' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -70.26 -35.79 74.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 45.5 t30 178.14 152.16 0.28 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.745 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.6 125.96 32.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -79.84 131.11 64.74 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.799 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.61 -22.6 67.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.837 2.358 . . . . 0.0 111.027 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.65 -35.42 80.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.403 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.785 HG22 HG21 ' A' ' 5' ' ' THR . 23.4 mm -84.45 94.48 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.67 12.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.3 p90 -158.51 161.71 37.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.647 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.65 136.18 7.0 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.111 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -96.5 123.96 49.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.76 0.314 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 72.7 m -103.1 126.62 31.85 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.295 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.3 Cg_exo -71.88 121.39 7.57 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.596 2.197 . . . . 0.0 111.624 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.4 -37.13 10.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.33 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.857 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.772 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 13.0 ptm180 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.741 0.305 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.437 HD12 HG23 ' A' ' 3' ' ' ILE . 6.6 tt -148.92 133.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.048 0.451 . . . . 0.0 110.72 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.78 129.7 42.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 t -178.03 -154.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.404 ' HA ' HG13 ' A' ' 45' ' ' ILE . 21.1 p30 -148.33 172.2 14.78 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -52.97 -51.66 60.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.686 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -61.3 -46.78 88.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.502 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.19 29.5 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.588 . . . . 0.0 111.032 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.98 143.93 15.77 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.635 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -60.83 128.82 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.611 0.205 . . . . 0.0 110.901 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -50.06 128.55 19.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.979 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.47 -33.82 4.02 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.833 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.23 118.11 11.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -94.27 119.4 33.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.351 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.63 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 57.6 m-85 -93.67 139.82 30.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 111.323 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.574 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -124.27 160.86 27.03 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.723 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 167.82 17.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.985 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -61.09 -30.69 70.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.311 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -66.72 -26.71 67.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.273 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.56 2.08 25.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.159 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -88.1 145.4 25.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.468 . . . . 0.0 110.532 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 23.8 t80 -73.0 124.36 25.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 45' ' ' ILE . 73.7 t -92.98 -63.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.166 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.8 p -177.18 149.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.633 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 pt-20 -94.46 158.04 15.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.38 122.35 29.81 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.557 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.686 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 14.4 pt-20 -109.67 29.99 7.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.4 m -60.57 136.84 58.18 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t70 64.92 71.2 0.56 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.783 0.801 . . . . 0.0 110.142 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 2.0 Cg_endo -81.7 -5.17 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.741 2.294 . . . . 0.0 109.659 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 5.1 tpp85 76.33 -37.53 0.3 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 113.965 -1.471 . . . . 0.0 110.491 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.482 ' OD1' ' HB2' ' A' ' 31' ' ' PRO . 9.1 p-10 -85.84 149.86 51.82 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.56 119.36 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.276 1.984 . . . . 0.0 112.186 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -160.32 132.68 6.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.906 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 135.29 38.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.0 m -88.67 140.49 29.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.554 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.0 Cg_exo -62.73 134.6 47.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.87 2.38 . . . . 0.0 111.689 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.421 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 1.0 OUTLIER -90.11 46.11 1.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.101 0.477 . . . . 0.0 110.649 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.91 146.76 19.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.58 134.09 34.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 17.7 m-20 -78.96 127.54 79.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.059 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.91 -23.58 68.2 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.55 2.167 . . . . 0.0 110.901 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.574 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 10.6 ptp85 -70.39 -26.6 63.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.818 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 24' ' ' VAL . 23.5 mm -83.96 98.42 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.412 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.2 -42.08 11.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.694 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 4.2 p90 -157.38 174.03 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.085 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -150.14 134.43 4.81 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.687 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.9 mm -90.75 104.31 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.51 122.7 66.89 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.87 138.04 27.99 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.63 2.22 . . . . 0.0 112.265 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.64 -22.87 37.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.263 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.609 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 30.0 ttm180 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 47' ' ' TYR . 6.8 tt -144.24 137.27 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.876 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.99 127.86 35.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.672 HG21 HG21 ' A' ' 45' ' ' ILE . 12.4 t -178.52 -158.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.649 ' HA ' HG13 ' A' ' 45' ' ' ILE . 18.8 p30 -155.21 -173.42 4.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 m -62.37 -50.94 69.58 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.1 t -65.14 -48.87 72.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.743 0.306 . . . . 0.0 111.661 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.93 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.381 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.02 144.97 49.4 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -66.13 126.08 27.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.651 0.262 . . . . 0.0 110.745 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 86.7 tttt -53.79 131.79 40.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.43 -40.9 2.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.74 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.2 m -73.9 123.88 25.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 67.5 mttm -89.76 123.63 33.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 25.9 m-85 -96.89 134.92 39.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.785 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.577 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.2 m-85 -126.54 167.08 16.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.111 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.57 156.69 16.95 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.7 -26.43 67.13 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.546 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.26 -34.29 74.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.422 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.18 -5.25 8.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 m -89.29 146.43 24.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 111.694 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.7 t80 -76.5 130.96 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.566 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.779 HG13 HD13 ' A' ' 45' ' ' ILE . 95.0 t -99.11 -67.46 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.4 p -176.71 143.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.773 0.32 . . . . 0.0 110.434 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . 3.8 pt-20 -91.08 162.5 14.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.9 116.88 8.37 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.979 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.77 24.58 7.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.503 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 p -77.09 54.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.469 0.652 . . . . 0.0 111.354 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.12 117.33 60.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.729 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.18 32.49 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.382 2.722 . . . . 0.0 113.732 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -80.53 -22.68 40.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.531 0.682 . . . . 0.0 109.731 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -165.26 148.69 7.2 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.919 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.39 137.73 71.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.554 2.169 . . . . 0.0 111.369 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -150.81 136.89 18.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.79 0.329 . . . . 0.0 110.532 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.85 119.82 30.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.019 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.7 m -88.89 138.97 29.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 37.6 Cg_exo -57.5 128.45 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.616 2.211 . . . . 0.0 112.006 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -70.75 -20.78 62.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.479 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -71.85 132.46 44.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.941 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.25 123.18 30.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -79.61 121.25 82.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.417 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.97 -16.08 51.2 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.863 2.375 . . . . 0.0 110.237 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -67.44 -30.21 69.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.696 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.779 HD13 HG13 ' A' ' 24' ' ' VAL . 14.7 mm -88.62 112.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.34 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.43 -40.82 8.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.707 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.1 p90 -158.74 174.3 15.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.674 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.71 133.97 5.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.796 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.78 122.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.875 0.369 . . . . 0.0 110.579 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.2 m -92.56 136.64 25.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.142 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 27.8 Cg_exo -62.04 137.16 65.21 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.887 2.391 . . . . 0.0 112.167 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.1 151.48 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.3 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.904 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.591 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 42.8 ptt85 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 47' ' ' TYR . 10.1 tt -78.35 133.88 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.504 0.669 . . . . 0.0 110.965 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.07 112.58 24.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.55 HG23 HG22 ' A' ' 45' ' ' ILE . 15.3 t -178.19 -163.11 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.702 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -160.24 164.54 32.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 63.2 m -52.13 -40.58 61.56 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HA ' ' CD ' ' A' ' 28' ' ' GLU . 24.8 t -58.5 -47.25 84.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.288 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.82 -16.82 49.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.6 133.54 41.41 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.049 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 31' ' ' PRO . 22.9 m -67.81 130.83 44.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.706 -0.247 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -61.95 97.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.277 0.56 . . . . 0.0 110.341 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.81 -39.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 84.8 m -73.1 119.24 17.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 49.7 mttp -88.95 112.29 23.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.134 0.492 . . . . 0.0 111.466 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.57 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 71.6 m-85 -93.72 132.58 37.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.14 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -120.96 152.22 38.79 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.253 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.401 ' N ' HG21 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -81.82 165.47 20.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.12 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -59.08 -30.43 68.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.547 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -67.37 -28.36 67.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.65 2.19 22.71 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.088 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 23' ' ' PHE . 25.2 m -88.52 146.42 25.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 0.0 110.524 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' N ' HG21 ' A' ' 22' ' ' THR . 24.5 t80 -72.77 127.04 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.598 HG13 ' SG ' ' A' ' 25' ' ' CYS . 52.1 t -93.16 -60.31 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.598 ' SG ' HG13 ' A' ' 24' ' ' VAL . 24.3 p -176.33 148.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 17.1 pt-20 -99.55 42.23 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.175 0.512 . . . . 0.0 111.079 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.13 -175.79 41.79 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.016 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG3' ' N ' ' A' ' 29' ' ' SER . 7.2 pt-20 -148.56 -42.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 50.3 m -77.28 139.65 39.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 1.004 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 16.7 t70 -61.79 144.11 93.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.146 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 89.3 Cg_exo -44.54 -26.33 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.529 2.819 . . . . 0.0 114.631 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.93 40.56 1.66 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 1.004 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 4.3 p-10 -94.12 146.61 31.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.824 0.345 . . . . 0.0 110.663 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 66.41 4.19 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.828 2.352 . . . . 0.0 112.481 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -136.92 128.81 29.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.421 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -123.68 138.92 54.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.522 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 39.1 m -130.61 62.49 65.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 3.1 Cg_exo -79.47 40.28 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.95 2.434 . . . . 0.0 111.821 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 51.1 ttp85 -67.12 -57.89 5.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 6.0 t-20 173.18 154.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.682 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.38 125.31 29.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 64.7 m-20 -77.66 123.33 86.59 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 2' ' ' ARG . 31.1 Cg_exo -61.17 -24.89 79.99 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.841 2.36 . . . . 0.0 110.751 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -64.63 -28.38 69.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.231 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.55 HG22 HG23 ' A' ' 5' ' ' THR . 30.9 mm -79.78 102.76 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.202 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.591 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -89.4 -51.18 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.461 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' ILE . 29.7 p90 -155.97 153.24 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.977 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -131.31 129.19 5.63 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.696 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.61 119.81 47.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -97.16 128.17 36.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.35 137.04 16.41 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.619 2.213 . . . . 0.0 112.162 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.416 ' N ' HD21 ' A' ' 52' ' ' LEU . 2.7 pt? -160.2 146.42 15.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.147 -179.693 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.808 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 39.9 ptt180 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tt -77.51 124.52 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 0.0 110.692 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.72 122.57 32.95 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.742 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.732 HG22 HG22 ' A' ' 45' ' ' ILE . 14.6 t -178.2 -158.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.008 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -153.02 177.17 11.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.58 -40.88 79.97 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.977 0.418 . . . . 0.0 111.437 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.27 -47.85 77.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.878 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.45 33.58 1.78 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.08 -129.11 5.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.311 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.548 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 14.8 m -153.56 127.51 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 29' ' ' SER . 24.1 tptm -48.63 127.16 13.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.818 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.71 -39.63 3.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.197 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.7 m -66.68 118.43 10.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.06 0.43 . . . . 0.0 110.467 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.905 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 19.6 mmmt -89.12 116.0 27.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.666 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.0 m-85 -86.93 134.42 33.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.22 0.533 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.486 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.5 m-85 -123.7 161.03 25.95 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.072 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.68 157.06 18.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -30.78 63.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.726 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -63.61 -29.67 70.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.336 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.29 0.37 16.4 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.263 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -88.66 147.03 24.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.052 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.401 ' CE1' ' HE3' ' A' ' 15' ' ' LYS . 23.3 t80 -76.06 132.94 40.41 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.759 HG11 HD12 ' A' ' 45' ' ' ILE . 98.6 t -103.32 -68.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 25.7 p -179.66 146.05 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.662 0.268 . . . . 0.0 111.541 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.905 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 3.8 pm0 -84.03 159.29 21.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.06 125.02 11.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.151 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.03 0.2 56.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.538 0.209 . . . . 0.0 111.347 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.654 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 1.3 m -61.94 109.31 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.69 138.78 24.99 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.29 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.57 -24.08 12.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.3 -23.48 67.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -147.55 133.73 9.68 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.219 0.533 . . . . 0.0 111.248 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.35 60.23 4.85 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 113.012 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.36 127.29 33.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.908 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -159.99 124.92 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 m -135.74 58.05 22.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.05 43.7 1.56 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.832 2.354 . . . . 0.0 111.69 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -97.02 -33.11 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -153.65 140.52 19.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.05 141.66 28.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.284 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -77.97 125.18 85.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.69 0.281 . . . . 0.0 110.832 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.88 47.58 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.488 2.792 . . . . 0.0 111.71 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.441 ' HD2' HG12 ' A' ' 24' ' ' VAL . 28.4 ptt180 -156.53 -30.8 0.09 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.492 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.759 HD12 HG11 ' A' ' 24' ' ' VAL . 31.2 mm -65.68 110.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.505 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.808 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -109.61 -41.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.475 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.2 p90 -159.72 147.59 17.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 111.594 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -112.5 125.27 7.04 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.821 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.1 115.42 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.827 0.346 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 60.4 m -94.52 124.95 53.63 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.0 Cg_exo -70.63 137.89 33.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.071 2.514 . . . . 0.0 112.219 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.55 53.77 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.221 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.17 0.919 . . . . 0.0 110.492 -178.922 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . 57.9 mtm180 . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tt -79.06 136.49 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.01 112.71 22.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.435 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.67 HG21 HG21 ' A' ' 45' ' ' ILE . 11.6 t -179.77 -166.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.849 ' HA ' HG13 ' A' ' 45' ' ' ILE . 12.9 p30 -161.97 -156.46 0.43 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.7 0.286 . . . . 0.0 110.927 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.451 ' H ' ' HB2' ' A' ' 6' ' ' ASN . 1.2 m -70.38 -48.66 55.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.351 0.596 . . . . 0.0 109.721 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.2 t -58.28 -52.59 64.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.32 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.78 -28.74 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.783 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.91 143.23 48.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.659 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -63.15 125.78 25.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.563 0.22 . . . . 0.0 110.919 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -55.93 117.95 4.16 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.618 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.27 -43.53 1.53 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.4 m -74.17 126.83 31.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.633 ' HG3' ' HB3' ' A' ' 26' ' ' GLU . 1.9 mptp? -89.37 125.3 35.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.53 0.205 . . . . 0.0 110.527 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.637 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 12.6 m-85 -99.14 133.82 42.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.517 0.675 . . . . 0.0 110.964 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -122.5 163.66 19.5 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.559 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 161.62 19.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.107 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.457 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 1.2 p30 -58.8 -28.81 66.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.813 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -64.95 -29.71 70.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.166 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.42 -0.09 18.51 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.321 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -88.57 144.85 26.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.031 0.443 . . . . 0.0 111.019 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.5 t80 -75.48 128.68 35.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.1 t -101.15 -60.55 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.487 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.8 p -177.84 150.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.633 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -96.01 166.22 11.88 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.962 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.97 140.04 45.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 16.9 pt-20 -121.15 20.47 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.89 0.376 . . . . 0.0 110.704 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -81.28 58.84 3.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.82 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 27.1 t70 -72.46 131.96 84.23 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.859 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.12 -26.01 48.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.583 2.855 . . . . 0.0 113.364 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttt85 -55.56 -39.98 71.34 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.714 0.292 . . . . 0.0 111.344 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.38 109.46 1.1 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 121.568 0.699 . . . . 0.0 111.795 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.85 146.69 23.67 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.983 2.455 . . . . 0.0 111.674 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -127.56 148.07 50.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.4 130.7 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.6 m -88.83 126.57 59.09 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.908 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 -57.02 0.96 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.828 2.352 . . . . 0.0 113.276 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 15.0 mmp_? -98.86 -38.3 9.09 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.959 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 t30 63.32 31.41 15.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.965 0.888 . . . . 0.0 110.317 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.82 110.54 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.279 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.5 ' CG ' ' HB3' ' A' ' 6' ' ' ASN . 24.2 m-20 -110.3 127.66 26.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.36 -29.23 67.01 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.489 2.793 . . . . 0.0 113.775 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 ptt85 -78.03 -20.56 52.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.849 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.9 mm -79.23 114.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 2' ' ' ARG . . . -105.06 -40.78 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.764 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.497 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.4 p90 -160.0 155.74 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -123.78 130.78 7.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.917 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.25 120.75 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.913 0.387 . . . . 0.0 110.586 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.94 126.98 55.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.145 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.22 136.82 27.5 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.557 2.171 . . . . 0.0 112.28 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.01 26.7 9.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.783 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.633 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 14.9 ptm180 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.997 0.427 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.469 HG21 ' HA ' ' A' ' 47' ' ' TYR . 10.4 tt -79.4 137.02 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.104 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.02 116.81 27.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.55 HG21 HG22 ' A' ' 45' ' ' ILE . 12.5 t -176.95 -172.96 0.44 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.7 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.1 p-10 -161.41 -168.57 2.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.438 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 57.8 m -59.76 -50.09 75.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' ALA . 41.8 t -70.58 -43.09 70.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.65 76.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.012 0.435 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.96 -179.45 45.83 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.44 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.4 m -110.8 133.35 53.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.36 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 1.096 ' HG3' ' HB3' ' A' ' 30' ' ' ASP . 2.7 mmmt -53.84 127.36 25.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.374 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.93 -39.97 2.56 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 48.4 t -72.24 129.74 39.14 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 71.4 mmtt -88.66 103.54 16.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.687 0.28 . . . . 0.0 111.513 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 78.9 m-85 -92.2 129.2 38.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 110.833 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -121.07 154.12 36.52 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.768 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.415 ' HB3' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -84.46 162.8 19.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.566 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' HB3' ' A' ' 46' ' ' ALA . 8.3 p-10 -62.02 -28.43 69.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.295 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.231 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 -3.7 11.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.187 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -90.15 148.72 22.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.09 0.471 . . . . 0.0 111.252 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.87 126.63 30.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.629 HG12 HD11 ' A' ' 45' ' ' ILE . 71.5 t -91.92 -59.32 3.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 p -175.13 154.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.067 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 9.7 pt-20 -96.7 39.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.108 0.48 . . . . 0.0 110.268 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.48 148.81 2.68 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG2' ' C ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -122.54 23.64 9.53 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.891 -0.77 . . . . 0.0 111.428 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.78 50.48 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.38 0.61 . . . . 0.0 110.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 1.096 ' HB3' ' HG3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -174.96 -55.36 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.492 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 43.7 Cg_endo -69.49 116.96 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 120.932 1.088 . . . . 0.0 110.84 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 31' ' ' PRO . 18.7 ttp-105 86.33 -37.35 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.692 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -171.78 126.45 0.58 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.307 0.575 . . . . 0.0 111.885 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.35 62.72 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.778 2.318 . . . . 0.0 111.784 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -130.63 139.11 50.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.858 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -102.71 137.89 40.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.524 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 67.7 m -89.15 108.4 23.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.858 0.361 . . . . 0.0 111.056 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 87.3 Cg_endo -88.16 30.65 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.869 2.379 . . . . 0.0 112.424 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -174.61 50.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 109.937 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -161.8 137.87 7.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -157.67 136.29 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.592 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.1 m-20 -82.35 125.17 77.21 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.711 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.89 -21.01 69.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.361 2.04 . . . . 0.0 109.721 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 24' ' ' VAL . 6.4 ttp180 -71.64 -34.18 69.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.12 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.7 HG13 ' HA ' ' A' ' 6' ' ' ASN . 31.1 mm -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.153 0.501 . . . . 0.0 111.566 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HB3' ' N ' ' A' ' 19' ' ' ASP . . . -115.48 -44.17 2.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.497 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.469 ' HA ' HG21 ' A' ' 3' ' ' ILE . 21.3 p90 -157.89 156.28 31.08 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.241 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -130.44 124.38 4.25 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.729 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -87.32 94.52 4.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 84.5 m -89.17 118.93 69.64 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.143 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 6.9 Cg_exo -73.65 134.55 20.45 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.008 2.472 . . . . 0.0 112.14 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 53' ' ' ALA . 7.0 mp -95.26 -143.32 0.26 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.161 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.422 ' H ' ' HB3' ' A' ' 52' ' ' LEU . . . . . . . . 0 C--O 1.247 0.953 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.176 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tt -78.3 130.43 36.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.791 0.805 . . . . 0.0 112.132 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.61 123.57 36.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.272 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.498 ' OG1' ' HB1' ' A' ' 9' ' ' ALA . 14.9 t -176.11 -165.71 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -145.36 178.15 8.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 m -54.25 -39.65 67.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.57 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 11.7 t -63.07 -55.93 21.27 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.897 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' OG1' ' A' ' 5' ' ' THR . . . -84.03 29.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.349 0.595 . . . . 0.0 111.286 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.69 145.15 17.6 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.433 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 m -71.72 127.56 32.97 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.74 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 22.5 ttmm -50.28 131.57 24.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 111.341 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.33 -39.25 3.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.142 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.588 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 48.8 t -66.13 122.12 16.71 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.12 117.06 32.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.076 0.465 . . . . 0.0 111.127 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.759 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 37.3 m-85 -86.06 140.33 30.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.898 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -124.83 158.02 34.44 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.674 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.667 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 1.1 p -86.45 161.83 18.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.537 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 11.3 p-10 -65.32 -28.61 69.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.03 -27.48 68.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.823 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.19 -2.93 20.71 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.411 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 23' ' ' PHE . 4.2 m -87.85 154.28 20.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.429 0.633 . . . . 0.0 111.002 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.533 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 24.2 t80 -75.77 128.81 35.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.762 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 44' ' ' ARG . 53.6 t -90.13 -67.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.439 ' SG ' HG12 ' A' ' 24' ' ' VAL . 27.3 p 177.07 148.63 0.13 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.542 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -90.13 144.88 25.48 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.74 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.81 143.36 46.58 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.815 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.57 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.0 OUTLIER -107.26 -18.77 13.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -63.84 129.36 39.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.082 0.468 . . . . 0.0 111.06 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.715 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 36.9 t70 -73.32 127.29 89.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.544 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.11 58.14 3.44 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.025 2.483 . . . . 0.0 111.527 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.422 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 23.5 ttm105 -150.39 -41.05 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.459 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 14.1 p-10 -133.29 135.17 24.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.018 0.437 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 16.9 Cg_exo -68.08 129.72 20.04 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.858 2.372 . . . . 0.0 112.265 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HZ2' ' CD ' ' A' ' 28' ' ' GLU . 27.6 ttpp -117.11 136.9 52.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.963 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.46 120.36 10.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.3 m -150.44 145.47 18.57 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.632 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 128.45 24.35 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.448 2.099 . . . . 0.0 111.809 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -86.03 46.74 1.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.789 0.804 . . . . 0.0 109.883 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.91 124.08 40.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.119 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB1' ' N ' ' A' ' 5' ' ' THR . . . -88.26 139.25 30.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.532 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.64 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 2.0 p30 -78.17 150.86 77.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.786 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.69 61.08 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.631 2.887 . . . . 0.0 112.047 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.667 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 19.2 ttp180 -171.2 -31.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.046 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 5' ' ' THR . 31.9 mm -59.0 112.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.605 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -105.03 -47.07 4.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.429 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -166.41 -169.14 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.403 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.759 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -149.51 132.47 4.05 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.936 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.45 97.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m -90.13 126.21 57.77 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 11.8 Cg_exo -70.57 133.25 23.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.799 2.333 . . . . 0.0 112.048 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.2 mm? -84.86 138.56 32.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.261 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.465 HH12 ' CG ' ' A' ' 19' ' ' ASP . 38.9 mtp85 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.8 tt -77.9 136.69 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.115 0.483 . . . . 0.0 110.009 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.34 106.07 17.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.214 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.663 HG23 HG21 ' A' ' 45' ' ' ILE . 13.3 t 179.37 -168.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.771 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.655 ' HA ' HG13 ' A' ' 45' ' ' ILE . 3.2 p-10 -161.2 -161.42 0.81 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.9 m -67.24 -45.84 75.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -64.93 -52.33 56.97 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.11 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 111.473 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.97 137.73 41.39 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.958 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 22.0 m -61.71 129.39 40.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.624 0.25 . . . . 0.0 110.616 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 39.9 tttp -53.25 130.27 34.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.803 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.44 -37.96 3.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.618 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 t -70.42 125.85 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 8.5 mmmt -94.65 116.89 29.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.262 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.634 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 39.4 m-85 -93.65 134.44 35.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -123.77 162.42 23.22 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.542 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.47 159.44 18.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.414 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.465 ' CG ' HH12 ' A' ' 2' ' ' ARG . 15.1 p-10 -59.46 -27.64 66.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.729 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -65.89 -27.6 68.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.933 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.29 -0.69 20.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.294 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.7 m -88.71 146.29 25.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.238 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.75 126.85 31.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.79 HG11 HD11 ' A' ' 45' ' ' ILE . 91.4 t -93.91 -63.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.306 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.4 p -177.76 149.39 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.182 0.515 . . . . 0.0 111.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.657 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 2.0 pt-20 -90.15 149.06 22.6 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.746 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.45 121.82 25.76 Favored Glycine 0 C--O 1.236 0.224 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.893 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 13.0 pt-20 -94.83 11.28 32.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.0 m -50.82 137.88 19.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.681 0.277 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -166.41 133.38 2.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.44 -5.9 17.12 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.881 2.387 . . . . 0.0 113.11 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.401 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.46 -33.61 69.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.7 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -151.65 146.4 18.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 84.95 0.17 Allowed 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.928 2.419 . . . . 0.0 113.19 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.71 60.42 3.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.462 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -77.12 106.04 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.073 0.463 . . . . 0.0 110.422 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.49 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 73.9 m -129.56 58.44 37.66 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 7.4 Cg_exo -72.41 -33.12 9.25 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.349 2.033 . . . . 0.0 112.06 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -98.69 46.0 1.0 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.375 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -150.45 121.21 7.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.933 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.66 128.8 12.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.842 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.7 m-20 -87.46 125.65 64.8 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.16 -18.73 64.55 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.247 1.965 . . . . 0.0 110.844 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 44' ' ' ARG . 1.0 OUTLIER -69.58 -34.35 74.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.376 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.79 HD11 HG11 ' A' ' 24' ' ' VAL . 38.9 mm -66.76 107.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.586 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB3' ' N ' ' A' ' 19' ' ' ASP . . . -105.48 -40.94 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 9.0 p90 -154.71 150.59 27.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -117.59 127.21 7.26 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.439 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.7 mt -93.09 100.14 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.21 127.97 53.29 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.81 140.55 51.21 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.737 2.292 . . . . 0.0 112.317 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -160.22 133.07 6.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.735 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.969 0 O-C-N 124.106 0.878 . . . . 0.0 110.696 -179.072 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.647 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 21.5 mmm-85 . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.13 129.99 36.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.604 0.716 . . . . 0.0 110.918 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.56 129.77 35.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 t -176.59 -160.45 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -153.59 166.17 33.6 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -51.61 -44.01 62.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.641 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 t -60.99 -49.65 76.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 111.449 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.99 -29.45 65.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.78 131.9 40.41 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.616 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 m -59.63 126.47 27.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.291 0.236 . . . . 0.0 110.926 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 48.6 tptt -58.83 120.43 9.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.919 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.86 -40.75 2.01 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 59.1 m -71.2 126.47 29.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 13.3 ptpt -88.3 110.84 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.221 0.534 . . . . 0.0 111.218 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.57 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 31.8 m-85 -93.95 129.09 40.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -113.28 151.65 30.83 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.807 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.457 ' N ' HG21 ' A' ' 24' ' ' VAL . 2.3 p -79.96 167.55 20.34 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.701 0.625 . . . . 0.0 111.351 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 12.4 p-10 -62.98 -29.23 70.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.28 -30.75 70.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.708 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.89 -9.74 10.4 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 114.014 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 23' ' ' PHE . 8.0 m -87.91 151.13 23.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.254 0.549 . . . . 0.0 111.525 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.439 ' N ' HG22 ' A' ' 22' ' ' THR . 24.9 t80 -68.2 126.78 30.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.743 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG11 ' SG ' ' A' ' 25' ' ' CYS . 39.1 t -94.77 -56.38 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' HG11 ' A' ' 24' ' ' VAL . 24.7 p -176.35 145.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.271 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -89.9 39.97 0.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.702 0.763 . . . . 0.0 110.076 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.69 172.62 16.43 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.379 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.641 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 15.3 pt-20 -157.04 27.45 0.31 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 p -79.06 66.97 4.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.49 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 41.0 t0 -61.57 119.57 48.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 15.2 Cg_exo -68.44 -19.35 43.25 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.714 2.276 . . . . 0.0 111.302 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -36.55 65.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.33 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.0 p30 -136.19 127.26 16.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 2.6 Cg_exo -76.2 90.23 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.985 2.457 . . . . 0.0 112.199 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -78.59 136.69 37.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.88 115.54 9.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 110.484 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -89.37 137.32 29.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.715 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.24 140.24 93.56 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.938 2.425 . . . . 0.0 112.071 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -83.49 43.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -159.46 146.8 17.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.86 30.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.11 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -78.06 118.78 74.32 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.527 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.06 -18.45 63.64 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.905 2.403 . . . . 0.0 110.638 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 18' ' ' SER . 20.0 ttp-105 -70.94 -32.49 69.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.906 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 mm -64.67 119.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.823 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.647 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -94.88 -52.62 4.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.498 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -166.69 157.69 12.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.253 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -126.86 115.98 2.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.59 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 46.9 mm -90.18 117.41 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.3 m -89.33 121.3 69.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.0 Cg_exo -76.59 130.37 11.65 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.006 2.47 . . . . 0.0 112.545 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.3 mm? -84.61 -21.65 30.26 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.836 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.434 179.545 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.826 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 17.7 ptp180 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.661 0.267 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -77.05 135.0 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 0.0 110.998 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.11 100.85 13.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.194 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -177.4 -173.21 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.638 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -160.54 -173.66 4.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.34 -45.7 92.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.676 0.275 . . . . 0.0 111.502 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 12.0 t -57.25 -42.07 80.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.945 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.72 -82.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . 31.97 -138.35 0.08 OUTLIER Glycine 0 C--N 1.337 0.588 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.753 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 98.6 m -165.46 126.7 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 46.6 mmtt -49.15 135.27 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 111.975 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.45 -43.52 2.78 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 32.8 t -71.82 116.22 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 0.0 109.823 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.687 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 38.0 mttp -99.07 119.97 38.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.039 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.735 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 35.6 m-85 -92.61 136.09 33.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.429 0.633 . . . . 0.0 111.556 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -119.61 158.14 26.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.941 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.18 162.03 21.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.653 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.468 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 9.7 p-10 -61.27 -26.69 67.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.621 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -66.59 -29.56 69.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.859 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.94 -0.89 17.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.388 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 m -88.86 146.17 25.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.068 0.461 . . . . 0.0 111.305 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.3 t80 -73.77 126.93 31.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.514 HG11 ' SG ' ' A' ' 25' ' ' CYS . 79.1 t -96.76 -63.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.952 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.514 ' SG ' HG11 ' A' ' 24' ' ' VAL . 25.8 p 179.52 155.15 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.62 0.248 . . . . 0.0 111.033 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.687 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 11.7 pt-20 -96.85 147.53 23.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.753 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -64.03 136.19 40.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.472 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' HA ' ' CE ' ' A' ' 12' ' ' LYS . 11.7 pt-20 -95.17 -3.64 47.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m 70.83 116.76 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.437 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.536 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.8 t70 -53.9 -57.6 17.02 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.628 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 89.9 Cg_endo -78.01 43.3 1.35 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.709 1.606 . . . . 0.0 112.299 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -163.66 31.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.541 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.0 p30 -161.15 149.94 13.26 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 3.9 Cg_exo -77.14 51.18 3.37 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.034 2.489 . . . . 0.0 113.794 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 9.9 mtmp? -157.98 126.65 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.294 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.47 117.21 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.572 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 88.9 m -141.55 51.82 2.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.865 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 17.3 Cg_exo -66.77 -25.0 46.46 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.349 2.033 . . . . 0.0 112.409 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -133.74 39.5 3.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.45 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -94.58 139.33 31.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.24 133.16 14.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.181 0.515 . . . . 0.0 112.191 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.3 m-20 -99.04 126.45 38.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.861 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.56 -29.34 88.67 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.773 2.315 . . . . 0.0 111.793 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.401 ' CG ' ' HB3' ' A' ' 42' ' ' ASP . 19.9 ptt180 -66.36 -27.63 68.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.468 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.638 HG13 ' HA ' ' A' ' 6' ' ' ASN . 42.4 mm -70.11 110.56 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.928 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.826 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -103.89 -46.71 4.41 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.168 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.4 p90 -150.06 143.27 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.904 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -113.29 130.01 9.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.752 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.7 94.31 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 71.5 m -89.44 132.76 36.28 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.281 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 18.1 Cg_exo -66.75 136.77 43.23 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.869 2.379 . . . . 0.0 112.009 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.81 -34.09 39.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.198 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.875 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.792 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.762 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 2.7 ptm180 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.999 0.428 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 3' ' ' ILE . 5.1 tt -156.37 134.46 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.216 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.82 128.11 36.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.872 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.529 ' OG1' ' HB1' ' A' ' 9' ' ' ALA . 12.5 t -177.11 -156.43 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -153.13 177.59 10.65 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 m -55.87 -39.75 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 31.8 t -70.58 -52.79 19.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.529 ' HB1' ' OG1' ' A' ' 5' ' ' THR . . . -74.02 -25.79 60.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.764 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.72 141.04 46.95 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.408 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -62.14 130.3 44.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.715 0.293 . . . . 0.0 111.424 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 21.5 tptm -54.44 123.48 13.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.829 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.605 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 106.66 -35.69 4.88 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -74.36 126.94 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.573 0.225 . . . . 0.0 110.479 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -90.81 119.82 31.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.49 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 90.3 m-85 -99.15 134.5 41.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.347 0.594 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.607 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.4 m-85 -121.72 160.41 24.59 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.758 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -82.68 169.09 16.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.308 178.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -60.25 -30.7 69.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.454 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -67.48 -28.54 67.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.481 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.32 1.28 23.48 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.075 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -88.16 144.49 26.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.537 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -72.57 126.73 30.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.069 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.65 HG12 ' HD2' ' A' ' 44' ' ' ARG . 70.6 t -96.61 -62.27 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 p -176.46 151.22 0.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.7 pt-20 -95.31 156.83 16.16 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.86 127.65 36.41 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.05 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.574 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.5 pp20? -114.39 29.34 8.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -75.78 54.66 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.767 0.794 . . . . 0.0 110.491 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -73.65 129.0 86.08 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.003 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.88 -21.58 41.46 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.227 2.618 . . . . 0.0 113.086 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -67.19 -31.07 71.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.634 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -103.0 132.42 21.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.58 64.85 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.936 2.424 . . . . 0.0 113.144 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -125.51 141.89 51.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.982 0.42 . . . . 0.0 110.956 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -150.65 128.36 11.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.327 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . 62.5 m -127.67 65.36 67.06 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.539 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 15.9 Cg_exo -67.89 -25.8 38.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.567 2.178 . . . . 0.0 112.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -115.2 52.79 0.85 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.317 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.707 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 20.9 t-20 -158.7 132.38 7.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -159.06 136.51 9.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 10.4 m-20 -84.57 127.28 66.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.72 -23.78 77.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.051 2.501 . . . . 0.0 112.741 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.65 ' HD2' HG12 ' A' ' 24' ' ' VAL . 4.5 ptp85 -79.62 -16.28 56.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.386 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 6' ' ' ASN . 21.8 mm -75.52 102.11 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.42 -39.64 10.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.762 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 3.1 p90 -157.42 166.21 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.461 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.93 136.11 6.65 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.573 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.7 mt -100.28 122.31 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.749 0.309 . . . . 0.0 110.552 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -101.03 133.22 21.14 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.08 138.73 37.46 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.644 2.229 . . . . 0.0 112.514 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -125.03 21.56 8.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.218 0.532 . . . . 0.0 110.261 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.54 179.82 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.545 ' H ' ' HD2' ' A' ' 2' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.286 0.565 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 tt -78.59 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.084 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.19 101.13 13.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.967 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.75 HG22 HG23 ' A' ' 45' ' ' ILE . 12.2 t -176.52 -161.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.731 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.3 p30 -160.02 -159.44 0.72 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.559 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 18.3 m -67.57 -54.99 15.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.529 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 49.7 t -70.23 -43.08 71.36 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.207 -0.308 . . . . 0.0 111.596 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.487 ' HB2' ' OG1' ' A' ' 5' ' ' THR . . . -69.05 -23.48 64.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.968 0.413 . . . . 0.0 110.839 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.84 147.92 47.27 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.267 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.553 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 m -59.58 126.29 27.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 0.0 111.085 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.946 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 34.5 ttpt -54.76 132.77 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.247 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 -37.64 3.36 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.878 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.553 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 35.8 m -70.27 126.99 31.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.79 ' HE3' ' HB3' ' A' ' 26' ' ' GLU . 2.5 mtpt -91.24 114.8 27.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.651 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.6 m-85 -89.66 135.85 33.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.353 0.597 . . . . 0.0 111.566 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.447 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.3 m-85 -125.9 160.4 30.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.9 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -83.79 163.83 19.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.889 178.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.4 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 26.7 p-10 -62.46 -28.51 69.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.458 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -66.91 -28.49 68.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.925 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.65 1.89 19.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -88.16 147.41 24.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.101 0.476 . . . . 0.0 111.031 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -75.21 133.39 41.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.096 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.714 HG12 HD12 ' A' ' 45' ' ' ILE . 86.3 t -105.08 -68.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.2 p -176.42 147.55 0.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.79 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 3.1 pm0 -85.87 156.55 20.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.837 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -64.5 119.97 17.44 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.712 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -102.63 34.04 2.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -79.72 71.31 6.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.229 0.538 . . . . 0.0 110.908 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.946 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 9.8 t70 -146.66 -59.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 30' ' ' ASP . 31.6 Cg_endo -64.46 -39.14 29.92 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.783 1.656 . . . . 0.0 112.869 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 58.03 37.83 26.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.745 0.783 . . . . 0.0 109.893 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -72.09 161.07 80.81 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.872 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.21 92.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.683 2.255 . . . . 0.0 111.766 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 2.5 tmmm? -160.85 134.22 6.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.935 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 39' ' ' ARG . . . -67.39 103.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.159 0.504 . . . . 0.0 111.85 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.6 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 83.7 m -89.83 -55.91 0.28 Allowed Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.797 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 97.5 Cg_endo -83.28 39.86 0.87 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.03 1.82 . . . . 0.0 111.975 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 34.5 ptt85 -69.32 -46.08 67.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.045 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 176.42 171.44 0.43 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.41 129.81 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -82.71 122.3 78.31 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.1 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.03 -27.46 79.53 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.01 2.473 . . . . 0.0 112.007 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.524 ' HD2' HG13 ' A' ' 24' ' ' VAL . 11.8 ptt-85 -68.35 -25.41 65.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.184 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 5' ' ' THR . 37.8 mm -79.95 94.87 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' HA ' ' CB ' ' A' ' 2' ' ' ARG . . . -89.87 -43.35 10.67 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.5 p90 -159.97 157.26 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.101 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.651 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -125.49 125.82 5.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.055 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.7 mt -86.62 111.97 22.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.838 0.352 . . . . 0.0 110.167 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.38 133.54 28.23 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.4 57.85 5.56 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.864 2.376 . . . . 0.0 112.198 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.34 137.06 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.91 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 9.0 tpt180 . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.442 0.639 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.44 ' H ' HG21 ' A' ' 3' ' ' ILE . 5.7 tt -78.1 124.49 36.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.15 127.06 40.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 45' ' ' ILE . 12.9 t -176.97 -155.74 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -146.08 178.58 8.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.523 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 26.9 m -56.19 -42.13 76.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.642 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 43.0 t -72.07 -49.52 35.86 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.84 29.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.337 0.589 . . . . 0.0 111.089 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 8' ' ' CYS . . . -104.94 145.58 15.95 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.19 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -59.65 126.72 28.7 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.883 0.341 . . . . 0.0 110.694 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 84.5 tttt -54.93 128.87 35.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 -39.77 2.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.894 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.5 124.11 26.61 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -100.37 126.57 46.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.029 0.443 . . . . 0.0 110.0 179.235 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.577 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 14.7 m-85 -89.04 137.7 32.08 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.173 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.548 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.0 m-85 -122.51 160.56 25.34 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 157.44 19.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.043 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.412 ' N ' ' HB1' ' A' ' 46' ' ' ALA . 18.7 p-10 -61.35 -29.05 69.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.34 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.32 -32.67 73.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.493 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.19 -2.15 9.73 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.853 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.51 HG21 ' N ' ' A' ' 23' ' ' PHE . 58.1 m -89.02 148.05 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.443 0.64 . . . . 0.0 111.559 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.712 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 18.8 t80 -76.92 131.56 38.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.925 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 16' ' ' TYR . 93.1 t -99.86 -68.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.867 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 p 178.72 148.88 0.21 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.831 0.348 . . . . 0.0 111.572 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.928 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 pm0 -87.02 152.67 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -67.67 121.58 15.11 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.614 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.642 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -89.36 41.19 1.02 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 111.526 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.9 m -77.81 53.1 1.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.722 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 9.1 t70 -93.46 -55.42 0.24 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.33 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 23.5 Cg_exo -63.9 111.11 1.46 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.764 1.643 . . . . 0.0 111.168 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -62.45 -20.84 64.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.349 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -68.91 133.48 90.15 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 110.546 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.3 132.53 27.83 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.657 2.238 . . . . 0.0 112.726 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.0 143.52 33.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.03 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.88 116.95 4.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.239 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.788 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 99.9 m -145.54 -47.6 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.312 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.788 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 58.3 Cg_endo -71.03 48.39 0.86 Allowed 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.216 1.944 . . . . 0.0 112.891 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -85.47 -26.65 26.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.94 174.87 7.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.677 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.25 140.6 52.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.717 0.294 . . . . 0.0 110.678 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.412 ' HB2' HG12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -78.72 125.2 84.66 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.559 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.54 -27.73 85.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.875 2.383 . . . . 0.0 111.569 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -66.87 -28.86 68.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.275 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 45' ' ' ILE . 23.3 mm -70.41 102.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.223 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -99.15 -42.35 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.563 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.1 p90 -156.92 151.52 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.816 0.341 . . . . 0.0 111.422 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.23 123.7 7.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 49' ' ' ILE . 49.2 mm -93.36 111.91 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.378 . . . . 0.0 110.26 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.6 m -94.59 136.49 23.11 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.83 141.91 50.6 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.667 2.245 . . . . 0.0 111.929 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -157.7 -44.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.281 -1.342 . . . . 0.0 108.661 179.196 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 mmm180 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.785 0.326 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 47' ' ' TYR . 7.1 tt -145.75 128.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.231 0.538 . . . . 0.0 109.851 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.01 117.12 29.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.979 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t 179.52 -159.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.604 ' HA ' HG13 ' A' ' 45' ' ' ILE . 16.5 p30 -145.61 -167.61 2.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.615 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m -67.17 -56.27 10.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.869 0.366 . . . . 0.0 111.409 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.453 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 3.7 t -58.25 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.1 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.91 24.17 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.651 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.13 -122.77 4.61 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.128 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.8 m -151.47 136.14 17.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 36.5 tttp -53.95 127.91 28.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.241 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.55 -30.74 3.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.246 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.44 122.31 14.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.754 ' HD3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 mmtm -92.67 113.56 25.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 69.2 m-85 -95.98 133.27 40.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 110.911 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.526 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -128.4 164.9 21.69 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.381 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.83 156.28 18.15 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.486 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 30.7 p-10 -62.99 -23.82 67.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.627 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.4 -33.57 75.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.02 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.22 -4.17 8.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.031 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.8 m -89.44 146.78 24.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.207 0.527 . . . . 0.0 111.545 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -77.31 129.24 35.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.416 ' CG1' HD13 ' A' ' 45' ' ' ILE . 92.9 t -95.66 -63.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.6 p -178.25 163.41 1.65 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.564 0.221 . . . . 0.0 110.517 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.754 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -110.23 153.33 24.95 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -68.16 115.96 7.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.528 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.7 pm0 -90.88 33.43 0.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -69.87 54.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.518 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.404 ' N ' ' HD3' ' A' ' 31' ' ' PRO . 52.7 t0 -179.13 62.34 0.13 Allowed Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.674 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' ASN . 88.9 Cg_endo -89.2 -8.56 4.68 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.62 2.213 . . . . 0.0 112.106 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 75.64 -39.4 0.38 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.843 0.857 . . . . 0.0 110.534 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' PRO . 9.1 p-10 -90.65 151.39 43.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.19 125.61 19.02 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.269 1.979 . . . . 0.0 111.895 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HE2' ' SG ' ' A' ' 8' ' ' CYS . 86.5 tttt -147.94 128.02 13.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.36 122.53 30.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.544 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -92.28 129.29 41.71 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.478 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.99 131.93 37.15 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.561 2.174 . . . . 0.0 111.641 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -79.91 -19.78 47.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.843 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.31 132.66 49.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.77 132.98 35.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -78.9 123.65 85.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.918 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.66 -25.39 78.87 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.887 2.391 . . . . 0.0 111.726 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -71.89 -27.67 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.424 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.604 HG13 ' HA ' ' A' ' 6' ' ' ASN . 25.4 mm -79.1 105.59 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.828 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.41 -42.12 7.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.372 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.0 p90 -155.16 163.11 40.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.79 131.73 4.75 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.377 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -86.88 94.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.3 m -91.04 134.01 30.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.053 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.5 Cg_exo -71.97 63.88 3.29 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.347 2.698 . . . . 0.0 112.443 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -80.48 -35.8 34.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.521 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.332 -1.318 . . . . 0.0 108.849 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.589 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 56.5 ttm-85 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 47' ' ' TYR . 13.1 tt -78.36 140.39 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.799 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.47 101.56 14.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.032 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 9' ' ' ALA . 13.7 t -179.1 -171.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.822 ' HA ' HG13 ' A' ' 45' ' ' ILE . 23.2 p30 -161.44 -155.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.33 -52.29 23.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.799 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 52.6 t -64.86 -41.76 95.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.899 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.468 ' HB3' ' OG1' ' A' ' 5' ' ' THR . . . -77.66 -23.65 49.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.23 148.35 50.03 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.784 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -75.14 141.11 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.761 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 29' ' ' SER . 45.7 mtmt -50.36 137.26 18.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.896 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.75 -36.52 3.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.816 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.96 120.41 14.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.705 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 47.7 mttp -98.03 122.12 40.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.537 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.8 m-85 -100.98 133.87 44.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.534 0.683 . . . . 0.0 111.256 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.531 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -121.85 162.65 20.56 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.249 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.44 159.26 19.39 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.261 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.462 ' N ' ' HB1' ' A' ' 46' ' ' ALA . 4.9 p-10 -59.53 -27.41 66.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.408 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.56 -34.86 78.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.11 -5.4 8.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.881 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 23' ' ' PHE . 31.3 m -89.39 146.59 24.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.154 0.502 . . . . 0.0 111.537 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.474 ' N ' HG23 ' A' ' 22' ' ' THR . 22.9 t80 -74.11 126.66 31.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.627 HG12 HD13 ' A' ' 45' ' ' ILE . 98.3 t -94.61 -61.37 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.468 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 p -179.17 153.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.705 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 6.4 pt-20 -96.94 160.94 14.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.148 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.1 136.22 34.99 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 113.882 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.461 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 9.1 pt-20 -118.66 15.89 13.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.724 -0.238 . . . . 0.0 111.408 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 44.7 m -58.38 123.49 16.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.281 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 31.7 t0 67.05 64.78 0.73 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 121.542 0.686 . . . . 0.0 110.715 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -88.72 41.58 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.554 2.169 . . . . 0.0 110.953 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 66.28 35.79 5.72 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.019 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.528 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 18.3 p30 -169.57 160.37 7.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.923 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 33' ' ' ASN . 37.0 Cg_endo -65.96 71.63 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.092 2.528 . . . . 0.0 114.657 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 31.6 mtpt -134.58 127.38 31.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.884 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.429 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -171.35 137.99 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.849 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 64.2 m -128.76 62.69 62.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 2.8 Cg_exo -75.83 44.87 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.894 2.396 . . . . 0.0 112.456 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -171.44 44.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.659 0.742 . . . . 0.0 109.081 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -159.17 142.65 14.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.029 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.78 26.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 m-20 -96.3 128.42 36.75 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 -26.41 82.7 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.806 2.337 . . . . 0.0 111.744 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 mtm-85 -68.07 -34.07 75.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.822 HG13 ' HA ' ' A' ' 6' ' ' ASN . 46.3 mm -72.15 114.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -107.89 -39.79 5.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.833 0.349 . . . . 0.0 110.591 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.6 p90 -154.73 155.12 33.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.401 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -138.81 135.02 7.11 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.642 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -91.46 102.96 14.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.28 120.9 66.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.315 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.12 136.99 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.563 2.176 . . . . 0.0 112.236 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.08 137.34 33.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.345 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.419 -1.277 . . . . 0.0 109.235 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.791 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 20.0 ptp180 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 47' ' ' TYR . 6.1 tt -77.52 128.49 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.484 0.659 . . . . 0.0 110.754 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.29 121.45 31.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.211 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t 179.9 -162.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -158.1 -174.38 4.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.427 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 4.5 m -59.99 -53.82 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.536 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 39.7 t -65.97 -42.57 89.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . . . -71.39 -30.5 66.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.9 146.49 50.39 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.3 m -66.08 133.19 50.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.532 0.205 . . . . 0.0 111.096 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 38.1 ttpt -52.55 135.46 34.13 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.17 -36.2 3.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.169 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.539 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 20.8 t -70.43 118.71 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 67.1 mttm -91.75 116.14 28.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.61 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 59.9 m-85 -94.53 132.91 38.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.079 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.8 m-85 -120.82 159.85 24.6 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.276 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.63 160.69 19.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.326 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -61.09 -27.14 68.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.434 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -64.4 -33.52 76.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.313 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.2 -4.53 9.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.91 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.485 HG21 ' N ' ' A' ' 23' ' ' PHE . 42.1 m -89.04 148.3 23.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.0 111.461 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.485 ' N ' HG21 ' A' ' 22' ' ' THR . 21.1 t80 -74.34 124.74 27.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.692 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.649 HG13 ' HD2' ' A' ' 44' ' ' ARG . 78.2 t -90.47 -64.23 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 p 179.98 150.7 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.265 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.549 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.6 pt-20 -97.69 155.39 17.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.155 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.9 138.33 48.98 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.219 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 13.0 pt-20 -119.78 14.17 12.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.929 0.395 . . . . 0.0 111.013 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 33.4 p -77.6 137.67 38.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.023 0.439 . . . . 0.0 111.81 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.581 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 9.9 t70 -156.85 133.77 6.51 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.38 -18.98 48.79 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.295 2.663 . . . . 0.0 113.55 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.08 -40.27 84.74 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.649 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 9.0 p30 -173.16 -41.23 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.508 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' A' ' 33' ' ' ASN . 56.7 Cg_endo -73.45 89.51 0.95 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 121.34 1.36 . . . . 0.0 111.491 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.79 143.27 36.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.683 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.64 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -53.78 143.93 19.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.759 0.662 . . . . 0.0 111.676 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.6 m -108.86 78.12 0.9 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.445 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 1.3 Cg_endo -84.15 41.19 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.024 2.482 . . . . 0.0 111.924 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -77.7 -32.45 52.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.81 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -163.05 152.81 15.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.48 132.77 44.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.762 0.315 . . . . 0.0 110.811 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.489 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 66.4 m-20 -79.28 121.12 82.61 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.409 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.63 -25.45 79.16 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.803 2.335 . . . . 0.0 111.553 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.649 ' HD2' HG13 ' A' ' 24' ' ' VAL . 33.0 ptt180 -67.23 -29.57 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.189 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 HD12 HG12 ' A' ' 24' ' ' VAL . 34.9 mm -72.55 112.22 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.64 0.257 . . . . 0.0 110.689 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.791 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -105.89 -43.4 4.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.77 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.3 p90 -156.1 150.19 25.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.866 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -128.58 130.42 6.54 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.252 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 49' ' ' ILE . 3.7 mp -88.97 100.74 11.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 82.8 m -89.94 125.7 59.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.039 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 7.4 Cg_exo -73.12 65.01 4.26 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.304 2.669 . . . . 0.0 112.591 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pp -156.92 32.63 0.3 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.493 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.815 179.579 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -78.71 141.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.218 0.532 . . . . 0.0 110.56 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.41 90.93 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.481 HG23 ' CE2' ' A' ' 16' ' ' TYR . 14.8 t -173.23 -171.96 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.073 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.767 ' HA ' HG13 ' A' ' 45' ' ' ILE . 2.3 p-10 -160.91 -164.96 1.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.259 -0.177 . . . . 0.0 110.612 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.523 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 59.1 m -59.59 -37.77 79.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.635 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 3.9 t -80.71 -59.18 2.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.407 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.94 -16.66 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.444 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -59.37 147.88 41.74 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.27 -0.491 . . . . 0.0 113.027 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -68.48 129.49 40.09 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.696 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 49.7 tttm -55.15 125.23 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.398 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.36 -38.47 3.14 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.0 m -72.04 121.89 19.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 68.2 mttm -89.8 121.3 31.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 48.9 m-85 -94.77 134.68 37.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.144 0.497 . . . . 0.0 110.829 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.7 m-85 -119.35 161.85 19.78 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.705 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.34 161.13 18.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.408 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.429 ' N ' ' HB3' ' A' ' 46' ' ' ALA . 1.6 p30 -57.17 -29.39 63.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.657 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.28 -33.69 76.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.34 -5.1 9.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.815 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 23' ' ' PHE . 48.9 m -88.39 148.04 24.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.528 . . . . 0.0 111.162 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.5 t80 -71.34 130.01 40.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.047 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.722 HG11 HD12 ' A' ' 45' ' ' ILE . 73.2 t -97.1 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.819 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 24' ' ' VAL . 25.5 p -178.95 153.22 0.62 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -97.66 147.68 24.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.696 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -70.77 138.12 28.05 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.375 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 8.1 pt-20 -89.75 -6.35 56.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 87.1 p 67.68 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.67 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.619 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 38.3 t0 -56.14 -56.04 35.35 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.646 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 84.8 Cg_endo -77.44 40.47 0.84 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.018 1.812 . . . . 0.0 113.676 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.9 tpt85 -106.61 -32.35 8.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.955 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 16.8 p30 -148.72 158.37 39.88 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.05 62.68 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.248 2.632 . . . . 0.0 112.722 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -153.7 112.65 3.71 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.4 124.27 19.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.369 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -88.53 -43.93 0.46 Allowed Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.9 46.63 0.53 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.577 2.184 . . . . 0.0 113.607 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.03 -34.24 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.851 0.358 . . . . 0.0 110.417 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -167.5 145.92 4.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.62 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.711 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.605 ' OD1' ' HB2' ' A' ' 6' ' ' ASN . 4.2 m-20 -78.1 122.04 84.81 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.12 -32.77 71.26 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.318 2.679 . . . . 0.0 113.551 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.483 ' NE ' HG12 ' A' ' 24' ' ' VAL . 25.3 ptt-85 -70.16 -17.54 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.767 HG13 ' HA ' ' A' ' 6' ' ' ASN . 30.4 mm -69.82 107.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' N ' ' A' ' 19' ' ' ASP . . . -103.15 -49.41 3.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.22 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.3 p90 -150.79 149.13 29.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.898 0.38 . . . . 0.0 111.249 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.657 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -118.23 134.25 10.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.114 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 49' ' ' ILE . 47.8 mm -110.2 120.45 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.878 0.37 . . . . 0.0 110.449 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.6 m -91.95 125.77 55.82 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.2 Cg_exo -68.29 126.38 14.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.734 2.289 . . . . 0.0 112.041 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.87 -35.44 14.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.342 -1.313 . . . . 0.0 108.568 179.778 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 . . . . . 0 N--CA 1.458 -0.07 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tt -142.12 131.36 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.312 0.577 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.65 124.4 35.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.698 HG22 HG21 ' A' ' 45' ' ' ILE . 12.5 t -179.24 -158.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . 0.827 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.8 p30 -151.58 -168.09 2.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 m -65.81 -58.84 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -62.87 -44.72 95.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.768 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.02 -11.68 60.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.2 145.23 35.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.48 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 14.9 m -67.23 137.0 55.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.552 0.215 . . . . 0.0 110.931 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.741 ' HZ2' ' HB2' ' A' ' 30' ' ' ASP . 59.0 mttm -49.23 133.27 19.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.716 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.2 -37.36 3.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.276 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.48 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 59.3 m -65.68 112.59 3.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.591 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 62.2 mttm -89.64 116.78 28.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.513 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 76.8 m-85 -94.46 135.64 35.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.454 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -120.53 161.54 21.13 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.749 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 1.8 p -80.74 164.5 22.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.275 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -60.82 -28.56 68.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.72 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.03 -33.88 76.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.938 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.25 -9.22 7.43 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.652 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 23' ' ' PHE . 23.3 m -86.6 146.0 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.378 0.609 . . . . 0.0 111.31 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -69.86 127.62 33.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.555 HG13 HD12 ' A' ' 45' ' ' ILE . 71.9 t -96.96 -61.2 2.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.3 p -178.16 148.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.446 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.591 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.5 pt-20 -94.17 159.85 14.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.336 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.31 127.69 45.52 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.196 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.719 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 5.5 pt-20 -126.49 35.41 4.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.589 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 22.9 m -63.11 102.66 0.4 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.741 ' HB2' ' HZ2' ' A' ' 12' ' ' LYS . 47.8 t0 -170.68 123.64 0.59 Allowed Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.936 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 9.7 Cg_exo -71.43 -6.42 19.12 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -58.19 -43.41 87.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.03 144.05 27.19 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.499 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.22 65.83 2.06 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.206 2.604 . . . . 0.0 113.532 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -140.89 132.0 26.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.36 139.29 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.224 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 8' ' ' CYS . 96.3 m -88.35 116.1 65.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 110.854 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 2.8 Cg_exo -75.62 137.59 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.12 2.546 . . . . 0.0 111.764 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -73.84 -28.88 61.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -67.64 139.22 56.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.209 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.51 142.54 37.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.677 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 22.5 m-20 -78.82 129.87 72.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.207 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 7.5 Cg_exo -71.92 56.23 2.4 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.6 2.867 . . . . 0.0 110.574 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 18' ' ' SER . 33.3 ptt180 -167.11 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.5 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.827 HG13 ' HA ' ' A' ' 6' ' ' ASN . 33.2 mm -73.62 102.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.418 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.86 -40.49 8.49 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.576 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.0 p90 -159.28 159.58 34.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.846 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.98 134.05 5.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.568 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 49' ' ' ILE . 4.4 mp -96.35 126.56 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 72.8 m -95.6 143.53 26.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo -75.73 52.94 3.48 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.994 2.463 . . . . 0.0 111.814 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -161.92 -42.18 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.406 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.34 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.91 179.566 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.584 ' OD1' ' HG2' ' A' ' 2' ' ' ARG . 10.5 t70 . . . . . 0 C--O 1.234 0.252 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.584 ' HG2' ' OD1' ' A' ' 1' ' ' ASP . 2.2 ptp85 -78.82 138.93 38.41 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 mt -134.85 130.53 52.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.28 114.98 27.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.6 t -166.49 -158.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.563 0.22 . . . . 0.0 110.463 -178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -155.17 167.65 29.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.26 -43.54 61.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.44 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 34.4 t -69.17 -45.4 70.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.11 55.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.55 142.9 48.06 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.019 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -67.15 135.06 52.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 23.5 tptp -55.44 131.56 46.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.7 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.36 -34.43 4.84 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.647 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.0 t -71.42 123.36 22.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.451 ' HG3' ' HE1' ' A' ' 17' ' ' PHE . 2.7 ptpp? -101.79 115.23 30.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.637 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 62.4 m-85 -92.47 135.93 33.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.3 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.9 m-85 -120.45 159.43 25.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -91.9 168.77 11.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.909 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -64.4 -31.75 73.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.547 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.15 -19.23 64.28 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.192 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.92 -4.04 52.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.659 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -89.4 148.25 23.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 21.0 t80 -70.56 128.49 36.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.809 HG12 HD12 ' A' ' 45' ' ' ILE . 79.6 t -90.54 -65.73 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.207 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.7 p -178.57 154.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.789 0.328 . . . . 0.0 111.186 -179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' ' 12' ' ' LYS . 0.5 OUTLIER -92.92 153.38 18.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.377 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.652 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.47 123.51 31.0 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.072 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 11.3 pt-20 -90.3 26.51 1.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.779 0.323 . . . . 0.0 111.439 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -78.2 64.17 3.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.794 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.557 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 3.3 t70 -67.15 128.23 93.73 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.298 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.64 -19.56 59.94 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.946 2.431 . . . . 0.0 113.327 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.557 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 7.7 tpm_? -70.51 -37.64 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.34 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -116.68 133.29 23.05 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 0.0 111.195 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.26 126.6 17.38 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.345 2.03 . . . . 0.0 111.338 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -159.09 146.43 17.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.958 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.476 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -168.77 122.78 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.559 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 m -128.93 51.86 8.15 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.29 40.65 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.439 2.092 . . . . 0.0 111.384 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.49 ' HD3' ' C ' ' A' ' 38' ' ' PRO . 1.6 mpp_? -132.07 32.24 4.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.912 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -174.43 152.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.954 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.41 125.65 17.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.761 ' HB2' HG12 ' A' ' 45' ' ' ILE . 73.8 m-20 -78.64 126.66 82.33 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.19 -29.3 74.9 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 123.438 2.758 . . . . 0.0 113.448 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.516 ' O ' ' HA ' ' A' ' 18' ' ' SER . 1.2 ptm85 -88.22 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.275 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.809 HD12 HG12 ' A' ' 24' ' ' VAL . 28.7 mm -79.21 94.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.25 -45.43 9.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.806 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.463 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -157.63 159.92 37.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.683 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -137.74 131.81 5.63 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.034 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.39 93.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 93.4 m -88.74 139.55 29.46 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.4 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.69 136.46 39.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.578 2.185 . . . . 0.0 112.231 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.9 -33.62 39.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.97 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.613 179.728 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.558 ' CG ' ' H ' ' A' ' 2' ' ' ARG . 17.7 t70 . . . . . 0 C--O 1.233 0.184 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.558 ' H ' ' CG ' ' A' ' 1' ' ' ASP . 0.6 OUTLIER -154.77 135.27 13.4 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.996 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tt -160.18 127.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.304 0.573 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -98.76 130.41 45.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.699 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.785 HG21 HG22 ' A' ' 45' ' ' ILE . 10.1 t -175.93 -148.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.484 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.468 ' HA ' HG13 ' A' ' 45' ' ' ILE . 17.0 p30 -154.62 164.96 37.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 m -48.99 -49.28 41.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 50.0 t -63.33 -43.58 97.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.053 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.49 29.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.913 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.64 144.79 15.86 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.2 m -63.1 121.92 14.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.679 0.276 . . . . 0.0 110.38 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 57.3 mtmt -54.07 130.55 38.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.891 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.83 -39.7 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -72.8 121.81 20.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 24.0 ttmm -93.11 120.88 33.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.542 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 77.0 m-85 -95.86 142.49 28.05 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.344 0.592 . . . . 0.0 111.933 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.562 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 11.3 m-85 -130.33 162.83 28.17 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.1 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.91 162.02 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.835 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.423 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.17 -32.15 73.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.75 -2.36 11.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.565 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.423 HG21 ' N ' ' A' ' 23' ' ' PHE . 89.8 m -88.23 146.96 25.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.51 0.671 . . . . 0.0 111.162 -179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.494 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 5.0 t80 -73.15 131.86 42.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.708 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.509 HG13 HD12 ' A' ' 45' ' ' ILE . 68.0 t -103.98 -67.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.375 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.3 p -179.11 147.19 0.33 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.685 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 pm0 -87.91 167.11 14.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.429 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.47 125.4 23.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.732 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -122.08 49.32 1.59 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.495 0.664 . . . . 0.0 110.939 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 18.3 m -75.99 52.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.816 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.559 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 20.3 t70 61.42 130.37 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 123.836 0.855 . . . . 0.0 112.133 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.19 -40.08 78.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.21 1.94 . . . . 0.0 112.533 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.589 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 31.4 ttm-85 -66.4 -53.39 36.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.589 ' HB3' ' O ' ' A' ' 32' ' ' ARG . 9.5 p30 142.86 -36.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 125.088 1.355 . . . . 0.0 114.294 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' OD2' ' A' ' 30' ' ' ASP . 16.7 Cg_exo -69.79 68.71 1.7 Allowed 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.52 2.147 . . . . 0.0 115.173 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.447 ' O ' ' HB3' ' A' ' 29' ' ' SER . 58.7 tttm -160.82 129.66 4.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.848 0.356 . . . . 0.0 110.414 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -162.41 142.33 9.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.54 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -127.97 72.15 78.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.713 0.292 . . . . 0.0 111.514 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.32 39.86 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.086 2.524 . . . . 0.0 112.012 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.618 ' HD3' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -70.26 -35.79 74.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.618 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 45.5 t30 178.14 152.16 0.28 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.745 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -84.6 125.96 32.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 42.3 m-20 -79.84 131.11 64.74 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.799 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -59.61 -22.6 67.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.837 2.358 . . . . 0.0 111.027 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.65 -35.42 80.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.403 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.785 HG22 HG21 ' A' ' 5' ' ' THR . 23.4 mm -84.45 94.48 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.67 12.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.562 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.3 p90 -158.51 161.71 37.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.647 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.542 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.65 136.18 7.0 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.111 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -96.5 123.96 49.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.76 0.314 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 72.7 m -103.1 126.62 31.85 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.295 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.3 Cg_exo -71.88 121.39 7.57 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.596 2.197 . . . . 0.0 111.624 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.4 -37.13 10.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.33 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.857 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.772 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.8 t0 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 13.0 ptm180 -161.79 144.73 12.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.448 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.437 HD12 HG23 ' A' ' 3' ' ' ILE . 6.6 tt -148.92 133.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.048 0.451 . . . . 0.0 110.72 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.78 129.7 42.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 t -178.03 -154.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.404 ' HA ' HG13 ' A' ' 45' ' ' ILE . 21.1 p30 -148.33 172.2 14.78 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -52.97 -51.66 60.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.686 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -61.3 -46.78 88.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.502 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.19 29.5 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.588 . . . . 0.0 111.032 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.98 143.93 15.77 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.635 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -60.83 128.82 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.611 0.205 . . . . 0.0 110.901 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -50.06 128.55 19.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.979 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.47 -33.82 4.02 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.833 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.23 118.11 11.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -94.27 119.4 33.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.351 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.63 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 57.6 m-85 -93.67 139.82 30.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 111.323 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.574 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -124.27 160.86 27.03 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.723 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 167.82 17.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.985 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -61.09 -30.69 70.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.311 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -66.72 -26.71 67.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.273 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.56 2.08 25.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.159 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -88.1 145.4 25.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.468 . . . . 0.0 110.532 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 23.8 t80 -73.0 124.36 25.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.427 HG11 HD12 ' A' ' 45' ' ' ILE . 73.7 t -92.98 -63.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.166 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.8 p -177.18 149.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.633 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 pt-20 -94.46 158.04 15.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.38 122.35 29.81 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.557 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.686 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 14.4 pt-20 -109.67 29.99 7.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.4 m -60.57 136.84 58.18 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t70 64.92 71.2 0.56 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.783 0.801 . . . . 0.0 110.142 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 2.0 Cg_endo -81.7 -5.17 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.741 2.294 . . . . 0.0 109.659 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 5.1 tpp85 76.33 -37.53 0.3 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 113.965 -1.471 . . . . 0.0 110.491 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.482 ' OD1' ' HB2' ' A' ' 31' ' ' PRO . 9.1 p-10 -85.84 149.86 51.82 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.56 119.36 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.276 1.984 . . . . 0.0 112.186 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -160.32 132.68 6.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.906 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 135.29 38.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.0 m -88.67 140.49 29.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.554 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.0 Cg_exo -62.73 134.6 47.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.87 2.38 . . . . 0.0 111.689 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.421 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 1.0 OUTLIER -90.11 46.11 1.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.101 0.477 . . . . 0.0 110.649 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.91 146.76 19.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.58 134.09 34.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.574 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 17.7 m-20 -78.96 127.54 79.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.059 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.91 -23.58 68.2 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.55 2.167 . . . . 0.0 110.901 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.574 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 10.6 ptp85 -70.39 -26.6 63.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.818 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.427 HD12 HG11 ' A' ' 24' ' ' VAL . 23.5 mm -83.96 98.42 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.412 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.2 -42.08 11.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.694 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 4.2 p90 -157.38 174.03 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.085 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.63 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -150.14 134.43 4.81 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.687 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.9 mm -90.75 104.31 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.51 122.7 66.89 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.87 138.04 27.99 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.63 2.22 . . . . 0.0 112.265 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.8 pp -81.64 -22.87 37.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.263 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.609 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.599 0.714 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 30.0 ttm180 -157.85 136.08 10.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.71 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.442 HG22 ' HA ' ' A' ' 47' ' ' TYR . 6.8 tt -144.24 137.27 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.876 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.99 127.86 35.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.672 HG21 HG21 ' A' ' 45' ' ' ILE . 12.4 t -178.52 -158.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.649 ' HA ' HG13 ' A' ' 45' ' ' ILE . 18.8 p30 -155.21 -173.42 4.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 m -62.37 -50.94 69.58 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.1 t -65.14 -48.87 72.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.743 0.306 . . . . 0.0 111.661 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.93 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.381 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.02 144.97 49.4 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -66.13 126.08 27.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.651 0.262 . . . . 0.0 110.745 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 86.7 tttt -53.79 131.79 40.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.43 -40.9 2.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.74 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.2 m -73.9 123.88 25.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 67.5 mttm -89.76 123.63 33.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 25.9 m-85 -96.89 134.92 39.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.785 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.577 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.2 m-85 -126.54 167.08 16.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.111 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.57 156.69 16.95 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.7 -26.43 67.13 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.546 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.26 -34.29 74.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.422 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.18 -5.25 8.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 m -89.29 146.43 24.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 111.694 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.452 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.7 t80 -76.5 130.96 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.566 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.779 HG13 HD13 ' A' ' 45' ' ' ILE . 95.0 t -99.11 -67.46 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.4 p -176.71 143.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.773 0.32 . . . . 0.0 110.434 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . 3.8 pt-20 -91.08 162.5 14.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.9 116.88 8.37 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.979 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.77 24.58 7.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.503 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 p -77.09 54.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.469 0.652 . . . . 0.0 111.354 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.12 117.33 60.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.729 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.18 32.49 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.382 2.722 . . . . 0.0 113.732 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -80.53 -22.68 40.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.531 0.682 . . . . 0.0 109.731 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -165.26 148.69 7.2 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.919 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.39 137.73 71.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.554 2.169 . . . . 0.0 111.369 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -150.81 136.89 18.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.79 0.329 . . . . 0.0 110.532 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.85 119.82 30.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.019 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 72.7 m -88.89 138.97 29.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 37.6 Cg_exo -57.5 128.45 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.616 2.211 . . . . 0.0 112.006 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -70.75 -20.78 62.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.479 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -71.85 132.46 44.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.941 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -85.25 123.18 30.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -79.61 121.25 82.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.417 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.97 -16.08 51.2 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.863 2.375 . . . . 0.0 110.237 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -67.44 -30.21 69.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.696 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.779 HD13 HG13 ' A' ' 24' ' ' VAL . 14.7 mm -88.62 112.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.34 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.43 -40.82 8.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.707 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.577 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.1 p90 -158.74 174.3 15.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.674 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.71 133.97 5.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.796 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.78 122.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.875 0.369 . . . . 0.0 110.579 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.2 m -92.56 136.64 25.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.142 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 27.8 Cg_exo -62.04 137.16 65.21 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.887 2.391 . . . . 0.0 112.167 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.1 151.48 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.3 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.904 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.086 0.469 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.591 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 42.8 ptt85 -161.45 153.0 18.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.838 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.614 HG23 ' HA ' ' A' ' 47' ' ' TYR . 10.1 tt -78.35 133.88 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.504 0.669 . . . . 0.0 110.965 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.07 112.58 24.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.55 HG23 HG22 ' A' ' 45' ' ' ILE . 15.3 t -178.19 -163.11 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.702 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -160.24 164.54 32.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 63.2 m -52.13 -40.58 61.56 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.505 ' HA ' ' CD ' ' A' ' 28' ' ' GLU . 24.8 t -58.5 -47.25 84.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.288 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.82 -16.82 49.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.6 133.54 41.41 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.049 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.48 HG22 ' HA ' ' A' ' 31' ' ' PRO . 22.9 m -67.81 130.83 44.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.706 -0.247 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.458 ' HZ1' ' CD ' ' A' ' 26' ' ' GLU . 0.3 OUTLIER -61.95 97.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.277 0.56 . . . . 0.0 110.341 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.81 -39.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 84.8 m -73.1 119.24 17.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 49.7 mttp -88.95 112.29 23.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.134 0.492 . . . . 0.0 111.466 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.57 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 71.6 m-85 -93.72 132.58 37.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.14 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -120.96 152.22 38.79 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.253 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.401 ' N ' HG21 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -81.82 165.47 20.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.12 178.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -59.08 -30.43 68.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.547 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -67.37 -28.36 67.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.65 2.19 22.71 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.088 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.419 HG21 ' N ' ' A' ' 23' ' ' PHE . 25.2 m -88.52 146.42 25.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 0.0 110.524 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' N ' HG21 ' A' ' 22' ' ' THR . 24.5 t80 -72.77 127.04 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.598 HG13 ' SG ' ' A' ' 25' ' ' CYS . 52.1 t -93.16 -60.31 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.598 ' SG ' HG13 ' A' ' 24' ' ' VAL . 24.3 p -176.33 148.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 17.1 pt-20 -99.55 42.23 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.175 0.512 . . . . 0.0 111.079 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.13 -175.79 41.79 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.016 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' HG3' ' N ' ' A' ' 29' ' ' SER . 7.2 pt-20 -148.56 -42.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 50.3 m -77.28 139.65 39.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 1.004 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 16.7 t70 -61.79 144.11 93.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.146 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.549 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 89.3 Cg_exo -44.54 -26.33 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.529 2.819 . . . . 0.0 114.631 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.93 40.56 1.66 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 1.004 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 4.3 p-10 -94.12 146.61 31.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.824 0.345 . . . . 0.0 110.663 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 66.41 4.19 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.828 2.352 . . . . 0.0 112.481 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -136.92 128.81 29.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.421 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -123.68 138.92 54.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.522 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 39.1 m -130.61 62.49 65.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 3.1 Cg_exo -79.47 40.28 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.95 2.434 . . . . 0.0 111.821 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 51.1 ttp85 -67.12 -57.89 5.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 6.0 t-20 173.18 154.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.682 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.38 125.31 29.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 64.7 m-20 -77.66 123.33 86.59 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.494 ' HA ' ' CZ ' ' A' ' 2' ' ' ARG . 31.1 Cg_exo -61.17 -24.89 79.99 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.841 2.36 . . . . 0.0 110.751 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.0 ttp-105 -64.63 -28.38 69.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.231 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.55 HG22 HG23 ' A' ' 5' ' ' THR . 30.9 mm -79.78 102.76 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.202 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.591 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -89.4 -51.18 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.461 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.614 ' HA ' HG23 ' A' ' 3' ' ' ILE . 29.7 p90 -155.97 153.24 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.977 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -131.31 129.19 5.63 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.696 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.61 119.81 47.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -97.16 128.17 36.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.35 137.04 16.41 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.619 2.213 . . . . 0.0 112.162 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.416 ' N ' HD21 ' A' ' 52' ' ' LEU . 2.7 pt? -160.2 146.42 15.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.147 -179.693 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.4 t0 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.808 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 39.9 ptt180 -160.42 148.79 16.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tt -77.51 124.52 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 0.0 110.692 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.72 122.57 32.95 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.742 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.732 HG22 HG22 ' A' ' 45' ' ' ILE . 14.6 t -178.2 -158.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.008 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -153.02 177.17 11.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.58 -40.88 79.97 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.977 0.418 . . . . 0.0 111.437 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.27 -47.85 77.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.878 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.45 33.58 1.78 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.08 -129.11 5.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.311 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.548 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 14.8 m -153.56 127.51 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.654 ' HB2' ' O ' ' A' ' 29' ' ' SER . 24.1 tptm -48.63 127.16 13.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.818 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.71 -39.63 3.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.197 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.7 m -66.68 118.43 10.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.06 0.43 . . . . 0.0 110.467 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.905 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 19.6 mmmt -89.12 116.0 27.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.666 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.0 m-85 -86.93 134.42 33.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.22 0.533 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.486 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.5 m-85 -123.7 161.03 25.95 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.072 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.68 157.06 18.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -30.78 63.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.726 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -63.61 -29.67 70.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.336 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.29 0.37 16.4 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.263 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -88.66 147.03 24.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.052 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.401 ' CE1' ' HE3' ' A' ' 15' ' ' LYS . 23.3 t80 -76.06 132.94 40.41 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.759 HG11 HD12 ' A' ' 45' ' ' ILE . 98.6 t -103.32 -68.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 16' ' ' TYR . 25.7 p -179.66 146.05 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.662 0.268 . . . . 0.0 111.541 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.905 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 3.8 pm0 -84.03 159.29 21.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.06 125.02 11.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.151 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.03 0.2 56.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.538 0.209 . . . . 0.0 111.347 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.654 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 1.3 m -61.94 109.31 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.69 138.78 24.99 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.29 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.57 -24.08 12.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.3 -23.48 67.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -147.55 133.73 9.68 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.219 0.533 . . . . 0.0 111.248 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.35 60.23 4.85 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 113.012 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.36 127.29 33.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.908 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -159.99 124.92 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.487 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 m -135.74 58.05 22.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.487 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.05 43.7 1.56 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.832 2.354 . . . . 0.0 111.69 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -97.02 -33.11 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -153.65 140.52 19.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.05 141.66 28.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.284 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -77.97 125.18 85.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.69 0.281 . . . . 0.0 110.832 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.88 47.58 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.488 2.792 . . . . 0.0 111.71 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.441 ' HD2' HG12 ' A' ' 24' ' ' VAL . 28.4 ptt180 -156.53 -30.8 0.09 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.492 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.759 HD12 HG11 ' A' ' 24' ' ' VAL . 31.2 mm -65.68 110.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.505 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.808 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -109.61 -41.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.475 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.486 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.2 p90 -159.72 147.59 17.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 111.594 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.666 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -112.5 125.27 7.04 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.821 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.1 115.42 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.827 0.346 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 60.4 m -94.52 124.95 53.63 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.0 Cg_exo -70.63 137.89 33.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.071 2.514 . . . . 0.0 112.219 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.55 53.77 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.221 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.17 0.919 . . . . 0.0 110.492 -178.922 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.358 0.599 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.509 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . 57.9 mtm180 -143.96 133.69 23.74 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.547 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tt -79.06 136.49 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.01 112.71 22.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.435 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.67 HG21 HG21 ' A' ' 45' ' ' ILE . 11.6 t -179.77 -166.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.849 ' HA ' HG13 ' A' ' 45' ' ' ILE . 12.9 p30 -161.97 -156.46 0.43 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.7 0.286 . . . . 0.0 110.927 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' H ' ' HB2' ' A' ' 6' ' ' ASN . 1.2 m -70.38 -48.66 55.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.351 0.596 . . . . 0.0 109.721 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.2 t -58.28 -52.59 64.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.32 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.78 -28.74 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.783 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.91 143.23 48.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.659 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -63.15 125.78 25.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.563 0.22 . . . . 0.0 110.919 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.675 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -55.93 117.95 4.16 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.618 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.27 -43.53 1.53 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.4 m -74.17 126.83 31.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.633 ' HG3' ' HB3' ' A' ' 26' ' ' GLU . 1.9 mptp? -89.37 125.3 35.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.53 0.205 . . . . 0.0 110.527 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.637 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 12.6 m-85 -99.14 133.82 42.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.517 0.675 . . . . 0.0 110.964 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.497 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -122.5 163.66 19.5 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.559 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 161.62 19.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.107 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.457 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 1.2 p30 -58.8 -28.81 66.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.813 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -64.95 -29.71 70.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.166 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.42 -0.09 18.51 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.321 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -88.57 144.85 26.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.031 0.443 . . . . 0.0 111.019 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.5 t80 -75.48 128.68 35.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.1 t -101.15 -60.55 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.487 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.8 p -177.84 150.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.633 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -96.01 166.22 11.88 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.962 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.675 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.97 140.04 45.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.429 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 16.9 pt-20 -121.15 20.47 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.89 0.376 . . . . 0.0 110.704 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -81.28 58.84 3.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.82 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.492 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 27.1 t70 -72.46 131.96 84.23 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.859 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.12 -26.01 48.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.583 2.855 . . . . 0.0 113.364 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttt85 -55.56 -39.98 71.34 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.714 0.292 . . . . 0.0 111.344 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.38 109.46 1.1 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 121.568 0.699 . . . . 0.0 111.795 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.85 146.69 23.67 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.983 2.455 . . . . 0.0 111.674 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -127.56 148.07 50.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.4 130.7 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.6 m -88.83 126.57 59.09 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.908 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 -57.02 0.96 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.828 2.352 . . . . 0.0 113.276 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 15.0 mmp_? -98.86 -38.3 9.09 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.959 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 t30 63.32 31.41 15.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.965 0.888 . . . . 0.0 110.317 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.82 110.54 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.279 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.5 ' CG ' ' HB3' ' A' ' 6' ' ' ASN . 24.2 m-20 -110.3 127.66 26.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.36 -29.23 67.01 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.489 2.793 . . . . 0.0 113.775 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 ptt85 -78.03 -20.56 52.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.849 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.9 mm -79.23 114.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.509 ' HA ' ' HB3' ' A' ' 2' ' ' ARG . . . -105.06 -40.78 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.764 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.497 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.4 p90 -160.0 155.74 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -123.78 130.78 7.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.917 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.25 120.75 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.913 0.387 . . . . 0.0 110.586 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.94 126.98 55.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.145 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.22 136.82 27.5 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.557 2.171 . . . . 0.0 112.28 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.01 26.7 9.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.783 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.633 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 122.288 1.042 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.411 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 14.9 ptm180 -79.66 133.58 36.4 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.56 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.469 HG21 ' HA ' ' A' ' 47' ' ' TYR . 10.4 tt -79.4 137.02 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.104 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.02 116.81 27.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.55 HG21 HG22 ' A' ' 45' ' ' ILE . 12.5 t -176.95 -172.96 0.44 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.7 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.1 p-10 -161.41 -168.57 2.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.438 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 57.8 m -59.76 -50.09 75.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' ALA . 41.8 t -70.58 -43.09 70.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.65 76.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.012 0.435 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.96 -179.45 45.83 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.44 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.4 m -110.8 133.35 53.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.36 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 1.096 ' HG3' ' HB3' ' A' ' 30' ' ' ASP . 2.7 mmmt -53.84 127.36 25.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.374 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.93 -39.97 2.56 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 48.4 t -72.24 129.74 39.14 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' NZ ' ' OE1' ' A' ' 26' ' ' GLU . 71.4 mmtt -88.66 103.54 16.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.687 0.28 . . . . 0.0 111.513 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 78.9 m-85 -92.2 129.2 38.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 110.833 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -121.07 154.12 36.52 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.768 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.415 ' HB3' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -84.46 162.8 19.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.566 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.481 ' N ' ' HB3' ' A' ' 46' ' ' ALA . 8.3 p-10 -62.02 -28.43 69.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.295 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.231 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 -3.7 11.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.187 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -90.15 148.72 22.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.09 0.471 . . . . 0.0 111.252 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.87 126.63 30.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.629 HG12 HD11 ' A' ' 45' ' ' ILE . 71.5 t -91.92 -59.32 3.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 p -175.13 154.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.067 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.591 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 9.7 pt-20 -96.7 39.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.108 0.48 . . . . 0.0 110.268 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.48 148.81 2.68 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG2' ' C ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -122.54 23.64 9.53 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.891 -0.77 . . . . 0.0 111.428 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.78 50.48 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.38 0.61 . . . . 0.0 110.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 1.096 ' HB3' ' HG3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -174.96 -55.36 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.492 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 43.7 Cg_endo -69.49 116.96 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 120.932 1.088 . . . . 0.0 110.84 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 31' ' ' PRO . 18.7 ttp-105 86.33 -37.35 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.692 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.401 HD21 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -171.78 126.45 0.58 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.307 0.575 . . . . 0.0 111.885 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.35 62.72 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.778 2.318 . . . . 0.0 111.784 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -130.63 139.11 50.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.858 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.467 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -102.71 137.89 40.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.524 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 67.7 m -89.15 108.4 23.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.858 0.361 . . . . 0.0 111.056 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 87.3 Cg_endo -88.16 30.65 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.869 2.379 . . . . 0.0 112.424 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -174.61 50.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 109.937 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -161.8 137.87 7.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -157.67 136.29 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.592 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.1 m-20 -82.35 125.17 77.21 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.711 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.89 -21.01 69.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.361 2.04 . . . . 0.0 109.721 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.489 ' HD2' HG21 ' A' ' 24' ' ' VAL . 6.4 ttp180 -71.64 -34.18 69.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.12 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.7 HG13 ' HA ' ' A' ' 6' ' ' ASN . 31.1 mm -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.153 0.501 . . . . 0.0 111.566 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.481 ' HB3' ' N ' ' A' ' 19' ' ' ASP . . . -115.48 -44.17 2.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.497 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.469 ' HA ' HG21 ' A' ' 3' ' ' ILE . 21.3 p90 -157.89 156.28 31.08 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.241 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -130.44 124.38 4.25 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.729 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -87.32 94.52 4.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 84.5 m -89.17 118.93 69.64 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.143 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 6.9 Cg_exo -73.65 134.55 20.45 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.008 2.472 . . . . 0.0 112.14 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB3' ' H ' ' A' ' 53' ' ' ALA . 7.0 mp -95.26 -143.32 0.26 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.161 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.422 ' H ' ' HB3' ' A' ' 52' ' ' LEU . . . . . . . . 0 C--O 1.247 0.953 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 C--O 1.235 0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -160.61 58.67 0.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tt -78.3 130.43 36.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.791 0.805 . . . . 0.0 112.132 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.61 123.57 36.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.272 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.498 ' OG1' ' HB1' ' A' ' 9' ' ' ALA . 14.9 t -176.11 -165.71 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -145.36 178.15 8.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 m -54.25 -39.65 67.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.57 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 11.7 t -63.07 -55.93 21.27 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.897 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.498 ' HB1' ' OG1' ' A' ' 5' ' ' THR . . . -84.03 29.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.349 0.595 . . . . 0.0 111.286 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.69 145.15 17.6 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.433 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 m -71.72 127.56 32.97 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.74 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 22.5 ttmm -50.28 131.57 24.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 111.341 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.33 -39.25 3.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.142 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.588 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 48.8 t -66.13 122.12 16.71 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.611 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.12 117.06 32.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.076 0.465 . . . . 0.0 111.127 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.759 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 37.3 m-85 -86.06 140.33 30.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.898 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -124.83 158.02 34.44 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.674 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.667 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 1.1 p -86.45 161.83 18.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.537 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 46' ' ' ALA . 11.3 p-10 -65.32 -28.61 69.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.03 -27.48 68.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.823 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.19 -2.93 20.71 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.411 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.417 HG23 ' H ' ' A' ' 23' ' ' PHE . 4.2 m -87.85 154.28 20.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.429 0.633 . . . . 0.0 111.002 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.533 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 24.2 t80 -75.77 128.81 35.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.762 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.542 HG11 ' CZ ' ' A' ' 44' ' ' ARG . 53.6 t -90.13 -67.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.439 ' SG ' HG12 ' A' ' 24' ' ' VAL . 27.3 p 177.07 148.63 0.13 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.542 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -90.13 144.88 25.48 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.74 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.81 143.36 46.58 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.815 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.57 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.0 OUTLIER -107.26 -18.77 13.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -63.84 129.36 39.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.082 0.468 . . . . 0.0 111.06 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.715 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 36.9 t70 -73.32 127.29 89.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.544 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.11 58.14 3.44 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.025 2.483 . . . . 0.0 111.527 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.422 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 23.5 ttm105 -150.39 -41.05 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.459 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 14.1 p-10 -133.29 135.17 24.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.018 0.437 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 16.9 Cg_exo -68.08 129.72 20.04 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.858 2.372 . . . . 0.0 112.265 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.462 ' HZ2' ' CD ' ' A' ' 28' ' ' GLU . 27.6 ttpp -117.11 136.9 52.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.963 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.46 120.36 10.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.3 m -150.44 145.47 18.57 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.632 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 128.45 24.35 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.448 2.099 . . . . 0.0 111.809 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -86.03 46.74 1.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.789 0.804 . . . . 0.0 109.883 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.91 124.08 40.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.119 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB1' ' N ' ' A' ' 5' ' ' THR . . . -88.26 139.25 30.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.532 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.64 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 2.0 p30 -78.17 150.86 77.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.786 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.69 61.08 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.631 2.887 . . . . 0.0 112.047 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.667 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 19.2 ttp180 -171.2 -31.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.046 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 5' ' ' THR . 31.9 mm -59.0 112.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.605 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -105.03 -47.07 4.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.429 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -166.41 -169.14 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.403 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.759 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -149.51 132.47 4.05 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.936 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.45 97.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m -90.13 126.21 57.77 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.588 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 11.8 Cg_exo -70.57 133.25 23.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.799 2.333 . . . . 0.0 112.048 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.457 HD22 ' N ' ' A' ' 52' ' ' LEU . 3.2 mm? -84.86 138.56 32.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.261 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.465 HH12 ' CG ' ' A' ' 19' ' ' ASP . 38.9 mtp85 -139.92 122.54 16.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 8.8 tt -77.9 136.69 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.115 0.483 . . . . 0.0 110.009 179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.34 106.07 17.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.214 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.663 HG23 HG21 ' A' ' 45' ' ' ILE . 13.3 t 179.37 -168.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.771 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.655 ' HA ' HG13 ' A' ' 45' ' ' ILE . 3.2 p-10 -161.2 -161.42 0.81 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.438 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.9 m -67.24 -45.84 75.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -64.93 -52.33 56.97 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.11 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 111.473 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.97 137.73 41.39 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.958 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 22.0 m -61.71 129.39 40.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.624 0.25 . . . . 0.0 110.616 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 39.9 tttp -53.25 130.27 34.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.803 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.44 -37.96 3.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.618 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 t -70.42 125.85 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.657 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 8.5 mmmt -94.65 116.89 29.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.262 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.634 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 39.4 m-85 -93.65 134.44 35.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -123.77 162.42 23.22 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.542 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.47 159.44 18.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.414 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.465 ' CG ' HH12 ' A' ' 2' ' ' ARG . 15.1 p-10 -59.46 -27.64 66.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.729 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -65.89 -27.6 68.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.933 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.29 -0.69 20.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.294 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.7 m -88.71 146.29 25.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.238 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.75 126.85 31.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.79 HG11 HD11 ' A' ' 45' ' ' ILE . 91.4 t -93.91 -63.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.306 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.4 p -177.76 149.39 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.182 0.515 . . . . 0.0 111.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.657 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 2.0 pt-20 -90.15 149.06 22.6 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.746 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.45 121.82 25.76 Favored Glycine 0 C--O 1.236 0.224 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.893 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 13.0 pt-20 -94.83 11.28 32.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.0 m -50.82 137.88 19.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.681 0.277 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -166.41 133.38 2.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.44 -5.9 17.12 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.881 2.387 . . . . 0.0 113.11 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.401 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.46 -33.61 69.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.7 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -151.65 146.4 18.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 84.95 0.17 Allowed 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.928 2.419 . . . . 0.0 113.19 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.71 60.42 3.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.462 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -77.12 106.04 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.073 0.463 . . . . 0.0 110.422 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.49 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 73.9 m -129.56 58.44 37.66 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 7.4 Cg_exo -72.41 -33.12 9.25 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.349 2.033 . . . . 0.0 112.06 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -98.69 46.0 1.0 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.375 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -150.45 121.21 7.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.933 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.66 128.8 12.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.842 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.494 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.7 m-20 -87.46 125.65 64.8 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.16 -18.73 64.55 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.247 1.965 . . . . 0.0 110.844 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.445 HH11 ' HG2' ' A' ' 44' ' ' ARG . 1.0 OUTLIER -69.58 -34.35 74.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.376 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.79 HD11 HG11 ' A' ' 24' ' ' VAL . 38.9 mm -66.76 107.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.586 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.462 ' HB3' ' N ' ' A' ' 19' ' ' ASP . . . -105.48 -40.94 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 9.0 p90 -154.71 150.59 27.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.634 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -117.59 127.21 7.26 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.439 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.7 mt -93.09 100.14 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.21 127.97 53.29 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.81 140.55 51.21 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.737 2.292 . . . . 0.0 112.317 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -160.22 133.07 6.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.735 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.969 0 O-C-N 124.106 0.878 . . . . 0.0 110.696 -179.072 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.447 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 51.7 t0 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.647 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 21.5 mmm-85 -151.98 64.06 0.84 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.119 0.568 . . . . 0.0 109.736 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.13 129.99 36.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.604 0.716 . . . . 0.0 110.918 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.56 129.77 35.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 t -176.59 -160.45 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -153.59 166.17 33.6 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -51.61 -44.01 62.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.641 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 t -60.99 -49.65 76.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 111.449 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.99 -29.45 65.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.78 131.9 40.41 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.616 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 m -59.63 126.47 27.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.291 0.236 . . . . 0.0 110.926 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 48.6 tptt -58.83 120.43 9.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.919 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.86 -40.75 2.01 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 59.1 m -71.2 126.47 29.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 13.3 ptpt -88.3 110.84 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.221 0.534 . . . . 0.0 111.218 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.57 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 31.8 m-85 -93.95 129.09 40.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -113.28 151.65 30.83 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.807 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.457 ' N ' HG21 ' A' ' 24' ' ' VAL . 2.3 p -79.96 167.55 20.34 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.701 0.625 . . . . 0.0 111.351 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 12.4 p-10 -62.98 -29.23 70.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.28 -30.75 70.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.708 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.89 -9.74 10.4 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 114.014 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.439 HG22 ' N ' ' A' ' 23' ' ' PHE . 8.0 m -87.91 151.13 23.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.254 0.549 . . . . 0.0 111.525 -178.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.439 ' N ' HG22 ' A' ' 22' ' ' THR . 24.9 t80 -68.2 126.78 30.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.743 179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG11 ' SG ' ' A' ' 25' ' ' CYS . 39.1 t -94.77 -56.38 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.464 ' SG ' HG11 ' A' ' 24' ' ' VAL . 24.7 p -176.35 145.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.271 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.0 OUTLIER -89.9 39.97 0.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.702 0.763 . . . . 0.0 110.076 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.69 172.62 16.43 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.379 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.641 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 15.3 pt-20 -157.04 27.45 0.31 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 p -79.06 66.97 4.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.49 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.425 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 41.0 t0 -61.57 119.57 48.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 15.2 Cg_exo -68.44 -19.35 43.25 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.714 2.276 . . . . 0.0 111.302 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -36.55 65.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.33 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.447 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.0 p30 -136.19 127.26 16.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 2.6 Cg_exo -76.2 90.23 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.985 2.457 . . . . 0.0 112.199 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -78.59 136.69 37.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.88 115.54 9.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 110.484 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -89.37 137.32 29.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.715 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.24 140.24 93.56 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.938 2.425 . . . . 0.0 112.071 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -83.49 43.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -159.46 146.8 17.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.86 30.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.11 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -78.06 118.78 74.32 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.527 179.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.06 -18.45 63.64 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.905 2.403 . . . . 0.0 110.638 178.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.4 ' O ' ' HA ' ' A' ' 18' ' ' SER . 20.0 ttp-105 -70.94 -32.49 69.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.906 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 mm -64.67 119.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.823 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.647 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -94.88 -52.62 4.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.498 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -166.69 157.69 12.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.253 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.57 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -126.86 115.98 2.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.59 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.429 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 46.9 mm -90.18 117.41 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.3 m -89.33 121.3 69.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.0 Cg_exo -76.59 130.37 11.65 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.006 2.47 . . . . 0.0 112.545 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 52' ' ' LEU . 3.3 mm? -84.61 -21.65 30.26 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.836 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.434 179.545 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.826 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 17.7 ptp180 -162.3 164.45 27.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.521 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -77.05 135.0 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 0.0 110.998 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.11 100.85 13.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.194 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -177.4 -173.21 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.638 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -160.54 -173.66 4.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.34 -45.7 92.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.676 0.275 . . . . 0.0 111.502 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.423 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 12.0 t -57.25 -42.07 80.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.945 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.72 -82.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.501 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . 31.97 -138.35 0.08 OUTLIER Glycine 0 C--N 1.337 0.588 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.753 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 98.6 m -165.46 126.7 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 46.6 mmtt -49.15 135.27 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 111.975 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.45 -43.52 2.78 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 32.8 t -71.82 116.22 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 0.0 109.823 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.687 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 38.0 mttp -99.07 119.97 38.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.039 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.735 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 35.6 m-85 -92.61 136.09 33.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.429 0.633 . . . . 0.0 111.556 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.474 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -119.61 158.14 26.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.941 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.18 162.03 21.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.653 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.468 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 9.7 p-10 -61.27 -26.69 67.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.621 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -66.59 -29.56 69.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.859 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.94 -0.89 17.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.388 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 m -88.86 146.17 25.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.068 0.461 . . . . 0.0 111.305 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.3 t80 -73.77 126.93 31.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.514 HG11 ' SG ' ' A' ' 25' ' ' CYS . 79.1 t -96.76 -63.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.952 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.514 ' SG ' HG11 ' A' ' 24' ' ' VAL . 25.8 p 179.52 155.15 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.62 0.248 . . . . 0.0 111.033 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.687 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 11.7 pt-20 -96.85 147.53 23.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.753 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -64.03 136.19 40.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.472 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' HA ' ' CE ' ' A' ' 12' ' ' LYS . 11.7 pt-20 -95.17 -3.64 47.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m 70.83 116.76 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.437 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.536 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.8 t70 -53.9 -57.6 17.02 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.628 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 89.9 Cg_endo -78.01 43.3 1.35 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.709 1.606 . . . . 0.0 112.299 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -163.66 31.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.541 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.0 p30 -161.15 149.94 13.26 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 3.9 Cg_exo -77.14 51.18 3.37 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.034 2.489 . . . . 0.0 113.794 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.541 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 9.9 mtmp? -157.98 126.65 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.294 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.47 117.21 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.572 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 88.9 m -141.55 51.82 2.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.865 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 17.3 Cg_exo -66.77 -25.0 46.46 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.349 2.033 . . . . 0.0 112.409 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -133.74 39.5 3.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.45 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -94.58 139.33 31.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.24 133.16 14.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.181 0.515 . . . . 0.0 112.191 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.3 m-20 -99.04 126.45 38.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.861 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.56 -29.34 88.67 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.773 2.315 . . . . 0.0 111.793 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.401 ' CG ' ' HB3' ' A' ' 42' ' ' ASP . 19.9 ptt180 -66.36 -27.63 68.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.468 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.638 HG13 ' HA ' ' A' ' 6' ' ' ASN . 42.4 mm -70.11 110.56 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.928 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.826 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -103.89 -46.71 4.41 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.168 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.4 p90 -150.06 143.27 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.904 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.735 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -113.29 130.01 9.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.752 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.7 94.31 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.45 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 71.5 m -89.44 132.76 36.28 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.281 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 18.1 Cg_exo -66.75 136.77 43.23 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.869 2.379 . . . . 0.0 112.009 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.81 -34.09 39.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.198 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.875 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.792 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 46.0 t0 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.762 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 2.7 ptm180 -77.5 132.9 38.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.349 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 3' ' ' ILE . 5.1 tt -156.37 134.46 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.216 -179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.82 128.11 36.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.872 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.529 ' OG1' ' HB1' ' A' ' 9' ' ' ALA . 12.5 t -177.11 -156.43 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -153.13 177.59 10.65 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 m -55.87 -39.75 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.574 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 31.8 t -70.58 -52.79 19.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.529 ' HB1' ' OG1' ' A' ' 5' ' ' THR . . . -74.02 -25.79 60.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.764 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.72 141.04 46.95 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.408 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -62.14 130.3 44.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.715 0.293 . . . . 0.0 111.424 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.63 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 21.5 tptm -54.44 123.48 13.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.829 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.605 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 106.66 -35.69 4.88 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -74.36 126.94 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.573 0.225 . . . . 0.0 110.479 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.605 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -90.81 119.82 31.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.49 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 90.3 m-85 -99.15 134.5 41.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.347 0.594 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.607 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.4 m-85 -121.72 160.41 24.59 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.758 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -82.68 169.09 16.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.308 178.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -60.25 -30.7 69.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.454 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -67.48 -28.54 67.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.481 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.32 1.28 23.48 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.075 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -88.16 144.49 26.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.537 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -72.57 126.73 30.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.069 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.65 HG12 ' HD2' ' A' ' 44' ' ' ARG . 70.6 t -96.61 -62.27 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 p -176.46 151.22 0.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.7 pt-20 -95.31 156.83 16.16 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.86 127.65 36.41 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.05 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.574 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.5 pp20? -114.39 29.34 8.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -75.78 54.66 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.767 0.794 . . . . 0.0 110.491 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -73.65 129.0 86.08 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.003 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.88 -21.58 41.46 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.227 2.618 . . . . 0.0 113.086 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -67.19 -31.07 71.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.634 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -103.0 132.42 21.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.58 64.85 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.936 2.424 . . . . 0.0 113.144 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 10.6 mtmp? -125.51 141.89 51.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.982 0.42 . . . . 0.0 110.956 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -150.65 128.36 11.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.327 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . 62.5 m -127.67 65.36 67.06 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.539 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.419 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 15.9 Cg_exo -67.89 -25.8 38.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.567 2.178 . . . . 0.0 112.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -115.2 52.79 0.85 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.317 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.707 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 20.9 t-20 -158.7 132.38 7.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -159.06 136.51 9.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 10.4 m-20 -84.57 127.28 66.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.72 -23.78 77.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.051 2.501 . . . . 0.0 112.741 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.65 ' HD2' HG12 ' A' ' 24' ' ' VAL . 4.5 ptp85 -79.62 -16.28 56.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.386 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 6' ' ' ASN . 21.8 mm -75.52 102.11 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.42 -39.64 10.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.762 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 3.1 p90 -157.42 166.21 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.461 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.49 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.93 136.11 6.65 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.573 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.7 mt -100.28 122.31 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.749 0.309 . . . . 0.0 110.552 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -101.03 133.22 21.14 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.08 138.73 37.46 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.644 2.229 . . . . 0.0 112.514 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -125.03 21.56 8.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.218 0.532 . . . . 0.0 110.261 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.54 179.82 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 2' ' ' ARG . 11.7 t70 . . . . . 0 C--O 1.233 0.209 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.545 ' H ' ' HD2' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -124.48 135.89 53.58 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.286 0.565 . . . . 0.0 111.164 -179.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.2 tt -78.59 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.084 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.19 101.13 13.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.967 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.75 HG22 HG23 ' A' ' 45' ' ' ILE . 12.2 t -176.52 -161.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.731 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.3 p30 -160.02 -159.44 0.72 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.559 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 18.3 m -67.57 -54.99 15.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.529 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 49.7 t -70.23 -43.08 71.36 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.207 -0.308 . . . . 0.0 111.596 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.487 ' HB2' ' OG1' ' A' ' 5' ' ' THR . . . -69.05 -23.48 64.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.968 0.413 . . . . 0.0 110.839 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.84 147.92 47.27 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.267 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.553 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 m -59.58 126.29 27.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 0.0 111.085 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.946 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 34.5 ttpt -54.76 132.77 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.247 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 -37.64 3.36 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.878 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.553 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 35.8 m -70.27 126.99 31.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.79 ' HE3' ' HB3' ' A' ' 26' ' ' GLU . 2.5 mtpt -91.24 114.8 27.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.651 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.6 m-85 -89.66 135.85 33.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.353 0.597 . . . . 0.0 111.566 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.447 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.3 m-85 -125.9 160.4 30.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.9 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -83.79 163.83 19.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.889 178.495 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.4 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 26.7 p-10 -62.46 -28.51 69.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.458 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -66.91 -28.49 68.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.925 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.65 1.89 19.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -88.16 147.41 24.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.101 0.476 . . . . 0.0 111.031 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -75.21 133.39 41.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.096 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.714 HG12 HD12 ' A' ' 45' ' ' ILE . 86.3 t -105.08 -68.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.2 p -176.42 147.55 0.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.79 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 3.1 pm0 -85.87 156.55 20.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.837 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -64.5 119.97 17.44 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.712 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -102.63 34.04 2.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -79.72 71.31 6.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.229 0.538 . . . . 0.0 110.908 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.946 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 9.8 t70 -146.66 -59.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.515 ' HD2' ' H ' ' A' ' 30' ' ' ASP . 31.6 Cg_endo -64.46 -39.14 29.92 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.783 1.656 . . . . 0.0 112.869 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 58.03 37.83 26.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.745 0.783 . . . . 0.0 109.893 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -72.09 161.07 80.81 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.872 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.21 92.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.683 2.255 . . . . 0.0 111.766 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 2.5 tmmm? -160.85 134.22 6.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.935 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' A' ' 39' ' ' ARG . . . -67.39 103.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.159 0.504 . . . . 0.0 111.85 -178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.6 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 83.7 m -89.83 -55.91 0.28 Allowed Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.797 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 97.5 Cg_endo -83.28 39.86 0.87 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.03 1.82 . . . . 0.0 111.975 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.443 ' HB3' ' HB1' ' A' ' 36' ' ' ALA . 34.5 ptt85 -69.32 -46.08 67.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.045 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 176.42 171.44 0.43 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.41 129.81 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -82.71 122.3 78.31 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.1 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.03 -27.46 79.53 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.01 2.473 . . . . 0.0 112.007 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.524 ' HD2' HG13 ' A' ' 24' ' ' VAL . 11.8 ptt-85 -68.35 -25.41 65.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.184 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.75 HG23 HG22 ' A' ' 5' ' ' THR . 37.8 mm -79.95 94.87 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' HA ' ' CB ' ' A' ' 2' ' ' ARG . . . -89.87 -43.35 10.67 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.5 p90 -159.97 157.26 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.101 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.651 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -125.49 125.82 5.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.055 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.7 mt -86.62 111.97 22.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.838 0.352 . . . . 0.0 110.167 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.38 133.54 28.23 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.4 57.85 5.56 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.864 2.376 . . . . 0.0 112.198 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.34 137.06 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.91 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 C--O 1.235 0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 9.0 tpt180 -158.58 58.63 0.44 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.442 0.639 . . . . 0.0 109.503 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.44 ' H ' HG21 ' A' ' 3' ' ' ILE . 5.7 tt -78.1 124.49 36.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.15 127.06 40.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.423 ' O ' HG13 ' A' ' 45' ' ' ILE . 12.9 t -176.97 -155.74 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -146.08 178.58 8.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.523 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 26.9 m -56.19 -42.13 76.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.642 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 43.0 t -72.07 -49.52 35.86 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.84 29.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.337 0.589 . . . . 0.0 111.089 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.423 ' H ' ' C ' ' A' ' 8' ' ' CYS . . . -104.94 145.58 15.95 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.19 179.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -59.65 126.72 28.7 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.883 0.341 . . . . 0.0 110.694 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 84.5 tttt -54.93 128.87 35.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 -39.77 2.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.894 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.5 124.11 26.61 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.928 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -100.37 126.57 46.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.029 0.443 . . . . 0.0 110.0 179.235 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 14.7 m-85 -89.04 137.7 32.08 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.173 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.548 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.0 m-85 -122.51 160.56 25.34 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 157.44 19.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.043 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.412 ' N ' ' HB1' ' A' ' 46' ' ' ALA . 18.7 p-10 -61.35 -29.05 69.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.34 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.32 -32.67 73.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.493 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.19 -2.15 9.73 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.853 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.51 HG21 ' N ' ' A' ' 23' ' ' PHE . 58.1 m -89.02 148.05 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.443 0.64 . . . . 0.0 111.559 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.712 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 18.8 t80 -76.92 131.56 38.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.925 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.406 ' HB ' ' O ' ' A' ' 16' ' ' TYR . 93.1 t -99.86 -68.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.867 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.6 p 178.72 148.88 0.21 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.831 0.348 . . . . 0.0 111.572 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.928 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 pm0 -87.02 152.67 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -67.67 121.58 15.11 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.614 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.642 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -89.36 41.19 1.02 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 111.526 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.9 m -77.81 53.1 1.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.722 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 9.1 t70 -93.46 -55.42 0.24 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.33 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.722 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 23.5 Cg_exo -63.9 111.11 1.46 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.764 1.643 . . . . 0.0 111.168 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -62.45 -20.84 64.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.349 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -68.91 133.48 90.15 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 110.546 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.3 132.53 27.83 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.657 2.238 . . . . 0.0 112.726 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.0 143.52 33.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.03 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.88 116.95 4.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.239 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.788 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 99.9 m -145.54 -47.6 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.312 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.788 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 58.3 Cg_endo -71.03 48.39 0.86 Allowed 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.216 1.944 . . . . 0.0 112.891 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -85.47 -26.65 26.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.94 174.87 7.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.677 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.25 140.6 52.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.717 0.294 . . . . 0.0 110.678 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.412 ' HB2' HG12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -78.72 125.2 84.66 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.559 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -60.54 -27.73 85.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.875 2.383 . . . . 0.0 111.569 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 25.4 ptt180 -66.87 -28.86 68.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.275 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 HD13 HG22 ' A' ' 45' ' ' ILE . 23.3 mm -70.41 102.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.223 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.696 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -99.15 -42.35 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.563 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.1 p90 -156.92 151.52 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.816 0.341 . . . . 0.0 111.422 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.23 123.7 7.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 49' ' ' ILE . 49.2 mm -93.36 111.91 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.378 . . . . 0.0 110.26 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.6 m -94.59 136.49 23.11 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.83 141.91 50.6 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.667 2.245 . . . . 0.0 111.929 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -157.7 -44.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.281 -1.342 . . . . 0.0 108.661 179.196 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.0 p30 . . . . . 0 CA--C 1.514 -0.44 0 CA-C-O 122.186 0.993 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 mmm180 -133.0 138.34 46.81 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.455 HG22 ' HA ' ' A' ' 47' ' ' TYR . 7.1 tt -145.75 128.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.231 0.538 . . . . 0.0 109.851 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.01 117.12 29.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.979 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t 179.52 -159.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.604 ' HA ' HG13 ' A' ' 45' ' ' ILE . 16.5 p30 -145.61 -167.61 2.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.615 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m -67.17 -56.27 10.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.869 0.366 . . . . 0.0 111.409 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.453 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 3.7 t -58.25 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.1 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.91 24.17 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.651 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.13 -122.77 4.61 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.128 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.8 m -151.47 136.14 17.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 36.5 tttp -53.95 127.91 28.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.241 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.55 -30.74 3.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.246 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.44 122.31 14.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.754 ' HD3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 mmtm -92.67 113.56 25.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.52 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 69.2 m-85 -95.98 133.27 40.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 110.911 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.526 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -128.4 164.9 21.69 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.381 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.83 156.28 18.15 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.486 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 30.7 p-10 -62.99 -23.82 67.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.627 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.4 -33.57 75.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.02 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.22 -4.17 8.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.031 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.8 m -89.44 146.78 24.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.207 0.527 . . . . 0.0 111.545 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -77.31 129.24 35.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.416 ' CG1' HD13 ' A' ' 45' ' ' ILE . 92.9 t -95.66 -63.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.6 p -178.25 163.41 1.65 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.564 0.221 . . . . 0.0 110.517 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.754 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -110.23 153.33 24.95 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -68.16 115.96 7.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.528 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.412 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.7 pm0 -90.88 33.43 0.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -69.87 54.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.518 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.404 ' N ' ' HD3' ' A' ' 31' ' ' PRO . 52.7 t0 -179.13 62.34 0.13 Allowed Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.674 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 33' ' ' ASN . 88.9 Cg_endo -89.2 -8.56 4.68 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.62 2.213 . . . . 0.0 112.106 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 75.64 -39.4 0.38 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.843 0.857 . . . . 0.0 110.534 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 31' ' ' PRO . 9.1 p-10 -90.65 151.39 43.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.19 125.61 19.02 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.269 1.979 . . . . 0.0 111.895 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.453 ' HE2' ' SG ' ' A' ' 8' ' ' CYS . 86.5 tttt -147.94 128.02 13.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.36 122.53 30.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.544 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -92.28 129.29 41.71 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.478 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.99 131.93 37.15 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.561 2.174 . . . . 0.0 111.641 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -79.91 -19.78 47.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.843 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.31 132.66 49.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.77 132.98 35.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -78.9 123.65 85.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.918 178.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.66 -25.39 78.87 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.887 2.391 . . . . 0.0 111.726 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.7 ptt180 -71.89 -27.67 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.424 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.604 HG13 ' HA ' ' A' ' 6' ' ' ASN . 25.4 mm -79.1 105.59 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.828 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.41 -42.12 7.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.372 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.526 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.0 p90 -155.16 163.11 40.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.52 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.79 131.73 4.75 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.377 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 4.1 mp -86.88 94.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.422 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.3 m -91.04 134.01 30.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.053 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.5 Cg_exo -71.97 63.88 3.29 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.347 2.698 . . . . 0.0 112.443 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -80.48 -35.8 34.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.521 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.332 -1.318 . . . . 0.0 108.849 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 45.0 t0 . . . . . 0 C--O 1.236 0.366 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.589 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 56.5 ttm-85 -160.7 110.76 1.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.456 HG21 ' HA ' ' A' ' 47' ' ' TYR . 13.1 tt -78.36 140.39 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.799 -179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.47 101.56 14.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.032 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.468 ' OG1' ' HB3' ' A' ' 9' ' ' ALA . 13.7 t -179.1 -171.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.822 ' HA ' HG13 ' A' ' 45' ' ' ILE . 23.2 p30 -161.44 -155.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.33 -52.29 23.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.799 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.461 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 52.6 t -64.86 -41.76 95.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.899 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' HB3' ' OG1' ' A' ' 5' ' ' THR . . . -77.66 -23.65 49.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.23 148.35 50.03 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.784 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -75.14 141.11 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.761 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 29' ' ' SER . 45.7 mtmt -50.36 137.26 18.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.896 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.75 -36.52 3.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.816 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.96 120.41 14.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.705 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 47.7 mttp -98.03 122.12 40.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.537 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.8 m-85 -100.98 133.87 44.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.534 0.683 . . . . 0.0 111.256 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.531 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -121.85 162.65 20.56 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.249 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.44 159.26 19.39 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.261 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.462 ' N ' ' HB1' ' A' ' 46' ' ' ALA . 4.9 p-10 -59.53 -27.41 66.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.408 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.56 -34.86 78.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.11 -5.4 8.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.881 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.474 HG23 ' N ' ' A' ' 23' ' ' PHE . 31.3 m -89.39 146.59 24.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.154 0.502 . . . . 0.0 111.537 -179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.474 ' N ' HG23 ' A' ' 22' ' ' THR . 22.9 t80 -74.11 126.66 31.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.627 HG12 HD13 ' A' ' 45' ' ' ILE . 98.3 t -94.61 -61.37 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.468 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 p -179.17 153.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.705 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 6.4 pt-20 -96.94 160.94 14.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.148 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.1 136.22 34.99 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 113.882 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.461 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 9.1 pt-20 -118.66 15.89 13.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.724 -0.238 . . . . 0.0 111.408 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 44.7 m -58.38 123.49 16.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.281 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.442 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 31.7 t0 67.05 64.78 0.73 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 121.542 0.686 . . . . 0.0 110.715 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -88.72 41.58 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.554 2.169 . . . . 0.0 110.953 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 66.28 35.79 5.72 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.019 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.528 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 18.3 p30 -169.57 160.37 7.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.923 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.528 ' HD2' ' HB2' ' A' ' 33' ' ' ASN . 37.0 Cg_endo -65.96 71.63 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.092 2.528 . . . . 0.0 114.657 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 31.6 mtpt -134.58 127.38 31.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.884 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.429 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -171.35 137.99 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.849 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 64.2 m -128.76 62.69 62.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 2.8 Cg_exo -75.83 44.87 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.894 2.396 . . . . 0.0 112.456 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -171.44 44.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.659 0.742 . . . . 0.0 109.081 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -159.17 142.65 14.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.029 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.78 26.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 m-20 -96.3 128.42 36.75 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 -26.41 82.7 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.806 2.337 . . . . 0.0 111.744 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 mtm-85 -68.07 -34.07 75.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.822 HG13 ' HA ' ' A' ' 6' ' ' ASN . 46.3 mm -72.15 114.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.589 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -107.89 -39.79 5.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.833 0.349 . . . . 0.0 110.591 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.531 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.6 p90 -154.73 155.12 33.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.401 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.537 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -138.81 135.02 7.11 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.642 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -91.46 102.96 14.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.28 120.9 66.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.315 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.12 136.99 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.563 2.176 . . . . 0.0 112.236 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.08 137.34 33.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.345 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.419 -1.277 . . . . 0.0 109.235 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--O 1.235 0.316 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.791 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 20.0 ptp180 -161.58 152.01 17.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.228 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.438 HG22 ' HA ' ' A' ' 47' ' ' TYR . 6.1 tt -77.52 128.49 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.484 0.659 . . . . 0.0 110.754 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.29 121.45 31.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.211 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t 179.9 -162.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -158.1 -174.38 4.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.427 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 4.5 m -59.99 -53.82 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.536 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 39.7 t -65.97 -42.57 89.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.562 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . . . -71.39 -30.5 66.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.9 146.49 50.39 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.3 m -66.08 133.19 50.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.532 0.205 . . . . 0.0 111.096 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 38.1 ttpt -52.55 135.46 34.13 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.17 -36.2 3.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.169 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.539 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 20.8 t -70.43 118.71 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.549 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 67.1 mttm -91.75 116.14 28.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.61 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 59.9 m-85 -94.53 132.91 38.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.079 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.449 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.8 m-85 -120.82 159.85 24.6 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.276 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.63 160.69 19.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.326 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -61.09 -27.14 68.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.434 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -64.4 -33.52 76.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.313 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.2 -4.53 9.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.91 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.485 HG21 ' N ' ' A' ' 23' ' ' PHE . 42.1 m -89.04 148.3 23.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.0 111.461 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.485 ' N ' HG21 ' A' ' 22' ' ' THR . 21.1 t80 -74.34 124.74 27.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.692 179.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.649 HG13 ' HD2' ' A' ' 44' ' ' ARG . 78.2 t -90.47 -64.23 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 p 179.98 150.7 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.265 -179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.549 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.6 pt-20 -97.69 155.39 17.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.155 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.645 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.9 138.33 48.98 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.219 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 13.0 pt-20 -119.78 14.17 12.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.929 0.395 . . . . 0.0 111.013 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.604 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 33.4 p -77.6 137.67 38.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.023 0.439 . . . . 0.0 111.81 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.581 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 9.9 t70 -156.85 133.77 6.51 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.38 -18.98 48.79 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.295 2.663 . . . . 0.0 113.55 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.08 -40.27 84.74 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.649 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 9.0 p30 -173.16 -41.23 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.508 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.649 ' HD2' ' H ' ' A' ' 33' ' ' ASN . 56.7 Cg_endo -73.45 89.51 0.95 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 121.34 1.36 . . . . 0.0 111.491 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.79 143.27 36.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.683 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.64 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -53.78 143.93 19.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.759 0.662 . . . . 0.0 111.676 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.6 m -108.86 78.12 0.9 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.445 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.64 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 1.3 Cg_endo -84.15 41.19 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.024 2.482 . . . . 0.0 111.924 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -77.7 -32.45 52.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.81 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -163.05 152.81 15.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.48 132.77 44.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.762 0.315 . . . . 0.0 110.811 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.489 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 66.4 m-20 -79.28 121.12 82.61 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.409 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.63 -25.45 79.16 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.803 2.335 . . . . 0.0 111.553 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.649 ' HD2' HG13 ' A' ' 24' ' ' VAL . 33.0 ptt180 -67.23 -29.57 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.189 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 HD12 HG12 ' A' ' 24' ' ' VAL . 34.9 mm -72.55 112.22 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.64 0.257 . . . . 0.0 110.689 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.791 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -105.89 -43.4 4.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.77 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.3 p90 -156.1 150.19 25.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.866 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -128.58 130.42 6.54 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.252 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 49' ' ' ILE . 3.7 mp -88.97 100.74 11.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 82.8 m -89.94 125.7 59.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.039 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 7.4 Cg_exo -73.12 65.01 4.26 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.304 2.669 . . . . 0.0 112.591 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pp -156.92 32.63 0.3 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.493 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.815 179.579 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--O 1.235 0.342 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 -146.84 123.79 11.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -78.71 141.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.218 0.532 . . . . 0.0 110.56 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.41 90.93 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.481 HG23 ' CE2' ' A' ' 16' ' ' TYR . 14.8 t -173.23 -171.96 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.073 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.767 ' HA ' HG13 ' A' ' 45' ' ' ILE . 2.3 p-10 -160.91 -164.96 1.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.259 -0.177 . . . . 0.0 110.612 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.523 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 59.1 m -59.59 -37.77 79.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.635 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 3.9 t -80.71 -59.18 2.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.407 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.94 -16.66 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.444 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -59.37 147.88 41.74 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.27 -0.491 . . . . 0.0 113.027 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -68.48 129.49 40.09 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.696 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 49.7 tttm -55.15 125.23 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.398 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.36 -38.47 3.14 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.0 m -72.04 121.89 19.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 68.2 mttm -89.8 121.3 31.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.657 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 48.9 m-85 -94.77 134.68 37.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.144 0.497 . . . . 0.0 110.829 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.414 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.7 m-85 -119.35 161.85 19.78 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.705 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.34 161.13 18.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.408 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.429 ' N ' ' HB3' ' A' ' 46' ' ' ALA . 1.6 p30 -57.17 -29.39 63.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.657 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.28 -33.69 76.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.34 -5.1 9.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.815 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.477 HG22 ' N ' ' A' ' 23' ' ' PHE . 48.9 m -88.39 148.04 24.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.528 . . . . 0.0 111.162 -179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.569 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.5 t80 -71.34 130.01 40.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.047 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.722 HG11 HD12 ' A' ' 45' ' ' ILE . 73.2 t -97.1 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.819 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 24' ' ' VAL . 25.5 p -178.95 153.22 0.62 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -97.66 147.68 24.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.696 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -70.77 138.12 28.05 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.375 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.635 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 8.1 pt-20 -89.75 -6.35 56.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 87.1 p 67.68 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.67 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.619 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 38.3 t0 -56.14 -56.04 35.35 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.646 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.619 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 84.8 Cg_endo -77.44 40.47 0.84 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.018 1.812 . . . . 0.0 113.676 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.9 tpt85 -106.61 -32.35 8.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.955 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 16.8 p30 -148.72 158.37 39.88 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.05 62.68 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.248 2.632 . . . . 0.0 112.722 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -153.7 112.65 3.71 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.4 124.27 19.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.369 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -88.53 -43.93 0.46 Allowed Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.9 46.63 0.53 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.577 2.184 . . . . 0.0 113.607 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.03 -34.24 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.851 0.358 . . . . 0.0 110.417 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -167.5 145.92 4.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.62 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.711 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.605 ' OD1' ' HB2' ' A' ' 6' ' ' ASN . 4.2 m-20 -78.1 122.04 84.81 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.12 -32.77 71.26 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.318 2.679 . . . . 0.0 113.551 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.483 ' NE ' HG12 ' A' ' 24' ' ' VAL . 25.3 ptt-85 -70.16 -17.54 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.767 HG13 ' HA ' ' A' ' 6' ' ' ASN . 30.4 mm -69.82 107.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.429 ' HB3' ' N ' ' A' ' 19' ' ' ASP . . . -103.15 -49.41 3.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.22 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.3 p90 -150.79 149.13 29.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.898 0.38 . . . . 0.0 111.249 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.657 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -118.23 134.25 10.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.114 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.434 HD11 HG23 ' A' ' 49' ' ' ILE . 47.8 mm -110.2 120.45 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.878 0.37 . . . . 0.0 110.449 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.6 m -91.95 125.77 55.82 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.2 Cg_exo -68.29 126.38 14.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.734 2.289 . . . . 0.0 112.041 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.87 -35.44 14.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.342 -1.313 . . . . 0.0 108.568 179.778 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.6 t0 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.1 mmt180 -142.38 126.69 17.62 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.5 tt -142.12 131.36 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.312 0.577 . . . . 0.0 111.162 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.65 124.4 35.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.698 HG22 HG21 ' A' ' 45' ' ' ILE . 12.5 t -179.24 -158.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . 0.827 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.8 p30 -151.58 -168.09 2.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 m -65.81 -58.84 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.719 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -62.87 -44.72 95.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.768 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.02 -11.68 60.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.2 145.23 35.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.48 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 14.9 m -67.23 137.0 55.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.552 0.215 . . . . 0.0 110.931 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.741 ' HZ2' ' HB2' ' A' ' 30' ' ' ASP . 59.0 mttm -49.23 133.27 19.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.716 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.2 -37.36 3.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.276 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.48 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 59.3 m -65.68 112.59 3.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.591 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 62.2 mttm -89.64 116.78 28.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.513 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 76.8 m-85 -94.46 135.64 35.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.454 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -120.53 161.54 21.13 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.749 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.501 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 1.8 p -80.74 164.5 22.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.275 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -60.82 -28.56 68.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.72 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.03 -33.88 76.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.938 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.25 -9.22 7.43 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.652 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 23' ' ' PHE . 23.3 m -86.6 146.0 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.378 0.609 . . . . 0.0 111.31 -178.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.457 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -69.86 127.62 33.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.555 HG13 HD12 ' A' ' 45' ' ' ILE . 71.9 t -96.96 -61.2 2.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.3 p -178.16 148.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.446 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.591 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.5 pt-20 -94.17 159.85 14.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.336 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.31 127.69 45.52 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.196 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.719 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 5.5 pt-20 -126.49 35.41 4.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.589 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 22.9 m -63.11 102.66 0.4 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.741 ' HB2' ' HZ2' ' A' ' 12' ' ' LYS . 47.8 t0 -170.68 123.64 0.59 Allowed Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.936 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 9.7 Cg_exo -71.43 -6.42 19.12 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -58.19 -43.41 87.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.03 144.05 27.19 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.499 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.22 65.83 2.06 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.206 2.604 . . . . 0.0 113.532 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -140.89 132.0 26.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.36 139.29 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.224 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.431 ' HA ' ' HB3' ' A' ' 8' ' ' CYS . 96.3 m -88.35 116.1 65.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 110.854 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 2.8 Cg_exo -75.62 137.59 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.12 2.546 . . . . 0.0 111.764 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.519 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -73.84 -28.88 61.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -67.64 139.22 56.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.209 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.51 142.54 37.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.677 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.483 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 22.5 m-20 -78.82 129.87 72.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.207 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 7.5 Cg_exo -71.92 56.23 2.4 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.6 2.867 . . . . 0.0 110.574 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 18' ' ' SER . 33.3 ptt180 -167.11 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.5 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.827 HG13 ' HA ' ' A' ' 6' ' ' ASN . 33.2 mm -73.62 102.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.418 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -97.86 -40.49 8.49 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.576 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.454 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.0 p90 -159.28 159.58 34.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.846 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.98 134.05 5.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.568 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.462 HD11 ' N ' ' A' ' 49' ' ' ILE . 4.4 mp -96.35 126.56 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 72.8 m -95.6 143.53 26.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo -75.73 52.94 3.48 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.994 2.463 . . . . 0.0 111.814 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -161.92 -42.18 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.406 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.34 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.91 179.566 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 2' ' ' ARG . 2.2 ptp85 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.962 0.411 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 mt -134.85 130.53 52.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.28 114.98 27.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.541 HG22 HG21 ' A' ' 45' ' ' ILE . 13.6 t -166.49 -158.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.563 0.22 . . . . 0.0 110.463 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -155.17 167.65 29.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.26 -43.54 61.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 34.4 t -69.17 -45.4 70.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.11 55.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.55 142.9 48.06 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.019 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -67.15 135.06 52.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 23.5 tptp -55.44 131.56 46.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.7 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.36 -34.43 4.84 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.647 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.0 t -71.42 123.36 22.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 2.7 ptpp? -101.79 115.23 30.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.655 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 62.4 m-85 -92.47 135.93 33.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.3 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.485 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.9 m-85 -120.45 159.43 25.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -91.9 168.77 11.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.909 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -64.4 -31.75 73.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.547 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.15 -19.23 64.28 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.192 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.92 -4.04 52.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.659 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -89.4 148.25 23.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 21.0 t80 -70.56 128.49 36.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' A' ' 25' ' ' CYS . 79.6 t -90.54 -65.73 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.207 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 24' ' ' VAL . 26.7 p -178.57 154.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.789 0.328 . . . . 0.0 111.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -92.92 153.38 18.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.377 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.47 123.51 31.0 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.072 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 11.3 pt-20 -90.3 26.51 1.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.779 0.323 . . . . 0.0 111.439 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -78.2 64.17 3.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.794 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 3.3 t70 -67.15 128.23 93.73 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.298 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.64 -19.56 59.94 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.946 2.431 . . . . 0.0 113.327 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 7.7 tpm_? -70.51 -37.64 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.34 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -116.68 133.29 23.05 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 0.0 111.195 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.26 126.6 17.38 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.345 2.03 . . . . 0.0 111.338 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -159.09 146.43 17.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.958 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.491 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -168.77 122.78 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 m -128.93 51.86 8.15 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.29 40.65 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.439 2.092 . . . . 0.0 111.384 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 38' ' ' PRO . 1.6 mpp_? -132.07 32.24 4.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.912 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -174.43 152.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.954 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.41 125.65 17.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.807 ' HB2' HG12 ' A' ' 45' ' ' ILE . 73.8 m-20 -78.64 126.66 82.33 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.19 -29.3 74.9 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 123.438 2.758 . . . . 0.0 113.448 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 18' ' ' SER . 1.2 ptm85 -88.22 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.275 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.807 HG12 ' HB2' ' A' ' 42' ' ' ASP . 28.7 mm -79.21 94.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.25 -45.43 9.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.806 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -157.63 159.92 37.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.683 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -137.74 131.81 5.63 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.034 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.39 93.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 93.4 m -88.74 139.55 29.46 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.4 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.69 136.46 39.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.578 2.185 . . . . 0.0 112.231 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.9 -33.62 39.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.97 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.613 179.728 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 121.055 0.455 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tt -160.18 127.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.304 0.573 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.474 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -98.76 130.41 45.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.699 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -175.93 -148.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.445 ' HA ' HG13 ' A' ' 45' ' ' ILE . 17.0 p30 -154.62 164.96 37.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 m -48.99 -49.28 41.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 50.0 t -63.33 -43.58 97.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.053 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.49 29.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.913 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.64 144.79 15.86 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.2 m -63.1 121.92 14.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.679 0.276 . . . . 0.0 110.38 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 57.3 mtmt -54.07 130.55 38.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.891 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.83 -39.7 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -72.8 121.81 20.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 24.0 ttmm -93.11 120.88 33.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 77.0 m-85 -95.86 142.49 28.05 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.344 0.592 . . . . 0.0 111.933 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 11.3 m-85 -130.33 162.83 28.17 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.1 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.91 162.02 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.835 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.423 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.17 -32.15 73.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.75 -2.36 11.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.565 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -88.23 146.96 25.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.51 0.671 . . . . 0.0 111.162 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 5.0 t80 -73.15 131.86 42.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.708 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.0 t -103.98 -67.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.375 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.3 p -179.11 147.19 0.33 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.685 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 pm0 -87.91 167.11 14.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.47 125.4 23.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.732 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 35' ' ' LYS . 1.2 pp20? -122.08 49.32 1.59 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.495 0.664 . . . . 0.0 110.939 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 18.3 m -75.99 52.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.816 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.573 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 20.3 t70 61.42 130.37 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 123.836 0.855 . . . . 0.0 112.133 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.19 -40.08 78.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.21 1.94 . . . . 0.0 112.533 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.586 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 31.4 ttm-85 -66.4 -53.39 36.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HB3' ' O ' ' A' ' 32' ' ' ARG . 9.5 p30 142.86 -36.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 125.088 1.355 . . . . 0.0 114.294 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 30' ' ' ASP . 16.7 Cg_exo -69.79 68.71 1.7 Allowed 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.52 2.147 . . . . 0.0 115.173 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 29' ' ' SER . 58.7 tttm -160.82 129.66 4.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.848 0.356 . . . . 0.0 110.414 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -162.41 142.33 9.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.54 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -127.97 72.15 78.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.713 0.292 . . . . 0.0 111.514 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.32 39.86 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.086 2.524 . . . . 0.0 112.012 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -70.26 -35.79 74.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.614 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 45.5 t30 178.14 152.16 0.28 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.745 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -84.6 125.96 32.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 42.3 m-20 -79.84 131.11 64.74 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.799 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.2 Cg_exo -59.61 -22.6 67.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.837 2.358 . . . . 0.0 111.027 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.65 -35.42 80.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.403 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' A' ' 16' ' ' TYR . 23.4 mm -84.45 94.48 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.67 12.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.3 p90 -158.51 161.71 37.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.647 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.65 136.18 7.0 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.111 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -96.5 123.96 49.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.76 0.314 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 72.7 m -103.1 126.62 31.85 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.295 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.3 Cg_exo -71.88 121.39 7.57 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.596 2.197 . . . . 0.0 111.624 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.4 -37.13 10.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.33 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.857 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.772 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.652 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 13.0 ptm180 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.741 0.305 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tt -148.92 133.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.048 0.451 . . . . 0.0 110.72 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.78 129.7 42.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 t -178.03 -154.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -148.33 172.2 14.78 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -52.97 -51.66 60.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.708 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -61.3 -46.78 88.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.502 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.19 29.5 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.588 . . . . 0.0 111.032 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.98 143.93 15.77 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.635 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -60.83 128.82 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.611 0.205 . . . . 0.0 110.901 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -50.06 128.55 19.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.979 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.47 -33.82 4.02 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.833 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.23 118.11 11.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -94.27 119.4 33.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.351 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.66 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 57.6 m-85 -93.67 139.82 30.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 111.323 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -124.27 160.86 27.03 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.723 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 167.82 17.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.985 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -61.09 -30.69 70.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.311 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -66.72 -26.71 67.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.273 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.56 2.08 25.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.159 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -88.1 145.4 25.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.468 . . . . 0.0 110.532 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 23.8 t80 -73.0 124.36 25.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -92.98 -63.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.8 p -177.18 149.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.633 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 pt-20 -94.46 158.04 15.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.38 122.35 29.81 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.557 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.708 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 14.4 pt-20 -109.67 29.99 7.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.4 m -60.57 136.84 58.18 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t70 64.92 71.2 0.56 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.783 0.801 . . . . 0.0 110.142 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.494 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 2.0 Cg_endo -81.7 -5.17 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.741 2.294 . . . . 0.0 109.659 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 5.1 tpp85 76.33 -37.53 0.3 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 113.965 -1.471 . . . . 0.0 110.491 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' A' ' 31' ' ' PRO . 9.1 p-10 -85.84 149.86 51.82 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.56 119.36 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.276 1.984 . . . . 0.0 112.186 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -160.32 132.68 6.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.906 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 135.29 38.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.0 m -88.67 140.49 29.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.554 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.0 Cg_exo -62.73 134.6 47.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.87 2.38 . . . . 0.0 111.689 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' HD3' ' N ' ' A' ' 39' ' ' ARG . 1.0 OUTLIER -90.11 46.11 1.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.101 0.477 . . . . 0.0 110.649 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.91 146.76 19.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.58 134.09 34.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 17.7 m-20 -78.96 127.54 79.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.059 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.91 -23.58 68.2 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.55 2.167 . . . . 0.0 110.901 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 10.6 ptp85 -70.39 -26.6 63.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.818 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 16' ' ' TYR . 23.5 mm -83.96 98.42 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.412 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.2 -42.08 11.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.694 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 4.2 p90 -157.38 174.03 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.085 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.66 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -150.14 134.43 4.81 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.687 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.9 mm -90.75 104.31 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.51 122.7 66.89 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.87 138.04 27.99 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.63 2.22 . . . . 0.0 112.265 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.8 pp -81.64 -22.87 37.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.263 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.609 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 30.0 ttm180 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 tt -144.24 137.27 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.876 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -88.99 127.86 35.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 HG21 ' A' ' 45' ' ' ILE . 12.4 t -178.52 -158.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.654 ' HA ' HG13 ' A' ' 45' ' ' ILE . 18.8 p30 -155.21 -173.42 4.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 m -62.37 -50.94 69.58 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.1 t -65.14 -48.87 72.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.743 0.306 . . . . 0.0 111.661 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.93 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.381 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.02 144.97 49.4 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -66.13 126.08 27.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.651 0.262 . . . . 0.0 110.745 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 86.7 tttt -53.79 131.79 40.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.43 -40.9 2.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.74 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.2 m -73.9 123.88 25.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 67.5 mttm -89.76 123.63 33.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.623 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 25.9 m-85 -96.89 134.92 39.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.785 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.2 m-85 -126.54 167.08 16.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.111 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.57 156.69 16.95 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.7 -26.43 67.13 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.546 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.26 -34.29 74.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.422 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.18 -5.25 8.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 m -89.29 146.43 24.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 111.694 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.7 t80 -76.5 130.96 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.566 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 45' ' ' ILE . 95.0 t -99.11 -67.46 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.4 p -176.71 143.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.773 0.32 . . . . 0.0 110.434 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.594 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . 3.8 pt-20 -91.08 162.5 14.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.9 116.88 8.37 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.979 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.77 24.58 7.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.503 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 p -77.09 54.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.469 0.652 . . . . 0.0 111.354 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.12 117.33 60.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.729 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.18 32.49 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.382 2.722 . . . . 0.0 113.732 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -80.53 -22.68 40.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.531 0.682 . . . . 0.0 109.731 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -165.26 148.69 7.2 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.919 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.39 137.73 71.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.554 2.169 . . . . 0.0 111.369 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -150.81 136.89 18.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.79 0.329 . . . . 0.0 110.532 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.85 119.82 30.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.019 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -88.89 138.97 29.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.5 128.45 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.616 2.211 . . . . 0.0 112.006 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -70.75 -20.78 62.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.479 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -71.85 132.46 44.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.941 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -85.25 123.18 30.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -79.61 121.25 82.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.417 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.97 -16.08 51.2 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.863 2.375 . . . . 0.0 110.237 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -67.44 -30.21 69.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.696 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.654 HG13 ' HA ' ' A' ' 6' ' ' ASN . 14.7 mm -88.62 112.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.34 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.43 -40.82 8.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.707 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.1 p90 -158.74 174.3 15.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.674 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.71 133.97 5.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.796 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.78 122.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.875 0.369 . . . . 0.0 110.579 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.2 m -92.56 136.64 25.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.142 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 27.8 Cg_exo -62.04 137.16 65.21 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.887 2.391 . . . . 0.0 112.167 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.1 151.48 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.3 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.904 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 42.8 ptt85 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 47' ' ' TYR . 10.1 tt -78.35 133.88 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.504 0.669 . . . . 0.0 110.965 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.07 112.58 24.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -178.19 -163.11 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.702 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -160.24 164.54 32.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 63.2 m -52.13 -40.58 61.56 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.522 ' HA ' ' CD ' ' A' ' 28' ' ' GLU . 24.8 t -58.5 -47.25 84.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.288 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.82 -16.82 49.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.6 133.54 41.41 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.049 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 31' ' ' PRO . 22.9 m -67.81 130.83 44.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.706 -0.247 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -61.95 97.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.277 0.56 . . . . 0.0 110.341 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.81 -39.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 84.8 m -73.1 119.24 17.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 49.7 mttp -88.95 112.29 23.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.134 0.492 . . . . 0.0 111.466 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 71.6 m-85 -93.72 132.58 37.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.14 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -120.96 152.22 38.79 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.253 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.82 165.47 20.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.12 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -59.08 -30.43 68.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.547 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -67.37 -28.36 67.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.65 2.19 22.71 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.088 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -88.52 146.42 25.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 0.0 110.524 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -72.77 127.04 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.751 HG13 ' HE ' ' A' ' 44' ' ' ARG . 52.1 t -93.16 -60.31 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.565 ' SG ' HG12 ' A' ' 24' ' ' VAL . 24.3 p -176.33 148.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.644 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 17.1 pt-20 -99.55 42.23 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.175 0.512 . . . . 0.0 111.079 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.13 -175.79 41.79 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.016 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.559 ' HG3' ' N ' ' A' ' 29' ' ' SER . 7.2 pt-20 -148.56 -42.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 50.3 m -77.28 139.65 39.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 1.024 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 16.7 t70 -61.79 144.11 93.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.146 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 89.3 Cg_exo -44.54 -26.33 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.529 2.819 . . . . 0.0 114.631 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.93 40.56 1.66 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 1.024 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 4.3 p-10 -94.12 146.61 31.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.824 0.345 . . . . 0.0 110.663 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 66.41 4.19 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.828 2.352 . . . . 0.0 112.481 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -136.92 128.81 29.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.434 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -123.68 138.92 54.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.522 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 39.1 m -130.61 62.49 65.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 3.1 Cg_exo -79.47 40.28 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.95 2.434 . . . . 0.0 111.821 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 51.1 ttp85 -67.12 -57.89 5.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 6.0 t-20 173.18 154.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.682 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.38 125.31 29.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.433 ' HB2' HG12 ' A' ' 45' ' ' ILE . 64.7 m-20 -77.66 123.33 86.59 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 2' ' ' ARG . 31.1 Cg_exo -61.17 -24.89 79.99 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.841 2.36 . . . . 0.0 110.751 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.751 ' HE ' HG13 ' A' ' 24' ' ' VAL . 19.0 ttp-105 -64.63 -28.38 69.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.231 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.47 HD13 HG11 ' A' ' 24' ' ' VAL . 30.9 mm -79.78 102.76 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.202 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -89.4 -51.18 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.461 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 3' ' ' ILE . 29.7 p90 -155.97 153.24 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.977 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -131.31 129.19 5.63 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.696 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.61 119.81 47.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -97.16 128.17 36.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.35 137.04 16.41 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.619 2.213 . . . . 0.0 112.162 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -160.2 146.42 15.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.147 -179.693 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.817 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 39.9 ptt180 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tt -77.51 124.52 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 0.0 110.692 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.72 122.57 32.95 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.742 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -178.2 -158.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.008 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -153.02 177.17 11.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.58 -40.88 79.97 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.977 0.418 . . . . 0.0 111.437 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.27 -47.85 77.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.878 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.45 33.58 1.78 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.08 -129.11 5.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.311 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.598 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 14.8 m -153.56 127.51 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 29' ' ' SER . 24.1 tptm -48.63 127.16 13.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.818 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.71 -39.63 3.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.197 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.7 m -66.68 118.43 10.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.06 0.43 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.914 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 19.6 mmmt -89.12 116.0 27.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.689 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.0 m-85 -86.93 134.42 33.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.22 0.533 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.5 m-85 -123.7 161.03 25.95 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.072 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.68 157.06 18.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -30.78 63.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.726 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -63.61 -29.67 70.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.336 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.29 0.37 16.4 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.263 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -88.66 147.03 24.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.052 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.404 ' CE1' ' HE3' ' A' ' 15' ' ' LYS . 23.3 t80 -76.06 132.94 40.41 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.481 HG12 ' SG ' ' A' ' 25' ' ' CYS . 98.6 t -103.32 -68.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.7 p -179.66 146.05 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.662 0.268 . . . . 0.0 111.541 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.914 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 3.8 pm0 -84.03 159.29 21.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.598 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.06 125.02 11.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.151 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.03 0.2 56.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.538 0.209 . . . . 0.0 111.347 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.665 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 1.3 m -61.94 109.31 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.69 138.78 24.99 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.29 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.57 -24.08 12.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.3 -23.48 67.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -147.55 133.73 9.68 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.219 0.533 . . . . 0.0 111.248 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.35 60.23 4.85 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 113.012 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.36 127.29 33.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.908 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -159.99 124.92 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 m -135.74 58.05 22.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.05 43.7 1.56 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.832 2.354 . . . . 0.0 111.69 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -97.02 -33.11 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -153.65 140.52 19.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.05 141.66 28.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.284 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.97 125.18 85.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.69 0.281 . . . . 0.0 110.832 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.88 47.58 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.488 2.792 . . . . 0.0 111.71 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -156.53 -30.8 0.09 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.492 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.2 mm -65.68 110.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.505 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.817 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -109.61 -41.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.475 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.2 p90 -159.72 147.59 17.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 111.594 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -112.5 125.27 7.04 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.821 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.1 115.42 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.827 0.346 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 60.4 m -94.52 124.95 53.63 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.0 Cg_exo -70.63 137.89 33.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.071 2.514 . . . . 0.0 112.219 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.55 53.77 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.221 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.17 0.919 . . . . 0.0 110.492 -178.922 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.511 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . 57.9 mtm180 . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tt -79.06 136.49 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.01 112.71 22.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.435 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.424 HG23 HG21 ' A' ' 45' ' ' ILE . 11.6 t -179.77 -166.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.868 ' HA ' HG13 ' A' ' 45' ' ' ILE . 12.9 p30 -161.97 -156.46 0.43 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.7 0.286 . . . . 0.0 110.927 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 m -70.38 -48.66 55.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.351 0.596 . . . . 0.0 109.721 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.2 t -58.28 -52.59 64.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.32 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.78 -28.74 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.783 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.91 143.23 48.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.659 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -63.15 125.78 25.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.563 0.22 . . . . 0.0 110.919 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -55.93 117.95 4.16 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.618 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.27 -43.53 1.53 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.4 m -74.17 126.83 31.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 26' ' ' GLU . 1.9 mptp? -89.37 125.3 35.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.53 0.205 . . . . 0.0 110.527 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.662 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 12.6 m-85 -99.14 133.82 42.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.517 0.675 . . . . 0.0 110.964 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.511 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -122.5 163.66 19.5 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.559 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 161.62 19.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.107 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.8 -28.81 66.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.813 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -64.95 -29.71 70.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.166 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.42 -0.09 18.51 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.321 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -88.57 144.85 26.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.031 0.443 . . . . 0.0 111.019 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.5 t80 -75.48 128.68 35.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.1 t -101.15 -60.55 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.487 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.8 p -177.84 150.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.648 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -96.01 166.22 11.88 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.962 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.686 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.97 140.04 45.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 16.9 pt-20 -121.15 20.47 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.89 0.376 . . . . 0.0 110.704 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -81.28 58.84 3.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.82 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 27.1 t70 -72.46 131.96 84.23 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.859 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 51.1 Cg_exo -55.12 -26.01 48.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.583 2.855 . . . . 0.0 113.364 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttt85 -55.56 -39.98 71.34 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.714 0.292 . . . . 0.0 111.344 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.38 109.46 1.1 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 121.568 0.699 . . . . 0.0 111.795 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.85 146.69 23.67 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.983 2.455 . . . . 0.0 111.674 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -127.56 148.07 50.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.4 130.7 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.6 m -88.83 126.57 59.09 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.908 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 -57.02 0.96 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.828 2.352 . . . . 0.0 113.276 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 15.0 mmp_? -98.86 -38.3 9.09 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.959 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 t30 63.32 31.41 15.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.965 0.888 . . . . 0.0 110.317 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.82 110.54 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.279 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' CG ' ' HB3' ' A' ' 6' ' ' ASN . 24.2 m-20 -110.3 127.66 26.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.36 -29.23 67.01 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.489 2.793 . . . . 0.0 113.775 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 ptt85 -78.03 -20.56 52.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.868 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.9 mm -79.23 114.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 2' ' ' ARG . . . -105.06 -40.78 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.764 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.4 p90 -160.0 155.74 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -123.78 130.78 7.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.917 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.25 120.75 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.913 0.387 . . . . 0.0 110.586 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.94 126.98 55.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.145 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.22 136.82 27.5 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.557 2.171 . . . . 0.0 112.28 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.01 26.7 9.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.783 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.633 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 14.9 ptm180 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.997 0.427 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 47' ' ' TYR . 10.4 tt -79.4 137.02 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.104 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.02 116.81 27.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -176.95 -172.96 0.44 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.703 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.1 p-10 -161.41 -168.57 2.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 57.8 m -59.76 -50.09 75.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ALA . 41.8 t -70.58 -43.09 70.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.65 76.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.012 0.435 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.96 -179.45 45.83 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.44 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.4 m -110.8 133.35 53.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.36 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 1.122 ' HG3' ' HB3' ' A' ' 30' ' ' ASP . 2.7 mmmt -53.84 127.36 25.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.374 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.93 -39.97 2.56 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 48.4 t -72.24 129.74 39.14 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.66 103.54 16.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.687 0.28 . . . . 0.0 111.513 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 78.9 m-85 -92.2 129.2 38.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 110.833 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -121.07 154.12 36.52 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.768 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -84.46 162.8 19.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.566 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -62.02 -28.43 69.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.295 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.231 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 -3.7 11.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.187 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -90.15 148.72 22.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.09 0.471 . . . . 0.0 111.252 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.87 126.63 30.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 45' ' ' ILE . 71.5 t -91.92 -59.32 3.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.6 p -175.13 154.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.067 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 9.7 pt-20 -96.7 39.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.108 0.48 . . . . 0.0 110.268 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.48 148.81 2.68 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG2' ' C ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -122.54 23.64 9.53 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.891 -0.77 . . . . 0.0 111.428 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.78 50.48 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.38 0.61 . . . . 0.0 110.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 1.122 ' HB3' ' HG3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -174.96 -55.36 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.492 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 43.7 Cg_endo -69.49 116.96 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 120.932 1.088 . . . . 0.0 110.84 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 31' ' ' PRO . 18.7 ttp-105 86.33 -37.35 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.692 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -171.78 126.45 0.58 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.307 0.575 . . . . 0.0 111.885 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.35 62.72 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.778 2.318 . . . . 0.0 111.784 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -130.63 139.11 50.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.858 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -102.71 137.89 40.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.524 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 67.7 m -89.15 108.4 23.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.858 0.361 . . . . 0.0 111.056 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 87.3 Cg_endo -88.16 30.65 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.869 2.379 . . . . 0.0 112.424 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -174.61 50.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 109.937 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -161.8 137.87 7.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -157.67 136.29 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.622 ' H ' ' HB3' ' A' ' 6' ' ' ASN . 1.1 m-20 -82.35 125.17 77.21 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.711 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.89 -21.01 69.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.361 2.04 . . . . 0.0 109.721 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 18' ' ' SER . 6.4 ttp180 -71.64 -34.18 69.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.12 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.703 HG13 ' HA ' ' A' ' 6' ' ' ASN . 31.1 mm -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.153 0.501 . . . . 0.0 111.566 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -115.48 -44.17 2.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.497 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 3' ' ' ILE . 21.3 p90 -157.89 156.28 31.08 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.241 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -130.44 124.38 4.25 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.729 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -87.32 94.52 4.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 84.5 m -89.17 118.93 69.64 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.143 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 6.9 Cg_exo -73.65 134.55 20.45 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.008 2.472 . . . . 0.0 112.14 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.43 ' HB3' ' H ' ' A' ' 53' ' ' ALA . 7.0 mp -95.26 -143.32 0.26 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.161 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 52' ' ' LEU . . . . . . . . 0 C--O 1.247 0.953 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.176 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tt -78.3 130.43 36.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.791 0.805 . . . . 0.0 112.132 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.61 123.57 36.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.272 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' HG13 ' A' ' 45' ' ' ILE . 14.9 t -176.11 -165.71 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -145.36 178.15 8.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 m -54.25 -39.65 67.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.58 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 11.7 t -63.07 -55.93 21.27 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.897 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.03 29.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.349 0.595 . . . . 0.0 111.286 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -98.69 145.15 17.6 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.433 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 m -71.72 127.56 32.97 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.754 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 22.5 ttmm -50.28 131.57 24.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 111.341 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.33 -39.25 3.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.142 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.612 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 48.8 t -66.13 122.12 16.71 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.12 117.06 32.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.076 0.465 . . . . 0.0 111.127 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.78 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 37.3 m-85 -86.06 140.33 30.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.898 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -124.83 158.02 34.44 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.674 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.704 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 1.1 p -86.45 161.83 18.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.537 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.44 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 11.3 p-10 -65.32 -28.61 69.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.03 -27.48 68.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.823 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.19 -2.93 20.71 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.411 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.2 m -87.85 154.28 20.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.429 0.633 . . . . 0.0 111.002 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 24.2 t80 -75.77 128.81 35.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.762 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG12 ' SG ' ' A' ' 25' ' ' CYS . 53.6 t -90.13 -67.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.541 ' SG ' HG12 ' A' ' 24' ' ' VAL . 27.3 p 177.07 148.63 0.13 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.542 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -90.13 144.88 25.48 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.81 143.36 46.58 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.815 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.58 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.0 OUTLIER -107.26 -18.77 13.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -63.84 129.36 39.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.082 0.468 . . . . 0.0 111.06 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.73 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 36.9 t70 -73.32 127.29 89.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.544 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.11 58.14 3.44 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.025 2.483 . . . . 0.0 111.527 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 23.5 ttm105 -150.39 -41.05 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.459 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 14.1 p-10 -133.29 135.17 24.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.018 0.437 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 16.9 Cg_exo -68.08 129.72 20.04 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.858 2.372 . . . . 0.0 112.265 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.11 136.9 52.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.963 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.46 120.36 10.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.3 m -150.44 145.47 18.57 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.632 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 128.45 24.35 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.448 2.099 . . . . 0.0 111.809 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -86.03 46.74 1.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.789 0.804 . . . . 0.0 109.883 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.91 124.08 40.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.119 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.26 139.25 30.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.643 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 2.0 p30 -78.17 150.86 77.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.786 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.69 61.08 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.631 2.887 . . . . 0.0 112.047 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.704 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 19.2 ttp180 -171.2 -31.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.046 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.536 HD13 HG11 ' A' ' 24' ' ' VAL . 31.9 mm -59.0 112.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -105.03 -47.07 4.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.429 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -166.41 -169.14 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.403 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -149.51 132.47 4.05 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.936 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.45 97.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m -90.13 126.21 57.77 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 11.8 Cg_exo -70.57 133.25 23.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.799 2.333 . . . . 0.0 112.048 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.86 138.56 32.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.261 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.472 HH12 ' CG ' ' A' ' 19' ' ' ASP . 38.9 mtp85 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.486 HG23 HG22 ' A' ' 45' ' ' ILE . 8.8 tt -77.9 136.69 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.115 0.483 . . . . 0.0 110.009 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.34 106.07 17.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.214 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 HG21 ' A' ' 45' ' ' ILE . 13.3 t 179.37 -168.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.771 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.652 ' HA ' HG13 ' A' ' 45' ' ' ILE . 3.2 p-10 -161.2 -161.42 0.81 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.9 m -67.24 -45.84 75.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -64.93 -52.33 56.97 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.11 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 111.473 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.97 137.73 41.39 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.958 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 22.0 m -61.71 129.39 40.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.624 0.25 . . . . 0.0 110.616 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 39.9 tttp -53.25 130.27 34.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.803 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.44 -37.96 3.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.618 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 t -70.42 125.85 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 8.5 mmmt -94.65 116.89 29.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.262 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.656 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 39.4 m-85 -93.65 134.44 35.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -123.77 162.42 23.22 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.542 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.47 159.44 18.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.414 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' CG ' HH12 ' A' ' 2' ' ' ARG . 15.1 p-10 -59.46 -27.64 66.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.729 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -65.89 -27.6 68.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.933 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.29 -0.69 20.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.294 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.7 m -88.71 146.29 25.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.238 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.75 126.85 31.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.91 -63.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.306 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.4 p -177.76 149.39 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.182 0.515 . . . . 0.0 111.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.677 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 2.0 pt-20 -90.15 149.06 22.6 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.746 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.45 121.82 25.76 Favored Glycine 0 C--O 1.236 0.224 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.893 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 13.0 pt-20 -94.83 11.28 32.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.0 m -50.82 137.88 19.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.681 0.277 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -166.41 133.38 2.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.44 -5.9 17.12 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.881 2.387 . . . . 0.0 113.11 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.46 -33.61 69.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.7 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -151.65 146.4 18.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 84.95 0.17 Allowed 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.928 2.419 . . . . 0.0 113.19 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.71 60.42 3.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.475 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -77.12 106.04 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.073 0.463 . . . . 0.0 110.422 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 73.9 m -129.56 58.44 37.66 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 7.4 Cg_exo -72.41 -33.12 9.25 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.349 2.033 . . . . 0.0 112.06 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -98.69 46.0 1.0 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.375 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.3 t-20 -150.45 121.21 7.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.933 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.66 128.8 12.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.842 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.7 m-20 -87.46 125.65 64.8 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.16 -18.73 64.55 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.247 1.965 . . . . 0.0 110.844 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 44' ' ' ARG . 1.0 OUTLIER -69.58 -34.35 74.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.376 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.652 HG13 ' HA ' ' A' ' 6' ' ' ASN . 38.9 mm -66.76 107.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.586 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.48 -40.94 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 9.0 p90 -154.71 150.59 27.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -117.59 127.21 7.26 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.439 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.7 mt -93.09 100.14 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.21 127.97 53.29 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.81 140.55 51.21 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.737 2.292 . . . . 0.0 112.317 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -160.22 133.07 6.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.735 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.969 0 O-C-N 124.106 0.878 . . . . 0.0 110.696 -179.072 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.652 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 21.5 mmm-85 . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.13 129.99 36.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.604 0.716 . . . . 0.0 110.918 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.56 129.77 35.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 t -176.59 -160.45 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -153.59 166.17 33.6 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -51.61 -44.01 62.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.665 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 t -60.99 -49.65 76.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 111.449 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.99 -29.45 65.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.78 131.9 40.41 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.616 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 m -59.63 126.47 27.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.291 0.236 . . . . 0.0 110.926 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 48.6 tptt -58.83 120.43 9.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.919 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.86 -40.75 2.01 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 59.1 m -71.2 126.47 29.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 13.3 ptpt -88.3 110.84 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.221 0.534 . . . . 0.0 111.218 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 31.8 m-85 -93.95 129.09 40.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -113.28 151.65 30.83 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.807 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.438 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 2.3 p -79.96 167.55 20.34 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.701 0.625 . . . . 0.0 111.351 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.527 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 12.4 p-10 -62.98 -29.23 70.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.28 -30.75 70.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.708 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.89 -9.74 10.4 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 114.014 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 m -87.91 151.13 23.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.254 0.549 . . . . 0.0 111.525 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -68.2 126.78 30.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.743 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.525 HG12 ' SG ' ' A' ' 25' ' ' CYS . 39.1 t -94.77 -56.38 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' A' ' 24' ' ' VAL . 24.7 p -176.35 145.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.271 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -89.9 39.97 0.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.702 0.763 . . . . 0.0 110.076 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.69 172.62 16.43 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.379 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.665 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 15.3 pt-20 -157.04 27.45 0.31 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 p -79.06 66.97 4.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.49 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 41.0 t0 -61.57 119.57 48.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 15.2 Cg_exo -68.44 -19.35 43.25 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.714 2.276 . . . . 0.0 111.302 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -36.55 65.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.33 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.0 p30 -136.19 127.26 16.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 2.6 Cg_exo -76.2 90.23 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.985 2.457 . . . . 0.0 112.199 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -78.59 136.69 37.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.88 115.54 9.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 110.484 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -89.37 137.32 29.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.715 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.24 140.24 93.56 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.938 2.425 . . . . 0.0 112.071 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -83.49 43.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -159.46 146.8 17.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.86 30.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.11 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 20.6 m-20 -78.06 118.78 74.32 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.527 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 22.7 Cg_exo -64.06 -18.45 63.64 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.905 2.403 . . . . 0.0 110.638 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 20.0 ttp-105 -70.94 -32.49 69.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.906 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 mm -64.67 119.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.823 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.652 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -94.88 -52.62 4.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.498 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -166.69 157.69 12.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.253 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -126.86 115.98 2.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.59 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 46.9 mm -90.18 117.41 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.3 m -89.33 121.3 69.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.0 Cg_exo -76.59 130.37 11.65 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.006 2.47 . . . . 0.0 112.545 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.61 -21.65 30.26 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.836 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.434 179.545 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.854 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 17.7 ptp180 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.661 0.267 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -77.05 135.0 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 0.0 110.998 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.11 100.85 13.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.194 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -177.4 -173.21 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.645 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -160.54 -173.66 4.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.34 -45.7 92.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.676 0.275 . . . . 0.0 111.502 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 12.0 t -57.25 -42.07 80.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.945 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.72 -82.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . 31.97 -138.35 0.08 OUTLIER Glycine 0 C--N 1.337 0.588 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.746 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 98.6 m -165.46 126.7 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 28' ' ' GLU . 46.6 mmtt -49.15 135.27 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 111.975 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.45 -43.52 2.78 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 32.8 t -71.82 116.22 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 0.0 109.823 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.713 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 38.0 mttp -99.07 119.97 38.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.039 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.754 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 35.6 m-85 -92.61 136.09 33.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.429 0.633 . . . . 0.0 111.556 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.492 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -119.61 158.14 26.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.941 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.18 162.03 21.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.653 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.27 -26.69 67.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.621 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -66.59 -29.56 69.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.859 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.94 -0.89 17.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.388 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 m -88.86 146.17 25.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.068 0.461 . . . . 0.0 111.305 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.3 t80 -73.77 126.93 31.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.517 HG12 ' SG ' ' A' ' 25' ' ' CYS . 79.1 t -96.76 -63.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.952 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.8 p 179.52 155.15 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.62 0.248 . . . . 0.0 111.033 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 11.7 pt-20 -96.85 147.53 23.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.746 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -64.03 136.19 40.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.472 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HA ' ' CE ' ' A' ' 12' ' ' LYS . 11.7 pt-20 -95.17 -3.64 47.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m 70.83 116.76 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.437 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.552 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.8 t70 -53.9 -57.6 17.02 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.628 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 89.9 Cg_endo -78.01 43.3 1.35 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.709 1.606 . . . . 0.0 112.299 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -163.66 31.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.542 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.0 p30 -161.15 149.94 13.26 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 3.9 Cg_exo -77.14 51.18 3.37 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.034 2.489 . . . . 0.0 113.794 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 9.9 mtmp? -157.98 126.65 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.294 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.47 117.21 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.579 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 88.9 m -141.55 51.82 2.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.865 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 17.3 Cg_exo -66.77 -25.0 46.46 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.349 2.033 . . . . 0.0 112.409 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -133.74 39.5 3.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.45 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -94.58 139.33 31.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -152.24 133.16 14.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.181 0.515 . . . . 0.0 112.191 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.626 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.3 m-20 -99.04 126.45 38.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.861 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.56 -29.34 88.67 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.773 2.315 . . . . 0.0 111.793 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 44' ' ' ARG . 19.9 ptt180 -66.36 -27.63 68.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.468 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.645 HG13 ' HA ' ' A' ' 6' ' ' ASN . 42.4 mm -70.11 110.56 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.928 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.854 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -103.89 -46.71 4.41 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.168 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.4 p90 -150.06 143.27 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.904 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -113.29 130.01 9.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.752 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.7 94.31 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 71.5 m -89.44 132.76 36.28 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.281 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 18.1 Cg_exo -66.75 136.77 43.23 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.869 2.379 . . . . 0.0 112.009 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.81 -34.09 39.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.198 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.875 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.792 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.789 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 2.7 ptm180 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.999 0.428 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.37 134.46 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.216 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.82 128.11 36.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.872 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -177.11 -156.43 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -153.13 177.59 10.65 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 m -55.87 -39.75 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 31.8 t -70.58 -52.79 19.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.79 60.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.764 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.72 141.04 46.95 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.408 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -62.14 130.3 44.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.715 0.293 . . . . 0.0 111.424 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 21.5 tptm -54.44 123.48 13.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.829 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.612 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 106.66 -35.69 4.88 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -74.36 126.94 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.573 0.225 . . . . 0.0 110.479 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -90.81 119.82 31.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 90.3 m-85 -99.15 134.5 41.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.347 0.594 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.622 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.4 m-85 -121.72 160.41 24.59 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.758 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -82.68 169.09 16.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.308 178.497 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -60.25 -30.7 69.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.454 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -67.48 -28.54 67.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.481 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.32 1.28 23.48 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.075 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -88.16 144.49 26.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.537 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -72.57 126.73 30.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.069 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG21 ' HG3' ' A' ' 44' ' ' ARG . 70.6 t -96.61 -62.27 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 p -176.46 151.22 0.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.448 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.7 pt-20 -95.31 156.83 16.16 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.86 127.65 36.41 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.05 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.568 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.5 pp20? -114.39 29.34 8.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -75.78 54.66 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.767 0.794 . . . . 0.0 110.491 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -73.65 129.0 86.08 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.003 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.88 -21.58 41.46 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.227 2.618 . . . . 0.0 113.086 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -67.19 -31.07 71.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.634 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -103.0 132.42 21.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.58 64.85 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.936 2.424 . . . . 0.0 113.144 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 28' ' ' GLU . 10.6 mtmp? -125.51 141.89 51.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.982 0.42 . . . . 0.0 110.956 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -150.65 128.36 11.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.327 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . 62.5 m -127.67 65.36 67.06 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.539 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 15.9 Cg_exo -67.89 -25.8 38.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.567 2.178 . . . . 0.0 112.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -115.2 52.79 0.85 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.317 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 20.9 t-20 -158.7 132.38 7.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -159.06 136.51 9.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 10.4 m-20 -84.57 127.28 66.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.72 -23.78 77.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.051 2.501 . . . . 0.0 112.741 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 18' ' ' SER . 4.5 ptp85 -79.62 -16.28 56.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.386 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 6' ' ' ASN . 21.8 mm -75.52 102.11 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.42 -39.64 10.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.789 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 3.1 p90 -157.42 166.21 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.461 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.93 136.11 6.65 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.573 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.7 mt -100.28 122.31 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.749 0.309 . . . . 0.0 110.552 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -101.03 133.22 21.14 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.08 138.73 37.46 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.644 2.229 . . . . 0.0 112.514 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.492 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -125.03 21.56 8.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.218 0.532 . . . . 0.0 110.261 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.54 179.82 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.286 0.565 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.406 HG23 HG22 ' A' ' 45' ' ' ILE . 12.2 tt -78.59 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.084 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.19 101.13 13.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.967 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.602 HG23 HG21 ' A' ' 45' ' ' ILE . 12.2 t -176.52 -161.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.728 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.3 p30 -160.02 -159.44 0.72 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 18.3 m -67.57 -54.99 15.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.537 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 49.7 t -70.23 -43.08 71.36 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.207 -0.308 . . . . 0.0 111.596 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -23.48 64.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.968 0.413 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.84 147.92 47.27 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.267 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.563 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 m -59.58 126.29 27.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 0.0 111.085 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.971 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 34.5 ttpt -54.76 132.77 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.247 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 -37.64 3.36 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.878 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 35.8 m -70.27 126.99 31.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.817 ' HE3' ' HB3' ' A' ' 26' ' ' GLU . 2.5 mtpt -91.24 114.8 27.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.668 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.6 m-85 -89.66 135.85 33.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.353 0.597 . . . . 0.0 111.566 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.464 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.3 m-85 -125.9 160.4 30.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.9 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -83.79 163.83 19.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.889 178.495 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -62.46 -28.51 69.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.458 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -66.91 -28.49 68.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.925 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.65 1.89 19.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -88.16 147.41 24.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.101 0.476 . . . . 0.0 111.031 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.402 ' CE1' ' HE2' ' A' ' 15' ' ' LYS . 26.9 t80 -75.21 133.39 41.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.096 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -105.08 -68.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.2 p -176.42 147.55 0.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.817 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 3.1 pm0 -85.87 156.55 20.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.837 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -64.5 119.97 17.44 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.712 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -102.63 34.04 2.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -79.72 71.31 6.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.229 0.538 . . . . 0.0 110.908 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.971 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 9.8 t70 -146.66 -59.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD2' ' H ' ' A' ' 30' ' ' ASP . 31.6 Cg_endo -64.46 -39.14 29.92 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.783 1.656 . . . . 0.0 112.869 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 58.03 37.83 26.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.745 0.783 . . . . 0.0 109.893 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -72.09 161.07 80.81 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.872 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.21 92.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.683 2.255 . . . . 0.0 111.766 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 2.5 tmmm? -160.85 134.22 6.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.935 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 103.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.159 0.504 . . . . 0.0 111.85 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.638 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 83.7 m -89.83 -55.91 0.28 Allowed Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.797 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 97.5 Cg_endo -83.28 39.86 0.87 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.03 1.82 . . . . 0.0 111.975 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -69.32 -46.08 67.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 176.42 171.44 0.43 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.41 129.81 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -82.71 122.3 78.31 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.1 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.03 -27.46 79.53 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.01 2.473 . . . . 0.0 112.007 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' SER . 11.8 ptt-85 -68.35 -25.41 65.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.184 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.728 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.8 mm -79.95 94.87 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 2' ' ' ARG . . . -89.87 -43.35 10.67 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.5 p90 -159.97 157.26 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.101 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -125.49 125.82 5.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.055 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.7 mt -86.62 111.97 22.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.838 0.352 . . . . 0.0 110.167 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.38 133.54 28.23 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.4 57.85 5.56 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.864 2.376 . . . . 0.0 112.198 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.34 137.06 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.91 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 9.0 tpt180 . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.442 0.639 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 tt -78.1 124.49 36.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.15 127.06 40.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' HG13 ' A' ' 45' ' ' ILE . 12.9 t -176.97 -155.74 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -146.08 178.58 8.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.526 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 26.9 m -56.19 -42.13 76.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.668 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 43.0 t -72.07 -49.52 35.86 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.84 29.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.337 0.589 . . . . 0.0 111.089 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.94 145.58 15.95 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.19 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -59.65 126.72 28.7 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.883 0.341 . . . . 0.0 110.694 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 84.5 tttt -54.93 128.87 35.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 -39.77 2.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.894 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.5 124.11 26.61 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.956 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -100.37 126.57 46.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.029 0.443 . . . . 0.0 110.0 179.235 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.588 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 14.7 m-85 -89.04 137.7 32.08 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.173 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.0 m-85 -122.51 160.56 25.34 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 157.44 19.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.043 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -61.35 -29.05 69.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.34 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.32 -32.67 73.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.493 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.19 -2.15 9.73 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.853 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 m -89.02 148.05 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.443 0.64 . . . . 0.0 111.559 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.73 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 18.8 t80 -76.92 131.56 38.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.925 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG12 ' SG ' ' A' ' 25' ' ' CYS . 93.1 t -99.86 -68.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.867 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.6 p 178.72 148.88 0.21 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.831 0.348 . . . . 0.0 111.572 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.956 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 pm0 -87.02 152.67 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -67.67 121.58 15.11 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.614 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.668 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -89.36 41.19 1.02 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 111.526 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.9 m -77.81 53.1 1.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.732 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 9.1 t70 -93.46 -55.42 0.24 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.33 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 23.5 Cg_exo -63.9 111.11 1.46 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.764 1.643 . . . . 0.0 111.168 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -62.45 -20.84 64.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.349 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -68.91 133.48 90.15 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 110.546 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.3 132.53 27.83 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.657 2.238 . . . . 0.0 112.726 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.0 143.52 33.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.03 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.88 116.95 4.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.239 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.88 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 99.9 m -145.54 -47.6 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.312 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.88 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 58.3 Cg_endo -71.03 48.39 0.86 Allowed 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.216 1.944 . . . . 0.0 112.891 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -85.47 -26.65 26.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.94 174.87 7.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.677 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.25 140.6 52.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.717 0.294 . . . . 0.0 110.678 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.461 ' HB2' HG12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -78.72 125.2 84.66 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.559 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 38.1 Cg_exo -60.54 -27.73 85.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.875 2.383 . . . . 0.0 111.569 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.441 ' HD2' HG13 ' A' ' 24' ' ' VAL . 25.4 ptt180 -66.87 -28.86 68.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.275 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 42' ' ' ASP . 23.3 mm -70.41 102.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.223 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -99.15 -42.35 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.563 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.1 p90 -156.92 151.52 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.816 0.341 . . . . 0.0 111.422 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.23 123.7 7.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.36 111.91 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.378 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.6 m -94.59 136.49 23.11 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.83 141.91 50.6 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.667 2.245 . . . . 0.0 111.929 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -157.7 -44.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.281 -1.342 . . . . 0.0 108.661 179.196 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 mmm180 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.785 0.326 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 47' ' ' TYR . 7.1 tt -145.75 128.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.231 0.538 . . . . 0.0 109.851 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.01 117.12 29.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.979 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t 179.52 -159.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.607 ' HA ' HG13 ' A' ' 45' ' ' ILE . 16.5 p30 -145.61 -167.61 2.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.632 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m -67.17 -56.27 10.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.869 0.366 . . . . 0.0 111.409 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 3.7 t -58.25 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.1 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.91 24.17 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.651 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.13 -122.77 4.61 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.128 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.8 m -151.47 136.14 17.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 36.5 tttp -53.95 127.91 28.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.241 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.55 -30.74 3.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.246 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.44 122.31 14.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.783 ' HD3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 mmtm -92.67 113.56 25.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 69.2 m-85 -95.98 133.27 40.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 110.911 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.546 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -128.4 164.9 21.69 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.381 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.83 156.28 18.15 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.493 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 30.7 p-10 -62.99 -23.82 67.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.627 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.4 -33.57 75.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.02 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.22 -4.17 8.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.031 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.8 m -89.44 146.78 24.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.207 0.527 . . . . 0.0 111.545 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -77.31 129.24 35.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.57 HG13 ' HD2' ' A' ' 44' ' ' ARG . 92.9 t -95.66 -63.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.6 p -178.25 163.41 1.65 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.564 0.221 . . . . 0.0 110.517 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.783 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -110.23 153.33 24.95 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -68.16 115.96 7.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.528 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.7 pm0 -90.88 33.43 0.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -69.87 54.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.518 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.413 ' N ' ' HD3' ' A' ' 31' ' ' PRO . 52.7 t0 -179.13 62.34 0.13 Allowed Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.674 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 30' ' ' ASP . 88.9 Cg_endo -89.2 -8.56 4.68 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.62 2.213 . . . . 0.0 112.106 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 75.64 -39.4 0.38 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.843 0.857 . . . . 0.0 110.534 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -90.65 151.39 43.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.19 125.61 19.02 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.269 1.979 . . . . 0.0 111.895 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' HE2' ' SG ' ' A' ' 8' ' ' CYS . 86.5 tttt -147.94 128.02 13.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.36 122.53 30.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.544 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -92.28 129.29 41.71 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.478 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.99 131.93 37.15 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.561 2.174 . . . . 0.0 111.641 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -79.91 -19.78 47.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.843 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.31 132.66 49.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.77 132.98 35.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 26.6 m-20 -78.9 123.65 85.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.918 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.66 -25.39 78.87 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.887 2.391 . . . . 0.0 111.726 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.57 ' HD2' HG13 ' A' ' 24' ' ' VAL . 31.7 ptt180 -71.89 -27.67 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.424 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.607 HG13 ' HA ' ' A' ' 6' ' ' ASN . 25.4 mm -79.1 105.59 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.828 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.41 -42.12 7.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.372 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.57 ' HA ' HG22 ' A' ' 3' ' ' ILE . 6.0 p90 -155.16 163.11 40.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.79 131.73 4.75 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.377 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 49' ' ' ILE . 4.1 mp -86.88 94.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.3 m -91.04 134.01 30.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.053 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.5 Cg_exo -71.97 63.88 3.29 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.347 2.698 . . . . 0.0 112.443 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -80.48 -35.8 34.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.521 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.332 -1.318 . . . . 0.0 108.849 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 56.5 ttm-85 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -78.36 140.39 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.799 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.47 101.56 14.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.032 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -179.1 -171.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.839 ' HA ' HG13 ' A' ' 45' ' ' ILE . 23.2 p30 -161.44 -155.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.33 -52.29 23.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.799 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 52.6 t -64.86 -41.76 95.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.899 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.66 -23.65 49.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.23 148.35 50.03 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.784 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -75.14 141.11 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.761 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 29' ' ' SER . 45.7 mtmt -50.36 137.26 18.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.896 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.75 -36.52 3.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.816 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.96 120.41 14.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.731 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 47.7 mttp -98.03 122.12 40.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.8 m-85 -100.98 133.87 44.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.534 0.683 . . . . 0.0 111.256 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -121.85 162.65 20.56 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.249 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.44 159.26 19.39 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.261 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' CG ' HH22 ' A' ' 2' ' ' ARG . 4.9 p-10 -59.53 -27.41 66.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.408 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.56 -34.86 78.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.11 -5.4 8.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.881 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 m -89.39 146.59 24.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.154 0.502 . . . . 0.0 111.537 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -74.11 126.66 31.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.61 -61.37 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.468 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 p -179.17 153.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.731 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 6.4 pt-20 -96.94 160.94 14.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.148 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.1 136.22 34.99 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 113.882 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 9.1 pt-20 -118.66 15.89 13.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.724 -0.238 . . . . 0.0 111.408 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 44.7 m -58.38 123.49 16.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.281 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 31.7 t0 67.05 64.78 0.73 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 121.542 0.686 . . . . 0.0 110.715 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -88.72 41.58 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.554 2.169 . . . . 0.0 110.953 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 66.28 35.79 5.72 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.019 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 18.3 p30 -169.57 160.37 7.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.923 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 33' ' ' ASN . 37.0 Cg_endo -65.96 71.63 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.092 2.528 . . . . 0.0 114.657 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 31.6 mtpt -134.58 127.38 31.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.884 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.443 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -171.35 137.99 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.849 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 64.2 m -128.76 62.69 62.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 2.8 Cg_exo -75.83 44.87 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.894 2.396 . . . . 0.0 112.456 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -171.44 44.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.659 0.742 . . . . 0.0 109.081 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -159.17 142.65 14.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.029 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.78 26.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 m-20 -96.3 128.42 36.75 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 -26.41 82.7 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.806 2.337 . . . . 0.0 111.744 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 mtm-85 -68.07 -34.07 75.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.839 HG13 ' HA ' ' A' ' 6' ' ' ASN . 46.3 mm -72.15 114.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.615 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -107.89 -39.79 5.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.833 0.349 . . . . 0.0 110.591 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.544 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.6 p90 -154.73 155.12 33.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.401 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -138.81 135.02 7.11 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.642 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -91.46 102.96 14.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.28 120.9 66.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.315 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.12 136.99 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.563 2.176 . . . . 0.0 112.236 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.08 137.34 33.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.345 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.419 -1.277 . . . . 0.0 109.235 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.815 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 20.0 ptp180 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.52 128.49 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.484 0.659 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.29 121.45 31.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.211 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t 179.9 -162.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -158.1 -174.38 4.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 4.5 m -59.99 -53.82 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 39.7 t -65.97 -42.57 89.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . . . -71.39 -30.5 66.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.9 146.49 50.39 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.3 m -66.08 133.19 50.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.532 0.205 . . . . 0.0 111.096 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 38.1 ttpt -52.55 135.46 34.13 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.17 -36.2 3.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.169 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 20.8 t -70.43 118.71 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 67.1 mttm -91.75 116.14 28.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.633 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 59.9 m-85 -94.53 132.91 38.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.079 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.8 m-85 -120.82 159.85 24.6 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.276 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.63 160.69 19.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.326 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -61.09 -27.14 68.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.434 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -64.4 -33.52 76.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.313 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.2 -4.53 9.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.91 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 m -89.04 148.3 23.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.0 111.461 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.34 124.74 27.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.692 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.443 HG12 ' SG ' ' A' ' 25' ' ' CYS . 78.2 t -90.47 -64.23 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 24' ' ' VAL . 26.5 p 179.98 150.7 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.265 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.6 pt-20 -97.69 155.39 17.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.155 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.9 138.33 48.98 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.219 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 13.0 pt-20 -119.78 14.17 12.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.929 0.395 . . . . 0.0 111.013 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 33.4 p -77.6 137.67 38.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.023 0.439 . . . . 0.0 111.81 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.615 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 9.9 t70 -156.85 133.77 6.51 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.38 -18.98 48.79 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.295 2.663 . . . . 0.0 113.55 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.08 -40.27 84.74 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.725 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 9.0 p30 -173.16 -41.23 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.508 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.725 ' HD2' ' H ' ' A' ' 33' ' ' ASN . 56.7 Cg_endo -73.45 89.51 0.95 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 121.34 1.36 . . . . 0.0 111.491 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.79 143.27 36.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.683 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.659 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -53.78 143.93 19.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.759 0.662 . . . . 0.0 111.676 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.6 m -108.86 78.12 0.9 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.445 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 1.3 Cg_endo -84.15 41.19 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.024 2.482 . . . . 0.0 111.924 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -77.7 -32.45 52.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.81 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -163.05 152.81 15.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.48 132.77 44.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.762 0.315 . . . . 0.0 110.811 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 66.4 m-20 -79.28 121.12 82.61 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.409 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.63 -25.45 79.16 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.803 2.335 . . . . 0.0 111.553 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 33.0 ptt180 -67.23 -29.57 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.189 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -72.55 112.22 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.64 0.257 . . . . 0.0 110.689 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -105.89 -43.4 4.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.77 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.3 p90 -156.1 150.19 25.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.866 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -128.58 130.42 6.54 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.252 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 49' ' ' ILE . 3.7 mp -88.97 100.74 11.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 82.8 m -89.94 125.7 59.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.039 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.56 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 7.4 Cg_exo -73.12 65.01 4.26 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.304 2.669 . . . . 0.0 112.591 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pp -156.92 32.63 0.3 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.493 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.815 179.579 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -78.71 141.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.218 0.532 . . . . 0.0 110.56 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.41 90.93 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t -173.23 -171.96 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.073 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.78 ' HA ' HG13 ' A' ' 45' ' ' ILE . 2.3 p-10 -160.91 -164.96 1.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.259 -0.177 . . . . 0.0 110.612 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.529 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 59.1 m -59.59 -37.77 79.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 3.9 t -80.71 -59.18 2.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.407 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.94 -16.66 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -59.37 147.88 41.74 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.27 -0.491 . . . . 0.0 113.027 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -68.48 129.49 40.09 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 49.7 tttm -55.15 125.23 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.398 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.36 -38.47 3.14 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.0 m -72.04 121.89 19.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 68.2 mttm -89.8 121.3 31.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 48.9 m-85 -94.77 134.68 37.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.144 0.497 . . . . 0.0 110.829 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.433 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.7 m-85 -119.35 161.85 19.78 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.705 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.34 161.13 18.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.408 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.17 -29.39 63.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.657 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.28 -33.69 76.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.34 -5.1 9.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.815 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.9 m -88.39 148.04 24.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.528 . . . . 0.0 111.162 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.5 t80 -71.34 130.01 40.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.047 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.552 HG12 ' SG ' ' A' ' 25' ' ' CYS . 73.2 t -97.1 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.819 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.5 p -178.95 153.22 0.62 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -97.66 147.68 24.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -70.77 138.12 28.05 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.375 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.667 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 8.1 pt-20 -89.75 -6.35 56.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 87.1 p 67.68 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.67 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.64 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 38.3 t0 -56.14 -56.04 35.35 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.646 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 84.8 Cg_endo -77.44 40.47 0.84 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.018 1.812 . . . . 0.0 113.676 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 48.9 tpt85 -106.61 -32.35 8.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.955 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 16.8 p30 -148.72 158.37 39.88 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.05 62.68 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.248 2.632 . . . . 0.0 112.722 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -153.7 112.65 3.71 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.4 124.27 19.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.369 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -88.53 -43.93 0.46 Allowed Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.9 46.63 0.53 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.577 2.184 . . . . 0.0 113.607 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.03 -34.24 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.851 0.358 . . . . 0.0 110.417 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -167.5 145.92 4.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.711 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.61 ' OD1' ' HB2' ' A' ' 6' ' ' ASN . 4.2 m-20 -78.1 122.04 84.81 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.12 -32.77 71.26 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.318 2.679 . . . . 0.0 113.551 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' NE ' HG13 ' A' ' 24' ' ' VAL . 25.3 ptt-85 -70.16 -17.54 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.78 HG13 ' HA ' ' A' ' 6' ' ' ASN . 30.4 mm -69.82 107.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.15 -49.41 3.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.22 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.3 p90 -150.79 149.13 29.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.898 0.38 . . . . 0.0 111.249 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.686 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -118.23 134.25 10.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.114 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.8 mm -110.2 120.45 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.878 0.37 . . . . 0.0 110.449 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.6 m -91.95 125.77 55.82 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.2 Cg_exo -68.29 126.38 14.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.734 2.289 . . . . 0.0 112.041 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.87 -35.44 14.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.342 -1.313 . . . . 0.0 108.568 179.778 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.421 HH11 ' HB1' ' A' ' 46' ' ' ALA . 27.1 mmt180 . . . . . 0 N--CA 1.458 -0.07 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 47' ' ' TYR . 6.5 tt -142.12 131.36 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.312 0.577 . . . . 0.0 111.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.65 124.4 35.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -179.24 -158.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . 0.825 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.8 p30 -151.58 -168.09 2.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 m -65.81 -58.84 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -62.87 -44.72 95.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.768 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.02 -11.68 60.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.2 145.23 35.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.493 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 14.9 m -67.23 137.0 55.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.552 0.215 . . . . 0.0 110.931 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 29' ' ' SER . 59.0 mttm -49.23 133.27 19.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.716 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.2 -37.36 3.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.276 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 59.3 m -65.68 112.59 3.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 62.2 mttm -89.64 116.78 28.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.535 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 76.8 m-85 -94.46 135.64 35.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -120.53 161.54 21.13 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.749 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 1.8 p -80.74 164.5 22.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.275 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -60.82 -28.56 68.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.72 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.03 -33.88 76.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.938 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.25 -9.22 7.43 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.652 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 m -86.6 146.0 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.378 0.609 . . . . 0.0 111.31 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -69.86 127.62 33.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' SG ' ' A' ' 25' ' ' CYS . 71.9 t -96.96 -61.2 2.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' HG12 ' A' ' 24' ' ' VAL . 23.3 p -178.16 148.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.446 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.613 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.5 pt-20 -94.17 159.85 14.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.336 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.31 127.69 45.52 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.196 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.736 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 5.5 pt-20 -126.49 35.41 4.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.591 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 22.9 m -63.11 102.66 0.4 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 47.8 t0 -170.68 123.64 0.59 Allowed Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.936 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 9.7 Cg_exo -71.43 -6.42 19.12 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -58.19 -43.41 87.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.03 144.05 27.19 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.499 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.22 65.83 2.06 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.206 2.604 . . . . 0.0 113.532 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -140.89 132.0 26.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.36 139.29 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.224 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 96.3 m -88.35 116.1 65.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 110.854 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 2.8 Cg_exo -75.62 137.59 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.12 2.546 . . . . 0.0 111.764 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -73.84 -28.88 61.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -67.64 139.22 56.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.209 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.51 142.54 37.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.677 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 22.5 m-20 -78.82 129.87 72.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.207 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 7.5 Cg_exo -71.92 56.23 2.4 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.6 2.867 . . . . 0.0 110.574 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 18' ' ' SER . 33.3 ptt180 -167.11 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.5 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.825 HG13 ' HA ' ' A' ' 6' ' ' ASN . 33.2 mm -73.62 102.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.418 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB1' HH11 ' A' ' 2' ' ' ARG . . . -97.86 -40.49 8.49 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.576 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.0 p90 -159.28 159.58 34.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.846 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.98 134.05 5.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.568 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 49' ' ' ILE . 4.4 mp -96.35 126.56 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 72.8 m -95.6 143.53 26.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo -75.73 52.94 3.48 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.994 2.463 . . . . 0.0 111.814 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -161.92 -42.18 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.406 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.34 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.91 179.566 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.601 ' OD1' ' HG2' ' A' ' 2' ' ' ARG . 10.5 t70 . . . . . 0 C--O 1.234 0.252 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.601 ' HG2' ' OD1' ' A' ' 1' ' ' ASP . 2.2 ptp85 -78.82 138.93 38.41 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 mt -134.85 130.53 52.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.28 114.98 27.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.541 HG22 HG21 ' A' ' 45' ' ' ILE . 13.6 t -166.49 -158.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.563 0.22 . . . . 0.0 110.463 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -155.17 167.65 29.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.26 -43.54 61.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 34.4 t -69.17 -45.4 70.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.11 55.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.55 142.9 48.06 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.019 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -67.15 135.06 52.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 23.5 tptp -55.44 131.56 46.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.7 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.36 -34.43 4.84 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.647 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.0 t -71.42 123.36 22.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 2.7 ptpp? -101.79 115.23 30.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.655 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 62.4 m-85 -92.47 135.93 33.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.3 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.485 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.9 m-85 -120.45 159.43 25.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -91.9 168.77 11.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.909 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -64.4 -31.75 73.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.547 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.15 -19.23 64.28 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.192 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.92 -4.04 52.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.659 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -89.4 148.25 23.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 21.0 t80 -70.56 128.49 36.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' A' ' 25' ' ' CYS . 79.6 t -90.54 -65.73 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.207 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 24' ' ' VAL . 26.7 p -178.57 154.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.789 0.328 . . . . 0.0 111.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -92.92 153.38 18.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.377 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.47 123.51 31.0 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.072 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 11.3 pt-20 -90.3 26.51 1.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.779 0.323 . . . . 0.0 111.439 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -78.2 64.17 3.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.794 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 3.3 t70 -67.15 128.23 93.73 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.298 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.64 -19.56 59.94 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.946 2.431 . . . . 0.0 113.327 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 7.7 tpm_? -70.51 -37.64 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.34 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -116.68 133.29 23.05 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 0.0 111.195 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.26 126.6 17.38 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.345 2.03 . . . . 0.0 111.338 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -159.09 146.43 17.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.958 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -168.77 122.78 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 m -128.93 51.86 8.15 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.29 40.65 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.439 2.092 . . . . 0.0 111.384 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 38' ' ' PRO . 1.6 mpp_? -132.07 32.24 4.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.912 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -174.43 152.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.954 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.41 125.65 17.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.807 ' HB2' HG12 ' A' ' 45' ' ' ILE . 73.8 m-20 -78.64 126.66 82.33 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.19 -29.3 74.9 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 123.438 2.758 . . . . 0.0 113.448 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 18' ' ' SER . 1.2 ptm85 -88.22 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.275 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.807 HG12 ' HB2' ' A' ' 42' ' ' ASP . 28.7 mm -79.21 94.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.25 -45.43 9.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.806 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -157.63 159.92 37.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.683 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -137.74 131.81 5.63 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.034 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.39 93.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 93.4 m -88.74 139.55 29.46 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.4 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.69 136.46 39.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.578 2.185 . . . . 0.0 112.231 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.9 -33.62 39.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.97 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.613 179.728 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 2' ' ' ARG . 17.7 t70 . . . . . 0 C--O 1.233 0.184 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER -154.77 135.27 13.4 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.996 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tt -160.18 127.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.304 0.573 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.474 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -98.76 130.41 45.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.699 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -175.93 -148.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.445 ' HA ' HG13 ' A' ' 45' ' ' ILE . 17.0 p30 -154.62 164.96 37.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 m -48.99 -49.28 41.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 50.0 t -63.33 -43.58 97.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.053 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.49 29.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.913 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.64 144.79 15.86 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.2 m -63.1 121.92 14.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.679 0.276 . . . . 0.0 110.38 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 57.3 mtmt -54.07 130.55 38.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.891 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.83 -39.7 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -72.8 121.81 20.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 24.0 ttmm -93.11 120.88 33.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 77.0 m-85 -95.86 142.49 28.05 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.344 0.592 . . . . 0.0 111.933 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 11.3 m-85 -130.33 162.83 28.17 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.1 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.91 162.02 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.835 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.423 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.17 -32.15 73.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.75 -2.36 11.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.565 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -88.23 146.96 25.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.51 0.671 . . . . 0.0 111.162 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 5.0 t80 -73.15 131.86 42.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.708 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.0 t -103.98 -67.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.375 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.3 p -179.11 147.19 0.33 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.685 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 pm0 -87.91 167.11 14.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.47 125.4 23.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.732 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 35' ' ' LYS . 1.2 pp20? -122.08 49.32 1.59 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.495 0.664 . . . . 0.0 110.939 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 18.3 m -75.99 52.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.816 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.573 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 20.3 t70 61.42 130.37 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 123.836 0.855 . . . . 0.0 112.133 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.19 -40.08 78.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.21 1.94 . . . . 0.0 112.533 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.586 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 31.4 ttm-85 -66.4 -53.39 36.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HB3' ' O ' ' A' ' 32' ' ' ARG . 9.5 p30 142.86 -36.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 125.088 1.355 . . . . 0.0 114.294 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 30' ' ' ASP . 16.7 Cg_exo -69.79 68.71 1.7 Allowed 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.52 2.147 . . . . 0.0 115.173 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 29' ' ' SER . 58.7 tttm -160.82 129.66 4.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.848 0.356 . . . . 0.0 110.414 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -162.41 142.33 9.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.54 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -127.97 72.15 78.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.713 0.292 . . . . 0.0 111.514 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.32 39.86 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.086 2.524 . . . . 0.0 112.012 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -70.26 -35.79 74.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.614 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 45.5 t30 178.14 152.16 0.28 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.745 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -84.6 125.96 32.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 42.3 m-20 -79.84 131.11 64.74 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.799 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.2 Cg_exo -59.61 -22.6 67.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.837 2.358 . . . . 0.0 111.027 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.65 -35.42 80.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.403 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' A' ' 16' ' ' TYR . 23.4 mm -84.45 94.48 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.67 12.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.3 p90 -158.51 161.71 37.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.647 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.65 136.18 7.0 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.111 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -96.5 123.96 49.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.76 0.314 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 72.7 m -103.1 126.62 31.85 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.295 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.3 Cg_exo -71.88 121.39 7.57 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.596 2.197 . . . . 0.0 111.624 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.4 -37.13 10.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.33 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.857 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.772 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.8 t0 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.652 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 13.0 ptm180 -161.79 144.73 12.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.448 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tt -148.92 133.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.048 0.451 . . . . 0.0 110.72 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.78 129.7 42.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 t -178.03 -154.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -148.33 172.2 14.78 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -52.97 -51.66 60.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.708 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -61.3 -46.78 88.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.502 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.19 29.5 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.588 . . . . 0.0 111.032 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.98 143.93 15.77 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.635 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -60.83 128.82 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.611 0.205 . . . . 0.0 110.901 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -50.06 128.55 19.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.979 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.47 -33.82 4.02 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.833 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.23 118.11 11.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -94.27 119.4 33.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.351 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.66 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 57.6 m-85 -93.67 139.82 30.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 111.323 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -124.27 160.86 27.03 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.723 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 167.82 17.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.985 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -61.09 -30.69 70.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.311 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -66.72 -26.71 67.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.273 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.56 2.08 25.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.159 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -88.1 145.4 25.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.468 . . . . 0.0 110.532 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 23.8 t80 -73.0 124.36 25.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -92.98 -63.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.8 p -177.18 149.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.633 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 pt-20 -94.46 158.04 15.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.38 122.35 29.81 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.557 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.708 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 14.4 pt-20 -109.67 29.99 7.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.4 m -60.57 136.84 58.18 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t70 64.92 71.2 0.56 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.783 0.801 . . . . 0.0 110.142 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.494 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 2.0 Cg_endo -81.7 -5.17 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.741 2.294 . . . . 0.0 109.659 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 5.1 tpp85 76.33 -37.53 0.3 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 113.965 -1.471 . . . . 0.0 110.491 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' A' ' 31' ' ' PRO . 9.1 p-10 -85.84 149.86 51.82 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.56 119.36 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.276 1.984 . . . . 0.0 112.186 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -160.32 132.68 6.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.906 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 135.29 38.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.0 m -88.67 140.49 29.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.554 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.0 Cg_exo -62.73 134.6 47.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.87 2.38 . . . . 0.0 111.689 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' HD3' ' N ' ' A' ' 39' ' ' ARG . 1.0 OUTLIER -90.11 46.11 1.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.101 0.477 . . . . 0.0 110.649 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.91 146.76 19.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.58 134.09 34.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 17.7 m-20 -78.96 127.54 79.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.059 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.91 -23.58 68.2 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.55 2.167 . . . . 0.0 110.901 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 10.6 ptp85 -70.39 -26.6 63.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.818 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 16' ' ' TYR . 23.5 mm -83.96 98.42 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.412 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.2 -42.08 11.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.694 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 4.2 p90 -157.38 174.03 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.085 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.66 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -150.14 134.43 4.81 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.687 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.9 mm -90.75 104.31 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.51 122.7 66.89 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.87 138.04 27.99 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.63 2.22 . . . . 0.0 112.265 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.8 pp -81.64 -22.87 37.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.263 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.609 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.599 0.714 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 30.0 ttm180 -157.85 136.08 10.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.71 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 tt -144.24 137.27 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.876 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -88.99 127.86 35.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 HG21 ' A' ' 45' ' ' ILE . 12.4 t -178.52 -158.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.654 ' HA ' HG13 ' A' ' 45' ' ' ILE . 18.8 p30 -155.21 -173.42 4.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 m -62.37 -50.94 69.58 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.1 t -65.14 -48.87 72.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.743 0.306 . . . . 0.0 111.661 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.93 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.381 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.02 144.97 49.4 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -66.13 126.08 27.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.651 0.262 . . . . 0.0 110.745 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 86.7 tttt -53.79 131.79 40.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.43 -40.9 2.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.74 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.2 m -73.9 123.88 25.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 67.5 mttm -89.76 123.63 33.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.623 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 25.9 m-85 -96.89 134.92 39.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.785 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.2 m-85 -126.54 167.08 16.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.111 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.57 156.69 16.95 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.7 -26.43 67.13 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.546 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.26 -34.29 74.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.422 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.18 -5.25 8.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 m -89.29 146.43 24.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 111.694 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.7 t80 -76.5 130.96 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.566 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 45' ' ' ILE . 95.0 t -99.11 -67.46 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.4 p -176.71 143.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.773 0.32 . . . . 0.0 110.434 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.594 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . 3.8 pt-20 -91.08 162.5 14.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.9 116.88 8.37 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.979 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.77 24.58 7.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.503 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 p -77.09 54.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.469 0.652 . . . . 0.0 111.354 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.12 117.33 60.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.729 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.18 32.49 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.382 2.722 . . . . 0.0 113.732 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -80.53 -22.68 40.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.531 0.682 . . . . 0.0 109.731 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -165.26 148.69 7.2 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.919 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.39 137.73 71.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.554 2.169 . . . . 0.0 111.369 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -150.81 136.89 18.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.79 0.329 . . . . 0.0 110.532 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.85 119.82 30.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.019 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -88.89 138.97 29.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.5 128.45 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.616 2.211 . . . . 0.0 112.006 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -70.75 -20.78 62.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.479 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -71.85 132.46 44.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.941 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -85.25 123.18 30.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -79.61 121.25 82.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.417 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.97 -16.08 51.2 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.863 2.375 . . . . 0.0 110.237 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -67.44 -30.21 69.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.696 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.654 HG13 ' HA ' ' A' ' 6' ' ' ASN . 14.7 mm -88.62 112.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.34 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.43 -40.82 8.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.707 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.1 p90 -158.74 174.3 15.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.674 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.71 133.97 5.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.796 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.78 122.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.875 0.369 . . . . 0.0 110.579 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.2 m -92.56 136.64 25.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.142 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 27.8 Cg_exo -62.04 137.16 65.21 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.887 2.391 . . . . 0.0 112.167 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.1 151.48 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.3 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.904 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.086 0.469 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 42.8 ptt85 -161.45 153.0 18.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.838 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 47' ' ' TYR . 10.1 tt -78.35 133.88 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.504 0.669 . . . . 0.0 110.965 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.07 112.58 24.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -178.19 -163.11 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.702 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -160.24 164.54 32.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 63.2 m -52.13 -40.58 61.56 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.522 ' HA ' ' CD ' ' A' ' 28' ' ' GLU . 24.8 t -58.5 -47.25 84.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.288 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.82 -16.82 49.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.6 133.54 41.41 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.049 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 31' ' ' PRO . 22.9 m -67.81 130.83 44.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.706 -0.247 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -61.95 97.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.277 0.56 . . . . 0.0 110.341 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.81 -39.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 84.8 m -73.1 119.24 17.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 49.7 mttp -88.95 112.29 23.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.134 0.492 . . . . 0.0 111.466 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 71.6 m-85 -93.72 132.58 37.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.14 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -120.96 152.22 38.79 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.253 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.82 165.47 20.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.12 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -59.08 -30.43 68.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.547 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -67.37 -28.36 67.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.65 2.19 22.71 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.088 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -88.52 146.42 25.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 0.0 110.524 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -72.77 127.04 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.751 HG13 ' HE ' ' A' ' 44' ' ' ARG . 52.1 t -93.16 -60.31 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.565 ' SG ' HG12 ' A' ' 24' ' ' VAL . 24.3 p -176.33 148.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.644 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 17.1 pt-20 -99.55 42.23 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.175 0.512 . . . . 0.0 111.079 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.13 -175.79 41.79 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.016 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.559 ' HG3' ' N ' ' A' ' 29' ' ' SER . 7.2 pt-20 -148.56 -42.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 50.3 m -77.28 139.65 39.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 1.024 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 16.7 t70 -61.79 144.11 93.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.146 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 89.3 Cg_exo -44.54 -26.33 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.529 2.819 . . . . 0.0 114.631 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.93 40.56 1.66 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 1.024 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 4.3 p-10 -94.12 146.61 31.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.824 0.345 . . . . 0.0 110.663 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 66.41 4.19 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.828 2.352 . . . . 0.0 112.481 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -136.92 128.81 29.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.434 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -123.68 138.92 54.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.522 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 39.1 m -130.61 62.49 65.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 3.1 Cg_exo -79.47 40.28 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.95 2.434 . . . . 0.0 111.821 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 51.1 ttp85 -67.12 -57.89 5.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 6.0 t-20 173.18 154.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.682 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.38 125.31 29.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.433 ' HB2' HG12 ' A' ' 45' ' ' ILE . 64.7 m-20 -77.66 123.33 86.59 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 2' ' ' ARG . 31.1 Cg_exo -61.17 -24.89 79.99 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.841 2.36 . . . . 0.0 110.751 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.751 ' HE ' HG13 ' A' ' 24' ' ' VAL . 19.0 ttp-105 -64.63 -28.38 69.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.231 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.47 HD13 HG11 ' A' ' 24' ' ' VAL . 30.9 mm -79.78 102.76 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.202 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -89.4 -51.18 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.461 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 3' ' ' ILE . 29.7 p90 -155.97 153.24 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.977 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -131.31 129.19 5.63 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.696 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.61 119.81 47.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -97.16 128.17 36.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.35 137.04 16.41 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.619 2.213 . . . . 0.0 112.162 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -160.2 146.42 15.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.147 -179.693 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.4 t0 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.817 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 39.9 ptt180 -160.42 148.79 16.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tt -77.51 124.52 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 0.0 110.692 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.72 122.57 32.95 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.742 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -178.2 -158.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.008 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -153.02 177.17 11.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.58 -40.88 79.97 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.977 0.418 . . . . 0.0 111.437 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.27 -47.85 77.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.878 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.45 33.58 1.78 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.08 -129.11 5.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.311 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.598 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 14.8 m -153.56 127.51 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 29' ' ' SER . 24.1 tptm -48.63 127.16 13.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.818 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.71 -39.63 3.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.197 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.7 m -66.68 118.43 10.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.06 0.43 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.914 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 19.6 mmmt -89.12 116.0 27.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.689 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.0 m-85 -86.93 134.42 33.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.22 0.533 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.5 m-85 -123.7 161.03 25.95 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.072 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.68 157.06 18.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -30.78 63.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.726 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -63.61 -29.67 70.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.336 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.29 0.37 16.4 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.263 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -88.66 147.03 24.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.052 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.404 ' CE1' ' HE3' ' A' ' 15' ' ' LYS . 23.3 t80 -76.06 132.94 40.41 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.481 HG12 ' SG ' ' A' ' 25' ' ' CYS . 98.6 t -103.32 -68.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.7 p -179.66 146.05 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.662 0.268 . . . . 0.0 111.541 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.914 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 3.8 pm0 -84.03 159.29 21.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.598 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.06 125.02 11.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.151 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.03 0.2 56.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.538 0.209 . . . . 0.0 111.347 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.665 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 1.3 m -61.94 109.31 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.69 138.78 24.99 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.29 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.57 -24.08 12.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.3 -23.48 67.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -147.55 133.73 9.68 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.219 0.533 . . . . 0.0 111.248 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.35 60.23 4.85 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 113.012 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.36 127.29 33.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.908 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -159.99 124.92 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 m -135.74 58.05 22.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.05 43.7 1.56 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.832 2.354 . . . . 0.0 111.69 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -97.02 -33.11 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -153.65 140.52 19.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.05 141.66 28.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.284 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.97 125.18 85.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.69 0.281 . . . . 0.0 110.832 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.88 47.58 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.488 2.792 . . . . 0.0 111.71 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -156.53 -30.8 0.09 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.492 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.2 mm -65.68 110.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.505 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.817 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -109.61 -41.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.475 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.2 p90 -159.72 147.59 17.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 111.594 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -112.5 125.27 7.04 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.821 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.1 115.42 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.827 0.346 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 60.4 m -94.52 124.95 53.63 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.0 Cg_exo -70.63 137.89 33.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.071 2.514 . . . . 0.0 112.219 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.55 53.77 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.221 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.17 0.919 . . . . 0.0 110.492 -178.922 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.358 0.599 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.511 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . 57.9 mtm180 -143.96 133.69 23.74 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.547 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tt -79.06 136.49 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.01 112.71 22.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.435 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.424 HG23 HG21 ' A' ' 45' ' ' ILE . 11.6 t -179.77 -166.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.868 ' HA ' HG13 ' A' ' 45' ' ' ILE . 12.9 p30 -161.97 -156.46 0.43 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.7 0.286 . . . . 0.0 110.927 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 m -70.38 -48.66 55.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.351 0.596 . . . . 0.0 109.721 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.2 t -58.28 -52.59 64.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.32 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.78 -28.74 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.783 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.91 143.23 48.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.659 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -63.15 125.78 25.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.563 0.22 . . . . 0.0 110.919 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -55.93 117.95 4.16 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.618 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.27 -43.53 1.53 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.4 m -74.17 126.83 31.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 26' ' ' GLU . 1.9 mptp? -89.37 125.3 35.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.53 0.205 . . . . 0.0 110.527 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.662 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 12.6 m-85 -99.14 133.82 42.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.517 0.675 . . . . 0.0 110.964 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.511 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -122.5 163.66 19.5 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.559 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 161.62 19.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.107 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.8 -28.81 66.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.813 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -64.95 -29.71 70.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.166 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.42 -0.09 18.51 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.321 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -88.57 144.85 26.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.031 0.443 . . . . 0.0 111.019 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.5 t80 -75.48 128.68 35.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.1 t -101.15 -60.55 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.487 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.8 p -177.84 150.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.648 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -96.01 166.22 11.88 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.962 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.686 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.97 140.04 45.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 16.9 pt-20 -121.15 20.47 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.89 0.376 . . . . 0.0 110.704 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -81.28 58.84 3.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.82 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 27.1 t70 -72.46 131.96 84.23 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.859 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 51.1 Cg_exo -55.12 -26.01 48.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.583 2.855 . . . . 0.0 113.364 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttt85 -55.56 -39.98 71.34 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.714 0.292 . . . . 0.0 111.344 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.38 109.46 1.1 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 121.568 0.699 . . . . 0.0 111.795 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.85 146.69 23.67 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.983 2.455 . . . . 0.0 111.674 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -127.56 148.07 50.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.4 130.7 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.6 m -88.83 126.57 59.09 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.908 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 -57.02 0.96 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.828 2.352 . . . . 0.0 113.276 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 15.0 mmp_? -98.86 -38.3 9.09 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.959 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 t30 63.32 31.41 15.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.965 0.888 . . . . 0.0 110.317 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.82 110.54 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.279 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' CG ' ' HB3' ' A' ' 6' ' ' ASN . 24.2 m-20 -110.3 127.66 26.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.36 -29.23 67.01 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.489 2.793 . . . . 0.0 113.775 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 ptt85 -78.03 -20.56 52.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.868 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.9 mm -79.23 114.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 2' ' ' ARG . . . -105.06 -40.78 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.764 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.4 p90 -160.0 155.74 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -123.78 130.78 7.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.917 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.25 120.75 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.913 0.387 . . . . 0.0 110.586 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.94 126.98 55.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.145 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.22 136.82 27.5 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.557 2.171 . . . . 0.0 112.28 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.01 26.7 9.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.783 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.633 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 122.288 1.042 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 14.9 ptm180 -79.66 133.58 36.4 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.56 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 47' ' ' TYR . 10.4 tt -79.4 137.02 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.104 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.02 116.81 27.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -176.95 -172.96 0.44 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.703 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.1 p-10 -161.41 -168.57 2.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 57.8 m -59.76 -50.09 75.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ALA . 41.8 t -70.58 -43.09 70.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.65 76.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.012 0.435 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.96 -179.45 45.83 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.44 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.4 m -110.8 133.35 53.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.36 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 1.122 ' HG3' ' HB3' ' A' ' 30' ' ' ASP . 2.7 mmmt -53.84 127.36 25.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.374 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.93 -39.97 2.56 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 48.4 t -72.24 129.74 39.14 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.66 103.54 16.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.687 0.28 . . . . 0.0 111.513 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 78.9 m-85 -92.2 129.2 38.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 110.833 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -121.07 154.12 36.52 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.768 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -84.46 162.8 19.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.566 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -62.02 -28.43 69.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.295 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.231 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 -3.7 11.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.187 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -90.15 148.72 22.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.09 0.471 . . . . 0.0 111.252 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.87 126.63 30.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 45' ' ' ILE . 71.5 t -91.92 -59.32 3.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.6 p -175.13 154.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.067 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 9.7 pt-20 -96.7 39.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.108 0.48 . . . . 0.0 110.268 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.48 148.81 2.68 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG2' ' C ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -122.54 23.64 9.53 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.891 -0.77 . . . . 0.0 111.428 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.78 50.48 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.38 0.61 . . . . 0.0 110.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 1.122 ' HB3' ' HG3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -174.96 -55.36 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.492 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 43.7 Cg_endo -69.49 116.96 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 120.932 1.088 . . . . 0.0 110.84 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 31' ' ' PRO . 18.7 ttp-105 86.33 -37.35 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.692 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -171.78 126.45 0.58 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.307 0.575 . . . . 0.0 111.885 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.35 62.72 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.778 2.318 . . . . 0.0 111.784 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -130.63 139.11 50.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.858 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -102.71 137.89 40.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.524 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 67.7 m -89.15 108.4 23.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.858 0.361 . . . . 0.0 111.056 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 87.3 Cg_endo -88.16 30.65 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.869 2.379 . . . . 0.0 112.424 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -174.61 50.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 109.937 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -161.8 137.87 7.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -157.67 136.29 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.622 ' H ' ' HB3' ' A' ' 6' ' ' ASN . 1.1 m-20 -82.35 125.17 77.21 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.711 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.89 -21.01 69.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.361 2.04 . . . . 0.0 109.721 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 18' ' ' SER . 6.4 ttp180 -71.64 -34.18 69.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.12 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.703 HG13 ' HA ' ' A' ' 6' ' ' ASN . 31.1 mm -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.153 0.501 . . . . 0.0 111.566 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -115.48 -44.17 2.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.497 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 3' ' ' ILE . 21.3 p90 -157.89 156.28 31.08 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.241 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -130.44 124.38 4.25 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.729 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -87.32 94.52 4.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 84.5 m -89.17 118.93 69.64 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.143 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 6.9 Cg_exo -73.65 134.55 20.45 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.008 2.472 . . . . 0.0 112.14 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.43 ' HB3' ' H ' ' A' ' 53' ' ' ALA . 7.0 mp -95.26 -143.32 0.26 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.161 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 52' ' ' LEU . . . . . . . . 0 C--O 1.247 0.953 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 C--O 1.235 0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -160.61 58.67 0.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tt -78.3 130.43 36.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.791 0.805 . . . . 0.0 112.132 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.61 123.57 36.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.272 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' HG13 ' A' ' 45' ' ' ILE . 14.9 t -176.11 -165.71 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -145.36 178.15 8.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 m -54.25 -39.65 67.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.58 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 11.7 t -63.07 -55.93 21.27 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.897 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.03 29.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.349 0.595 . . . . 0.0 111.286 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -98.69 145.15 17.6 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.433 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 m -71.72 127.56 32.97 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.754 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 22.5 ttmm -50.28 131.57 24.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 111.341 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.33 -39.25 3.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.142 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.612 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 48.8 t -66.13 122.12 16.71 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.12 117.06 32.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.076 0.465 . . . . 0.0 111.127 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.78 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 37.3 m-85 -86.06 140.33 30.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.898 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -124.83 158.02 34.44 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.674 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.704 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 1.1 p -86.45 161.83 18.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.537 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.44 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 11.3 p-10 -65.32 -28.61 69.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.03 -27.48 68.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.823 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.19 -2.93 20.71 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.411 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.2 m -87.85 154.28 20.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.429 0.633 . . . . 0.0 111.002 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 24.2 t80 -75.77 128.81 35.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.762 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG12 ' SG ' ' A' ' 25' ' ' CYS . 53.6 t -90.13 -67.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.541 ' SG ' HG12 ' A' ' 24' ' ' VAL . 27.3 p 177.07 148.63 0.13 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.542 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -90.13 144.88 25.48 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.81 143.36 46.58 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.815 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.58 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.0 OUTLIER -107.26 -18.77 13.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -63.84 129.36 39.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.082 0.468 . . . . 0.0 111.06 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.73 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 36.9 t70 -73.32 127.29 89.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.544 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.11 58.14 3.44 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.025 2.483 . . . . 0.0 111.527 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 23.5 ttm105 -150.39 -41.05 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.459 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 14.1 p-10 -133.29 135.17 24.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.018 0.437 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 16.9 Cg_exo -68.08 129.72 20.04 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.858 2.372 . . . . 0.0 112.265 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.11 136.9 52.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.963 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.46 120.36 10.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.3 m -150.44 145.47 18.57 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.632 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 128.45 24.35 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.448 2.099 . . . . 0.0 111.809 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -86.03 46.74 1.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.789 0.804 . . . . 0.0 109.883 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.91 124.08 40.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.119 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.26 139.25 30.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.643 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 2.0 p30 -78.17 150.86 77.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.786 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.69 61.08 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.631 2.887 . . . . 0.0 112.047 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.704 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 19.2 ttp180 -171.2 -31.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.046 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.536 HD13 HG11 ' A' ' 24' ' ' VAL . 31.9 mm -59.0 112.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -105.03 -47.07 4.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.429 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -166.41 -169.14 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.403 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -149.51 132.47 4.05 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.936 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.45 97.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m -90.13 126.21 57.77 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 11.8 Cg_exo -70.57 133.25 23.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.799 2.333 . . . . 0.0 112.048 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.86 138.56 32.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.261 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.472 HH12 ' CG ' ' A' ' 19' ' ' ASP . 38.9 mtp85 -139.92 122.54 16.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.486 HG23 HG22 ' A' ' 45' ' ' ILE . 8.8 tt -77.9 136.69 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.115 0.483 . . . . 0.0 110.009 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.34 106.07 17.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.214 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 HG21 ' A' ' 45' ' ' ILE . 13.3 t 179.37 -168.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.771 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.652 ' HA ' HG13 ' A' ' 45' ' ' ILE . 3.2 p-10 -161.2 -161.42 0.81 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.9 m -67.24 -45.84 75.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -64.93 -52.33 56.97 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.11 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 111.473 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.97 137.73 41.39 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.958 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 22.0 m -61.71 129.39 40.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.624 0.25 . . . . 0.0 110.616 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 39.9 tttp -53.25 130.27 34.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.803 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.44 -37.96 3.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.618 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 t -70.42 125.85 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 8.5 mmmt -94.65 116.89 29.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.262 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.656 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 39.4 m-85 -93.65 134.44 35.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -123.77 162.42 23.22 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.542 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.47 159.44 18.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.414 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' CG ' HH12 ' A' ' 2' ' ' ARG . 15.1 p-10 -59.46 -27.64 66.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.729 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -65.89 -27.6 68.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.933 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.29 -0.69 20.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.294 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.7 m -88.71 146.29 25.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.238 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.75 126.85 31.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.91 -63.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.306 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.4 p -177.76 149.39 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.182 0.515 . . . . 0.0 111.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.677 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 2.0 pt-20 -90.15 149.06 22.6 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.746 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.45 121.82 25.76 Favored Glycine 0 C--O 1.236 0.224 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.893 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 13.0 pt-20 -94.83 11.28 32.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.0 m -50.82 137.88 19.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.681 0.277 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -166.41 133.38 2.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.44 -5.9 17.12 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.881 2.387 . . . . 0.0 113.11 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.46 -33.61 69.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.7 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -151.65 146.4 18.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 84.95 0.17 Allowed 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.928 2.419 . . . . 0.0 113.19 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.71 60.42 3.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.475 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -77.12 106.04 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.073 0.463 . . . . 0.0 110.422 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 73.9 m -129.56 58.44 37.66 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 7.4 Cg_exo -72.41 -33.12 9.25 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.349 2.033 . . . . 0.0 112.06 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -98.69 46.0 1.0 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.375 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.3 t-20 -150.45 121.21 7.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.933 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.66 128.8 12.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.842 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.7 m-20 -87.46 125.65 64.8 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.16 -18.73 64.55 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.247 1.965 . . . . 0.0 110.844 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.456 ' HG2' HH11 ' A' ' 44' ' ' ARG . 1.0 OUTLIER -69.58 -34.35 74.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.376 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.652 HG13 ' HA ' ' A' ' 6' ' ' ASN . 38.9 mm -66.76 107.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.586 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.48 -40.94 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 9.0 p90 -154.71 150.59 27.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -117.59 127.21 7.26 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.439 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.7 mt -93.09 100.14 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.21 127.97 53.29 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.81 140.55 51.21 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.737 2.292 . . . . 0.0 112.317 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -160.22 133.07 6.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.735 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.969 0 O-C-N 124.106 0.878 . . . . 0.0 110.696 -179.072 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 51.7 t0 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.652 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 21.5 mmm-85 -151.98 64.06 0.84 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.119 0.568 . . . . 0.0 109.736 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.13 129.99 36.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.604 0.716 . . . . 0.0 110.918 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.56 129.77 35.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 t -176.59 -160.45 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -153.59 166.17 33.6 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -51.61 -44.01 62.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.665 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 t -60.99 -49.65 76.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 111.449 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.99 -29.45 65.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.78 131.9 40.41 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.616 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 m -59.63 126.47 27.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.291 0.236 . . . . 0.0 110.926 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 48.6 tptt -58.83 120.43 9.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.919 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.86 -40.75 2.01 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 59.1 m -71.2 126.47 29.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 13.3 ptpt -88.3 110.84 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.221 0.534 . . . . 0.0 111.218 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 31.8 m-85 -93.95 129.09 40.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -113.28 151.65 30.83 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.807 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.438 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 2.3 p -79.96 167.55 20.34 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.701 0.625 . . . . 0.0 111.351 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.527 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 12.4 p-10 -62.98 -29.23 70.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.28 -30.75 70.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.708 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.89 -9.74 10.4 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 114.014 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 m -87.91 151.13 23.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.254 0.549 . . . . 0.0 111.525 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -68.2 126.78 30.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.743 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.525 HG12 ' SG ' ' A' ' 25' ' ' CYS . 39.1 t -94.77 -56.38 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' A' ' 24' ' ' VAL . 24.7 p -176.35 145.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.271 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -89.9 39.97 0.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.702 0.763 . . . . 0.0 110.076 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.69 172.62 16.43 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.379 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.665 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 15.3 pt-20 -157.04 27.45 0.31 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 p -79.06 66.97 4.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.49 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 41.0 t0 -61.57 119.57 48.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 15.2 Cg_exo -68.44 -19.35 43.25 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.714 2.276 . . . . 0.0 111.302 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -36.55 65.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.33 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.0 p30 -136.19 127.26 16.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 2.6 Cg_exo -76.2 90.23 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.985 2.457 . . . . 0.0 112.199 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -78.59 136.69 37.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.88 115.54 9.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 110.484 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -89.37 137.32 29.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.715 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.24 140.24 93.56 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.938 2.425 . . . . 0.0 112.071 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -83.49 43.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -159.46 146.8 17.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.86 30.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.11 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 20.6 m-20 -78.06 118.78 74.32 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.527 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 22.7 Cg_exo -64.06 -18.45 63.64 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.905 2.403 . . . . 0.0 110.638 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 20.0 ttp-105 -70.94 -32.49 69.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.906 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 mm -64.67 119.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.823 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.652 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -94.88 -52.62 4.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.498 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -166.69 157.69 12.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.253 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -126.86 115.98 2.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.59 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 46.9 mm -90.18 117.41 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.3 m -89.33 121.3 69.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.0 Cg_exo -76.59 130.37 11.65 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.006 2.47 . . . . 0.0 112.545 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.61 -21.65 30.26 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.836 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.434 179.545 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.854 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 17.7 ptp180 -162.3 164.45 27.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.521 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -77.05 135.0 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 0.0 110.998 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.11 100.85 13.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.194 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -177.4 -173.21 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.645 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -160.54 -173.66 4.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.34 -45.7 92.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.676 0.275 . . . . 0.0 111.502 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 12.0 t -57.25 -42.07 80.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.945 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.72 -82.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . 31.97 -138.35 0.08 OUTLIER Glycine 0 C--N 1.337 0.588 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.746 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 98.6 m -165.46 126.7 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 28' ' ' GLU . 46.6 mmtt -49.15 135.27 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 111.975 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.45 -43.52 2.78 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 32.8 t -71.82 116.22 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 0.0 109.823 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.713 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 38.0 mttp -99.07 119.97 38.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.039 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.754 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 35.6 m-85 -92.61 136.09 33.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.429 0.633 . . . . 0.0 111.556 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.492 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -119.61 158.14 26.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.941 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.18 162.03 21.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.653 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.27 -26.69 67.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.621 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -66.59 -29.56 69.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.859 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.94 -0.89 17.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.388 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 m -88.86 146.17 25.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.068 0.461 . . . . 0.0 111.305 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.3 t80 -73.77 126.93 31.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.517 HG12 ' SG ' ' A' ' 25' ' ' CYS . 79.1 t -96.76 -63.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.952 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.8 p 179.52 155.15 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.62 0.248 . . . . 0.0 111.033 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 11.7 pt-20 -96.85 147.53 23.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.746 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -64.03 136.19 40.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.472 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HA ' ' CE ' ' A' ' 12' ' ' LYS . 11.7 pt-20 -95.17 -3.64 47.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m 70.83 116.76 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.437 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.552 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.8 t70 -53.9 -57.6 17.02 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.628 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 89.9 Cg_endo -78.01 43.3 1.35 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.709 1.606 . . . . 0.0 112.299 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -163.66 31.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.542 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.0 p30 -161.15 149.94 13.26 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 3.9 Cg_exo -77.14 51.18 3.37 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.034 2.489 . . . . 0.0 113.794 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 9.9 mtmp? -157.98 126.65 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.294 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.47 117.21 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.579 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 88.9 m -141.55 51.82 2.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.865 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 17.3 Cg_exo -66.77 -25.0 46.46 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.349 2.033 . . . . 0.0 112.409 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -133.74 39.5 3.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.45 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -94.58 139.33 31.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -152.24 133.16 14.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.181 0.515 . . . . 0.0 112.191 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.626 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.3 m-20 -99.04 126.45 38.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.861 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.56 -29.34 88.67 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.773 2.315 . . . . 0.0 111.793 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 44' ' ' ARG . 19.9 ptt180 -66.36 -27.63 68.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.468 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.645 HG13 ' HA ' ' A' ' 6' ' ' ASN . 42.4 mm -70.11 110.56 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.928 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.854 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -103.89 -46.71 4.41 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.168 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.4 p90 -150.06 143.27 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.904 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -113.29 130.01 9.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.752 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.7 94.31 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 71.5 m -89.44 132.76 36.28 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.281 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 18.1 Cg_exo -66.75 136.77 43.23 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.869 2.379 . . . . 0.0 112.009 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.81 -34.09 39.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.198 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.875 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.792 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 46.0 t0 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.789 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 2.7 ptm180 -77.5 132.9 38.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.349 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.37 134.46 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.216 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.82 128.11 36.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.872 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -177.11 -156.43 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -153.13 177.59 10.65 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 m -55.87 -39.75 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 31.8 t -70.58 -52.79 19.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.79 60.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.764 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.72 141.04 46.95 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.408 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -62.14 130.3 44.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.715 0.293 . . . . 0.0 111.424 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 21.5 tptm -54.44 123.48 13.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.829 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.612 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 106.66 -35.69 4.88 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -74.36 126.94 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.573 0.225 . . . . 0.0 110.479 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -90.81 119.82 31.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 90.3 m-85 -99.15 134.5 41.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.347 0.594 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.622 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.4 m-85 -121.72 160.41 24.59 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.758 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -82.68 169.09 16.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.308 178.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -60.25 -30.7 69.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.454 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -67.48 -28.54 67.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.481 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.32 1.28 23.48 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.075 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -88.16 144.49 26.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.537 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -72.57 126.73 30.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.069 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG21 ' HG3' ' A' ' 44' ' ' ARG . 70.6 t -96.61 -62.27 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 p -176.46 151.22 0.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.448 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.7 pt-20 -95.31 156.83 16.16 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.86 127.65 36.41 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.05 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.568 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.5 pp20? -114.39 29.34 8.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -75.78 54.66 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.767 0.794 . . . . 0.0 110.491 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -73.65 129.0 86.08 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.003 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.88 -21.58 41.46 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.227 2.618 . . . . 0.0 113.086 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.536 ' HD3' ' O ' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -67.19 -31.07 71.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.634 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -103.0 132.42 21.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.58 64.85 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.936 2.424 . . . . 0.0 113.144 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 28' ' ' GLU . 10.6 mtmp? -125.51 141.89 51.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.982 0.42 . . . . 0.0 110.956 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -150.65 128.36 11.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.327 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . 62.5 m -127.67 65.36 67.06 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.539 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 15.9 Cg_exo -67.89 -25.8 38.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.567 2.178 . . . . 0.0 112.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -115.2 52.79 0.85 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.317 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 20.9 t-20 -158.7 132.38 7.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -159.06 136.51 9.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 10.4 m-20 -84.57 127.28 66.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.72 -23.78 77.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.051 2.501 . . . . 0.0 112.741 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 18' ' ' SER . 4.5 ptp85 -79.62 -16.28 56.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.386 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 6' ' ' ASN . 21.8 mm -75.52 102.11 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.42 -39.64 10.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.789 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 3.1 p90 -157.42 166.21 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.461 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.93 136.11 6.65 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.573 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.7 mt -100.28 122.31 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.749 0.309 . . . . 0.0 110.552 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -101.03 133.22 21.14 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.08 138.73 37.46 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.644 2.229 . . . . 0.0 112.514 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.492 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -125.03 21.56 8.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.218 0.532 . . . . 0.0 110.261 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.54 179.82 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 2' ' ' ARG . 11.7 t70 . . . . . 0 C--O 1.233 0.209 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.568 ' HD2' ' H ' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -124.48 135.89 53.58 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.286 0.565 . . . . 0.0 111.164 -179.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.406 HG23 HG22 ' A' ' 45' ' ' ILE . 12.2 tt -78.59 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.084 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.19 101.13 13.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.967 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.602 HG23 HG21 ' A' ' 45' ' ' ILE . 12.2 t -176.52 -161.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.728 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.3 p30 -160.02 -159.44 0.72 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 18.3 m -67.57 -54.99 15.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.537 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 49.7 t -70.23 -43.08 71.36 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.207 -0.308 . . . . 0.0 111.596 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -23.48 64.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.968 0.413 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.84 147.92 47.27 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.267 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.563 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 m -59.58 126.29 27.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 0.0 111.085 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.971 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 34.5 ttpt -54.76 132.77 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.247 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 -37.64 3.36 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.878 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 35.8 m -70.27 126.99 31.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.817 ' HE3' ' HB3' ' A' ' 26' ' ' GLU . 2.5 mtpt -91.24 114.8 27.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.668 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.6 m-85 -89.66 135.85 33.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.353 0.597 . . . . 0.0 111.566 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.464 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.3 m-85 -125.9 160.4 30.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.9 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -83.79 163.83 19.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.889 178.495 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -62.46 -28.51 69.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.458 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -66.91 -28.49 68.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.925 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.65 1.89 19.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -88.16 147.41 24.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.101 0.476 . . . . 0.0 111.031 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' CE1' ' HE2' ' A' ' 15' ' ' LYS . 26.9 t80 -75.21 133.39 41.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.096 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -105.08 -68.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.2 p -176.42 147.55 0.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.817 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 3.1 pm0 -85.87 156.55 20.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.837 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -64.5 119.97 17.44 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.712 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -102.63 34.04 2.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -79.72 71.31 6.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.229 0.538 . . . . 0.0 110.908 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.971 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 9.8 t70 -146.66 -59.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD2' ' H ' ' A' ' 30' ' ' ASP . 31.6 Cg_endo -64.46 -39.14 29.92 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.783 1.656 . . . . 0.0 112.869 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 58.03 37.83 26.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.745 0.783 . . . . 0.0 109.893 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -72.09 161.07 80.81 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.872 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.21 92.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.683 2.255 . . . . 0.0 111.766 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 2.5 tmmm? -160.85 134.22 6.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.935 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 103.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.159 0.504 . . . . 0.0 111.85 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.638 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 83.7 m -89.83 -55.91 0.28 Allowed Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.797 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 97.5 Cg_endo -83.28 39.86 0.87 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.03 1.82 . . . . 0.0 111.975 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -69.32 -46.08 67.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 176.42 171.44 0.43 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.41 129.81 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -82.71 122.3 78.31 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.1 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.03 -27.46 79.53 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.01 2.473 . . . . 0.0 112.007 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' SER . 11.8 ptt-85 -68.35 -25.41 65.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.184 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.728 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.8 mm -79.95 94.87 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 2' ' ' ARG . . . -89.87 -43.35 10.67 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.5 p90 -159.97 157.26 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.101 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -125.49 125.82 5.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.055 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.7 mt -86.62 111.97 22.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.838 0.352 . . . . 0.0 110.167 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.38 133.54 28.23 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.4 57.85 5.56 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.864 2.376 . . . . 0.0 112.198 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.34 137.06 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.91 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 C--O 1.235 0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 9.0 tpt180 -158.58 58.63 0.44 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.442 0.639 . . . . 0.0 109.503 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 tt -78.1 124.49 36.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.15 127.06 40.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' HG13 ' A' ' 45' ' ' ILE . 12.9 t -176.97 -155.74 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -146.08 178.58 8.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 26.9 m -56.19 -42.13 76.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.668 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 43.0 t -72.07 -49.52 35.86 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.84 29.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.337 0.589 . . . . 0.0 111.089 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.94 145.58 15.95 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.19 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -59.65 126.72 28.7 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.883 0.341 . . . . 0.0 110.694 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 84.5 tttt -54.93 128.87 35.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 -39.77 2.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.894 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.5 124.11 26.61 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.956 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -100.37 126.57 46.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.029 0.443 . . . . 0.0 110.0 179.235 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 14.7 m-85 -89.04 137.7 32.08 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.173 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.0 m-85 -122.51 160.56 25.34 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 157.44 19.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.043 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -61.35 -29.05 69.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.34 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.32 -32.67 73.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.493 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.19 -2.15 9.73 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.853 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 m -89.02 148.05 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.443 0.64 . . . . 0.0 111.559 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.73 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 18.8 t80 -76.92 131.56 38.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.925 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG12 ' SG ' ' A' ' 25' ' ' CYS . 93.1 t -99.86 -68.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.867 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.6 p 178.72 148.88 0.21 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.831 0.348 . . . . 0.0 111.572 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.956 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 pm0 -87.02 152.67 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -67.67 121.58 15.11 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.614 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.668 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -89.36 41.19 1.02 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 111.526 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.9 m -77.81 53.1 1.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.732 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 9.1 t70 -93.46 -55.42 0.24 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.33 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 23.5 Cg_exo -63.9 111.11 1.46 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.764 1.643 . . . . 0.0 111.168 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -62.45 -20.84 64.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.349 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -68.91 133.48 90.15 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 110.546 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.3 132.53 27.83 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.657 2.238 . . . . 0.0 112.726 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.0 143.52 33.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.03 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.88 116.95 4.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.239 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.88 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 99.9 m -145.54 -47.6 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.312 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.88 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 58.3 Cg_endo -71.03 48.39 0.86 Allowed 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.216 1.944 . . . . 0.0 112.891 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -85.47 -26.65 26.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.94 174.87 7.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.677 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.25 140.6 52.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.717 0.294 . . . . 0.0 110.678 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.461 ' HB2' HG12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -78.72 125.2 84.66 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.559 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 38.1 Cg_exo -60.54 -27.73 85.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.875 2.383 . . . . 0.0 111.569 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.441 ' HD2' HG13 ' A' ' 24' ' ' VAL . 25.4 ptt180 -66.87 -28.86 68.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.275 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 42' ' ' ASP . 23.3 mm -70.41 102.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.223 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -99.15 -42.35 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.563 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.1 p90 -156.92 151.52 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.816 0.341 . . . . 0.0 111.422 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.23 123.7 7.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.36 111.91 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.378 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.6 m -94.59 136.49 23.11 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.83 141.91 50.6 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.667 2.245 . . . . 0.0 111.929 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -157.7 -44.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.281 -1.342 . . . . 0.0 108.661 179.196 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.406 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 2.0 p30 . . . . . 0 CA--C 1.514 -0.44 0 CA-C-O 122.186 0.993 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 mmm180 -133.0 138.34 46.81 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 47' ' ' TYR . 7.1 tt -145.75 128.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.231 0.538 . . . . 0.0 109.851 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.01 117.12 29.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.979 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t 179.52 -159.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.607 ' HA ' HG13 ' A' ' 45' ' ' ILE . 16.5 p30 -145.61 -167.61 2.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.632 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m -67.17 -56.27 10.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.869 0.366 . . . . 0.0 111.409 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 3.7 t -58.25 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.1 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.91 24.17 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.651 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.13 -122.77 4.61 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.128 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.8 m -151.47 136.14 17.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 36.5 tttp -53.95 127.91 28.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.241 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.55 -30.74 3.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.246 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.44 122.31 14.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.783 ' HD3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 mmtm -92.67 113.56 25.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 69.2 m-85 -95.98 133.27 40.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 110.911 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.546 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -128.4 164.9 21.69 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.381 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.83 156.28 18.15 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.493 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 30.7 p-10 -62.99 -23.82 67.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.627 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.4 -33.57 75.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.02 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.22 -4.17 8.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.031 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.8 m -89.44 146.78 24.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.207 0.527 . . . . 0.0 111.545 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -77.31 129.24 35.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.57 HG13 ' HD2' ' A' ' 44' ' ' ARG . 92.9 t -95.66 -63.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.6 p -178.25 163.41 1.65 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.564 0.221 . . . . 0.0 110.517 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.783 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -110.23 153.33 24.95 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -68.16 115.96 7.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.528 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.7 pm0 -90.88 33.43 0.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -69.87 54.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.518 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.413 ' N ' ' HD3' ' A' ' 31' ' ' PRO . 52.7 t0 -179.13 62.34 0.13 Allowed Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.674 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 30' ' ' ASP . 88.9 Cg_endo -89.2 -8.56 4.68 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.62 2.213 . . . . 0.0 112.106 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 75.64 -39.4 0.38 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.843 0.857 . . . . 0.0 110.534 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -90.65 151.39 43.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.19 125.61 19.02 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.269 1.979 . . . . 0.0 111.895 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.449 ' HE2' ' SG ' ' A' ' 8' ' ' CYS . 86.5 tttt -147.94 128.02 13.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.36 122.53 30.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.544 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -92.28 129.29 41.71 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.478 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.99 131.93 37.15 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.561 2.174 . . . . 0.0 111.641 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -79.91 -19.78 47.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.843 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.31 132.66 49.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.77 132.98 35.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 26.6 m-20 -78.9 123.65 85.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.918 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.66 -25.39 78.87 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.887 2.391 . . . . 0.0 111.726 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.57 ' HD2' HG13 ' A' ' 24' ' ' VAL . 31.7 ptt180 -71.89 -27.67 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.424 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.607 HG13 ' HA ' ' A' ' 6' ' ' ASN . 25.4 mm -79.1 105.59 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.828 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.41 -42.12 7.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.372 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.57 ' HA ' HG22 ' A' ' 3' ' ' ILE . 6.0 p90 -155.16 163.11 40.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.79 131.73 4.75 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.377 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 49' ' ' ILE . 4.1 mp -86.88 94.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.3 m -91.04 134.01 30.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.053 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.5 Cg_exo -71.97 63.88 3.29 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.347 2.698 . . . . 0.0 112.443 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -80.48 -35.8 34.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.521 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.332 -1.318 . . . . 0.0 108.849 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 45.0 t0 . . . . . 0 C--O 1.236 0.366 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 56.5 ttm-85 -160.7 110.76 1.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -78.36 140.39 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.799 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.47 101.56 14.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.032 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -179.1 -171.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.839 ' HA ' HG13 ' A' ' 45' ' ' ILE . 23.2 p30 -161.44 -155.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.33 -52.29 23.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.799 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 52.6 t -64.86 -41.76 95.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.899 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.66 -23.65 49.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.23 148.35 50.03 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.784 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -75.14 141.11 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.761 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 29' ' ' SER . 45.7 mtmt -50.36 137.26 18.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.896 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.75 -36.52 3.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.816 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.96 120.41 14.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.731 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 47.7 mttp -98.03 122.12 40.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.8 m-85 -100.98 133.87 44.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.534 0.683 . . . . 0.0 111.256 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -121.85 162.65 20.56 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.249 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.44 159.26 19.39 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.261 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' CG ' HH22 ' A' ' 2' ' ' ARG . 4.9 p-10 -59.53 -27.41 66.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.408 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.56 -34.86 78.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.11 -5.4 8.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.881 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 m -89.39 146.59 24.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.154 0.502 . . . . 0.0 111.537 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -74.11 126.66 31.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.61 -61.37 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.468 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 p -179.17 153.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.731 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 6.4 pt-20 -96.94 160.94 14.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.148 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.1 136.22 34.99 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 113.882 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 9.1 pt-20 -118.66 15.89 13.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.724 -0.238 . . . . 0.0 111.408 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 44.7 m -58.38 123.49 16.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.281 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 31.7 t0 67.05 64.78 0.73 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 121.542 0.686 . . . . 0.0 110.715 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -88.72 41.58 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.554 2.169 . . . . 0.0 110.953 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 66.28 35.79 5.72 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.019 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 18.3 p30 -169.57 160.37 7.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.923 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 33' ' ' ASN . 37.0 Cg_endo -65.96 71.63 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.092 2.528 . . . . 0.0 114.657 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 31.6 mtpt -134.58 127.38 31.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.884 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.443 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -171.35 137.99 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.849 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 64.2 m -128.76 62.69 62.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 2.8 Cg_exo -75.83 44.87 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.894 2.396 . . . . 0.0 112.456 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -171.44 44.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.659 0.742 . . . . 0.0 109.081 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -159.17 142.65 14.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.029 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.78 26.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 m-20 -96.3 128.42 36.75 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 -26.41 82.7 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.806 2.337 . . . . 0.0 111.744 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 mtm-85 -68.07 -34.07 75.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.839 HG13 ' HA ' ' A' ' 6' ' ' ASN . 46.3 mm -72.15 114.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.615 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -107.89 -39.79 5.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.833 0.349 . . . . 0.0 110.591 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.544 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.6 p90 -154.73 155.12 33.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.401 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -138.81 135.02 7.11 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.642 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -91.46 102.96 14.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.28 120.9 66.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.315 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.12 136.99 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.563 2.176 . . . . 0.0 112.236 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.08 137.34 33.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.345 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.419 -1.277 . . . . 0.0 109.235 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--O 1.235 0.316 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.815 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 20.0 ptp180 -161.58 152.01 17.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.228 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.52 128.49 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.484 0.659 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.29 121.45 31.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.211 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t 179.9 -162.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -158.1 -174.38 4.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 4.5 m -59.99 -53.82 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 39.7 t -65.97 -42.57 89.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . . . -71.39 -30.5 66.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.9 146.49 50.39 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.3 m -66.08 133.19 50.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.532 0.205 . . . . 0.0 111.096 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 38.1 ttpt -52.55 135.46 34.13 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.17 -36.2 3.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.169 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 20.8 t -70.43 118.71 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 67.1 mttm -91.75 116.14 28.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.633 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 59.9 m-85 -94.53 132.91 38.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.079 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.8 m-85 -120.82 159.85 24.6 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.276 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.63 160.69 19.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.326 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -61.09 -27.14 68.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.434 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -64.4 -33.52 76.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.313 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.2 -4.53 9.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.91 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 m -89.04 148.3 23.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.0 111.461 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.34 124.74 27.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.692 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.443 HG12 ' SG ' ' A' ' 25' ' ' CYS . 78.2 t -90.47 -64.23 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 24' ' ' VAL . 26.5 p 179.98 150.7 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.265 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.6 pt-20 -97.69 155.39 17.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.155 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.9 138.33 48.98 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.219 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 13.0 pt-20 -119.78 14.17 12.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.929 0.395 . . . . 0.0 111.013 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 33.4 p -77.6 137.67 38.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.023 0.439 . . . . 0.0 111.81 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.615 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 9.9 t70 -156.85 133.77 6.51 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.38 -18.98 48.79 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.295 2.663 . . . . 0.0 113.55 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.08 -40.27 84.74 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.725 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 9.0 p30 -173.16 -41.23 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.508 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.725 ' HD2' ' H ' ' A' ' 33' ' ' ASN . 56.7 Cg_endo -73.45 89.51 0.95 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 121.34 1.36 . . . . 0.0 111.491 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.79 143.27 36.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.683 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.659 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -53.78 143.93 19.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.759 0.662 . . . . 0.0 111.676 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.6 m -108.86 78.12 0.9 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.445 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 1.3 Cg_endo -84.15 41.19 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.024 2.482 . . . . 0.0 111.924 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -77.7 -32.45 52.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.81 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -163.05 152.81 15.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.48 132.77 44.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.762 0.315 . . . . 0.0 110.811 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 66.4 m-20 -79.28 121.12 82.61 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.409 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.63 -25.45 79.16 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.803 2.335 . . . . 0.0 111.553 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 33.0 ptt180 -67.23 -29.57 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.189 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -72.55 112.22 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.64 0.257 . . . . 0.0 110.689 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -105.89 -43.4 4.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.77 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.3 p90 -156.1 150.19 25.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.866 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -128.58 130.42 6.54 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.252 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 49' ' ' ILE . 3.7 mp -88.97 100.74 11.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 82.8 m -89.94 125.7 59.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.039 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.56 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 7.4 Cg_exo -73.12 65.01 4.26 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.304 2.669 . . . . 0.0 112.591 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pp -156.92 32.63 0.3 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.493 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.815 179.579 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--O 1.235 0.342 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 -146.84 123.79 11.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -78.71 141.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.218 0.532 . . . . 0.0 110.56 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.41 90.93 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t -173.23 -171.96 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.073 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.78 ' HA ' HG13 ' A' ' 45' ' ' ILE . 2.3 p-10 -160.91 -164.96 1.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.259 -0.177 . . . . 0.0 110.612 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.529 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 59.1 m -59.59 -37.77 79.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 3.9 t -80.71 -59.18 2.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.407 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.94 -16.66 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -59.37 147.88 41.74 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.27 -0.491 . . . . 0.0 113.027 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -68.48 129.49 40.09 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 49.7 tttm -55.15 125.23 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.398 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.36 -38.47 3.14 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.0 m -72.04 121.89 19.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 68.2 mttm -89.8 121.3 31.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 48.9 m-85 -94.77 134.68 37.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.144 0.497 . . . . 0.0 110.829 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.433 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.7 m-85 -119.35 161.85 19.78 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.705 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.34 161.13 18.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.408 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.17 -29.39 63.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.657 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.28 -33.69 76.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.34 -5.1 9.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.815 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.9 m -88.39 148.04 24.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.528 . . . . 0.0 111.162 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.5 t80 -71.34 130.01 40.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.047 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.552 HG12 ' SG ' ' A' ' 25' ' ' CYS . 73.2 t -97.1 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.819 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.5 p -178.95 153.22 0.62 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -97.66 147.68 24.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -70.77 138.12 28.05 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.375 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.667 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 8.1 pt-20 -89.75 -6.35 56.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 87.1 p 67.68 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.67 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.64 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 38.3 t0 -56.14 -56.04 35.35 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.646 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 84.8 Cg_endo -77.44 40.47 0.84 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.018 1.812 . . . . 0.0 113.676 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 48.9 tpt85 -106.61 -32.35 8.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.955 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 16.8 p30 -148.72 158.37 39.88 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.05 62.68 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.248 2.632 . . . . 0.0 112.722 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -153.7 112.65 3.71 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.4 124.27 19.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.369 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -88.53 -43.93 0.46 Allowed Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.9 46.63 0.53 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.577 2.184 . . . . 0.0 113.607 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.03 -34.24 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.851 0.358 . . . . 0.0 110.417 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -167.5 145.92 4.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.711 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.61 ' OD1' ' HB2' ' A' ' 6' ' ' ASN . 4.2 m-20 -78.1 122.04 84.81 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.12 -32.77 71.26 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.318 2.679 . . . . 0.0 113.551 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' NE ' HG13 ' A' ' 24' ' ' VAL . 25.3 ptt-85 -70.16 -17.54 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.78 HG13 ' HA ' ' A' ' 6' ' ' ASN . 30.4 mm -69.82 107.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.15 -49.41 3.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.22 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.3 p90 -150.79 149.13 29.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.898 0.38 . . . . 0.0 111.249 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.686 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -118.23 134.25 10.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.114 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.8 mm -110.2 120.45 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.878 0.37 . . . . 0.0 110.449 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.6 m -91.95 125.77 55.82 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.2 Cg_exo -68.29 126.38 14.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.734 2.289 . . . . 0.0 112.041 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.87 -35.44 14.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.342 -1.313 . . . . 0.0 108.568 179.778 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.6 t0 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.421 HH11 ' HB1' ' A' ' 46' ' ' ALA . 27.1 mmt180 -142.38 126.69 17.62 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 47' ' ' TYR . 6.5 tt -142.12 131.36 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.312 0.577 . . . . 0.0 111.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.65 124.4 35.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -179.24 -158.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . 0.825 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.8 p30 -151.58 -168.09 2.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 m -65.81 -58.84 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -62.87 -44.72 95.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.768 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.02 -11.68 60.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.2 145.23 35.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.493 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 14.9 m -67.23 137.0 55.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.552 0.215 . . . . 0.0 110.931 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 29' ' ' SER . 59.0 mttm -49.23 133.27 19.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.716 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.2 -37.36 3.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.276 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 59.3 m -65.68 112.59 3.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 62.2 mttm -89.64 116.78 28.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.535 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 76.8 m-85 -94.46 135.64 35.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -120.53 161.54 21.13 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.749 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 1.8 p -80.74 164.5 22.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.275 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -60.82 -28.56 68.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.72 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.03 -33.88 76.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.938 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.25 -9.22 7.43 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.652 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 m -86.6 146.0 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.378 0.609 . . . . 0.0 111.31 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -69.86 127.62 33.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' SG ' ' A' ' 25' ' ' CYS . 71.9 t -96.96 -61.2 2.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' HG12 ' A' ' 24' ' ' VAL . 23.3 p -178.16 148.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.446 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.613 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.5 pt-20 -94.17 159.85 14.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.336 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.31 127.69 45.52 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.196 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.736 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 5.5 pt-20 -126.49 35.41 4.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.591 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 22.9 m -63.11 102.66 0.4 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 47.8 t0 -170.68 123.64 0.59 Allowed Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.936 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 9.7 Cg_exo -71.43 -6.42 19.12 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -58.19 -43.41 87.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.03 144.05 27.19 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.499 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.22 65.83 2.06 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.206 2.604 . . . . 0.0 113.532 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -140.89 132.0 26.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.36 139.29 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.224 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 96.3 m -88.35 116.1 65.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 110.854 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 2.8 Cg_exo -75.62 137.59 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.12 2.546 . . . . 0.0 111.764 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.524 ' HD3' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -73.84 -28.88 61.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -67.64 139.22 56.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.209 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.51 142.54 37.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.677 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 22.5 m-20 -78.82 129.87 72.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.207 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 7.5 Cg_exo -71.92 56.23 2.4 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.6 2.867 . . . . 0.0 110.574 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 18' ' ' SER . 33.3 ptt180 -167.11 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.5 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.825 HG13 ' HA ' ' A' ' 6' ' ' ASN . 33.2 mm -73.62 102.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.418 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB1' HH11 ' A' ' 2' ' ' ARG . . . -97.86 -40.49 8.49 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.576 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.0 p90 -159.28 159.58 34.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.846 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.98 134.05 5.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.568 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 49' ' ' ILE . 4.4 mp -96.35 126.56 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 72.8 m -95.6 143.53 26.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo -75.73 52.94 3.48 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.994 2.463 . . . . 0.0 111.814 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -161.92 -42.18 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.406 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.34 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.91 179.566 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 2' ' ' ARG . 2.2 ptp85 . . . . . 0 N--CA 1.456 -0.152 0 CA-C-O 120.962 0.411 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 mt -134.85 130.53 52.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.28 114.98 27.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.541 HG22 HG21 ' A' ' 45' ' ' ILE . 13.6 t -166.49 -158.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.563 0.22 . . . . 0.0 110.463 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -155.17 167.65 29.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.26 -43.54 61.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 34.4 t -69.17 -45.4 70.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.11 55.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.55 142.9 48.06 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.019 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -67.15 135.06 52.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 23.5 tptp -55.44 131.56 46.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.7 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.36 -34.43 4.84 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.647 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.0 t -71.42 123.36 22.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 2.7 ptpp? -101.79 115.23 30.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.655 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 62.4 m-85 -92.47 135.93 33.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.3 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.485 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.9 m-85 -120.45 159.43 25.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -91.9 168.77 11.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.909 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -64.4 -31.75 73.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.547 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.15 -19.23 64.28 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.192 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.92 -4.04 52.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.659 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -89.4 148.25 23.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 21.0 t80 -70.56 128.49 36.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' A' ' 25' ' ' CYS . 79.6 t -90.54 -65.73 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.207 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 24' ' ' VAL . 26.7 p -178.57 154.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.789 0.328 . . . . 0.0 111.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -92.92 153.38 18.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.47 123.51 31.0 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.072 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 11.3 pt-20 -90.3 26.51 1.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.779 0.323 . . . . 0.0 111.439 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -78.2 64.17 3.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.794 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 3.3 t70 -67.15 128.23 93.73 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.298 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.64 -19.56 59.94 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.946 2.431 . . . . 0.0 113.327 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 7.7 tpm_? -70.51 -37.64 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.34 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -116.68 133.29 23.05 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 0.0 111.195 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.26 126.6 17.38 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.345 2.03 . . . . 0.0 111.338 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -159.09 146.43 17.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.958 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.491 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -168.77 122.78 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 m -128.93 51.86 8.15 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.29 40.65 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.439 2.092 . . . . 0.0 111.384 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 38' ' ' PRO . 1.6 mpp_? -132.07 32.24 4.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.912 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -174.43 152.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.954 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.41 125.65 17.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.807 ' HB2' HG12 ' A' ' 45' ' ' ILE . 73.8 m-20 -78.64 126.66 82.33 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.19 -29.3 74.9 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 123.438 2.758 . . . . 0.0 113.448 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 18' ' ' SER . 1.2 ptm85 -88.22 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.275 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.807 HG12 ' HB2' ' A' ' 42' ' ' ASP . 28.7 mm -79.21 94.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.25 -45.43 9.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.806 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -157.63 159.92 37.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.683 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -137.74 131.81 5.63 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.034 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.39 93.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 93.4 m -88.74 139.55 29.46 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.4 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.69 136.46 39.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.578 2.185 . . . . 0.0 112.231 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.9 -33.62 39.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.97 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.613 179.728 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 121.055 0.455 . . . . 0.0 110.996 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tt -160.18 127.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.304 0.573 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.474 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -98.76 130.41 45.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.699 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -175.93 -148.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.445 ' HA ' HG13 ' A' ' 45' ' ' ILE . 17.0 p30 -154.62 164.96 37.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 m -48.99 -49.28 41.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 50.0 t -63.33 -43.58 97.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.053 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.49 29.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.913 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.64 144.79 15.86 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.2 m -63.1 121.92 14.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.679 0.276 . . . . 0.0 110.38 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 57.3 mtmt -54.07 130.55 38.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.891 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.83 -39.7 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -72.8 121.81 20.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 24.0 ttmm -93.11 120.88 33.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 77.0 m-85 -95.86 142.49 28.05 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.344 0.592 . . . . 0.0 111.933 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 11.3 m-85 -130.33 162.83 28.17 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.1 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.91 162.02 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.835 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.423 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.17 -32.15 73.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.75 -2.36 11.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.565 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -88.23 146.96 25.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.51 0.671 . . . . 0.0 111.162 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 5.0 t80 -73.15 131.86 42.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.708 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.0 t -103.98 -67.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.375 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.3 p -179.11 147.19 0.33 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.685 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 pm0 -87.91 167.11 14.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.47 125.4 23.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.732 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 35' ' ' LYS . 1.2 pp20? -122.08 49.32 1.59 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.495 0.664 . . . . 0.0 110.939 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 18.3 m -75.99 52.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.816 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.573 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 20.3 t70 61.42 130.37 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 123.836 0.855 . . . . 0.0 112.133 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.19 -40.08 78.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.21 1.94 . . . . 0.0 112.533 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.586 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 31.4 ttm-85 -66.4 -53.39 36.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HB3' ' O ' ' A' ' 32' ' ' ARG . 9.5 p30 142.86 -36.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 125.088 1.355 . . . . 0.0 114.294 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 30' ' ' ASP . 16.7 Cg_exo -69.79 68.71 1.7 Allowed 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.52 2.147 . . . . 0.0 115.173 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 29' ' ' SER . 58.7 tttm -160.82 129.66 4.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.848 0.356 . . . . 0.0 110.414 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -162.41 142.33 9.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.54 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -127.97 72.15 78.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.713 0.292 . . . . 0.0 111.514 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.32 39.86 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.086 2.524 . . . . 0.0 112.012 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -70.26 -35.79 74.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.614 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 45.5 t30 178.14 152.16 0.28 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.745 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -84.6 125.96 32.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 42.3 m-20 -79.84 131.11 64.74 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.799 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.2 Cg_exo -59.61 -22.6 67.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.837 2.358 . . . . 0.0 111.027 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.65 -35.42 80.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.403 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' A' ' 16' ' ' TYR . 23.4 mm -84.45 94.48 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.67 12.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.3 p90 -158.51 161.71 37.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.647 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.65 136.18 7.0 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.111 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -96.5 123.96 49.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.76 0.314 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 72.7 m -103.1 126.62 31.85 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.295 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.3 Cg_exo -71.88 121.39 7.57 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.596 2.197 . . . . 0.0 111.624 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.4 -37.13 10.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.33 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.857 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.772 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.652 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 13.0 ptm180 . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.741 0.305 . . . . 0.0 110.448 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tt -148.92 133.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.048 0.451 . . . . 0.0 110.72 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.78 129.7 42.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 t -178.03 -154.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -148.33 172.2 14.78 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -52.97 -51.66 60.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.708 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -61.3 -46.78 88.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.502 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.19 29.5 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.588 . . . . 0.0 111.032 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.98 143.93 15.77 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.635 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -60.83 128.82 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.611 0.205 . . . . 0.0 110.901 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -50.06 128.55 19.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.979 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.47 -33.82 4.02 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.833 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.23 118.11 11.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -94.27 119.4 33.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.351 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.66 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 57.6 m-85 -93.67 139.82 30.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 111.323 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -124.27 160.86 27.03 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.723 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 167.82 17.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.985 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -61.09 -30.69 70.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.311 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -66.72 -26.71 67.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.273 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.56 2.08 25.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.159 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -88.1 145.4 25.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.468 . . . . 0.0 110.532 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 23.8 t80 -73.0 124.36 25.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -92.98 -63.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.8 p -177.18 149.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.633 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 pt-20 -94.46 158.04 15.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.38 122.35 29.81 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.557 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.708 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 14.4 pt-20 -109.67 29.99 7.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.4 m -60.57 136.84 58.18 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t70 64.92 71.2 0.56 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.783 0.801 . . . . 0.0 110.142 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.494 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 2.0 Cg_endo -81.7 -5.17 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.741 2.294 . . . . 0.0 109.659 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 5.1 tpp85 76.33 -37.53 0.3 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 113.965 -1.471 . . . . 0.0 110.491 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' A' ' 31' ' ' PRO . 9.1 p-10 -85.84 149.86 51.82 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.56 119.36 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.276 1.984 . . . . 0.0 112.186 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -160.32 132.68 6.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.906 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 135.29 38.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.0 m -88.67 140.49 29.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.554 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.0 Cg_exo -62.73 134.6 47.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.87 2.38 . . . . 0.0 111.689 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 1.0 OUTLIER -90.11 46.11 1.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.101 0.477 . . . . 0.0 110.649 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.91 146.76 19.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.58 134.09 34.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 17.7 m-20 -78.96 127.54 79.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.059 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.91 -23.58 68.2 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.55 2.167 . . . . 0.0 110.901 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 10.6 ptp85 -70.39 -26.6 63.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.818 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 16' ' ' TYR . 23.5 mm -83.96 98.42 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.412 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.2 -42.08 11.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.694 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 4.2 p90 -157.38 174.03 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.085 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.66 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -150.14 134.43 4.81 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.687 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.9 mm -90.75 104.31 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.51 122.7 66.89 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.87 138.04 27.99 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.63 2.22 . . . . 0.0 112.265 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.8 pp -81.64 -22.87 37.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.263 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.609 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 30.0 ttm180 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.993 0.425 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 tt -144.24 137.27 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.876 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -88.99 127.86 35.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 HG21 ' A' ' 45' ' ' ILE . 12.4 t -178.52 -158.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.654 ' HA ' HG13 ' A' ' 45' ' ' ILE . 18.8 p30 -155.21 -173.42 4.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 m -62.37 -50.94 69.58 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.1 t -65.14 -48.87 72.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.743 0.306 . . . . 0.0 111.661 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.93 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.381 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.02 144.97 49.4 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -66.13 126.08 27.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.651 0.262 . . . . 0.0 110.745 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 86.7 tttt -53.79 131.79 40.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.43 -40.9 2.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.74 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.2 m -73.9 123.88 25.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 67.5 mttm -89.76 123.63 33.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.623 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 25.9 m-85 -96.89 134.92 39.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.785 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.2 m-85 -126.54 167.08 16.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.111 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.57 156.69 16.95 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.7 -26.43 67.13 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.546 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.26 -34.29 74.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.422 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.18 -5.25 8.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 m -89.29 146.43 24.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 111.694 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.7 t80 -76.5 130.96 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.566 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 45' ' ' ILE . 95.0 t -99.11 -67.46 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.4 p -176.71 143.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.773 0.32 . . . . 0.0 110.434 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.594 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . 3.8 pt-20 -91.08 162.5 14.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.9 116.88 8.37 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.979 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.77 24.58 7.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.503 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 p -77.09 54.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.469 0.652 . . . . 0.0 111.354 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.12 117.33 60.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.729 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.18 32.49 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.382 2.722 . . . . 0.0 113.732 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -80.53 -22.68 40.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.531 0.682 . . . . 0.0 109.731 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -165.26 148.69 7.2 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.919 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.39 137.73 71.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.554 2.169 . . . . 0.0 111.369 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -150.81 136.89 18.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.79 0.329 . . . . 0.0 110.532 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.85 119.82 30.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.019 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -88.89 138.97 29.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.5 128.45 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.616 2.211 . . . . 0.0 112.006 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -70.75 -20.78 62.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.479 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -71.85 132.46 44.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.941 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -85.25 123.18 30.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -79.61 121.25 82.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.417 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.97 -16.08 51.2 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.863 2.375 . . . . 0.0 110.237 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -67.44 -30.21 69.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.696 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.654 HG13 ' HA ' ' A' ' 6' ' ' ASN . 14.7 mm -88.62 112.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.34 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.43 -40.82 8.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.707 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.1 p90 -158.74 174.3 15.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.674 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.71 133.97 5.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.796 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.78 122.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.875 0.369 . . . . 0.0 110.579 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.2 m -92.56 136.64 25.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.142 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 27.8 Cg_exo -62.04 137.16 65.21 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.887 2.391 . . . . 0.0 112.167 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.1 151.48 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.3 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.904 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 42.8 ptt85 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 47' ' ' TYR . 10.1 tt -78.35 133.88 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.504 0.669 . . . . 0.0 110.965 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.07 112.58 24.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -178.19 -163.11 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.702 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -160.24 164.54 32.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 63.2 m -52.13 -40.58 61.56 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.522 ' HA ' ' CD ' ' A' ' 28' ' ' GLU . 24.8 t -58.5 -47.25 84.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.288 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.82 -16.82 49.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.6 133.54 41.41 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.049 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 31' ' ' PRO . 22.9 m -67.81 130.83 44.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.706 -0.247 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -61.95 97.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.277 0.56 . . . . 0.0 110.341 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.81 -39.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 84.8 m -73.1 119.24 17.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 49.7 mttp -88.95 112.29 23.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.134 0.492 . . . . 0.0 111.466 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 71.6 m-85 -93.72 132.58 37.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.14 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -120.96 152.22 38.79 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.253 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.82 165.47 20.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.12 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -59.08 -30.43 68.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.547 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -67.37 -28.36 67.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.65 2.19 22.71 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.088 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -88.52 146.42 25.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 0.0 110.524 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -72.77 127.04 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.751 HG13 ' HE ' ' A' ' 44' ' ' ARG . 52.1 t -93.16 -60.31 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.565 ' SG ' HG12 ' A' ' 24' ' ' VAL . 24.3 p -176.33 148.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.644 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 17.1 pt-20 -99.55 42.23 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.175 0.512 . . . . 0.0 111.079 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.13 -175.79 41.79 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.016 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.559 ' HG3' ' N ' ' A' ' 29' ' ' SER . 7.2 pt-20 -148.56 -42.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 50.3 m -77.28 139.65 39.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 1.024 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 16.7 t70 -61.79 144.11 93.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.146 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 89.3 Cg_exo -44.54 -26.33 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.529 2.819 . . . . 0.0 114.631 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.93 40.56 1.66 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 1.024 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 4.3 p-10 -94.12 146.61 31.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.824 0.345 . . . . 0.0 110.663 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 66.41 4.19 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.828 2.352 . . . . 0.0 112.481 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -136.92 128.81 29.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.434 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -123.68 138.92 54.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.522 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 39.1 m -130.61 62.49 65.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 3.1 Cg_exo -79.47 40.28 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.95 2.434 . . . . 0.0 111.821 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 51.1 ttp85 -67.12 -57.89 5.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 6.0 t-20 173.18 154.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.682 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.38 125.31 29.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.433 ' HB2' HG12 ' A' ' 45' ' ' ILE . 64.7 m-20 -77.66 123.33 86.59 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 2' ' ' ARG . 31.1 Cg_exo -61.17 -24.89 79.99 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.841 2.36 . . . . 0.0 110.751 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.751 ' HE ' HG13 ' A' ' 24' ' ' VAL . 19.0 ttp-105 -64.63 -28.38 69.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.231 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.47 HD13 HG11 ' A' ' 24' ' ' VAL . 30.9 mm -79.78 102.76 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.202 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -89.4 -51.18 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.461 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 3' ' ' ILE . 29.7 p90 -155.97 153.24 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.977 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -131.31 129.19 5.63 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.696 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.61 119.81 47.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -97.16 128.17 36.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.35 137.04 16.41 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.619 2.213 . . . . 0.0 112.162 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -160.2 146.42 15.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.147 -179.693 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.817 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 39.9 ptt180 . . . . . 0 N--CA 1.454 -0.244 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tt -77.51 124.52 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 0.0 110.692 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.72 122.57 32.95 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.742 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -178.2 -158.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.008 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -153.02 177.17 11.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.58 -40.88 79.97 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.977 0.418 . . . . 0.0 111.437 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.27 -47.85 77.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.878 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.45 33.58 1.78 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.08 -129.11 5.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.311 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.598 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 14.8 m -153.56 127.51 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 29' ' ' SER . 24.1 tptm -48.63 127.16 13.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.818 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.71 -39.63 3.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.197 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.7 m -66.68 118.43 10.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.06 0.43 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.914 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 19.6 mmmt -89.12 116.0 27.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.689 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.0 m-85 -86.93 134.42 33.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.22 0.533 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.5 m-85 -123.7 161.03 25.95 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.072 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.68 157.06 18.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -30.78 63.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.726 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -63.61 -29.67 70.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.336 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.29 0.37 16.4 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.263 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -88.66 147.03 24.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.052 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.404 ' CE1' ' HE3' ' A' ' 15' ' ' LYS . 23.3 t80 -76.06 132.94 40.41 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.481 HG12 ' SG ' ' A' ' 25' ' ' CYS . 98.6 t -103.32 -68.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.7 p -179.66 146.05 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.662 0.268 . . . . 0.0 111.541 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.914 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 3.8 pm0 -84.03 159.29 21.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.598 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.06 125.02 11.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.151 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.03 0.2 56.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.538 0.209 . . . . 0.0 111.347 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.665 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 1.3 m -61.94 109.31 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.69 138.78 24.99 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.29 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.57 -24.08 12.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.3 -23.48 67.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -147.55 133.73 9.68 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.219 0.533 . . . . 0.0 111.248 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.35 60.23 4.85 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 113.012 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.36 127.29 33.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.908 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -159.99 124.92 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 m -135.74 58.05 22.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.05 43.7 1.56 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.832 2.354 . . . . 0.0 111.69 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -97.02 -33.11 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -153.65 140.52 19.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.05 141.66 28.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.284 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.97 125.18 85.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.69 0.281 . . . . 0.0 110.832 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.88 47.58 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.488 2.792 . . . . 0.0 111.71 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -156.53 -30.8 0.09 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.492 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.2 mm -65.68 110.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.505 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.817 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -109.61 -41.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.475 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.2 p90 -159.72 147.59 17.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 111.594 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -112.5 125.27 7.04 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.821 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.1 115.42 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.827 0.346 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 60.4 m -94.52 124.95 53.63 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.0 Cg_exo -70.63 137.89 33.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.071 2.514 . . . . 0.0 112.219 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.55 53.77 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.221 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.17 0.919 . . . . 0.0 110.492 -178.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.511 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . 57.9 mtm180 . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tt -79.06 136.49 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.01 112.71 22.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.435 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.424 HG23 HG21 ' A' ' 45' ' ' ILE . 11.6 t -179.77 -166.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.868 ' HA ' HG13 ' A' ' 45' ' ' ILE . 12.9 p30 -161.97 -156.46 0.43 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.7 0.286 . . . . 0.0 110.927 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 m -70.38 -48.66 55.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.351 0.596 . . . . 0.0 109.721 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.2 t -58.28 -52.59 64.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.32 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.78 -28.74 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.783 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.91 143.23 48.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.659 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -63.15 125.78 25.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.563 0.22 . . . . 0.0 110.919 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -55.93 117.95 4.16 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.618 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.27 -43.53 1.53 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.4 m -74.17 126.83 31.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 26' ' ' GLU . 1.9 mptp? -89.37 125.3 35.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.53 0.205 . . . . 0.0 110.527 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.662 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 12.6 m-85 -99.14 133.82 42.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.517 0.675 . . . . 0.0 110.964 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.511 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -122.5 163.66 19.5 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.559 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 161.62 19.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.107 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.8 -28.81 66.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.813 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -64.95 -29.71 70.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.166 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.42 -0.09 18.51 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.321 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -88.57 144.85 26.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.031 0.443 . . . . 0.0 111.019 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.5 t80 -75.48 128.68 35.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.1 t -101.15 -60.55 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.487 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.8 p -177.84 150.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.648 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -96.01 166.22 11.88 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.962 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.686 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.97 140.04 45.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 16.9 pt-20 -121.15 20.47 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.89 0.376 . . . . 0.0 110.704 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -81.28 58.84 3.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.82 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 27.1 t70 -72.46 131.96 84.23 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.859 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 51.1 Cg_exo -55.12 -26.01 48.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.583 2.855 . . . . 0.0 113.364 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttt85 -55.56 -39.98 71.34 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.714 0.292 . . . . 0.0 111.344 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.38 109.46 1.1 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 121.568 0.699 . . . . 0.0 111.795 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.85 146.69 23.67 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.983 2.455 . . . . 0.0 111.674 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -127.56 148.07 50.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.4 130.7 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.6 m -88.83 126.57 59.09 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.908 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 -57.02 0.96 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.828 2.352 . . . . 0.0 113.276 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 15.0 mmp_? -98.86 -38.3 9.09 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.959 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 t30 63.32 31.41 15.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.965 0.888 . . . . 0.0 110.317 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.82 110.54 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.279 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.512 ' CG ' ' HB3' ' A' ' 6' ' ' ASN . 24.2 m-20 -110.3 127.66 26.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.36 -29.23 67.01 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.489 2.793 . . . . 0.0 113.775 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 ptt85 -78.03 -20.56 52.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.868 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.9 mm -79.23 114.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 2' ' ' ARG . . . -105.06 -40.78 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.764 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.4 p90 -160.0 155.74 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -123.78 130.78 7.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.917 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.25 120.75 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.913 0.387 . . . . 0.0 110.586 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.94 126.98 55.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.145 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.22 136.82 27.5 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.557 2.171 . . . . 0.0 112.28 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.01 26.7 9.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.783 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.633 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 14.9 ptm180 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.997 0.427 . . . . 0.0 110.56 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 47' ' ' TYR . 10.4 tt -79.4 137.02 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.104 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.02 116.81 27.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -176.95 -172.96 0.44 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.703 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.1 p-10 -161.41 -168.57 2.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.444 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 57.8 m -59.76 -50.09 75.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ALA . 41.8 t -70.58 -43.09 70.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.65 76.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.012 0.435 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.96 -179.45 45.83 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.44 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.4 m -110.8 133.35 53.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.36 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 1.122 ' HG3' ' HB3' ' A' ' 30' ' ' ASP . 2.7 mmmt -53.84 127.36 25.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.374 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.93 -39.97 2.56 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 48.4 t -72.24 129.74 39.14 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.66 103.54 16.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.687 0.28 . . . . 0.0 111.513 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 78.9 m-85 -92.2 129.2 38.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 110.833 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -121.07 154.12 36.52 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.768 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -84.46 162.8 19.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.566 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -62.02 -28.43 69.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.295 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.231 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 -3.7 11.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.187 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -90.15 148.72 22.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.09 0.471 . . . . 0.0 111.252 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.87 126.63 30.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 45' ' ' ILE . 71.5 t -91.92 -59.32 3.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.6 p -175.13 154.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.067 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 9.7 pt-20 -96.7 39.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.108 0.48 . . . . 0.0 110.268 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.48 148.81 2.68 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG2' ' C ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -122.54 23.64 9.53 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.891 -0.77 . . . . 0.0 111.428 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.78 50.48 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.38 0.61 . . . . 0.0 110.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 1.122 ' HB3' ' HG3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -174.96 -55.36 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.492 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 43.7 Cg_endo -69.49 116.96 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 120.932 1.088 . . . . 0.0 110.84 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 31' ' ' PRO . 18.7 ttp-105 86.33 -37.35 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.692 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -171.78 126.45 0.58 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.307 0.575 . . . . 0.0 111.885 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.35 62.72 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.778 2.318 . . . . 0.0 111.784 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -130.63 139.11 50.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.858 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -102.71 137.89 40.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.524 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 67.7 m -89.15 108.4 23.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.858 0.361 . . . . 0.0 111.056 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 87.3 Cg_endo -88.16 30.65 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.869 2.379 . . . . 0.0 112.424 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -174.61 50.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 109.937 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -161.8 137.87 7.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -157.67 136.29 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.622 ' H ' ' HB3' ' A' ' 6' ' ' ASN . 1.1 m-20 -82.35 125.17 77.21 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.711 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.89 -21.01 69.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.361 2.04 . . . . 0.0 109.721 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 18' ' ' SER . 6.4 ttp180 -71.64 -34.18 69.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.12 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.703 HG13 ' HA ' ' A' ' 6' ' ' ASN . 31.1 mm -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.153 0.501 . . . . 0.0 111.566 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -115.48 -44.17 2.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.497 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 3' ' ' ILE . 21.3 p90 -157.89 156.28 31.08 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.241 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -130.44 124.38 4.25 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.729 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -87.32 94.52 4.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 84.5 m -89.17 118.93 69.64 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.143 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 6.9 Cg_exo -73.65 134.55 20.45 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.008 2.472 . . . . 0.0 112.14 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.43 ' HB3' ' H ' ' A' ' 53' ' ' ALA . 7.0 mp -95.26 -143.32 0.26 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.161 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 52' ' ' LEU . . . . . . . . 0 C--O 1.247 0.953 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.176 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tt -78.3 130.43 36.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.791 0.805 . . . . 0.0 112.132 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.61 123.57 36.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.272 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' HG13 ' A' ' 45' ' ' ILE . 14.9 t -176.11 -165.71 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -145.36 178.15 8.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 m -54.25 -39.65 67.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.58 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 11.7 t -63.07 -55.93 21.27 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.897 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.03 29.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.349 0.595 . . . . 0.0 111.286 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.41 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -98.69 145.15 17.6 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.433 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 m -71.72 127.56 32.97 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.754 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 22.5 ttmm -50.28 131.57 24.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 111.341 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.33 -39.25 3.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.142 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.612 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 48.8 t -66.13 122.12 16.71 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.12 117.06 32.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.076 0.465 . . . . 0.0 111.127 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.78 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 37.3 m-85 -86.06 140.33 30.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.898 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -124.83 158.02 34.44 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.674 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.704 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 1.1 p -86.45 161.83 18.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.537 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.44 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 11.3 p-10 -65.32 -28.61 69.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.03 -27.48 68.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.823 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.19 -2.93 20.71 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.411 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.2 m -87.85 154.28 20.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.429 0.633 . . . . 0.0 111.002 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 24.2 t80 -75.77 128.81 35.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.762 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.541 HG12 ' SG ' ' A' ' 25' ' ' CYS . 53.6 t -90.13 -67.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.541 ' SG ' HG12 ' A' ' 24' ' ' VAL . 27.3 p 177.07 148.63 0.13 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.542 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -90.13 144.88 25.48 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.81 143.36 46.58 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.815 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.58 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.0 OUTLIER -107.26 -18.77 13.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -63.84 129.36 39.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.082 0.468 . . . . 0.0 111.06 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.73 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 36.9 t70 -73.32 127.29 89.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.544 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.11 58.14 3.44 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.025 2.483 . . . . 0.0 111.527 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.439 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 23.5 ttm105 -150.39 -41.05 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.459 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 14.1 p-10 -133.29 135.17 24.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.018 0.437 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 16.9 Cg_exo -68.08 129.72 20.04 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.858 2.372 . . . . 0.0 112.265 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.11 136.9 52.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.963 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.46 120.36 10.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.3 m -150.44 145.47 18.57 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.632 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 128.45 24.35 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.448 2.099 . . . . 0.0 111.809 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -86.03 46.74 1.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.789 0.804 . . . . 0.0 109.883 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.91 124.08 40.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.119 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.26 139.25 30.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.643 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 2.0 p30 -78.17 150.86 77.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.786 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.69 61.08 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.631 2.887 . . . . 0.0 112.047 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.704 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 19.2 ttp180 -171.2 -31.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.046 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.536 HD13 HG11 ' A' ' 24' ' ' VAL . 31.9 mm -59.0 112.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -105.03 -47.07 4.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.429 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -166.41 -169.14 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.403 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -149.51 132.47 4.05 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.936 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.45 97.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m -90.13 126.21 57.77 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 11.8 Cg_exo -70.57 133.25 23.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.799 2.333 . . . . 0.0 112.048 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.86 138.56 32.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.261 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.472 HH12 ' CG ' ' A' ' 19' ' ' ASP . 38.9 mtp85 . . . . . 0 N--CA 1.454 -0.252 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.486 HG23 HG22 ' A' ' 45' ' ' ILE . 8.8 tt -77.9 136.69 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.115 0.483 . . . . 0.0 110.009 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.34 106.07 17.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.214 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 HG21 ' A' ' 45' ' ' ILE . 13.3 t 179.37 -168.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.771 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.652 ' HA ' HG13 ' A' ' 45' ' ' ILE . 3.2 p-10 -161.2 -161.42 0.81 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.9 m -67.24 -45.84 75.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -64.93 -52.33 56.97 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.11 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 111.473 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.97 137.73 41.39 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.958 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 22.0 m -61.71 129.39 40.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.624 0.25 . . . . 0.0 110.616 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 39.9 tttp -53.25 130.27 34.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.803 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.44 -37.96 3.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.618 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 t -70.42 125.85 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 8.5 mmmt -94.65 116.89 29.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.262 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.656 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 39.4 m-85 -93.65 134.44 35.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -123.77 162.42 23.22 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.542 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.47 159.44 18.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.414 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.472 ' CG ' HH12 ' A' ' 2' ' ' ARG . 15.1 p-10 -59.46 -27.64 66.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.729 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -65.89 -27.6 68.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.933 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.29 -0.69 20.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.294 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.7 m -88.71 146.29 25.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.238 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.75 126.85 31.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.91 -63.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.306 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.4 p -177.76 149.39 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.182 0.515 . . . . 0.0 111.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.677 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 2.0 pt-20 -90.15 149.06 22.6 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.746 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.45 121.82 25.76 Favored Glycine 0 C--O 1.236 0.224 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.893 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 13.0 pt-20 -94.83 11.28 32.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.0 m -50.82 137.88 19.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.681 0.277 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -166.41 133.38 2.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.44 -5.9 17.12 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.881 2.387 . . . . 0.0 113.11 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.46 -33.61 69.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.7 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -151.65 146.4 18.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 84.95 0.17 Allowed 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.928 2.419 . . . . 0.0 113.19 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.71 60.42 3.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.475 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -77.12 106.04 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.073 0.463 . . . . 0.0 110.422 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 73.9 m -129.56 58.44 37.66 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 7.4 Cg_exo -72.41 -33.12 9.25 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.349 2.033 . . . . 0.0 112.06 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -98.69 46.0 1.0 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.375 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.3 t-20 -150.45 121.21 7.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.933 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.66 128.8 12.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.842 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.7 m-20 -87.46 125.65 64.8 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.16 -18.73 64.55 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.247 1.965 . . . . 0.0 110.844 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 44' ' ' ARG . 1.0 OUTLIER -69.58 -34.35 74.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.376 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.652 HG13 ' HA ' ' A' ' 6' ' ' ASN . 38.9 mm -66.76 107.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.586 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.48 -40.94 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 9.0 p90 -154.71 150.59 27.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -117.59 127.21 7.26 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.439 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.7 mt -93.09 100.14 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.21 127.97 53.29 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.81 140.55 51.21 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.737 2.292 . . . . 0.0 112.317 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -160.22 133.07 6.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.735 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.969 0 O-C-N 124.106 0.878 . . . . 0.0 110.696 -179.072 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.652 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 21.5 mmm-85 . . . . . 0 N--CA 1.455 -0.209 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.13 129.99 36.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.604 0.716 . . . . 0.0 110.918 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.56 129.77 35.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 t -176.59 -160.45 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -153.59 166.17 33.6 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -51.61 -44.01 62.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.665 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 t -60.99 -49.65 76.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 111.449 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.99 -29.45 65.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.78 131.9 40.41 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.616 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 m -59.63 126.47 27.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.291 0.236 . . . . 0.0 110.926 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 48.6 tptt -58.83 120.43 9.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.919 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.86 -40.75 2.01 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 59.1 m -71.2 126.47 29.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 13.3 ptpt -88.3 110.84 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.221 0.534 . . . . 0.0 111.218 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 31.8 m-85 -93.95 129.09 40.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -113.28 151.65 30.83 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.807 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.438 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 2.3 p -79.96 167.55 20.34 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.701 0.625 . . . . 0.0 111.351 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.527 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 12.4 p-10 -62.98 -29.23 70.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.28 -30.75 70.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.708 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.89 -9.74 10.4 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 114.014 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 m -87.91 151.13 23.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.254 0.549 . . . . 0.0 111.525 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -68.2 126.78 30.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.743 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.525 HG12 ' SG ' ' A' ' 25' ' ' CYS . 39.1 t -94.77 -56.38 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' A' ' 24' ' ' VAL . 24.7 p -176.35 145.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.271 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -89.9 39.97 0.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.702 0.763 . . . . 0.0 110.076 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.69 172.62 16.43 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.379 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.665 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 15.3 pt-20 -157.04 27.45 0.31 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 p -79.06 66.97 4.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.49 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 41.0 t0 -61.57 119.57 48.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 15.2 Cg_exo -68.44 -19.35 43.25 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.714 2.276 . . . . 0.0 111.302 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -36.55 65.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.33 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.0 p30 -136.19 127.26 16.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 2.6 Cg_exo -76.2 90.23 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.985 2.457 . . . . 0.0 112.199 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -78.59 136.69 37.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.88 115.54 9.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 110.484 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -89.37 137.32 29.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.715 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.24 140.24 93.56 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.938 2.425 . . . . 0.0 112.071 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -83.49 43.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -159.46 146.8 17.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.86 30.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.11 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 20.6 m-20 -78.06 118.78 74.32 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.527 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 22.7 Cg_exo -64.06 -18.45 63.64 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.905 2.403 . . . . 0.0 110.638 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 20.0 ttp-105 -70.94 -32.49 69.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.906 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 mm -64.67 119.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.823 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.652 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -94.88 -52.62 4.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.498 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -166.69 157.69 12.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.253 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -126.86 115.98 2.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.59 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 46.9 mm -90.18 117.41 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.3 m -89.33 121.3 69.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.0 Cg_exo -76.59 130.37 11.65 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.006 2.47 . . . . 0.0 112.545 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.61 -21.65 30.26 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.836 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.434 179.545 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.854 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 17.7 ptp180 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.661 0.267 . . . . 0.0 110.521 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -77.05 135.0 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 0.0 110.998 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.11 100.85 13.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.194 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -177.4 -173.21 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.645 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -160.54 -173.66 4.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.34 -45.7 92.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.676 0.275 . . . . 0.0 111.502 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 12.0 t -57.25 -42.07 80.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.945 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.72 -82.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . 31.97 -138.35 0.08 OUTLIER Glycine 0 C--N 1.337 0.588 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.746 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 98.6 m -165.46 126.7 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 28' ' ' GLU . 46.6 mmtt -49.15 135.27 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 111.975 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.45 -43.52 2.78 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 32.8 t -71.82 116.22 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 0.0 109.823 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.713 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 38.0 mttp -99.07 119.97 38.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.039 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.754 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 35.6 m-85 -92.61 136.09 33.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.429 0.633 . . . . 0.0 111.556 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.492 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -119.61 158.14 26.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.941 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.18 162.03 21.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.653 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.27 -26.69 67.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.621 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -66.59 -29.56 69.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.859 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.94 -0.89 17.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.388 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 m -88.86 146.17 25.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.068 0.461 . . . . 0.0 111.305 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.3 t80 -73.77 126.93 31.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.517 HG12 ' SG ' ' A' ' 25' ' ' CYS . 79.1 t -96.76 -63.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.952 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.8 p 179.52 155.15 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.62 0.248 . . . . 0.0 111.033 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 11.7 pt-20 -96.85 147.53 23.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.746 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -64.03 136.19 40.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.472 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HA ' ' CE ' ' A' ' 12' ' ' LYS . 11.7 pt-20 -95.17 -3.64 47.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m 70.83 116.76 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.437 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.552 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.8 t70 -53.9 -57.6 17.02 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.628 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 89.9 Cg_endo -78.01 43.3 1.35 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.709 1.606 . . . . 0.0 112.299 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -163.66 31.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.542 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.0 p30 -161.15 149.94 13.26 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 3.9 Cg_exo -77.14 51.18 3.37 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.034 2.489 . . . . 0.0 113.794 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 9.9 mtmp? -157.98 126.65 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.294 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.47 117.21 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.579 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 88.9 m -141.55 51.82 2.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.865 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 17.3 Cg_exo -66.77 -25.0 46.46 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.349 2.033 . . . . 0.0 112.409 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -133.74 39.5 3.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.45 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -94.58 139.33 31.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -152.24 133.16 14.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.181 0.515 . . . . 0.0 112.191 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.626 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.3 m-20 -99.04 126.45 38.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.861 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.56 -29.34 88.67 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.773 2.315 . . . . 0.0 111.793 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 44' ' ' ARG . 19.9 ptt180 -66.36 -27.63 68.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.468 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.645 HG13 ' HA ' ' A' ' 6' ' ' ASN . 42.4 mm -70.11 110.56 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.928 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.854 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -103.89 -46.71 4.41 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.168 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.4 p90 -150.06 143.27 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.904 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -113.29 130.01 9.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.752 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.7 94.31 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 71.5 m -89.44 132.76 36.28 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.281 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 18.1 Cg_exo -66.75 136.77 43.23 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.869 2.379 . . . . 0.0 112.009 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.81 -34.09 39.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.198 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.875 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.792 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.789 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 2.7 ptm180 . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.999 0.428 . . . . 0.0 110.349 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.37 134.46 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.216 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.82 128.11 36.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.872 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -177.11 -156.43 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -153.13 177.59 10.65 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 m -55.87 -39.75 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 31.8 t -70.58 -52.79 19.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.79 60.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.764 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.72 141.04 46.95 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.408 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -62.14 130.3 44.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.715 0.293 . . . . 0.0 111.424 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 21.5 tptm -54.44 123.48 13.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.829 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.612 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 106.66 -35.69 4.88 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -74.36 126.94 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.573 0.225 . . . . 0.0 110.479 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -90.81 119.82 31.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 90.3 m-85 -99.15 134.5 41.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.347 0.594 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.622 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.4 m-85 -121.72 160.41 24.59 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.758 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -82.68 169.09 16.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.308 178.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -60.25 -30.7 69.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.454 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -67.48 -28.54 67.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.481 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.32 1.28 23.48 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.075 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -88.16 144.49 26.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.537 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -72.57 126.73 30.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.069 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG21 ' HG3' ' A' ' 44' ' ' ARG . 70.6 t -96.61 -62.27 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 p -176.46 151.22 0.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.448 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.7 pt-20 -95.31 156.83 16.16 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.86 127.65 36.41 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.05 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.568 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.5 pp20? -114.39 29.34 8.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -75.78 54.66 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.767 0.794 . . . . 0.0 110.491 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -73.65 129.0 86.08 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.003 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.88 -21.58 41.46 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.227 2.618 . . . . 0.0 113.086 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.536 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -67.19 -31.07 71.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.634 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -103.0 132.42 21.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.58 64.85 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.936 2.424 . . . . 0.0 113.144 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 28' ' ' GLU . 10.6 mtmp? -125.51 141.89 51.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.982 0.42 . . . . 0.0 110.956 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -150.65 128.36 11.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.327 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . 62.5 m -127.67 65.36 67.06 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.539 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 15.9 Cg_exo -67.89 -25.8 38.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.567 2.178 . . . . 0.0 112.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -115.2 52.79 0.85 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.317 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 20.9 t-20 -158.7 132.38 7.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -159.06 136.51 9.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 10.4 m-20 -84.57 127.28 66.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.72 -23.78 77.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.051 2.501 . . . . 0.0 112.741 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 18' ' ' SER . 4.5 ptp85 -79.62 -16.28 56.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.386 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 6' ' ' ASN . 21.8 mm -75.52 102.11 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.42 -39.64 10.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.789 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 3.1 p90 -157.42 166.21 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.461 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.93 136.11 6.65 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.573 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.7 mt -100.28 122.31 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.749 0.309 . . . . 0.0 110.552 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -101.03 133.22 21.14 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.08 138.73 37.46 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.644 2.229 . . . . 0.0 112.514 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.492 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -125.03 21.56 8.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.218 0.532 . . . . 0.0 110.261 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.54 179.82 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.503 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 121.286 0.565 . . . . 0.0 111.164 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.406 HG23 HG22 ' A' ' 45' ' ' ILE . 12.2 tt -78.59 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.084 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.19 101.13 13.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.967 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.602 HG23 HG21 ' A' ' 45' ' ' ILE . 12.2 t -176.52 -161.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.728 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.3 p30 -160.02 -159.44 0.72 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 18.3 m -67.57 -54.99 15.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.537 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 49.7 t -70.23 -43.08 71.36 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.207 -0.308 . . . . 0.0 111.596 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -23.48 64.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.968 0.413 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.84 147.92 47.27 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.267 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.563 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 m -59.58 126.29 27.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 0.0 111.085 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.971 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 34.5 ttpt -54.76 132.77 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.247 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 -37.64 3.36 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.878 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 35.8 m -70.27 126.99 31.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.817 ' HE3' ' HB3' ' A' ' 26' ' ' GLU . 2.5 mtpt -91.24 114.8 27.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.668 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.6 m-85 -89.66 135.85 33.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.353 0.597 . . . . 0.0 111.566 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.464 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.3 m-85 -125.9 160.4 30.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.9 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -83.79 163.83 19.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.889 178.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -62.46 -28.51 69.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.458 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -66.91 -28.49 68.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.925 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.65 1.89 19.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -88.16 147.41 24.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.101 0.476 . . . . 0.0 111.031 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.402 ' CE1' ' HE2' ' A' ' 15' ' ' LYS . 26.9 t80 -75.21 133.39 41.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.096 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -105.08 -68.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.2 p -176.42 147.55 0.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.817 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 3.1 pm0 -85.87 156.55 20.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.837 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -64.5 119.97 17.44 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.712 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -102.63 34.04 2.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -79.72 71.31 6.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.229 0.538 . . . . 0.0 110.908 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.971 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 9.8 t70 -146.66 -59.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD2' ' H ' ' A' ' 30' ' ' ASP . 31.6 Cg_endo -64.46 -39.14 29.92 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.783 1.656 . . . . 0.0 112.869 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 58.03 37.83 26.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.745 0.783 . . . . 0.0 109.893 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -72.09 161.07 80.81 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.872 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.21 92.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.683 2.255 . . . . 0.0 111.766 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 2.5 tmmm? -160.85 134.22 6.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.935 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 103.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.159 0.504 . . . . 0.0 111.85 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.638 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 83.7 m -89.83 -55.91 0.28 Allowed Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.797 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 97.5 Cg_endo -83.28 39.86 0.87 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.03 1.82 . . . . 0.0 111.975 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -69.32 -46.08 67.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 176.42 171.44 0.43 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.41 129.81 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -82.71 122.3 78.31 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.1 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.03 -27.46 79.53 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.01 2.473 . . . . 0.0 112.007 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' SER . 11.8 ptt-85 -68.35 -25.41 65.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.184 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.728 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.8 mm -79.95 94.87 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 2' ' ' ARG . . . -89.87 -43.35 10.67 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.5 p90 -159.97 157.26 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.101 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -125.49 125.82 5.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.055 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.7 mt -86.62 111.97 22.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.838 0.352 . . . . 0.0 110.167 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.38 133.54 28.23 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.4 57.85 5.56 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.864 2.376 . . . . 0.0 112.198 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.34 137.06 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.91 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 9.0 tpt180 . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 121.442 0.639 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 tt -78.1 124.49 36.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.15 127.06 40.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' HG13 ' A' ' 45' ' ' ILE . 12.9 t -176.97 -155.74 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -146.08 178.58 8.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.526 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 26.9 m -56.19 -42.13 76.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.668 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 43.0 t -72.07 -49.52 35.86 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.84 29.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.337 0.589 . . . . 0.0 111.089 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.94 145.58 15.95 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.19 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -59.65 126.72 28.7 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.883 0.341 . . . . 0.0 110.694 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 84.5 tttt -54.93 128.87 35.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 -39.77 2.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.894 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.5 124.11 26.61 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.956 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -100.37 126.57 46.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.029 0.443 . . . . 0.0 110.0 179.235 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.588 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 14.7 m-85 -89.04 137.7 32.08 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.173 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.0 m-85 -122.51 160.56 25.34 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 157.44 19.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.043 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -61.35 -29.05 69.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.34 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.32 -32.67 73.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.493 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.19 -2.15 9.73 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.853 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 m -89.02 148.05 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.443 0.64 . . . . 0.0 111.559 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.73 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 18.8 t80 -76.92 131.56 38.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.925 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.466 HG12 ' SG ' ' A' ' 25' ' ' CYS . 93.1 t -99.86 -68.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.867 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.6 p 178.72 148.88 0.21 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.831 0.348 . . . . 0.0 111.572 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.956 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 pm0 -87.02 152.67 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -67.67 121.58 15.11 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.614 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.668 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -89.36 41.19 1.02 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 111.526 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.9 m -77.81 53.1 1.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.732 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 9.1 t70 -93.46 -55.42 0.24 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.33 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 23.5 Cg_exo -63.9 111.11 1.46 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.764 1.643 . . . . 0.0 111.168 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -62.45 -20.84 64.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.349 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -68.91 133.48 90.15 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 110.546 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.3 132.53 27.83 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.657 2.238 . . . . 0.0 112.726 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.0 143.52 33.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.03 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.88 116.95 4.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.239 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.88 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 99.9 m -145.54 -47.6 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.312 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.88 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 58.3 Cg_endo -71.03 48.39 0.86 Allowed 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.216 1.944 . . . . 0.0 112.891 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -85.47 -26.65 26.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.94 174.87 7.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.677 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.25 140.6 52.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.717 0.294 . . . . 0.0 110.678 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.461 ' HB2' HG12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -78.72 125.2 84.66 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.559 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 38.1 Cg_exo -60.54 -27.73 85.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.875 2.383 . . . . 0.0 111.569 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.441 ' HD2' HG13 ' A' ' 24' ' ' VAL . 25.4 ptt180 -66.87 -28.86 68.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.275 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 42' ' ' ASP . 23.3 mm -70.41 102.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.223 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -99.15 -42.35 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.563 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.1 p90 -156.92 151.52 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.816 0.341 . . . . 0.0 111.422 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.23 123.7 7.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.36 111.91 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.378 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.6 m -94.59 136.49 23.11 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.83 141.91 50.6 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.667 2.245 . . . . 0.0 111.929 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -157.7 -44.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.281 -1.342 . . . . 0.0 108.661 179.196 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 mmm180 . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.785 0.326 . . . . 0.0 110.439 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 47' ' ' TYR . 7.1 tt -145.75 128.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.231 0.538 . . . . 0.0 109.851 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.01 117.12 29.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.979 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t 179.52 -159.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.607 ' HA ' HG13 ' A' ' 45' ' ' ILE . 16.5 p30 -145.61 -167.61 2.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.632 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m -67.17 -56.27 10.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.869 0.366 . . . . 0.0 111.409 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 3.7 t -58.25 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.1 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.91 24.17 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.651 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.13 -122.77 4.61 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.128 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.8 m -151.47 136.14 17.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 36.5 tttp -53.95 127.91 28.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.241 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.55 -30.74 3.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.246 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.44 122.31 14.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.783 ' HD3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 mmtm -92.67 113.56 25.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 69.2 m-85 -95.98 133.27 40.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 110.911 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.546 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -128.4 164.9 21.69 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.381 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.83 156.28 18.15 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.493 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 30.7 p-10 -62.99 -23.82 67.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.627 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.4 -33.57 75.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.02 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.22 -4.17 8.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.031 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.8 m -89.44 146.78 24.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.207 0.527 . . . . 0.0 111.545 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -77.31 129.24 35.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.57 HG13 ' HD2' ' A' ' 44' ' ' ARG . 92.9 t -95.66 -63.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.6 p -178.25 163.41 1.65 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.564 0.221 . . . . 0.0 110.517 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.783 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -110.23 153.33 24.95 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -68.16 115.96 7.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.528 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.7 pm0 -90.88 33.43 0.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -69.87 54.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.518 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.413 ' N ' ' HD3' ' A' ' 31' ' ' PRO . 52.7 t0 -179.13 62.34 0.13 Allowed Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.674 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 30' ' ' ASP . 88.9 Cg_endo -89.2 -8.56 4.68 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.62 2.213 . . . . 0.0 112.106 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 75.64 -39.4 0.38 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.843 0.857 . . . . 0.0 110.534 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -90.65 151.39 43.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.19 125.61 19.02 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.269 1.979 . . . . 0.0 111.895 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' HE2' ' SG ' ' A' ' 8' ' ' CYS . 86.5 tttt -147.94 128.02 13.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.36 122.53 30.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.544 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -92.28 129.29 41.71 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.478 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.99 131.93 37.15 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.561 2.174 . . . . 0.0 111.641 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -79.91 -19.78 47.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.843 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.31 132.66 49.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.77 132.98 35.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 26.6 m-20 -78.9 123.65 85.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.918 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.66 -25.39 78.87 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.887 2.391 . . . . 0.0 111.726 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.57 ' HD2' HG13 ' A' ' 24' ' ' VAL . 31.7 ptt180 -71.89 -27.67 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.424 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.607 HG13 ' HA ' ' A' ' 6' ' ' ASN . 25.4 mm -79.1 105.59 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.828 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.41 -42.12 7.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.372 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.57 ' HA ' HG22 ' A' ' 3' ' ' ILE . 6.0 p90 -155.16 163.11 40.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.79 131.73 4.75 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.377 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 49' ' ' ILE . 4.1 mp -86.88 94.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.3 m -91.04 134.01 30.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.053 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.5 Cg_exo -71.97 63.88 3.29 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.347 2.698 . . . . 0.0 112.443 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -80.48 -35.8 34.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.521 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.332 -1.318 . . . . 0.0 108.849 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 56.5 ttm-85 . . . . . 0 N--CA 1.452 -0.355 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -78.36 140.39 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.799 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.47 101.56 14.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.032 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -179.1 -171.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.839 ' HA ' HG13 ' A' ' 45' ' ' ILE . 23.2 p30 -161.44 -155.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.33 -52.29 23.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.799 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 52.6 t -64.86 -41.76 95.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.899 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.66 -23.65 49.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.23 148.35 50.03 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.784 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -75.14 141.11 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.761 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 29' ' ' SER . 45.7 mtmt -50.36 137.26 18.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.896 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.75 -36.52 3.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.816 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.96 120.41 14.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.731 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 47.7 mttp -98.03 122.12 40.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.8 m-85 -100.98 133.87 44.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.534 0.683 . . . . 0.0 111.256 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -121.85 162.65 20.56 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.249 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.44 159.26 19.39 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.261 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.432 ' CG ' HH22 ' A' ' 2' ' ' ARG . 4.9 p-10 -59.53 -27.41 66.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.408 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.56 -34.86 78.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.11 -5.4 8.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.881 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 m -89.39 146.59 24.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.154 0.502 . . . . 0.0 111.537 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -74.11 126.66 31.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.61 -61.37 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.468 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 p -179.17 153.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.731 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 6.4 pt-20 -96.94 160.94 14.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.148 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.1 136.22 34.99 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 113.882 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 9.1 pt-20 -118.66 15.89 13.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.724 -0.238 . . . . 0.0 111.408 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 44.7 m -58.38 123.49 16.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.281 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 31.7 t0 67.05 64.78 0.73 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 121.542 0.686 . . . . 0.0 110.715 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -88.72 41.58 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.554 2.169 . . . . 0.0 110.953 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 66.28 35.79 5.72 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.019 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 18.3 p30 -169.57 160.37 7.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.923 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 33' ' ' ASN . 37.0 Cg_endo -65.96 71.63 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.092 2.528 . . . . 0.0 114.657 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 31.6 mtpt -134.58 127.38 31.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.884 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.443 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -171.35 137.99 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.849 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 64.2 m -128.76 62.69 62.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 2.8 Cg_exo -75.83 44.87 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.894 2.396 . . . . 0.0 112.456 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -171.44 44.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.659 0.742 . . . . 0.0 109.081 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -159.17 142.65 14.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.029 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.78 26.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 m-20 -96.3 128.42 36.75 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 -26.41 82.7 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.806 2.337 . . . . 0.0 111.744 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 mtm-85 -68.07 -34.07 75.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.839 HG13 ' HA ' ' A' ' 6' ' ' ASN . 46.3 mm -72.15 114.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.615 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -107.89 -39.79 5.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.833 0.349 . . . . 0.0 110.591 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.544 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.6 p90 -154.73 155.12 33.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.401 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -138.81 135.02 7.11 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.642 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -91.46 102.96 14.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.28 120.9 66.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.315 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.12 136.99 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.563 2.176 . . . . 0.0 112.236 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.08 137.34 33.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.345 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.419 -1.277 . . . . 0.0 109.235 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.815 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 20.0 ptp180 . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.52 128.49 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.484 0.659 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.29 121.45 31.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.211 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t 179.9 -162.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -158.1 -174.38 4.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 4.5 m -59.99 -53.82 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 39.7 t -65.97 -42.57 89.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . . . -71.39 -30.5 66.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.9 146.49 50.39 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.3 m -66.08 133.19 50.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.532 0.205 . . . . 0.0 111.096 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 38.1 ttpt -52.55 135.46 34.13 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.17 -36.2 3.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.169 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.56 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 20.8 t -70.43 118.71 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 67.1 mttm -91.75 116.14 28.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.633 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 59.9 m-85 -94.53 132.91 38.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.079 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.8 m-85 -120.82 159.85 24.6 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.276 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.63 160.69 19.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.326 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -61.09 -27.14 68.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.434 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -64.4 -33.52 76.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.313 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.2 -4.53 9.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.91 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 m -89.04 148.3 23.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.0 111.461 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.34 124.74 27.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.692 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.443 HG12 ' SG ' ' A' ' 25' ' ' CYS . 78.2 t -90.47 -64.23 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 24' ' ' VAL . 26.5 p 179.98 150.7 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.265 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.6 pt-20 -97.69 155.39 17.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.155 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.9 138.33 48.98 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.219 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 13.0 pt-20 -119.78 14.17 12.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.929 0.395 . . . . 0.0 111.013 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 33.4 p -77.6 137.67 38.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.023 0.439 . . . . 0.0 111.81 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.615 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 9.9 t70 -156.85 133.77 6.51 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.38 -18.98 48.79 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.295 2.663 . . . . 0.0 113.55 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.08 -40.27 84.74 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.725 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 9.0 p30 -173.16 -41.23 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.508 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.725 ' HD2' ' H ' ' A' ' 33' ' ' ASN . 56.7 Cg_endo -73.45 89.51 0.95 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 121.34 1.36 . . . . 0.0 111.491 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.79 143.27 36.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.683 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.659 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -53.78 143.93 19.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.759 0.662 . . . . 0.0 111.676 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.6 m -108.86 78.12 0.9 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.445 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 1.3 Cg_endo -84.15 41.19 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.024 2.482 . . . . 0.0 111.924 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -77.7 -32.45 52.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.81 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -163.05 152.81 15.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.48 132.77 44.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.762 0.315 . . . . 0.0 110.811 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 66.4 m-20 -79.28 121.12 82.61 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.409 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.63 -25.45 79.16 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.803 2.335 . . . . 0.0 111.553 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 33.0 ptt180 -67.23 -29.57 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.189 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -72.55 112.22 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.64 0.257 . . . . 0.0 110.689 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -105.89 -43.4 4.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.77 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.3 p90 -156.1 150.19 25.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.866 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -128.58 130.42 6.54 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.252 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 49' ' ' ILE . 3.7 mp -88.97 100.74 11.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 82.8 m -89.94 125.7 59.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.039 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.56 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 7.4 Cg_exo -73.12 65.01 4.26 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.304 2.669 . . . . 0.0 112.591 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pp -156.92 32.63 0.3 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.493 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.815 179.579 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -78.71 141.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.218 0.532 . . . . 0.0 110.56 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.41 90.93 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t -173.23 -171.96 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.073 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.78 ' HA ' HG13 ' A' ' 45' ' ' ILE . 2.3 p-10 -160.91 -164.96 1.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.259 -0.177 . . . . 0.0 110.612 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.529 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 59.1 m -59.59 -37.77 79.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 3.9 t -80.71 -59.18 2.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.407 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.94 -16.66 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.457 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -59.37 147.88 41.74 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.27 -0.491 . . . . 0.0 113.027 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -68.48 129.49 40.09 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 49.7 tttm -55.15 125.23 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.398 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.36 -38.47 3.14 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.0 m -72.04 121.89 19.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 68.2 mttm -89.8 121.3 31.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 48.9 m-85 -94.77 134.68 37.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.144 0.497 . . . . 0.0 110.829 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.433 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.7 m-85 -119.35 161.85 19.78 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.705 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.34 161.13 18.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.408 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.17 -29.39 63.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.657 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.28 -33.69 76.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.34 -5.1 9.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.815 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.9 m -88.39 148.04 24.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.528 . . . . 0.0 111.162 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.5 t80 -71.34 130.01 40.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.047 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.552 HG12 ' SG ' ' A' ' 25' ' ' CYS . 73.2 t -97.1 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.819 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.5 p -178.95 153.22 0.62 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -97.66 147.68 24.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -70.77 138.12 28.05 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.375 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.667 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 8.1 pt-20 -89.75 -6.35 56.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 87.1 p 67.68 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.67 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.64 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 38.3 t0 -56.14 -56.04 35.35 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.646 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 84.8 Cg_endo -77.44 40.47 0.84 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.018 1.812 . . . . 0.0 113.676 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 48.9 tpt85 -106.61 -32.35 8.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.955 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 16.8 p30 -148.72 158.37 39.88 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.05 62.68 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.248 2.632 . . . . 0.0 112.722 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -153.7 112.65 3.71 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.4 124.27 19.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.369 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -88.53 -43.93 0.46 Allowed Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.9 46.63 0.53 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.577 2.184 . . . . 0.0 113.607 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.03 -34.24 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.851 0.358 . . . . 0.0 110.417 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -167.5 145.92 4.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.711 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.61 ' OD1' ' HB2' ' A' ' 6' ' ' ASN . 4.2 m-20 -78.1 122.04 84.81 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.12 -32.77 71.26 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.318 2.679 . . . . 0.0 113.551 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.445 ' NE ' HG13 ' A' ' 24' ' ' VAL . 25.3 ptt-85 -70.16 -17.54 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.78 HG13 ' HA ' ' A' ' 6' ' ' ASN . 30.4 mm -69.82 107.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.15 -49.41 3.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.22 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.3 p90 -150.79 149.13 29.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.898 0.38 . . . . 0.0 111.249 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.686 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -118.23 134.25 10.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.114 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.8 mm -110.2 120.45 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.878 0.37 . . . . 0.0 110.449 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.6 m -91.95 125.77 55.82 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.2 Cg_exo -68.29 126.38 14.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.734 2.289 . . . . 0.0 112.041 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.87 -35.44 14.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.342 -1.313 . . . . 0.0 108.568 179.778 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.421 HH11 ' HB1' ' A' ' 46' ' ' ALA . 27.1 mmt180 . . . . . 0 N--CA 1.458 -0.07 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 47' ' ' TYR . 6.5 tt -142.12 131.36 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.312 0.577 . . . . 0.0 111.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.65 124.4 35.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -179.24 -158.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . 0.825 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.8 p30 -151.58 -168.09 2.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 m -65.81 -58.84 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -62.87 -44.72 95.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.768 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.02 -11.68 60.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.2 145.23 35.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.493 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 14.9 m -67.23 137.0 55.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.552 0.215 . . . . 0.0 110.931 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 29' ' ' SER . 59.0 mttm -49.23 133.27 19.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.716 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.2 -37.36 3.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.276 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 59.3 m -65.68 112.59 3.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 62.2 mttm -89.64 116.78 28.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.535 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 76.8 m-85 -94.46 135.64 35.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -120.53 161.54 21.13 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.749 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 1.8 p -80.74 164.5 22.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.275 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -60.82 -28.56 68.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.72 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.03 -33.88 76.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.938 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.25 -9.22 7.43 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.652 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 m -86.6 146.0 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.378 0.609 . . . . 0.0 111.31 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -69.86 127.62 33.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' SG ' ' A' ' 25' ' ' CYS . 71.9 t -96.96 -61.2 2.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' HG12 ' A' ' 24' ' ' VAL . 23.3 p -178.16 148.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.446 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.613 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.5 pt-20 -94.17 159.85 14.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.336 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.31 127.69 45.52 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.196 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.736 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 5.5 pt-20 -126.49 35.41 4.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.591 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 22.9 m -63.11 102.66 0.4 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 47.8 t0 -170.68 123.64 0.59 Allowed Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.936 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 9.7 Cg_exo -71.43 -6.42 19.12 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -58.19 -43.41 87.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.03 144.05 27.19 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.499 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.22 65.83 2.06 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.206 2.604 . . . . 0.0 113.532 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -140.89 132.0 26.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.36 139.29 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.224 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 96.3 m -88.35 116.1 65.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 110.854 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 2.8 Cg_exo -75.62 137.59 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.12 2.546 . . . . 0.0 111.764 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.524 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -73.84 -28.88 61.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -67.64 139.22 56.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.209 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.51 142.54 37.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.677 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 22.5 m-20 -78.82 129.87 72.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.207 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 7.5 Cg_exo -71.92 56.23 2.4 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.6 2.867 . . . . 0.0 110.574 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 18' ' ' SER . 33.3 ptt180 -167.11 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.5 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.825 HG13 ' HA ' ' A' ' 6' ' ' ASN . 33.2 mm -73.62 102.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.418 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB1' HH11 ' A' ' 2' ' ' ARG . . . -97.86 -40.49 8.49 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.576 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.0 p90 -159.28 159.58 34.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.846 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.98 134.05 5.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.568 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 49' ' ' ILE . 4.4 mp -96.35 126.56 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 72.8 m -95.6 143.53 26.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo -75.73 52.94 3.48 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.994 2.463 . . . . 0.0 111.814 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -161.92 -42.18 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.406 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.34 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.91 179.566 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.601 ' OD1' ' HG2' ' A' ' 2' ' ' ARG . 10.5 t70 . . . . . 0 C--O 1.234 0.252 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.601 ' HG2' ' OD1' ' A' ' 1' ' ' ASP . 2.2 ptp85 -78.82 138.93 38.41 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.827 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 48.6 mt -134.85 130.53 52.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.946 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.28 114.98 27.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.541 HG22 HG21 ' A' ' 45' ' ' ILE . 13.6 t -166.49 -158.61 0.33 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.563 0.22 . . . . 0.0 110.463 -178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 17.3 p30 -155.17 167.65 29.65 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 44.4 m -51.26 -43.54 61.57 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -178.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.451 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 34.4 t -69.17 -45.4 70.11 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.08 -22.11 55.97 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.55 142.9 48.06 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.208 -0.52 . . . . 0.0 113.019 -179.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.7 m -67.15 135.06 52.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.534 -0.173 . . . . 0.0 110.534 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.66 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 23.5 tptp -55.44 131.56 46.22 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.574 -0.284 . . . . 0.0 110.7 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.36 -34.43 4.84 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.443 -0.884 . . . . 0.0 111.647 -179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 38.0 t -71.42 123.36 22.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.488 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 2.7 ptpp? -101.79 115.23 30.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.777 -179.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.655 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 62.4 m-85 -92.47 135.93 33.64 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.3 -178.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.485 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.9 m-85 -120.45 159.43 25.14 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.312 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -91.9 168.77 11.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.909 179.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -64.4 -31.75 73.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.034 -0.985 . . . . 0.0 109.547 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -63.15 -19.23 64.28 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.192 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.92 -4.04 52.62 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.659 178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 m -89.4 148.25 23.59 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.009 0.433 . . . . 0.0 110.833 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 21.0 t80 -70.56 128.49 36.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' A' ' 25' ' ' CYS . 79.6 t -90.54 -65.73 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.955 -0.298 . . . . 0.0 111.207 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 24' ' ' VAL . 26.7 p -178.57 154.94 0.81 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.789 0.328 . . . . 0.0 111.186 -179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.5 OUTLIER -92.92 153.38 18.82 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 177.377 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.66 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.47 123.51 31.0 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.203 -0.999 . . . . 0.0 112.072 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.451 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 11.3 pt-20 -90.3 26.51 1.91 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.779 0.323 . . . . 0.0 111.439 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 70.7 m -78.2 64.17 3.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.794 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.569 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 3.3 t70 -67.15 128.23 93.73 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.298 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.64 -19.56 59.94 Favored 'Trans proline' 0 C--O 1.234 0.278 0 C-N-CA 122.946 2.431 . . . . 0.0 113.327 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.569 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 7.7 tpm_? -70.51 -37.64 74.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.759 -0.2 . . . . 0.0 111.34 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.5 p30 -116.68 133.29 23.05 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-O 120.899 0.38 . . . . 0.0 111.195 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -64.26 126.6 17.38 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.345 2.03 . . . . 0.0 111.338 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -159.09 146.43 17.36 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.958 -178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.491 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -168.77 122.78 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.191 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 72.6 m -128.93 51.86 8.15 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.29 40.65 1.0 Allowed 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.439 2.092 . . . . 0.0 111.384 178.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.489 ' HD3' ' C ' ' A' ' 38' ' ' PRO . 1.6 mpp_? -132.07 32.24 4.05 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.912 -179.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -174.43 152.01 1.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.954 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -141.41 125.65 17.47 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.807 ' HB2' HG12 ' A' ' 45' ' ' ILE . 73.8 m-20 -78.64 126.66 82.33 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -56.19 -29.3 74.9 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 123.438 2.758 . . . . 0.0 113.448 -178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.51 ' O ' ' HA ' ' A' ' 18' ' ' SER . 1.2 ptm85 -88.22 -1.79 58.23 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.416 -0.514 . . . . 0.0 112.275 -179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.807 HG12 ' HB2' ' A' ' 42' ' ' ASP . 28.7 mm -79.21 94.74 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 177.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.25 -45.43 9.53 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.806 -178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 0.9 OUTLIER -157.63 159.92 37.51 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.683 -178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -137.74 131.81 5.63 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.213 -0.994 . . . . 0.0 113.034 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 53.9 mt -84.39 93.63 3.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.581 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 93.4 m -88.74 139.55 29.46 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.4 -179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -67.69 136.46 39.12 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.578 2.185 . . . . 0.0 112.231 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -79.9 -33.62 39.71 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.97 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.281 0 CA-C-O 117.284 -1.341 . . . . 0.0 108.613 179.728 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.524 ' CG ' ' H ' ' A' ' 2' ' ' ARG . 17.7 t70 . . . . . 0 C--O 1.233 0.184 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 2' ' ' ARG . 0.6 OUTLIER -154.77 135.27 13.4 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.996 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.0 tt -160.18 127.73 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.304 0.573 . . . . 0.0 110.562 179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.474 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -98.76 130.41 45.22 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.699 -179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 10.1 t -175.93 -148.61 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.484 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.445 ' HA ' HG13 ' A' ' 45' ' ' ILE . 17.0 p30 -154.62 164.96 37.95 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.5 m -48.99 -49.28 41.53 Favored 'General case' 0 N--CA 1.467 0.42 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -177.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 37' ' ' CYS . 50.0 t -63.33 -43.58 97.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.053 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -94.49 29.0 2.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.14 0.495 . . . . 0.0 110.913 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.64 144.79 15.86 Favored Glycine 0 N--CA 1.444 -0.804 0 N-CA-C 111.469 -0.652 . . . . 0.0 111.469 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.2 m -63.1 121.92 14.81 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.679 0.276 . . . . 0.0 110.38 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 57.3 mtmt -54.07 130.55 38.38 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.891 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.83 -39.7 2.66 Favored Glycine 0 N--CA 1.447 -0.625 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.3 m -72.8 121.81 20.53 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 24.0 ttmm -93.11 120.88 33.88 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.571 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 77.0 m-85 -95.86 142.49 28.05 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.344 0.592 . . . . 0.0 111.933 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 11.3 m-85 -130.33 162.83 28.17 Favored 'General case' 0 C--O 1.243 0.715 0 CA-C-N 115.245 -0.888 . . . . 0.0 110.1 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.91 162.02 19.62 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.835 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -59.58 -29.59 68.06 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.423 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -65.17 -32.15 73.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.926 -179.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 121.75 -2.36 11.01 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.565 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 89.8 m -88.23 146.96 25.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.51 0.671 . . . . 0.0 111.162 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.488 ' HA ' ' CD2' ' A' ' 17' ' ' PHE . 5.0 t80 -73.15 131.86 42.56 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.708 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 68.0 t -103.98 -67.43 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.375 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.3 p -179.11 147.19 0.33 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.825 0.345 . . . . 0.0 111.685 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 3.5 pm0 -87.91 167.11 14.03 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -67.47 125.4 23.47 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.732 -179.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.403 ' CD ' ' HZ1' ' A' ' 35' ' ' LYS . 1.2 pp20? -122.08 49.32 1.59 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.495 0.664 . . . . 0.0 110.939 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 35' ' ' LYS . 18.3 m -75.99 52.04 0.69 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.816 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.573 ' OD2' ' HB3' ' A' ' 32' ' ' ARG . 20.3 t70 61.42 130.37 0.02 OUTLIER Pre-proline 0 N--CA 1.475 0.825 0 C-N-CA 123.836 0.855 . . . . 0.0 112.133 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.19 -40.08 78.46 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.21 1.94 . . . . 0.0 112.533 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.586 ' O ' ' HB3' ' A' ' 33' ' ' ASN . 31.4 ttm-85 -66.4 -53.39 36.32 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 178.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.586 ' HB3' ' O ' ' A' ' 32' ' ' ARG . 9.5 p30 142.86 -36.6 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 C-N-CA 125.088 1.355 . . . . 0.0 114.294 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' OD2' ' A' ' 30' ' ' ASP . 16.7 Cg_exo -69.79 68.71 1.7 Allowed 'Trans proline' 0 C--N 1.363 1.329 0 C-N-CA 122.52 2.147 . . . . 0.0 115.173 -177.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' ' HB3' ' A' ' 29' ' ' SER . 58.7 tttm -160.82 129.66 4.69 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.848 0.356 . . . . 0.0 110.414 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -162.41 142.33 9.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.54 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 8' ' ' CYS . 61.3 m -127.97 72.15 78.93 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-O 120.713 0.292 . . . . 0.0 111.514 -179.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.32 39.86 0.83 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 123.086 2.524 . . . . 0.0 112.012 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.614 ' HD3' ' N ' ' A' ' 40' ' ' ASN . 0.0 OUTLIER -70.26 -35.79 74.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.609 -179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.614 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 45.5 t30 178.14 152.16 0.28 Allowed 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.745 -179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -84.6 125.96 32.91 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 42.3 m-20 -79.84 131.11 64.74 Favored Pre-proline 0 C--N 1.321 -0.649 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.799 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 36.2 Cg_exo -59.61 -22.6 67.74 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.837 2.358 . . . . 0.0 111.027 178.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 88.0 mtm180 -64.65 -35.42 80.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.403 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.489 HG23 ' HB3' ' A' ' 16' ' ' TYR . 23.4 mm -84.45 94.48 3.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.115 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -92.5 -37.67 12.38 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.937 0.399 . . . . 0.0 110.752 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.575 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.3 p90 -158.51 161.71 37.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.647 -179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.571 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.65 136.18 7.0 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.111 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 63.6 mt -96.5 123.96 49.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.76 0.314 . . . . 0.0 110.651 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 72.7 m -103.1 126.62 31.85 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.295 179.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.3 Cg_exo -71.88 121.39 7.57 Favored 'Trans proline' 0 N--CA 1.464 -0.239 0 C-N-CA 122.596 2.197 . . . . 0.0 111.624 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -96.4 -37.13 10.59 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.33 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.857 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.772 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.8 t0 . . . . . 0 C--O 1.235 0.309 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.652 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 13.0 ptm180 -161.79 144.73 12.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.448 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.6 tt -148.92 133.38 9.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.048 0.451 . . . . 0.0 110.72 179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.78 129.7 42.93 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.868 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.9 t -178.03 -154.45 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.1 p30 -148.33 172.2 14.78 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -52.97 -51.66 60.75 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -177.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.708 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -61.3 -46.78 88.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.502 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.19 29.5 0.84 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.334 0.588 . . . . 0.0 111.032 179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.98 143.93 15.77 Favored Glycine 0 N--CA 1.442 -0.915 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.635 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.5 m -60.83 128.82 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.611 0.205 . . . . 0.0 110.901 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -50.06 128.55 19.15 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.979 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.47 -33.82 4.02 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.833 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.0 t -69.23 118.11 11.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.603 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.6 OUTLIER -94.27 119.4 33.01 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.351 -179.027 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.66 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 57.6 m-85 -93.67 139.82 30.35 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.206 0.527 . . . . 0.0 111.323 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.59 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -124.27 160.86 27.03 Favored 'General case' 0 C--O 1.243 0.749 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.723 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.22 167.82 17.34 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.985 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -61.09 -30.69 70.5 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.311 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.6 p-10 -66.72 -26.71 67.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.273 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.56 2.08 25.91 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.159 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.6 m -88.1 145.4 25.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.084 0.468 . . . . 0.0 110.532 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.482 ' CE1' ' HB2' ' A' ' 15' ' ' LYS . 23.8 t80 -73.0 124.36 25.32 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.243 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.7 t -92.98 -63.81 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.166 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.8 p -177.18 149.18 0.66 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.633 -179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 1.4 pt-20 -94.46 158.04 15.73 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.222 178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.38 122.35 29.81 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.893 -0.594 . . . . 0.0 113.557 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.708 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 14.4 pt-20 -109.67 29.99 7.07 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.489 -0.356 . . . . 0.0 111.18 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.4 m -60.57 136.84 58.18 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t70 64.92 71.2 0.56 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.783 0.801 . . . . 0.0 110.142 -178.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.494 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 2.0 Cg_endo -81.7 -5.17 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.741 2.294 . . . . 0.0 109.659 179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.476 ' HD3' ' HA ' ' A' ' 32' ' ' ARG . 5.1 tpp85 76.33 -37.53 0.3 Allowed 'General case' 0 C--O 1.231 0.102 0 CA-C-N 113.965 -1.471 . . . . 0.0 110.491 -179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' A' ' 31' ' ' PRO . 9.1 p-10 -85.84 149.86 51.82 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -56.56 119.36 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.276 1.984 . . . . 0.0 112.186 -179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -160.32 132.68 6.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.906 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -96.63 135.29 38.76 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.023 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.437 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 87.0 m -88.67 140.49 29.71 Favored Pre-proline 0 C--N 1.324 -0.533 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.554 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 26.0 Cg_exo -62.73 134.6 47.95 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.87 2.38 . . . . 0.0 111.689 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.41 ' N ' ' HD3' ' A' ' 39' ' ' ARG . 1.0 OUTLIER -90.11 46.11 1.32 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.101 0.477 . . . . 0.0 110.649 -179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -157.91 146.76 19.34 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.388 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -83.58 134.09 34.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.823 0.344 . . . . 0.0 111.055 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 17.7 m-20 -78.96 127.54 79.42 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.059 179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -63.91 -23.58 68.2 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.55 2.167 . . . . 0.0 110.901 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 10.6 ptp85 -70.39 -26.6 63.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.818 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.469 HG23 ' HB3' ' A' ' 16' ' ' TYR . 23.5 mm -83.96 98.42 5.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.412 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -89.2 -42.08 11.85 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.694 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.652 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 4.2 p90 -157.38 174.03 16.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.085 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.66 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -150.14 134.43 4.81 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.261 -0.971 . . . . 0.0 112.687 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 46.9 mm -90.75 104.31 15.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.5 m -90.51 122.7 66.89 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.87 138.04 27.99 Favored 'Trans proline' 0 N--CA 1.464 -0.248 0 C-N-CA 122.63 2.22 . . . . 0.0 112.265 -179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.447 ' H ' ' HG ' ' A' ' 52' ' ' LEU . 2.8 pp -81.64 -22.87 37.32 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.263 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.609 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.599 0.714 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.655 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 30.0 ttm180 -157.85 136.08 10.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.71 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.8 tt -144.24 137.27 23.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.876 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 41' ' ' ALA . . . -88.99 127.86 35.68 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.958 -179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 HG21 ' A' ' 45' ' ' ILE . 12.4 t -178.52 -158.89 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.654 ' HA ' HG13 ' A' ' 45' ' ' ILE . 18.8 p30 -155.21 -173.42 4.55 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.8 m -62.37 -50.94 69.58 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 22.1 t -65.14 -48.87 72.05 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 120.743 0.306 . . . . 0.0 111.661 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.59 -21.93 64.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.381 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.02 144.97 49.4 Favored Glycine 0 N--CA 1.446 -0.641 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -66.13 126.08 27.53 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.651 0.262 . . . . 0.0 110.745 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 86.7 tttt -53.79 131.79 40.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.948 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.43 -40.9 2.35 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.74 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.2 m -73.9 123.88 25.09 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.594 ' HA ' ' HB3' ' A' ' 26' ' ' GLU . 67.5 mttm -89.76 123.63 33.92 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.21 -0.293 . . . . 0.0 110.21 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.623 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 25.9 m-85 -96.89 134.92 39.6 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.269 0.557 . . . . 0.0 110.785 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.591 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.2 m-85 -126.54 167.08 16.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.111 -179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.57 156.69 16.95 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -60.7 -26.43 67.13 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.546 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.26 -34.29 74.92 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.422 179.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.18 -5.25 8.27 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 121.014 -0.612 . . . . 0.0 112.878 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 34.6 m -89.29 146.43 24.73 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.223 0.535 . . . . 0.0 111.694 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 22.7 t80 -76.5 130.96 38.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.566 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.431 HG11 HD13 ' A' ' 45' ' ' ILE . 95.0 t -99.11 -67.46 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.4 p -176.71 143.94 0.47 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.773 0.32 . . . . 0.0 110.434 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.594 ' HB3' ' HA ' ' A' ' 15' ' ' LYS . 3.8 pt-20 -91.08 162.5 14.66 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.511 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.9 116.88 8.37 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.979 -178.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -98.77 24.58 7.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.289 0.566 . . . . 0.0 110.503 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 p -77.09 54.62 1.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.469 0.652 . . . . 0.0 111.354 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.12 117.33 60.65 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.729 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.18 32.49 0.4 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.382 2.722 . . . . 0.0 113.732 -178.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.5 ttm-85 -80.53 -22.68 40.64 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.531 0.682 . . . . 0.0 109.731 179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -165.26 148.69 7.2 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 114.979 -1.009 . . . . 0.0 109.919 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -61.39 137.73 71.93 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.554 2.169 . . . . 0.0 111.369 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.6 ptpp? -150.81 136.89 18.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.79 0.329 . . . . 0.0 110.532 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.85 119.82 30.56 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.019 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.7 m -88.89 138.97 29.12 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.207 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -57.5 128.45 29.43 Favored 'Trans proline' 0 N--CA 1.464 -0.247 0 C-N-CA 122.616 2.211 . . . . 0.0 112.006 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.9 ttp85 -70.75 -20.78 62.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.479 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -71.85 132.46 44.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.941 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.552 ' HB1' ' HB1' ' A' ' 4' ' ' ALA . . . -85.25 123.18 30.44 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -79.61 121.25 82.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.417 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.97 -16.08 51.2 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.863 2.375 . . . . 0.0 110.237 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 19.1 ttp-105 -67.44 -30.21 69.88 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.16 -1.382 . . . . 0.0 109.696 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.654 HG13 ' HA ' ' A' ' 6' ' ' ASN . 14.7 mm -88.62 112.72 24.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.34 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.655 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.43 -40.82 8.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.707 179.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.591 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.1 p90 -158.74 174.3 15.23 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.674 -179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.623 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.71 133.97 5.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.796 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 61.0 mt -107.78 122.94 62.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.875 0.369 . . . . 0.0 110.579 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.2 m -92.56 136.64 25.03 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.142 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 27.8 Cg_exo -62.04 137.16 65.21 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.887 2.391 . . . . 0.0 112.167 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.5 pp -154.1 151.48 29.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.3 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.9 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.904 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 C--O 1.232 0.145 0 CA-C-O 121.086 0.469 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.614 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 42.8 ptt85 -161.45 153.0 18.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.838 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 47' ' ' TYR . 10.1 tt -78.35 133.88 29.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.504 0.669 . . . . 0.0 110.965 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.07 112.58 24.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.699 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t -178.19 -163.11 0.07 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.702 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -160.24 164.54 32.62 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.411 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 63.2 m -52.13 -40.58 61.56 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.211 0.448 . . . . 0.0 112.211 -178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.522 ' HA ' ' CD ' ' A' ' 28' ' ' GLU . 24.8 t -58.5 -47.25 84.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.288 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.82 -16.82 49.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.001 0.429 . . . . 0.0 111.167 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.6 133.54 41.41 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.754 -0.657 . . . . 0.0 113.049 -179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.429 HG23 ' HA ' ' A' ' 31' ' ' PRO . 22.9 m -67.81 130.83 44.19 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.706 -0.247 . . . . 0.0 110.62 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.446 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -61.95 97.97 0.09 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.277 0.56 . . . . 0.0 110.341 -179.891 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 143.81 -39.76 1.25 Allowed Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 110.749 -0.941 . . . . 0.0 110.749 -179.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 84.8 m -73.1 119.24 17.07 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.644 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 49.7 mttp -88.95 112.29 23.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.134 0.492 . . . . 0.0 111.466 -178.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.595 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 71.6 m-85 -93.72 132.58 37.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.14 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -120.96 152.22 38.79 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.253 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.82 165.47 20.84 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.12 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -59.08 -30.43 68.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.547 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.1 p-10 -67.37 -28.36 67.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.515 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.65 2.19 22.71 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.088 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.2 m -88.52 146.42 25.18 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.098 0.475 . . . . 0.0 110.524 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -72.77 127.04 31.37 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.751 HG13 ' HE ' ' A' ' 44' ' ' ARG . 52.1 t -93.16 -60.31 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.565 ' SG ' HG12 ' A' ' 24' ' ' VAL . 24.3 p -176.33 148.21 0.75 Allowed 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 110.601 -0.148 . . . . 0.0 110.601 -178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.644 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 17.1 pt-20 -99.55 42.23 1.11 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.175 0.512 . . . . 0.0 111.079 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.13 -175.79 41.79 Favored Glycine 0 N--CA 1.452 -0.255 0 CA-C-N 115.683 -0.69 . . . . 0.0 113.016 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.559 ' HG3' ' N ' ' A' ' 29' ' ' SER . 7.2 pt-20 -148.56 -42.08 0.15 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.845 0.355 . . . . 0.0 110.888 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 50.3 m -77.28 139.65 39.87 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 1.024 ' HB3' ' HB3' ' A' ' 33' ' ' ASN . 16.7 t70 -61.79 144.11 93.58 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.146 178.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.561 ' HD2' ' OD1' ' A' ' 30' ' ' ASP . 89.3 Cg_exo -44.54 -26.33 1.73 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.529 2.819 . . . . 0.0 114.631 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.2 ttm180 -141.93 40.56 1.66 Allowed 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.099 0.476 . . . . 0.0 111.046 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 1.024 ' HB3' ' HB3' ' A' ' 30' ' ' ASP . 4.3 p-10 -94.12 146.61 31.93 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-O 120.824 0.345 . . . . 0.0 110.663 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.08 66.41 4.19 Favored 'Trans proline' 0 CA--C 1.53 0.276 0 C-N-CA 122.828 2.352 . . . . 0.0 112.481 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.7 tptm -136.92 128.81 29.17 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.434 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -123.68 138.92 54.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.522 179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.422 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 39.1 m -130.61 62.49 65.24 Favored Pre-proline 0 C--N 1.325 -0.467 0 C-N-CA 120.973 -0.291 . . . . 0.0 111.65 -179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 3.1 Cg_exo -79.47 40.28 0.93 Allowed 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.95 2.434 . . . . 0.0 111.821 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 40' ' ' ASN . 51.1 ttp85 -67.12 -57.89 5.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.425 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 39' ' ' ARG . 6.0 t-20 173.18 154.44 0.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.296 -0.866 . . . . 0.0 108.682 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -79.38 125.31 29.35 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.433 ' HB2' HG12 ' A' ' 45' ' ' ILE . 64.7 m-20 -77.66 123.33 86.59 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 2' ' ' ARG . 31.1 Cg_exo -61.17 -24.89 79.99 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.841 2.36 . . . . 0.0 110.751 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.751 ' HE ' HG13 ' A' ' 24' ' ' VAL . 19.0 ttp-105 -64.63 -28.38 69.58 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 113.981 -1.463 . . . . 0.0 111.231 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.47 HD13 HG11 ' A' ' 24' ' ' VAL . 30.9 mm -79.78 102.76 6.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.202 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.614 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -89.4 -51.18 5.69 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.461 179.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 3' ' ' ILE . 29.7 p90 -155.97 153.24 29.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.605 -0.271 . . . . 0.0 110.977 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -131.31 129.19 5.63 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.789 -0.72 . . . . 0.0 111.696 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.9 mm -98.61 119.81 47.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 120.827 0.346 . . . . 0.0 110.686 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -97.16 128.17 36.08 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.387 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.35 137.04 16.41 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.619 2.213 . . . . 0.0 112.162 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -160.2 146.42 15.57 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.147 0 CA-C-O 117.462 -1.256 . . . . 0.0 109.147 -179.693 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.4 t0 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.817 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 39.9 ptt180 -160.42 148.79 16.62 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.0 tt -77.51 124.52 36.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.568 0.699 . . . . 0.0 110.692 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.72 122.57 32.95 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.742 -179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.6 t -178.2 -158.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.008 179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 18.4 p30 -153.02 177.17 11.08 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -57.58 -40.88 79.97 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 120.977 0.418 . . . . 0.0 111.437 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 44.0 t -64.27 -47.85 77.98 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.878 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.45 33.58 1.78 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.186 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.08 -129.11 5.04 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.311 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.598 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 14.8 m -153.56 127.51 8.94 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.665 ' HB2' ' O ' ' A' ' 29' ' ' SER . 24.1 tptm -48.63 127.16 13.06 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.818 -179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.71 -39.63 3.1 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 121.013 -0.613 . . . . 0.0 113.197 179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 50' ' ' CYS . 61.7 m -66.68 118.43 10.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 117.06 0.43 . . . . 0.0 110.467 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.914 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 19.6 mmmt -89.12 116.0 27.06 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.689 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 18.0 m-85 -86.93 134.42 33.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.22 0.533 . . . . 0.0 111.125 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.506 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 5.5 m-85 -123.7 161.03 25.95 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.45 -0.796 . . . . 0.0 110.072 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.68 157.06 18.66 Favored 'General case' 0 N--CA 1.445 -0.714 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.293 178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.7 -30.78 63.81 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.726 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.2 p-10 -63.61 -29.67 70.89 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.336 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.29 0.37 16.4 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.202 -0.523 . . . . 0.0 112.263 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.9 m -88.66 147.03 24.74 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.018 0.437 . . . . 0.0 111.052 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.404 ' CE1' ' HE3' ' A' ' 15' ' ' LYS . 23.3 t80 -76.06 132.94 40.41 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.481 HG12 ' SG ' ' A' ' 25' ' ' CYS . 98.6 t -103.32 -68.11 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 112.006 0.372 . . . . 0.0 112.006 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.7 p -179.66 146.05 0.25 Allowed 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.662 0.268 . . . . 0.0 111.541 -178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.914 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 3.8 pm0 -84.03 159.29 21.22 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.598 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -71.06 125.02 11.83 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.56 -0.828 . . . . 0.0 112.151 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.03 0.2 56.89 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.538 0.209 . . . . 0.0 111.347 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.665 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 1.3 m -61.94 109.31 1.23 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -137.69 138.78 24.99 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.29 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -50.57 -24.08 12.0 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -64.3 -23.48 67.31 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -147.55 133.73 9.68 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.219 0.533 . . . . 0.0 111.248 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -74.35 60.23 4.85 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 113.012 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.0 mmmm -82.36 127.29 33.1 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.908 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -159.99 124.92 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 34.5 m -135.74 58.05 22.23 Favored Pre-proline 0 C--N 1.323 -0.567 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 1.6 Cg_endo -82.05 43.7 1.56 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.832 2.354 . . . . 0.0 111.69 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 22.3 tpp180 -97.02 -33.11 11.67 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.932 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -153.65 140.52 19.15 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.388 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -92.05 141.66 28.37 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.284 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -77.97 125.18 85.79 Favored Pre-proline 0 C--N 1.323 -0.573 0 CA-C-O 120.69 0.281 . . . . 0.0 110.832 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.88 47.58 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.488 2.792 . . . . 0.0 111.71 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 28.4 ptt180 -156.53 -30.8 0.09 Allowed 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.492 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.2 mm -65.68 110.29 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.505 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.817 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -109.61 -41.49 4.55 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 120.746 -0.382 . . . . 0.0 111.475 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.506 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.2 p90 -159.72 147.59 17.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.872 0.368 . . . . 0.0 111.594 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -112.5 125.27 7.04 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.821 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 62.1 mt -95.1 115.42 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.827 0.346 . . . . 0.0 110.321 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 60.4 m -94.52 124.95 53.63 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.408 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 12.0 Cg_exo -70.63 137.89 33.88 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 123.071 2.514 . . . . 0.0 112.219 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.55 53.77 2.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.221 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.005 0 O-C-N 124.17 0.919 . . . . 0.0 110.492 -178.922 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 52.6 p-10 . . . . . 0 C--O 1.234 0.245 0 CA-C-O 121.358 0.599 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.511 ' HB3' ' HA ' ' A' ' 46' ' ' ALA . 57.9 mtm180 -143.96 133.69 23.74 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.547 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.3 tt -79.06 136.49 23.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.005 0.431 . . . . 0.0 110.429 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.01 112.71 22.91 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.435 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.424 HG23 HG21 ' A' ' 45' ' ' ILE . 11.6 t -179.77 -166.18 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.164 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.868 ' HA ' HG13 ' A' ' 45' ' ' ILE . 12.9 p30 -161.97 -156.46 0.43 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.7 0.286 . . . . 0.0 110.927 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 1.2 m -70.38 -48.66 55.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.351 0.596 . . . . 0.0 109.721 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.2 t -58.28 -52.59 64.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.32 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.78 -28.74 55.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.51 -0.314 . . . . 0.0 111.783 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.91 143.23 48.52 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 121.235 -0.507 . . . . 0.0 112.659 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -63.15 125.78 25.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.563 0.22 . . . . 0.0 110.919 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.686 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -55.93 117.95 4.16 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.618 -179.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 120.27 -43.53 1.53 Allowed Glycine 0 N--CA 1.444 -0.791 0 N-CA-C 111.197 -0.761 . . . . 0.0 111.197 -179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.4 m -74.17 126.83 31.45 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.648 ' HG3' ' HB3' ' A' ' 26' ' ' GLU . 1.9 mptp? -89.37 125.3 35.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.53 0.205 . . . . 0.0 110.527 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.662 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 12.6 m-85 -99.14 133.82 42.88 Favored 'General case' 0 C--O 1.239 0.509 0 CA-C-O 121.517 0.675 . . . . 0.0 110.964 -179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.511 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -122.5 163.66 19.5 Favored 'General case' 0 C--O 1.244 0.775 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.559 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.5 161.62 19.28 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.107 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.8 -28.81 66.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.813 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.2 p-10 -64.95 -29.71 70.66 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.166 179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.42 -0.09 18.51 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 121.198 -0.525 . . . . 0.0 112.321 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.8 m -88.57 144.85 26.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.031 0.443 . . . . 0.0 111.019 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 24.5 t80 -75.48 128.68 35.86 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.1 t -101.15 -60.55 2.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 C-N-CA 120.903 -0.319 . . . . 0.0 111.487 -179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.8 p -177.84 150.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.648 ' HB3' ' HG3' ' A' ' 15' ' ' LYS . 11.8 pt-20 -96.01 166.22 11.88 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 120.443 -0.503 . . . . 0.0 109.962 178.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.686 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -62.97 140.04 45.29 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 121.081 -0.581 . . . . 0.0 113.057 -179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.456 ' HA ' ' HG2' ' A' ' 12' ' ' LYS . 16.9 pt-20 -121.15 20.47 11.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.89 0.376 . . . . 0.0 110.704 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.0 p -81.28 58.84 3.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.359 0.6 . . . . 0.0 110.82 179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.499 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 27.1 t70 -72.46 131.96 84.23 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.859 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 51.1 Cg_exo -55.12 -26.01 48.53 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.583 2.855 . . . . 0.0 113.364 -179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttt85 -55.56 -39.98 71.34 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.714 0.292 . . . . 0.0 111.344 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -162.38 109.46 1.1 Allowed Pre-proline 0 C--N 1.326 -0.421 0 CA-C-O 121.568 0.699 . . . . 0.0 111.795 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.85 146.69 23.67 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.983 2.455 . . . . 0.0 111.674 179.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -127.56 148.07 50.34 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.362 -0.236 . . . . 0.0 110.362 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -75.4 130.7 39.42 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.39 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 34.6 m -88.83 126.57 59.09 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.303 -0.408 . . . . 0.0 109.908 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.61 -57.02 0.96 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.828 2.352 . . . . 0.0 113.276 -178.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 15.0 mmp_? -98.86 -38.3 9.09 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.959 -179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 30.1 t30 63.32 31.41 15.32 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.965 0.888 . . . . 0.0 110.317 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 178.82 110.54 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.279 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.512 ' CG ' ' HB3' ' A' ' 6' ' ' ASN . 24.2 m-20 -110.3 127.66 26.66 Favored Pre-proline 0 C--N 1.32 -0.691 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.36 -29.23 67.01 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 123.489 2.793 . . . . 0.0 113.775 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.9 ptt85 -78.03 -20.56 52.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 -179.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.868 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.9 mm -79.23 114.26 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.615 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.511 ' HA ' ' HB3' ' A' ' 2' ' ' ARG . . . -105.06 -40.78 5.77 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.764 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.511 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.4 p90 -160.0 155.74 25.89 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.831 0.348 . . . . 0.0 111.602 -178.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -123.78 130.78 7.78 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.917 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.8 mt -105.25 120.75 56.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.913 0.387 . . . . 0.0 110.586 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 84.3 m -89.94 126.98 55.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.145 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -72.22 136.82 27.5 Favored 'Trans proline' 0 N--CA 1.462 -0.336 0 C-N-CA 122.557 2.171 . . . . 0.0 112.28 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.0 mt -107.01 26.7 9.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.783 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.633 179.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.8 p-10 . . . . . 0 CA--C 1.518 -0.287 0 CA-C-O 122.288 1.042 . . . . 0.0 110.25 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.428 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 14.9 ptm180 -79.66 133.58 36.4 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.325 -1.307 . . . . 0.0 110.56 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.485 HG22 ' HA ' ' A' ' 47' ' ' TYR . 10.4 tt -79.4 137.02 22.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.104 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.02 116.81 27.58 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.332 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -176.95 -172.96 0.44 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.703 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.1 p-10 -161.41 -168.57 2.04 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.444 ' C ' ' HG2' ' A' ' 28' ' ' GLU . 57.8 m -59.76 -50.09 75.17 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 111.646 0.239 . . . . 0.0 111.646 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 36' ' ' ALA . 41.8 t -70.58 -43.09 70.11 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 111.898 0.333 . . . . 0.0 111.898 -178.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.61 -33.65 76.14 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.012 0.435 . . . . 0.0 111.041 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.96 -179.45 45.83 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.736 -0.666 . . . . 0.0 113.44 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 27.4 m -110.8 133.35 53.42 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.685 -0.258 . . . . 0.0 111.36 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 1.122 ' HG3' ' HB3' ' A' ' 30' ' ' ASP . 2.7 mmmt -53.84 127.36 25.73 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.374 179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 115.93 -39.97 2.56 Favored Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.706 -0.958 . . . . 0.0 110.706 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 48.4 t -72.24 129.74 39.14 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -88.66 103.54 16.03 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.687 0.28 . . . . 0.0 111.513 -178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.575 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 78.9 m-85 -92.2 129.2 38.21 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 0.0 110.833 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -121.07 154.12 36.52 Favored 'General case' 0 C--O 1.245 0.858 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.768 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.453 ' HB3' ' HG3' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -84.46 162.8 19.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.566 177.892 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -62.02 -28.43 69.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.295 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.58 -33.3 74.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.231 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.9 -3.7 11.69 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.893 -0.67 . . . . 0.0 113.187 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.6 m -90.15 148.72 22.8 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.09 0.471 . . . . 0.0 111.252 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -72.87 126.63 30.39 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.45 HG11 HD11 ' A' ' 45' ' ' ILE . 71.5 t -91.92 -59.32 3.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.401 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.6 p -175.13 154.57 1.8 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.986 -0.286 . . . . 0.0 111.067 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 14' ' ' CYS . 9.7 pt-20 -96.7 39.54 1.16 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.108 0.48 . . . . 0.0 110.268 178.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.48 148.81 2.68 Favored Glycine 0 N--CA 1.452 -0.284 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' HG2' ' C ' ' A' ' 7' ' ' CYS . 17.1 pt-20 -122.54 23.64 9.53 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 121.891 -0.77 . . . . 0.0 111.428 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.78 50.48 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.38 0.61 . . . . 0.0 110.666 178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 1.122 ' HB3' ' HG3' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -174.96 -55.36 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.492 -179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.495 ' O ' ' HB3' ' A' ' 32' ' ' ARG . 43.7 Cg_endo -69.49 116.96 4.78 Favored 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 120.932 1.088 . . . . 0.0 110.84 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 31' ' ' PRO . 18.7 ttp-105 86.33 -37.35 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.692 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -171.78 126.45 0.58 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.307 0.575 . . . . 0.0 111.885 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -80.35 62.72 8.62 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.778 2.318 . . . . 0.0 111.784 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 33.3 mtmm -130.63 139.11 50.37 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.858 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -102.71 137.89 40.33 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.524 178.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 67.7 m -89.15 108.4 23.99 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-O 120.858 0.361 . . . . 0.0 111.056 -179.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 87.3 Cg_endo -88.16 30.65 0.43 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.869 2.379 . . . . 0.0 112.424 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.6 ttt85 -174.61 50.55 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.285 0.564 . . . . 0.0 109.937 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -161.8 137.87 7.87 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -157.67 136.29 11.32 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.067 0.461 . . . . 0.0 111.064 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.622 ' H ' ' HB3' ' A' ' 6' ' ' ASN . 1.1 m-20 -82.35 125.17 77.21 Favored Pre-proline 0 C--N 1.32 -0.682 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.711 179.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.89 -21.01 69.06 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.361 2.04 . . . . 0.0 109.721 177.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.453 ' HG3' ' HB3' ' A' ' 18' ' ' SER . 6.4 ttp180 -71.64 -34.18 69.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.12 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.703 HG13 ' HA ' ' A' ' 6' ' ' ASN . 31.1 mm -64.68 132.03 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.153 0.501 . . . . 0.0 111.566 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.428 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -115.48 -44.17 2.99 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.497 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.485 ' HA ' HG22 ' A' ' 3' ' ' ILE . 21.3 p90 -157.89 156.28 31.08 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.659 -0.416 . . . . 0.0 111.241 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -130.44 124.38 4.25 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.729 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 43.0 mm -87.32 94.52 4.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.48 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 84.5 m -89.17 118.93 69.64 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.143 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 6.9 Cg_exo -73.65 134.55 20.45 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.008 2.472 . . . . 0.0 112.14 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.43 ' HB3' ' H ' ' A' ' 53' ' ' ALA . 7.0 mp -95.26 -143.32 0.26 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.161 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.43 ' H ' ' HB3' ' A' ' 52' ' ' LEU . . . . . . . . 0 C--O 1.247 0.953 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.5 t70 . . . . . 0 C--O 1.235 0.295 0 CA-C-O 120.752 0.31 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.609 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 0.8 OUTLIER -160.61 58.67 0.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 9.9 tt -78.3 130.43 36.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 121.791 0.805 . . . . 0.0 112.132 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.61 123.57 36.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.272 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' HG13 ' A' ' 45' ' ' ILE . 14.9 t -176.11 -165.71 0.16 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -145.36 178.15 8.3 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.7 m -54.25 -39.65 67.02 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 111.879 0.326 . . . . 0.0 111.879 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.58 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 11.7 t -63.07 -55.93 21.27 Favored 'General case' 0 C--O 1.225 -0.202 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.897 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.03 29.15 0.57 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.349 0.595 . . . . 0.0 111.286 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.41 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -98.69 145.15 17.6 Favored Glycine 0 N--CA 1.442 -0.907 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.433 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.8 m -71.72 127.56 32.97 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.754 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 22.5 ttmm -50.28 131.57 24.06 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 120.983 0.42 . . . . 0.0 111.341 -179.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.33 -39.25 3.13 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.142 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.612 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 48.8 t -66.13 122.12 16.71 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.64 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -99.12 117.06 32.77 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.076 0.465 . . . . 0.0 111.127 -179.219 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.78 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 37.3 m-85 -86.06 140.33 30.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.898 -179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -124.83 158.02 34.44 Favored 'General case' 0 C--O 1.246 0.879 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.674 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.704 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 1.1 p -86.45 161.83 18.42 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.537 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.44 ' N ' ' HB2' ' A' ' 46' ' ' ALA . 11.3 p-10 -65.32 -28.61 69.43 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.204 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -65.03 -27.48 68.84 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.823 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.19 -2.93 20.71 Favored Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.632 -0.794 . . . . 0.0 113.411 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 4.2 m -87.85 154.28 20.66 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.429 0.633 . . . . 0.0 111.002 -179.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.552 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 24.2 t80 -75.77 128.81 35.95 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.762 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.541 HG12 ' SG ' ' A' ' 25' ' ' CYS . 53.6 t -90.13 -67.22 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.014 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.541 ' SG ' HG12 ' A' ' 24' ' ' VAL . 27.3 p 177.07 148.63 0.13 Allowed 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.542 -179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.64 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -90.13 144.88 25.48 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.23 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.754 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -64.81 143.36 46.58 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.815 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.58 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.0 OUTLIER -107.26 -18.77 13.79 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 111.611 0.226 . . . . 0.0 111.611 -179.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 30.5 m -63.84 129.36 39.76 Favored 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 121.082 0.468 . . . . 0.0 111.06 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.73 ' HA ' ' HE2' ' A' ' 12' ' ' LYS . 36.9 t70 -73.32 127.29 89.27 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.544 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -73.11 58.14 3.44 Favored 'Trans proline' 0 C--N 1.345 0.395 0 C-N-CA 123.025 2.483 . . . . 0.0 111.527 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' HB3' ' OD2' ' A' ' 30' ' ' ASP . 23.5 ttm105 -150.39 -41.05 0.13 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.459 -178.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 14.1 p-10 -133.29 135.17 24.98 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 121.018 0.437 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 16.9 Cg_exo -68.08 129.72 20.04 Favored 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.858 2.372 . . . . 0.0 112.265 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -117.11 136.9 52.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.963 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.46 120.36 10.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.158 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 96.3 m -150.44 145.47 18.57 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.632 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -61.88 128.45 24.35 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.448 2.099 . . . . 0.0 111.809 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.4 ttt85 -86.03 46.74 1.36 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.789 0.804 . . . . 0.0 109.883 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -125.91 124.08 40.03 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.119 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -88.26 139.25 30.69 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.532 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.643 ' OD1' ' HB3' ' A' ' 44' ' ' ARG . 2.0 p30 -78.17 150.86 77.99 Favored Pre-proline 0 C--N 1.324 -0.517 0 C-N-CA 120.525 -0.47 . . . . 0.0 109.786 179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.69 61.08 0.41 Allowed 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 123.631 2.887 . . . . 0.0 112.047 -178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.704 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 19.2 ttp180 -171.2 -31.02 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.547 -1.206 . . . . 0.0 109.046 -178.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.536 HD13 HG11 ' A' ' 24' ' ' VAL . 31.9 mm -59.0 112.22 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.511 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.609 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -105.03 -47.07 4.1 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.429 179.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -166.41 -169.14 1.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.403 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -149.51 132.47 4.05 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.936 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.2 mt -89.45 97.89 7.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.769 -0.456 . . . . 0.0 109.769 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 77.2 m -90.13 126.21 57.77 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.37 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.612 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 11.8 Cg_exo -70.57 133.25 23.68 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.799 2.333 . . . . 0.0 112.048 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -84.86 138.56 32.47 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.261 179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.014 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.786 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 43.9 t0 . . . . . 0 C--O 1.234 0.281 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.472 HH12 ' CG ' ' A' ' 19' ' ' ASP . 38.9 mtp85 -139.92 122.54 16.29 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.486 HG23 HG22 ' A' ' 45' ' ' ILE . 8.8 tt -77.9 136.69 23.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.115 0.483 . . . . 0.0 110.009 179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.34 106.07 17.68 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.214 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.403 HG23 HG21 ' A' ' 45' ' ' ILE . 13.3 t 179.37 -168.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.168 -0.924 . . . . 0.0 108.771 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.652 ' HA ' HG13 ' A' ' 45' ' ' ILE . 3.2 p-10 -161.2 -161.42 0.81 Allowed 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.445 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.9 m -67.24 -45.84 75.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.831 0.348 . . . . 0.0 111.178 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 39.9 t -64.93 -52.33 56.97 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.785 -179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -76.1 -12.11 60.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.985 0.422 . . . . 0.0 111.473 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.97 137.73 41.39 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.865 -0.607 . . . . 0.0 112.958 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.419 ' O ' ' HA3' ' A' ' 27' ' ' GLY . 22.0 m -61.71 129.39 40.81 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.624 0.25 . . . . 0.0 110.616 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.44 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 39.9 tttp -53.25 130.27 34.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.803 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.44 -37.96 3.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.618 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.9 t -70.42 125.85 27.97 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.677 ' HD2' ' HB3' ' A' ' 26' ' ' GLU . 8.5 mmmt -94.65 116.89 29.3 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.262 -179.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.656 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 39.4 m-85 -93.65 134.44 35.95 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.203 0.525 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -123.77 162.42 23.22 Favored 'General case' 0 C--O 1.244 0.808 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.542 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.47 159.44 18.66 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.414 178.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.472 ' CG ' HH12 ' A' ' 2' ' ' ARG . 15.1 p-10 -59.46 -27.64 66.27 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 114.998 -1.001 . . . . 0.0 111.729 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.8 p-10 -65.89 -27.6 68.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.933 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.29 -0.69 20.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.294 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.7 m -88.71 146.29 25.14 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.159 0.504 . . . . 0.0 111.238 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.9 t80 -75.75 126.85 31.8 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.4 t -93.91 -63.38 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.87 -0.332 . . . . 0.0 111.306 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.4 p -177.76 149.39 0.59 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.182 0.515 . . . . 0.0 111.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.677 ' HB3' ' HD2' ' A' ' 15' ' ' LYS . 2.0 pt-20 -90.15 149.06 22.6 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.746 178.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -56.45 121.82 25.76 Favored Glycine 0 C--O 1.236 0.224 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.893 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 7' ' ' CYS . 13.0 pt-20 -94.83 11.28 32.11 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.0 m -50.82 137.88 19.74 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.681 0.277 . . . . 0.0 110.907 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -166.41 133.38 2.06 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 110.173 -0.306 . . . . 0.0 110.173 -179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -69.44 -5.9 17.12 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.881 2.387 . . . . 0.0 113.11 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -58.46 -33.61 69.93 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.314 . . . . 0.0 110.7 -179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -151.65 146.4 18.77 Favored Pre-proline 0 C--N 1.328 -0.361 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.85 84.95 0.17 Allowed 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 122.928 2.419 . . . . 0.0 113.19 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -79.71 60.42 3.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.775 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.475 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -77.12 106.04 8.58 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.073 0.463 . . . . 0.0 110.422 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.489 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 73.9 m -129.56 58.44 37.66 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.337 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 7.4 Cg_exo -72.41 -33.12 9.25 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 122.349 2.033 . . . . 0.0 112.06 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 76.1 mtt85 -98.69 46.0 1.0 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.375 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 1.3 t-20 -150.45 121.21 7.55 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.933 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -149.66 128.8 12.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.052 -0.522 . . . . 0.0 109.842 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.7 m-20 -87.46 125.65 64.8 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.928 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -64.16 -18.73 64.55 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.247 1.965 . . . . 0.0 110.844 178.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.456 HH11 ' HG2' ' A' ' 44' ' ' ARG . 1.0 OUTLIER -69.58 -34.35 74.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.376 178.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.652 HG13 ' HA ' ' A' ' 6' ' ' ASN . 38.9 mm -66.76 107.94 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.586 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -105.48 -40.94 5.63 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 9.0 p90 -154.71 150.59 27.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.637 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -117.59 127.21 7.26 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.439 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 66.7 mt -93.09 100.14 10.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 62.3 m -89.21 127.97 53.29 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.235 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -67.81 140.55 51.21 Favored 'Trans proline' 0 C--O 1.234 0.275 0 C-N-CA 122.737 2.292 . . . . 0.0 112.317 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.0 tp -160.22 133.07 6.55 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.086 -0.506 . . . . 0.0 109.735 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.969 0 O-C-N 124.106 0.878 . . . . 0.0 110.696 -179.072 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.452 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 51.7 t0 . . . . . 0 C--O 1.232 0.178 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.652 ' NE ' ' HA ' ' A' ' 46' ' ' ALA . 21.5 mmm-85 -151.98 64.06 0.84 Allowed 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.119 0.568 . . . . 0.0 109.736 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.13 129.99 36.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.604 0.716 . . . . 0.0 110.918 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.56 129.77 35.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.598 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.1 t -176.59 -160.45 0.06 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -153.59 166.17 33.6 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 74.4 m -51.61 -44.01 62.74 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.665 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 33.3 t -60.99 -49.65 76.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.75 0.31 . . . . 0.0 111.449 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.99 -29.45 65.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.353 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.78 131.9 40.41 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 116.078 -0.51 . . . . 0.0 112.616 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.8 m -59.63 126.47 27.73 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.291 0.236 . . . . 0.0 110.926 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.589 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 48.6 tptt -58.83 120.43 9.0 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-N 116.262 -0.426 . . . . 0.0 109.919 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 121.86 -40.75 2.01 Favored Glycine 0 N--CA 1.442 -0.909 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 26' ' ' GLU . 59.1 m -71.2 126.47 29.69 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.474 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 13.3 ptpt -88.3 110.84 21.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.221 0.534 . . . . 0.0 111.218 -178.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.599 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 31.8 m-85 -93.95 129.09 40.55 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.851 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -113.28 151.65 30.83 Favored 'General case' 0 C--O 1.244 0.8 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.807 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.438 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 2.3 p -79.96 167.55 20.34 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.701 0.625 . . . . 0.0 111.351 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.527 ' HA ' ' HB2' ' A' ' 46' ' ' ALA . 12.4 p-10 -62.98 -29.23 70.66 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.111 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -67.28 -30.75 70.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.708 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 120.89 -9.74 10.4 Favored Glycine 0 C--N 1.335 0.497 0 C-N-CA 120.483 -0.865 . . . . 0.0 114.014 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.0 m -87.91 151.13 23.05 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.254 0.549 . . . . 0.0 111.525 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 24.9 t80 -68.2 126.78 30.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.743 179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.525 HG12 ' SG ' ' A' ' 25' ' ' CYS . 39.1 t -94.77 -56.38 5.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.525 ' SG ' HG12 ' A' ' 24' ' ' VAL . 24.7 p -176.35 145.06 0.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.697 0.284 . . . . 0.0 111.271 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.476 ' H ' ' CD ' ' A' ' 26' ' ' GLU . 1.0 OUTLIER -89.9 39.97 0.98 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.702 0.763 . . . . 0.0 110.076 178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.69 172.62 16.43 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.379 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.665 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 15.3 pt-20 -157.04 27.45 0.31 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.066 0.46 . . . . 0.0 110.791 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.9 p -79.06 66.97 4.65 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.49 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 41.0 t0 -61.57 119.57 48.24 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.965 -179.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 15.2 Cg_exo -68.44 -19.35 43.25 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.714 2.276 . . . . 0.0 111.302 179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.56 -36.55 65.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.33 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.454 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 2.0 p30 -136.19 127.26 16.84 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.398 0.618 . . . . 0.0 110.915 -179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 2.6 Cg_exo -76.2 90.23 1.19 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.985 2.457 . . . . 0.0 112.199 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -78.59 136.69 37.57 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.058 179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.88 115.54 9.23 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.946 0.403 . . . . 0.0 110.484 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 72.6 m -89.37 137.32 29.14 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.715 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.24 140.24 93.56 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.938 2.425 . . . . 0.0 112.071 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 37.6 mmt180 -83.49 43.8 0.92 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.172 0.511 . . . . 0.0 110.643 179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -159.46 146.8 17.01 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.16 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -97.11 140.86 30.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.11 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 20.6 m-20 -78.06 118.78 74.32 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.527 179.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 22.7 Cg_exo -64.06 -18.45 63.64 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.905 2.403 . . . . 0.0 110.638 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.438 ' HG2' ' HB3' ' A' ' 18' ' ' SER . 20.0 ttp-105 -70.94 -32.49 69.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.906 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 40.3 mm -64.67 119.69 9.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.852 0.358 . . . . 0.0 110.823 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.652 ' HA ' ' NE ' ' A' ' 2' ' ' ARG . . . -94.88 -52.62 4.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.498 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -166.69 157.69 12.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.253 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.599 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -126.86 115.98 2.36 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.59 179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.447 ' O ' ' HG2' ' A' ' 15' ' ' LYS . 46.9 mm -90.18 117.41 33.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.852 0.358 . . . . 0.0 110.839 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.488 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 80.3 m -89.33 121.3 69.5 Favored Pre-proline 0 C--N 1.321 -0.64 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 179.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.0 Cg_exo -76.59 130.37 11.65 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.006 2.47 . . . . 0.0 112.545 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -84.61 -21.65 30.26 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.836 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.434 179.545 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.3 t70 . . . . . 0 C--O 1.234 0.272 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.854 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 17.7 ptp180 -162.3 164.45 27.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.521 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.3 tp -77.05 135.0 27.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.422 0.63 . . . . 0.0 110.998 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.11 100.85 13.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.372 -0.831 . . . . 0.0 111.194 -179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t -177.4 -173.21 0.42 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.645 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -160.54 -173.66 4.09 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 m -62.34 -45.7 92.03 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.676 0.275 . . . . 0.0 111.502 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.426 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 12.0 t -57.25 -42.07 80.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.945 -178.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -84.72 -82.81 0.17 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.52 ' HA3' ' HA3' ' A' ' 27' ' ' GLY . . . 31.97 -138.35 0.08 OUTLIER Glycine 0 C--N 1.337 0.588 0 N-CA-C 115.418 0.927 . . . . 0.0 115.418 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.746 ' H ' ' HA3' ' A' ' 27' ' ' GLY . 98.6 m -165.46 126.7 1.95 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' A' ' 28' ' ' GLU . 46.6 mmtt -49.15 135.27 16.76 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.086 0.47 . . . . 0.0 111.975 -178.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.45 -43.52 2.78 Favored Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.839 -179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 32.8 t -71.82 116.22 11.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.035 0.445 . . . . 0.0 109.823 179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.713 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 38.0 mttp -99.07 119.97 38.7 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.039 -179.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.754 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 35.6 m-85 -92.61 136.09 33.52 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.429 0.633 . . . . 0.0 111.556 -178.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.492 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.5 m-85 -119.61 158.14 26.99 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.941 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.18 162.03 21.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.653 178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -61.27 -26.69 67.94 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.621 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -66.59 -29.56 69.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.859 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.94 -0.89 17.39 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.237 -0.506 . . . . 0.0 112.388 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.5 m -88.86 146.17 25.12 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.068 0.461 . . . . 0.0 111.305 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.479 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 19.3 t80 -73.77 126.93 31.48 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.517 HG12 ' SG ' ' A' ' 25' ' ' CYS . 79.1 t -96.76 -63.51 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.696 -0.402 . . . . 0.0 111.952 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.517 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.8 p 179.52 155.15 0.52 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.62 0.248 . . . . 0.0 111.033 -178.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.713 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 11.7 pt-20 -96.85 147.53 23.86 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 177.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.746 ' HA3' ' H ' ' A' ' 11' ' ' THR . . . -64.03 136.19 40.54 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.472 -179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.465 ' HA ' ' CE ' ' A' ' 12' ' ' LYS . 11.7 pt-20 -95.17 -3.64 47.46 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.6 m 70.83 116.76 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.144 -0.934 . . . . 0.0 111.437 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.552 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 17.8 t70 -53.9 -57.6 17.02 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.628 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.552 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 89.9 Cg_endo -78.01 43.3 1.35 Allowed 'Trans proline' 0 C--N 1.353 0.815 0 C-N-CA 121.709 1.606 . . . . 0.0 112.299 179.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -163.66 31.28 0.08 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.159 0.504 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.542 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.0 p30 -161.15 149.94 13.26 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 33' ' ' ASN . 3.9 Cg_exo -77.14 51.18 3.37 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.034 2.489 . . . . 0.0 113.794 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' HB2' ' OD1' ' A' ' 33' ' ' ASN . 9.9 mtmp? -157.98 126.65 5.58 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.294 178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.47 117.21 21.71 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.993 -0.283 . . . . 0.0 110.298 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.579 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 88.9 m -141.55 51.82 2.44 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.865 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 37' ' ' CYS . 17.3 Cg_exo -66.77 -25.0 46.46 Favored 'Trans proline' 0 C--N 1.352 0.739 0 C-N-CA 122.349 2.033 . . . . 0.0 112.409 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.6 mmm180 -133.74 39.5 3.17 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.45 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -94.58 139.33 31.32 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.415 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -152.24 133.16 14.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.181 0.515 . . . . 0.0 112.191 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.626 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 1.3 m-20 -99.04 126.45 38.15 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.861 178.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.56 -29.34 88.67 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.773 2.315 . . . . 0.0 111.793 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.415 ' HG2' ' H ' ' A' ' 44' ' ' ARG . 19.9 ptt180 -66.36 -27.63 68.02 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.468 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.645 HG13 ' HA ' ' A' ' 6' ' ' ASN . 42.4 mm -70.11 110.56 3.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.725 -0.216 . . . . 0.0 110.928 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.854 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -103.89 -46.71 4.41 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.168 179.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.492 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 7.4 p90 -150.06 143.27 25.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.904 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.754 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -113.29 130.01 9.2 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.512 -0.852 . . . . 0.0 112.752 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 45.5 mm -88.7 94.31 4.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 71.5 m -89.44 132.76 36.28 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.281 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 18.1 Cg_exo -66.75 136.77 43.23 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.869 2.379 . . . . 0.0 112.009 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.1 mt -79.81 -34.09 39.85 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.198 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.875 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 179.792 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 46.0 t0 . . . . . 0 C--O 1.236 0.372 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.789 ' HA ' ' HB3' ' A' ' 47' ' ' TYR . 2.7 ptm180 -77.5 132.9 38.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.349 179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.1 tt -156.37 134.46 2.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.216 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.82 128.11 36.1 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.872 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -177.11 -156.43 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.492 ' HA ' HG13 ' A' ' 45' ' ' ILE . 1.2 p-10 -153.13 177.59 10.65 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.6 m -55.87 -39.75 71.96 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.568 ' HA ' ' OE2' ' A' ' 28' ' ' GLU . 31.8 t -70.58 -52.79 19.16 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.02 -25.79 60.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.79 0.328 . . . . 0.0 111.764 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.72 141.04 46.95 Favored Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.408 -179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -62.14 130.3 44.8 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.715 0.293 . . . . 0.0 111.424 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 21.5 tptm -54.44 123.48 13.15 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.829 -179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.612 ' O ' ' HE3' ' A' ' 15' ' ' LYS . . . 106.66 -35.69 4.88 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.537 -0.84 . . . . 0.0 112.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.1 m -74.36 126.94 31.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.573 0.225 . . . . 0.0 110.479 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.612 ' HE3' ' O ' ' A' ' 13' ' ' GLY . 0.0 OUTLIER -90.81 119.82 31.34 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.595 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.515 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 90.3 m-85 -99.15 134.5 41.9 Favored 'General case' 0 C--O 1.238 0.449 0 CA-C-O 121.347 0.594 . . . . 0.0 111.406 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.622 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.4 m-85 -121.72 160.41 24.59 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.758 -179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -82.68 169.09 16.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.329 -0.85 . . . . 0.0 111.308 178.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -60.25 -30.7 69.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.134 -0.939 . . . . 0.0 111.454 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.9 p-10 -67.48 -28.54 67.94 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.481 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 114.32 1.28 23.48 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.075 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 22.1 m -88.16 144.49 26.44 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.023 0.439 . . . . 0.0 110.537 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -72.57 126.73 30.57 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.069 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG21 ' HG3' ' A' ' 44' ' ' ARG . 70.6 t -96.61 -62.27 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.216 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.4 p -176.46 151.22 0.95 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.391 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.448 ' HB3' ' HE2' ' A' ' 15' ' ' LYS . 12.7 pt-20 -95.31 156.83 16.16 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.642 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -63.86 127.65 36.41 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.05 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.568 ' OE2' ' HA ' ' A' ' 8' ' ' CYS . 1.5 pp20? -114.39 29.34 8.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.108 0.48 . . . . 0.0 111.038 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -75.78 54.66 0.82 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.767 0.794 . . . . 0.0 110.491 178.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -73.65 129.0 86.08 Favored Pre-proline 0 C--N 1.319 -0.755 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.003 -179.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -56.88 -21.58 41.46 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 123.227 2.618 . . . . 0.0 113.086 -179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.536 ' O ' ' HD3' ' A' ' 32' ' ' ARG . 0.0 OUTLIER -67.19 -31.07 71.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.634 -179.819 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 15.2 p30 -103.0 132.42 21.17 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.251 0.548 . . . . 0.0 110.818 179.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -78.58 64.85 8.65 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 122.936 2.424 . . . . 0.0 113.144 -178.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 28' ' ' GLU . 10.6 mtmp? -125.51 141.89 51.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.982 0.42 . . . . 0.0 110.956 179.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -150.65 128.36 11.61 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.327 179.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.732 ' HB3' ' HB3' ' A' ' 40' ' ' ASN . 62.5 m -127.67 65.36 67.06 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.615 -0.266 . . . . 0.0 111.539 -178.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 15.9 Cg_exo -67.89 -25.8 38.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.567 2.178 . . . . 0.0 112.102 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.5 mtm180 -115.2 52.79 0.85 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.317 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.732 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 20.9 t-20 -158.7 132.38 7.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.636 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.444 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -159.06 136.51 9.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.591 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.461 ' OD2' ' HB2' ' A' ' 6' ' ' ASN . 10.4 m-20 -84.57 127.28 66.26 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.441 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -60.72 -23.78 77.11 Favored 'Trans proline' 0 CA--C 1.528 0.204 0 C-N-CA 123.051 2.501 . . . . 0.0 112.741 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 18' ' ' SER . 4.5 ptp85 -79.62 -16.28 56.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.386 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.492 HG13 ' HA ' ' A' ' 6' ' ' ASN . 21.8 mm -75.52 102.11 2.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -93.42 -39.64 10.8 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.789 ' HB3' ' HA ' ' A' ' 2' ' ' ARG . 3.1 p90 -157.42 166.21 33.64 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.461 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.93 136.11 6.65 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.573 -179.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 60.7 mt -100.28 122.31 52.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.749 0.309 . . . . 0.0 110.552 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 77.0 m -101.03 133.22 21.14 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.132 179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.08 138.73 37.46 Favored 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.644 2.229 . . . . 0.0 112.514 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.492 ' N ' HD13 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -125.03 21.56 8.12 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.218 0.532 . . . . 0.0 110.261 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.868 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.54 179.82 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 2' ' ' ARG . 11.7 t70 . . . . . 0 C--O 1.233 0.209 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.568 ' H ' ' HD2' ' A' ' 2' ' ' ARG . 0.1 OUTLIER -124.48 135.89 53.58 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 121.286 0.565 . . . . 0.0 111.164 -179.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.406 HG23 HG22 ' A' ' 45' ' ' ILE . 12.2 tt -78.59 143.14 13.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.084 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.19 101.13 13.21 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.967 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.602 HG23 HG21 ' A' ' 45' ' ' ILE . 12.2 t -176.52 -161.44 0.07 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.456 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.728 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.3 p30 -160.02 -159.44 0.72 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.565 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 18.3 m -67.57 -54.99 15.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.537 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 49.7 t -70.23 -43.08 71.36 Favored 'General case' 0 C--N 1.329 -0.313 0 O-C-N 122.207 -0.308 . . . . 0.0 111.596 -178.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.05 -23.48 64.06 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.968 0.413 . . . . 0.0 110.839 -179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -68.84 147.92 47.27 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.267 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.563 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 6.7 m -59.58 126.29 27.03 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.949 0.404 . . . . 0.0 111.085 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.971 ' HD3' ' HB2' ' A' ' 30' ' ' ASP . 34.5 ttpt -54.76 132.77 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.247 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.94 -37.64 3.36 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.822 -0.704 . . . . 0.0 111.878 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.563 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 35.8 m -70.27 126.99 31.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.073 -0.343 . . . . 0.0 110.073 179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.817 ' HE3' ' HB3' ' A' ' 26' ' ' GLU . 2.5 mtpt -91.24 114.8 27.42 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.668 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 24.6 m-85 -89.66 135.85 33.38 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.353 0.597 . . . . 0.0 111.566 -179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.464 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.3 m-85 -125.9 160.4 30.03 Favored 'General case' 0 C--O 1.242 0.704 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.9 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 0.3 OUTLIER -83.79 163.83 19.91 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.889 178.495 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 p-10 -62.46 -28.51 69.86 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.458 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.6 p-10 -66.91 -28.49 68.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.925 179.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 116.65 1.89 19.5 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.38 -179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -88.16 147.41 24.9 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.101 0.476 . . . . 0.0 111.031 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.402 ' CE1' ' HE2' ' A' ' 15' ' ' LYS . 26.9 t80 -75.21 133.39 41.41 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.096 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.3 t -105.08 -68.38 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.2 p -176.42 147.55 0.69 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.925 0.393 . . . . 0.0 111.669 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.817 ' HB3' ' HE3' ' A' ' 15' ' ' LYS . 3.1 pm0 -85.87 156.55 20.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.837 178.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.565 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -64.5 119.97 17.44 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.712 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.537 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.1 OUTLIER -102.63 34.04 2.96 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 p -79.72 71.31 6.35 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.229 0.538 . . . . 0.0 110.908 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.971 ' HB2' ' HD3' ' A' ' 12' ' ' LYS . 9.8 t70 -146.66 -59.27 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.387 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.829 -179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.595 ' HD2' ' H ' ' A' ' 30' ' ' ASP . 31.6 Cg_endo -64.46 -39.14 29.92 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 121.783 1.656 . . . . 0.0 112.869 -179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.6 ttp85 58.03 37.83 26.64 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.745 0.783 . . . . 0.0 109.893 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -72.09 161.07 80.81 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.872 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.21 92.35 0.04 OUTLIER 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.683 2.255 . . . . 0.0 111.766 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 2.5 tmmm? -160.85 134.22 6.64 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.243 -0.89 . . . . 0.0 108.935 -178.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -67.39 103.95 1.41 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.159 0.504 . . . . 0.0 111.85 -178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.638 ' HB2' ' HD3' ' A' ' 38' ' ' PRO . 83.7 m -89.83 -55.91 0.28 Allowed Pre-proline 0 C--N 1.32 -0.698 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.797 179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.638 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 97.5 Cg_endo -83.28 39.86 0.87 Allowed 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.03 1.82 . . . . 0.0 111.975 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.5 ptt85 -69.32 -46.08 67.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.85 -0.613 . . . . 0.0 111.045 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 176.42 171.44 0.43 Allowed 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -87.41 129.81 34.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 179.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -82.71 122.3 78.31 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.1 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_endo -58.03 -27.46 79.53 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.01 2.473 . . . . 0.0 112.007 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' SER . 11.8 ptt-85 -68.35 -25.41 65.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.184 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.728 HG13 ' HA ' ' A' ' 6' ' ' ASN . 37.8 mm -79.95 94.87 2.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.797 0.332 . . . . 0.0 110.84 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.472 ' HA ' ' CB ' ' A' ' 2' ' ' ARG . . . -89.87 -43.35 10.67 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.621 -0.432 . . . . 0.0 111.096 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.5 p90 -159.97 157.26 28.53 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.101 -179.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.668 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -125.49 125.82 5.71 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.055 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 59.7 mt -86.62 111.97 22.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 120.838 0.352 . . . . 0.0 110.167 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 76.5 m -93.38 133.54 28.23 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.4 57.85 5.56 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.864 2.376 . . . . 0.0 112.198 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.5 mt -143.34 137.06 28.49 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.91 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.929 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 19.7 t70 . . . . . 0 C--O 1.235 0.325 0 CA-C-O 120.758 0.313 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.685 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 9.0 tpt180 -158.58 58.63 0.44 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.442 0.639 . . . . 0.0 109.503 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 5.7 tt -78.1 124.49 36.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-O 121.608 0.718 . . . . 0.0 111.018 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -95.15 127.06 40.91 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.185 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.441 ' O ' HG13 ' A' ' 45' ' ' ILE . 12.9 t -176.97 -155.74 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 20.0 p30 -146.08 178.58 8.1 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.526 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 26.9 m -56.19 -42.13 76.66 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.668 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 43.0 t -72.07 -49.52 35.86 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.84 29.56 0.39 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.337 0.589 . . . . 0.0 111.089 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -104.94 145.58 15.95 Favored Glycine 0 N--CA 1.441 -0.991 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.19 179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.5 m -59.65 126.72 28.7 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.883 0.341 . . . . 0.0 110.694 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.509 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 84.5 tttt -54.93 128.87 35.37 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.954 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.06 -39.77 2.81 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.894 -179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -75.5 124.11 26.61 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.956 ' HA ' ' HA ' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -100.37 126.57 46.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.029 0.443 . . . . 0.0 110.0 179.235 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.588 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 14.7 m-85 -89.04 137.7 32.08 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.173 -178.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.565 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 3.0 m-85 -122.51 160.56 25.34 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.649 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.14 157.44 19.37 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.043 178.12 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.7 p-10 -61.35 -29.05 69.66 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.34 -179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.32 -32.67 73.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.493 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.19 -2.15 9.73 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.853 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 58.1 m -89.02 148.05 23.95 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.443 0.64 . . . . 0.0 111.559 -179.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.73 ' HE1' ' HB2' ' A' ' 15' ' ' LYS . 18.8 t80 -76.92 131.56 38.61 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.925 179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.466 HG12 ' SG ' ' A' ' 25' ' ' CYS . 93.1 t -99.86 -68.94 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.867 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.466 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.6 p 178.72 148.88 0.21 Allowed 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.831 0.348 . . . . 0.0 111.572 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.956 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 2.2 pm0 -87.02 152.67 22.18 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -67.67 121.58 15.11 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.614 -179.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.668 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 0.4 OUTLIER -89.36 41.19 1.02 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.971 0.415 . . . . 0.0 111.526 179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 59.9 m -77.81 53.1 1.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.491 0.662 . . . . 0.0 110.578 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.732 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 9.1 t70 -93.46 -55.42 0.24 Allowed Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.33 179.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.732 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 23.5 Cg_exo -63.9 111.11 1.46 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 121.764 1.643 . . . . 0.0 111.168 179.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 37.8 ttm180 -62.45 -20.84 64.94 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.566 -0.743 . . . . 0.0 111.349 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -68.91 133.48 90.15 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.069 0.461 . . . . 0.0 110.546 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.3 132.53 27.83 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.657 2.238 . . . . 0.0 112.726 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.0 143.52 33.22 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.03 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.88 116.95 4.48 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.239 -178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.88 ' H ' ' HD2' ' A' ' 38' ' ' PRO . 99.9 m -145.54 -47.6 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.312 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.88 ' HD2' ' H ' ' A' ' 37' ' ' CYS . 58.3 Cg_endo -71.03 48.39 0.86 Allowed 'Trans proline' 0 C--N 1.361 1.208 0 C-N-CA 122.216 1.944 . . . . 0.0 112.891 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -85.47 -26.65 26.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.917 179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -167.94 174.87 7.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.273 -0.876 . . . . 0.0 108.677 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -123.25 140.6 52.85 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.717 0.294 . . . . 0.0 110.678 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.461 ' HB2' HG12 ' A' ' 45' ' ' ILE . 1.0 OUTLIER -78.72 125.2 84.66 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.559 179.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 38.1 Cg_exo -60.54 -27.73 85.38 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.875 2.383 . . . . 0.0 111.569 179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.441 ' HD2' HG13 ' A' ' 24' ' ' VAL . 25.4 ptt180 -66.87 -28.86 68.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.275 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.461 HG12 ' HB2' ' A' ' 42' ' ' ASP . 23.3 mm -70.41 102.55 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 120.742 0.306 . . . . 0.0 110.223 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.685 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -99.15 -42.35 7.1 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.563 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.565 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 5.1 p90 -156.92 151.52 25.57 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.816 0.341 . . . . 0.0 111.422 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.588 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -108.23 123.7 7.18 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.58 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.36 111.91 25.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 120.895 0.378 . . . . 0.0 110.26 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 85.6 m -94.59 136.49 23.11 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.83 141.91 50.6 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.667 2.245 . . . . 0.0 111.929 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -157.7 -44.99 0.06 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.281 -1.342 . . . . 0.0 108.661 179.196 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.406 ' O ' ' HD2' ' A' ' 2' ' ' ARG . 2.0 p30 . . . . . 0 CA--C 1.514 -0.44 0 CA-C-O 122.186 0.993 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.491 ' HA ' ' O ' ' A' ' 46' ' ' ALA . 13.4 mmm180 -133.0 138.34 46.81 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.322 -1.308 . . . . 0.0 110.439 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.57 HG22 ' HA ' ' A' ' 47' ' ' TYR . 7.1 tt -145.75 128.22 9.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.231 0.538 . . . . 0.0 109.851 178.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.01 117.12 29.65 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.979 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.3 t 179.52 -159.0 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.395 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.607 ' HA ' HG13 ' A' ' 45' ' ' ILE . 16.5 p30 -145.61 -167.61 2.75 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.632 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 1.8 m -67.17 -56.27 10.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.869 0.366 . . . . 0.0 111.409 -178.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.449 ' SG ' ' HE2' ' A' ' 35' ' ' LYS . 3.7 t -58.25 -49.78 75.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.1 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -82.91 24.17 0.77 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.81 0.338 . . . . 0.0 111.651 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.13 -122.77 4.61 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.128 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 59.8 m -151.47 136.14 17.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 36.5 tttp -53.95 127.91 28.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.241 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 84.55 -30.74 3.7 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.849 -0.691 . . . . 0.0 113.246 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.44 122.31 14.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.891 0.377 . . . . 0.0 110.033 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.783 ' HD3' ' HB3' ' A' ' 26' ' ' GLU . 44.2 mmtm -92.67 113.56 25.87 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.796 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.548 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 69.2 m-85 -95.98 133.27 40.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.359 0.6 . . . . 0.0 110.911 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.546 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 2.0 m-85 -128.4 164.9 21.69 Favored 'General case' 0 C--O 1.245 0.823 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.381 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.83 156.28 18.15 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 176.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.493 ' HA ' ' CE2' ' A' ' 47' ' ' TYR . 30.7 p-10 -62.99 -23.82 67.62 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.627 -179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -62.4 -33.57 75.04 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.02 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.22 -4.17 8.94 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.031 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.8 m -89.44 146.78 24.41 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.207 0.527 . . . . 0.0 111.545 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -77.31 129.24 35.59 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.57 HG13 ' HD2' ' A' ' 44' ' ' ARG . 92.9 t -95.66 -63.66 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.6 p -178.25 163.41 1.65 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.564 0.221 . . . . 0.0 110.517 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.783 ' HB3' ' HD3' ' A' ' 15' ' ' LYS . 15.2 pt-20 -110.23 153.33 24.95 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 177.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.632 ' HA2' ' O ' ' A' ' 7' ' ' CYS . . . -68.16 115.96 7.23 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.506 -0.854 . . . . 0.0 113.528 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 28' ' ' GLU . 8.7 pm0 -90.88 33.43 0.94 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 178.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -69.87 54.72 0.13 Allowed 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.314 -0.857 . . . . 0.0 112.518 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.413 ' N ' ' HD3' ' A' ' 31' ' ' PRO . 52.7 t0 -179.13 62.34 0.13 Allowed Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.674 179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.413 ' HD3' ' N ' ' A' ' 30' ' ' ASP . 88.9 Cg_endo -89.2 -8.56 4.68 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.62 2.213 . . . . 0.0 112.106 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 75.64 -39.4 0.38 Allowed 'General case' 0 N--CA 1.466 0.369 0 C-N-CA 123.843 0.857 . . . . 0.0 110.534 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -90.65 151.39 43.86 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 178.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -58.19 125.61 19.02 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.269 1.979 . . . . 0.0 111.895 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.449 ' HE2' ' SG ' ' A' ' 8' ' ' CYS . 86.5 tttt -147.94 128.02 13.69 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.898 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.36 122.53 30.46 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.544 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 85.6 m -92.28 129.29 41.71 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.478 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -61.99 131.93 37.15 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.561 2.174 . . . . 0.0 111.641 179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -79.91 -19.78 47.32 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.843 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -65.31 132.66 49.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.29 -0.414 . . . . 0.0 109.888 179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -80.77 132.98 35.57 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.333 -179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.411 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 26.6 m-20 -78.9 123.65 85.1 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.918 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.66 -25.39 78.87 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.887 2.391 . . . . 0.0 111.726 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.57 ' HD2' HG13 ' A' ' 24' ' ' VAL . 31.7 ptt180 -71.89 -27.67 63.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.424 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.607 HG13 ' HA ' ' A' ' 6' ' ' ASN . 25.4 mm -79.1 105.59 8.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.828 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' ARG . . . -98.41 -42.12 7.49 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.352 -0.539 . . . . 0.0 110.372 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.57 ' HA ' HG22 ' A' ' 3' ' ' ILE . 6.0 p90 -155.16 163.11 40.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.372 -179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.548 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -142.79 131.73 4.75 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.34 -0.933 . . . . 0.0 112.377 -179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.414 HD12 ' N ' ' A' ' 49' ' ' ILE . 4.1 mp -86.88 94.48 4.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 73.3 m -91.04 134.01 30.89 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.053 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 8.5 Cg_exo -71.97 63.88 3.29 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 123.347 2.698 . . . . 0.0 112.443 -179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.8 mt -80.48 -35.8 34.27 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.521 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.202 0 CA-C-O 117.332 -1.318 . . . . 0.0 108.849 179.921 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 45.0 t0 . . . . . 0 C--O 1.236 0.366 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.615 ' HG3' ' HA ' ' A' ' 46' ' ' ALA . 56.5 ttm-85 -160.7 110.76 1.75 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 13.1 tt -78.36 140.39 17.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.799 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -88.47 101.56 14.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.032 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 13.7 t -179.1 -171.82 0.22 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.839 ' HA ' HG13 ' A' ' 45' ' ' ILE . 23.2 p30 -161.44 -155.01 0.38 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -70.33 -52.29 23.84 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.022 0.439 . . . . 0.0 110.799 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HA ' ' CG ' ' A' ' 28' ' ' GLU . 52.6 t -64.86 -41.76 95.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.899 -179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -77.66 -23.65 49.6 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.969 0.359 . . . . 0.0 111.969 -179.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.23 148.35 50.03 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.784 -178.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -75.14 141.11 43.74 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.684 -0.258 . . . . 0.0 110.761 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 29' ' ' SER . 45.7 mtmt -50.36 137.26 18.93 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.896 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.75 -36.52 3.13 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.816 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.6 t -67.96 120.41 14.18 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.731 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 47.7 mttp -98.03 122.12 40.78 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 -179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.56 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 53.8 m-85 -100.98 133.87 44.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.534 0.683 . . . . 0.0 111.256 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.544 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.2 m-85 -121.85 162.65 20.56 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.249 -179.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -86.44 159.26 19.39 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.261 177.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.432 ' CG ' HH22 ' A' ' 2' ' ' ARG . 4.9 p-10 -59.53 -27.41 66.17 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.408 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -63.56 -34.86 78.74 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.441 179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 125.11 -5.4 8.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.934 -0.65 . . . . 0.0 112.881 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 31.3 m -89.39 146.59 24.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.154 0.502 . . . . 0.0 111.537 -179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 t80 -74.11 126.66 31.05 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.3 t -94.61 -61.37 2.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 120.74 -0.384 . . . . 0.0 111.468 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 27.5 p -179.17 153.33 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.765 0.317 . . . . 0.0 110.7 -179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.731 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 6.4 pt-20 -96.94 160.94 14.07 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.148 178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -66.1 136.22 34.99 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.848 -0.614 . . . . 0.0 113.882 -178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.468 ' CG ' ' HA ' ' A' ' 8' ' ' CYS . 9.1 pt-20 -118.66 15.89 13.63 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.724 -0.238 . . . . 0.0 111.408 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 12' ' ' LYS . 44.7 m -58.38 123.49 16.32 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.281 179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 12' ' ' LYS . 31.7 t0 67.05 64.78 0.73 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-O 121.542 0.686 . . . . 0.0 110.715 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -88.72 41.58 0.6 Allowed 'Trans proline' 0 N--CA 1.45 -1.046 0 C-N-CA 122.554 2.169 . . . . 0.0 110.953 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 66.28 35.79 5.72 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.019 -178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.543 ' HB2' ' HD2' ' A' ' 34' ' ' PRO . 18.3 p30 -169.57 160.37 7.26 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.704 -1.134 . . . . 0.0 108.923 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 33' ' ' ASN . 37.0 Cg_endo -65.96 71.63 0.37 Allowed 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.092 2.528 . . . . 0.0 114.657 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HE2' ' HB3' ' A' ' 35' ' ' LYS . 31.6 mtpt -134.58 127.38 31.14 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.011 0.434 . . . . 0.0 110.884 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.443 ' C ' ' HD3' ' A' ' 38' ' ' PRO . . . -171.35 137.99 1.16 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.164 -0.925 . . . . 0.0 108.849 179.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.415 ' N ' ' HD3' ' A' ' 38' ' ' PRO . 64.2 m -128.76 62.69 62.42 Favored Pre-proline 0 C--N 1.324 -0.536 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.443 ' HD3' ' C ' ' A' ' 36' ' ' ALA . 2.8 Cg_exo -75.83 44.87 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.894 2.396 . . . . 0.0 112.456 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -171.44 44.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.659 0.742 . . . . 0.0 109.081 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -159.17 142.65 14.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.029 -179.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.72 135.78 26.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.725 0.298 . . . . 0.0 111.317 -179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.426 ' HB2' ' HB3' ' A' ' 6' ' ' ASN . 5.5 m-20 -96.3 128.42 36.75 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.702 179.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -60.44 -26.41 82.7 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.806 2.337 . . . . 0.0 111.744 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 40.4 mtm-85 -68.07 -34.07 75.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.626 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.839 HG13 ' HA ' ' A' ' 6' ' ' ASN . 46.3 mm -72.15 114.98 11.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.012 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.615 ' HA ' ' HG3' ' A' ' 2' ' ' ARG . . . -107.89 -39.79 5.44 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.833 0.349 . . . . 0.0 110.591 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.544 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.6 p90 -154.73 155.12 33.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.401 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.56 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -138.81 135.02 7.11 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.642 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 58.2 mt -91.46 102.96 14.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 74.7 m -93.28 120.9 66.31 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.315 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.12 136.99 23.2 Favored 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.563 2.176 . . . . 0.0 112.236 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 94.8 mt -84.08 137.34 33.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.345 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.214 0 CA-C-O 117.419 -1.277 . . . . 0.0 109.235 179.86 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 29.7 t70 . . . . . 0 C--O 1.235 0.316 0 N-CA-C 110.377 -0.231 . . . . 0.0 110.377 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.815 ' HB2' ' HA ' ' A' ' 46' ' ' ALA . 20.0 ptp180 -161.58 152.01 17.55 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.228 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 6.1 tt -77.52 128.49 38.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.484 0.659 . . . . 0.0 110.754 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.29 121.45 31.58 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.211 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.2 t 179.9 -162.01 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 21.9 p30 -158.1 -174.38 4.8 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.434 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 4.5 m -59.99 -53.82 53.27 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.564 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 39.7 t -65.97 -42.57 89.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HA ' ' HB1' ' A' ' 36' ' ' ALA . . . -71.39 -30.5 66.2 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.727 0.299 . . . . 0.0 111.481 -179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.9 146.49 50.39 Favored Glycine 0 N--CA 1.448 -0.504 0 CA-C-N 116.123 -0.49 . . . . 0.0 112.688 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 10.3 m -66.08 133.19 50.23 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.532 0.205 . . . . 0.0 111.096 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 38.1 ttpt -52.55 135.46 34.13 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.477 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 92.17 -36.2 3.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.169 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.56 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 20.8 t -70.43 118.71 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.569 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 67.1 mttm -91.75 116.14 28.64 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.769 -179.008 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.633 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 59.9 m-85 -94.53 132.91 38.72 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.307 0.575 . . . . 0.0 111.079 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.467 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.8 m-85 -120.82 159.85 24.6 Favored 'General case' 0 C--O 1.244 0.794 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.276 -179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.63 160.69 19.53 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.326 178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -61.09 -27.14 68.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.434 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -64.4 -33.52 76.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.313 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.2 -4.53 9.59 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.91 179.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 42.1 m -89.04 148.3 23.81 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.222 0.534 . . . . 0.0 111.461 -179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -74.34 124.74 27.04 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.692 179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.443 HG12 ' SG ' ' A' ' 25' ' ' CYS . 78.2 t -90.47 -64.23 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.213 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.443 ' SG ' HG12 ' A' ' 24' ' ' VAL . 26.5 p 179.98 150.7 0.38 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.265 -179.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.569 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.6 pt-20 -97.69 155.39 17.02 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.155 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.658 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -59.9 138.33 48.98 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.896 -0.593 . . . . 0.0 113.219 -178.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.564 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 13.0 pt-20 -119.78 14.17 12.49 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.929 0.395 . . . . 0.0 111.013 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.621 ' O ' ' HB2' ' A' ' 12' ' ' LYS . 33.4 p -77.6 137.67 38.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.023 0.439 . . . . 0.0 111.81 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.615 ' HB3' ' HG2' ' A' ' 34' ' ' PRO . 9.9 t70 -156.85 133.77 6.51 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.38 -18.98 48.79 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 123.295 2.663 . . . . 0.0 113.55 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 10.9 tpt180 -59.08 -40.27 84.74 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 111.396 0.147 . . . . 0.0 111.396 -179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.725 ' H ' ' HD2' ' A' ' 34' ' ' PRO . 9.0 p30 -173.16 -41.23 0.0 OUTLIER Pre-proline 0 CA--C 1.543 0.688 0 CA-C-O 118.859 -0.591 . . . . 0.0 112.508 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.725 ' HD2' ' H ' ' A' ' 33' ' ' ASN . 56.7 Cg_endo -73.45 89.51 0.95 Allowed 'Trans proline' 0 C--N 1.364 1.368 0 C-N-CA 121.34 1.36 . . . . 0.0 111.491 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.5 ptpp? -78.79 143.27 36.24 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.683 -179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.659 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . -53.78 143.93 19.6 Favored 'General case' 0 C--N 1.329 -0.319 0 O-C-N 123.759 0.662 . . . . 0.0 111.676 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 55.6 m -108.86 78.12 0.9 Allowed Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.8 -0.637 . . . . 0.0 111.445 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.659 ' HD3' ' O ' ' A' ' 36' ' ' ALA . 1.3 Cg_endo -84.15 41.19 0.97 Allowed 'Trans proline' 0 N--CA 1.461 -0.409 0 C-N-CA 123.024 2.482 . . . . 0.0 111.924 179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 -77.7 -32.45 52.97 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.81 -179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -163.05 152.81 15.58 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -99.48 132.77 44.59 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.762 0.315 . . . . 0.0 110.811 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.517 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 66.4 m-20 -79.28 121.12 82.61 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.409 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -61.63 -25.45 79.16 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.803 2.335 . . . . 0.0 111.553 179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.517 ' HG2' ' HB3' ' A' ' 42' ' ' ASP . 33.0 ptt180 -67.23 -29.57 69.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.189 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -72.55 112.22 8.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 120.64 0.257 . . . . 0.0 110.689 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 2' ' ' ARG . . . -105.89 -43.4 4.88 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.77 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 4.3 p90 -156.1 150.19 25.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.866 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -128.58 130.42 6.54 Favored Glycine 0 N--CA 1.444 -0.822 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.252 -179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.417 HD12 ' N ' ' A' ' 49' ' ' ILE . 3.7 mp -88.97 100.74 11.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 179.478 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 82.8 m -89.94 125.7 59.82 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.039 -179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.56 ' HD3' ' HA ' ' A' ' 14' ' ' CYS . 7.4 Cg_exo -73.12 65.01 4.26 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.304 2.669 . . . . 0.0 112.591 -179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.3 pp -156.92 32.63 0.3 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.493 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.897 0 CA-C-N 115.246 -0.888 . . . . 0.0 108.815 179.579 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.5 t70 . . . . . 0 C--O 1.235 0.342 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 42.5 mtp85 -146.84 123.79 11.35 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 7.0 tp -78.71 141.97 14.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.218 0.532 . . . . 0.0 110.56 179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -87.41 90.93 8.55 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.621 -179.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.8 t -173.23 -171.96 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.073 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.78 ' HA ' HG13 ' A' ' 45' ' ' ILE . 2.3 p-10 -160.91 -164.96 1.27 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 121.259 -0.177 . . . . 0.0 110.612 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.529 ' O ' ' HA2' ' A' ' 27' ' ' GLY . 59.1 m -59.59 -37.77 79.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 111.552 -179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 3.9 t -80.71 -59.18 2.78 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.407 -178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.94 -16.66 63.58 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' C ' ' HA3' ' A' ' 27' ' ' GLY . . . -59.37 147.88 41.74 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.27 -0.491 . . . . 0.0 113.027 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.7 m -68.48 129.49 40.09 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 27' ' ' GLY . 49.7 tttm -55.15 125.23 19.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.398 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.36 -38.47 3.14 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 61.0 m -72.04 121.89 19.97 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.568 ' HB3' ' CE1' ' A' ' 23' ' ' PHE . 68.2 mttm -89.8 121.3 31.81 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.686 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 48.9 m-85 -94.77 134.68 37.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.144 0.497 . . . . 0.0 110.829 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.433 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.7 m-85 -119.35 161.85 19.78 Favored 'General case' 0 C--O 1.245 0.821 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.705 -179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.34 161.13 18.1 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.408 178.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -57.17 -29.39 63.62 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.657 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -65.28 -33.69 76.57 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.873 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.34 -5.1 9.45 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.815 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.9 m -88.39 148.04 24.43 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.21 0.528 . . . . 0.0 111.162 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.568 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 20.5 t80 -71.34 130.01 40.28 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.047 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.552 HG12 ' SG ' ' A' ' 25' ' ' CYS . 73.2 t -97.1 -63.78 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.819 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.552 ' SG ' HG12 ' A' ' 24' ' ' VAL . 25.5 p -178.95 153.22 0.62 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -97.66 147.68 24.08 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.705 ' O ' ' HA ' ' A' ' 12' ' ' LYS . . . -70.77 138.12 28.05 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.994 -0.622 . . . . 0.0 114.375 -177.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.667 ' HG2' ' HA ' ' A' ' 8' ' ' CYS . 8.1 pt-20 -89.75 -6.35 56.09 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.424 ' HB3' ' HB2' ' A' ' 12' ' ' LYS . 87.1 p 67.68 128.39 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.67 -178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.64 ' HB3' ' HD3' ' A' ' 31' ' ' PRO . 38.3 t0 -56.14 -56.04 35.35 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-N 115.026 -0.988 . . . . 0.0 112.646 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.64 ' HD3' ' HB3' ' A' ' 30' ' ' ASP . 84.8 Cg_endo -77.44 40.47 0.84 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.018 1.812 . . . . 0.0 113.676 -179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HB2' ' OG ' ' A' ' 29' ' ' SER . 48.9 tpt85 -106.61 -32.35 8.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.05 0.452 . . . . 0.0 110.955 179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 35' ' ' LYS . 16.8 p30 -148.72 158.37 39.88 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.188 -178.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.05 62.68 1.37 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.248 2.632 . . . . 0.0 112.722 -179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB3' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -153.7 112.65 3.71 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.4 124.27 19.5 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.369 -179.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 8.6 m -88.53 -43.93 0.46 Allowed Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 113.828 1.048 . . . . 0.0 113.828 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.9 46.63 0.53 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 122.577 2.184 . . . . 0.0 113.607 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -88.03 -34.24 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.851 0.358 . . . . 0.0 110.417 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -167.5 145.92 4.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.374 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 6' ' ' ASN . . . -103.64 139.93 38.26 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.711 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.61 ' OD1' ' HB2' ' A' ' 6' ' ' ASN . 4.2 m-20 -78.1 122.04 84.81 Favored Pre-proline 0 C--N 1.326 -0.429 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -54.12 -32.77 71.26 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.318 2.679 . . . . 0.0 113.551 -178.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.445 ' NE ' HG13 ' A' ' 24' ' ' VAL . 25.3 ptt-85 -70.16 -17.54 63.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.651 -179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.78 HG13 ' HA ' ' A' ' 6' ' ' ASN . 30.4 mm -69.82 107.11 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 179.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.15 -49.41 3.75 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.22 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 6.3 p90 -150.79 149.13 29.35 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.898 0.38 . . . . 0.0 111.249 -179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.686 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -118.23 134.25 10.86 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.114 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 47.8 mm -110.2 120.45 61.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 120.878 0.37 . . . . 0.0 110.449 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 61.6 m -91.95 125.77 55.82 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.857 179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 16.2 Cg_exo -68.29 126.38 14.23 Favored 'Trans proline' 0 N--CA 1.464 -0.206 0 C-N-CA 122.734 2.289 . . . . 0.0 112.041 -179.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 92.5 mt -91.87 -35.44 14.06 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.125 179.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.342 -1.313 . . . . 0.0 108.568 179.778 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 42.6 t0 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.421 HH11 ' HB1' ' A' ' 46' ' ' ALA . 27.1 mmt180 -142.38 126.69 17.62 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.935 -0.395 . . . . 0.0 109.935 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 47' ' ' TYR . 6.5 tt -142.12 131.36 22.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.312 0.577 . . . . 0.0 111.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -90.65 124.4 35.04 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.661 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.5 t -179.24 -158.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . 0.825 ' HA ' HG13 ' A' ' 45' ' ' ILE . 20.8 p30 -151.58 -168.09 2.98 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 7.5 m -65.81 -58.84 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -178.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.736 ' HA ' ' HG3' ' A' ' 28' ' ' GLU . 4.6 t -62.87 -44.72 95.36 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.768 -178.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -73.02 -11.68 60.65 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.758 0.313 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.2 145.23 35.86 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.499 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.493 ' HB ' ' SG ' ' A' ' 14' ' ' CYS . 14.9 m -67.23 137.0 55.85 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.552 0.215 . . . . 0.0 110.931 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.591 ' HE2' ' O ' ' A' ' 29' ' ' SER . 59.0 mttm -49.23 133.27 19.42 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.716 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 87.2 -37.36 3.22 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.78 -0.724 . . . . 0.0 113.276 179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.493 ' SG ' ' HB ' ' A' ' 11' ' ' THR . 59.3 m -65.68 112.59 3.74 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.707 -0.479 . . . . 0.0 109.707 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.613 ' HG2' ' HB3' ' A' ' 26' ' ' GLU . 62.2 mttm -89.64 116.78 28.03 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.262 -179.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.535 ' HA ' ' HA2' ' A' ' 48' ' ' GLY . 76.8 m-85 -94.46 135.64 35.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.477 0.656 . . . . 0.0 111.543 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' HB2' ' CE1' ' A' ' 47' ' ' TYR . 1.0 OUTLIER -120.53 161.54 21.13 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.749 -179.974 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 44' ' ' ARG . 1.8 p -80.74 164.5 22.73 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.275 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -60.82 -28.56 68.89 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.72 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -67.03 -33.88 76.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.938 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 126.25 -9.22 7.43 Favored Glycine 0 C--N 1.336 0.531 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.652 179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.3 m -86.6 146.0 26.51 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.378 0.609 . . . . 0.0 111.31 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 15' ' ' LYS . 26.9 t80 -69.86 127.62 33.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.281 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.449 HG12 ' SG ' ' A' ' 25' ' ' CYS . 71.9 t -96.96 -61.2 2.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.134 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.449 ' SG ' HG12 ' A' ' 24' ' ' VAL . 23.3 p -178.16 148.29 0.49 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.446 -179.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.613 ' HB3' ' HG2' ' A' ' 15' ' ' LYS . 4.5 pt-20 -94.17 159.85 14.96 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.336 179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -59.31 127.69 45.52 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.892 -0.594 . . . . 0.0 113.196 -178.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.736 ' HG3' ' HA ' ' A' ' 8' ' ' CYS . 5.5 pt-20 -126.49 35.41 4.65 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.259 0.466 . . . . 0.0 112.259 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.591 ' O ' ' HE2' ' A' ' 12' ' ' LYS . 22.9 m -63.11 102.66 0.4 Allowed 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 47.8 t0 -170.68 123.64 0.59 Allowed Pre-proline 0 C--N 1.327 -0.412 0 C-N-CA 121.085 -0.246 . . . . 0.0 110.936 -178.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 30' ' ' ASP . 9.7 Cg_exo -71.43 -6.42 19.12 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.974 2.45 . . . . 0.0 112.048 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.5 tpt180 -58.19 -43.41 87.55 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.142 -179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.03 144.05 27.19 Favored Pre-proline 0 C--N 1.325 -0.46 0 C-N-CA 121.019 -0.272 . . . . 0.0 110.499 179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -70.22 65.83 2.06 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 123.206 2.604 . . . . 0.0 113.532 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 53.7 mtmt -140.89 132.0 26.32 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.325 179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -90.36 139.29 30.8 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.224 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 38' ' ' PRO . 96.3 m -88.35 116.1 65.25 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-O 120.998 0.428 . . . . 0.0 110.854 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 37' ' ' CYS . 2.8 Cg_exo -75.62 137.59 20.56 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.12 2.546 . . . . 0.0 111.764 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.524 ' O ' ' HD3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -73.84 -28.88 61.82 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.732 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -67.64 139.22 56.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.209 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -78.51 142.54 37.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.677 179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.515 ' HB3' ' HG2' ' A' ' 44' ' ' ARG . 22.5 m-20 -78.82 129.87 72.21 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.207 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 42' ' ' ASP . 7.5 Cg_exo -71.92 56.23 2.4 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.6 2.867 . . . . 0.0 110.574 178.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 18' ' ' SER . 33.3 ptt180 -167.11 -31.65 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.5 -178.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.825 HG13 ' HA ' ' A' ' 6' ' ' ASN . 33.2 mm -73.62 102.76 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.418 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.421 ' HB1' HH11 ' A' ' 2' ' ' ARG . . . -97.86 -40.49 8.49 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.576 -179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 17' ' ' PHE . 2.0 p90 -159.28 159.58 34.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.709 -0.223 . . . . 0.0 110.846 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.535 ' HA2' ' HA ' ' A' ' 16' ' ' TYR . . . -143.98 134.05 5.6 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.544 -0.836 . . . . 0.0 112.568 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 49' ' ' ILE . 4.4 mp -96.35 126.56 48.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' CYS . 72.8 m -95.6 143.53 26.27 Favored Pre-proline 0 C--N 1.321 -0.664 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.552 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 50' ' ' CYS . 3.6 Cg_exo -75.73 52.94 3.48 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.994 2.463 . . . . 0.0 111.814 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 51.9 tp -161.92 -42.18 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.406 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.34 0 CA-C-O 117.521 -1.228 . . . . 0.0 108.91 179.566 . . . . . . . . 0 0 . 1 stop_ save_